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This study aimed to identify and characterize meat-based allergens and also to 
elucidate the underlining reasons for the observed paradox of high abundance of IgE-
binding to meats antigens in sera of allergic patients but no clinical presentation to these 
antigens. 
Our study based on an dot-blot immunoarray showed that the frequency of IgE 
binding to 3 commonly consumed meat is especially high in 1096 allergic patients’s sera 
[pork 46% (504/1096), beef 39% (428/1096), mutton 37% (403/1096) ]. Cross-inhibition 
ELISA showed that these meats are cross-reactive. In order to Identify and characterize 
the meat-based allergens, a dual bioinformatics and proteomics approach was employed.  
For the bioinformatics approach, allergenicity prediction was achieved by 
subjecting Unigenes sequences from cow, pig, chicken, trout, goat, sheep, cat and dog to 
both BLASTx algorithm and motif-based prediction. Many significant hits were found and 
many of these putative allergens (namely heat shock proteins, tropomyosins, aldehyde 
dehydrogenases, enolases and albumins) were similar across the species. The similarities 
seem to imply that there is a potential for cross-reactivity among these animal species. 
Additionally, nine of these putative allergens from cow and pig were cloned and expressed as 
recombinant proteins. However, they showed weak IgE-binding using patients’ sera on the 
immunoarray. This could be attributed to the lack of post-translational modifications or 
incorrect folding of the protein. 
 The proteomics approach involved separation of protein extracts from cow, pig 
and goat by both 1D and 2D electrophoresis followed by immunoblotting using sera from 
meat-allergic patients. IgE-binding protein spots were excised and analyzed by MALDI-
 xv
TOF-TOF mass spectrometry. A total of 58 spots were identified and many of which 
were similar to those predicted as putative allergens in the bioinformatics approach.   
 Despite presence of high levels of meat specific IgEs, only 2 out of 18 patients 
tested via SPT were beef-positive. This indicates that the high levels of IgE may not have 
clinical relevance as they are unable to elicit in vivo histamine release. We hypothesized 
that the lack of clinical relevance was due to unspecific IgEs binding to CCDs in meat 
sources and/or in vivo IgG blocking of histamine release resulting in negative SPTs. In 
the CCD study, the crude meat extracts from beef and pork were deglycosylated and IgE-
binding reactivity was validated by ELISA and immunoblots. Indeed, there was 
significant reduction in IgE-binding in deglycosylated samples suggesting that majority 
of the IgEs were binding to carbohydrate moieties.  In the IgG blocking study, 25 patients 
with high IgE-binding to meats were shown to have significantly higher levels of meat 
specific IgG on the immunoarray. PBMCs, from two patients with both high IgE and IgG 
to meats, co-incubated with plasma (IgG depleted) and meat extracts were able to elicit 
histamine release which was not seen in the non-depleted IgG plasma suggesting the 
presence of blocking IgG inhibit histamine release. 
 In conclusion, the high IgE-binding to meat extracts is mainly due to presence of 
mammalian cross-reactive carbohydrate determinants (CCDs). Negative SPT is due to 
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Figure 8 2-DE separation of O. aries (goat) proteins.  O. aries meat  94 
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sample buffer before 2-D PAGE. First dimension: pH 3 – 10 NL;  
second dimension: 12% SDS-PAGE gel. Protein spots were  
visualized by Coomaisse blue staining. Isoelectric points and  
molecular weight (kDa) are indicated at the top and on the left  
side, respectively. An arrow with numeral indicates an IgE-binding  
spot identified by MALDI-TOF-TOF mass spectrometry 
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Figure 1 Nucleotide and deduced amino acid sequence of Tropo 1.  125 
The predicted initiation Met start and stop codon (TAA) is in  
red. Highlighted in yellow are the forward and reverse primer  
sequences. Highlighted in green are likely regions of tropomyosin  
IgE-binding epitopes based on previously known epitopes.  
Underlined is the tropomyosin signature at amino acid position  
232 – 240. 
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Figure 2 Nucleotide and deduced amino acid sequence of Tropo 3.  126 
The predicted initiation Met start and stop codon (TAG) is in  
red. Highlighted in yellow are the forward and reverse primer  
sequences. Highlighted in green are likely regions of tropomyosin  
IgE-binding epitopes based on previously known epitopes.  
Underlined is the tropomyosin signature at amino acid position  
196 – 204. 
 
Figure 3 Multiple sequence alignments between Tropo 1 and Tropo 3.  127 
Amino acid with 100% identity colored in black and more than  
50% homology colored in blue. Dots have been introduced to  
maximize the alignments. 
 
Figure 4 Molecular cloning of Tropo 1. (A) RNA extraction: Agarose  128 
(1%) gel showing the total RNA extraction of meat from  
Sus scrofa using Trizol reagent in Lane 1. Distinct double bands  
were observed indicating integrity of the 28s and 18s RNA,  
however, there was an accumulation of 5S RNA. Nevertheless,  
the RNA was used for cDNA synthesis. (B) PCR amplification  
of target tropomyosin gene with gene specific primers using  
Expand long-template Taq DNA polymerase. Amplicons in Lane 1  
and 2 corresponds to correct expected size of ~900 bp. PCR  
amplicons from both lanes were extracted and purified using QIA 
quick Gel extraction Kit (Qiagen) and ligated to pGEMT-Easy  
vector followed by transformation into XL-1 blue non-expression  
host. (C) Colony screening of PCR inserts in pGEMT vector  
using SP6 and T7 primers: A total of 10 colonies were screened  
for insert. Only five lanes were showed here (Lane: 1 to 5). Only 5  
out of 10 clones showed the presence of insert with expected  
size of ~900 bp. (D): PCR amplification of target gene from  
pGEM-T plasmids with correct insert using designed LIC 
primer adaptors. Purified pGEM-T plasmid from clone 1 (Lane 1  
of Fig C) was used. The PCR amplified band was gel extracted,  
and purified. The final digested DNA fragment was ligated into  
pET-32a (+) expression vector (Novagen, USA) using T4 DNA  
ligase (Invitrogen, USA) and transformed into XL1-Blue  
non-expression host cell. (E): Colony screening of pET32a  
ligated insert in transformed XL 1-blue non-expression host  
strain using LIC primers. Lane 1 to 5 corresponds to 5 clones  
chosen with the correct size of insert. (F): Sub cloning of ligated  
Pet Vector plasmid into BL-21 (DE3) (Novagen, USA)  
expression host. Again, colony screening was performed  
(lane 1 to 5). The clones were subsequently sequenced from  
both ends to check for correct reading frame. Clone 2 and Clone  
4 were selected for protein expression. Glycerol stocks were made  
from those clones that were used for expression. 
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Figure 5 Nucleotide and deduced amino acid sequence of TRNT.   130 
 The predicted initiation Met start and stop codon (TAG) is  
 in red. Highlighted in yellow are the forward and reverse  
 primer sequences. Highlighted in red is the predicted  
 N-glycosylation site 
 
Figure 6 Multiple sequence alignments between TRNT, Bla g 6,   132 
Bet v 3, Bos d 3 and Ole e 3. Amino acid with 100% identity  
colored in black, 75% homology colored in pink and 50%  
homology colored in blue... Dots have been introduced to  
maximize the alignments 
 
Figure 7 Nucleotide and deduced amino acid sequence of Myo_L.  134 
The predicted initiation Met start and stop codon (TAG) is  
in red. Highlighted in yellow are the forward and reverse  
primer sequences. Highlighted in red are the predicted  
N-glycosylation sites. 
 
Figure 8 Nucleotide and deduced amino acid sequence of ADH.   135 
The predicted initiation Met start and stop codon (TAG) is  
in red. Highlighted in yellow are the forward and reverse  
primer sequences. Highlighted in red is the predicted  
N-glycosylation site. Underlined are the conserved glutamic  
acid site and cysteine site which are located at amino acid  
positions 268 - 275 and 296 - 307 respectively. 
 
Figure 9 Multiple sequence alignments between ADH, Alt a 10 and  138 
Cla h 3. Amino acid with 100% identity colored in black and  
more than 50% homology colored in blue. Dots have been  
introduced to maximize the alignments. 
 
Figure 10 Nucleotide and deduced amino acid sequence of ENO 1.  140 
The predicted initiation Met start and stop codon (TAG) is  
in red. Highlighted in yellow are the forward and reverse  
primer sequences. Highlighted in red are the predicted  
N-glycosylation sites. Underlined is the enolase signature at  
amino acid positions 340 – 353. 
 
Figure 11 Nucleotide and deduced amino acid sequence of pHSP70.  143 
The predicted initiation Met start and stop codon (TAG) is  
in red. Highlighted in yellow are the forward and reverse  
primer sequences. Highlighted in red are the predicted  
N-glycosylation sites. Underlined are the three heat shock  
hsp70 proteins family signatures at amino acid positions  
9 – 16, 197 – 210, and 334 – 348. 
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Figure 12 Nucleotide and deduced amino acid sequence of bHSP70.  146 
The predicted initiation Met start and stop codon (TAG) is  
in red. Highlighted in yellow are the forward and reverse  
primer sequences. Highlighted in red are the predicted  
N-glycosylation sites. Underlined are the three heat shock  
hsp70 proteins family signatures at amino acid positions  
9 – 16, 197 – 210, and 334 – 348. 
 
Figure 13 Nucleotide and deduced amino acid sequence of HSP90.  149 
The predicted initiation Met start and stop codon (TAG) is  
in red. Highlighted in yellow are the forward and reverse  
primer sequences. Highlighted in red are the predicted  
N-glycosylation sites. Underlined is the heat shock hsp90  
proteins family signature at amino acid positions 38 – 47. 
 
Figure 14 SDS-PAGE analyses of expression (A) and purification (B)  153 
of the recombinant allergens. 
 
Figure 15 Recombinant proteins immunoarray plate format and   155 
immunodot blots. (A) The plate format of the recombinant  
immunoarray where highlighted in blue, yellow and green are  
the controls, crude proteins and recombinant proteins  
respectively. (B) An example of the immunodot blots labeled 
+ve sera, -ve sera and blank (secondary antibody only). Dots  
in purple indicate positive IgE-binding.  
 





Figure 1 Protein separation of non-deglycosylated and    163 
deglycosylated pork and beef crude extracts. M: marker;  
ND: non-deglycosylated; N: deglycosylated. Indicated in  
arrows are bands or regions with noticeable changes before  
and after deglycosylation. 
 
Figure 2 Immunodetection after SDS-PAGE of pork (A) and   165 
beef (B) extracts (non-deglycosylated and deglycosylated)  
with patients’ sera. M: marker; ND: non-deglycosylated; N: 
deglycosylated. In both blots, membranes 1 – 7 were IgE  
immunoblots using 7 patients’ sera. Membranes 8 were  





Figure 3 ELISA validation of IgE-binding for non-deglycosylated  166 
and deglycosylated pork extract with patients’ sera. 
 
Figure 4 Correlation bi-plots between meat antigens (pig and cow)  168 
and CCDs markers (bromelain and horseradish peroxidase). 




Figure 1 Typical diagram showing Ficoll- Hypaque separation of  174 
whole blood sample. Samples are separated based on density 
after centrifugation 
 
Figure 2 Principle of the histamine enzyme immunoassay (EIA) kit.        176    
 
Figure 3 Comparison between levels of meat specific IgEs and IgGs.  178 
A total of 25 sera were screened for meat specific IgG  
antibodies. (Conversion for IgE is 1 IU = 2.4ng/protein; for  
IgG is 1 IU = 0.8147 mg). The difference in magnitude between  
IgG and IgE is more than 10000 times. 
 
Figure 4 SDS-PAGE of plasma and IgG depleted plasma from two  180 
patients. Lane 1: marker; Lane 2: Patient 1 IgG depleted  
plasma; Lane 3: Patient 1 plasma; Lane 4: Patient 2 IgG  
depleted plasma; Lane 5: Patient 2 plasma. Boxed region  
indicates the removal of IgG between 140 – 170 kDa when  
compared to non-IgG depleted plasma. 
 
Figure 5 ELISA confirmation of IgG removal from plasma samples 180 
 
Figure 6 Histamine release from PBMCs induced by either pork   182 
or beef extracts from two patients (P1 and P2). PBMCs  
were co-incubated with plasma (blue bars) or IgG depleted  
plasma (red bars). (A) Histamine release induced by beef extract  
with P1 plasma. (B) Histamine release induced by beef extract  
with P2 plasma. (C) Histamine release induced by pork extract  
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Meat allergy and the allergenic components: Underlining reasons for the absence of 
clinical presentation to meat antigens despite the presence of high levels of specific 
IgE  
 
Little is known about meat allergy and the allergenic components involved. Using a dot-
blot immunoarray, we showed high IgE-binding frequency to beef (8%), pork (12%) and 
mutton (5%) in 1096 allergic patients’ sera tested. High degree of cross-reactivity 
between the meat antigens was observed with inhibition ELISA. Identification and 
characterization of meat-based allergens were achieved using a dual bioinformatics 
(allergenicity prediction based on allergen-motif or sequence homology) and proteomics 
(2D electrophoresis and mass spectrometry) approach. Bioinformatics approach predicted 
252 distinct putative allergens from six animal species whereas proteomics approach 
identified 56 IgE-reactive proteins from beef, pork and mutton. Despite presence of high 
levels of meat specific IgEs, only 2 out of 18 patients tested via SPT were beef-positive. 
The high IgE-binding to meat extracts is mainly due to presence of mammalian cross-
reactive carbohydrate determinants (CCDs). Negative SPT is due to presence of 
“blocking” IgG antibodies which inhibits histamine release. 
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CHAPTER 1: INTRODUCTION 
 
1.1 ALLERGY 
1.1.1 Basic concepts of allergy 
 
The word “allergy” actually derived from Greek, meaning “altered reactivity” (Arshad, 
2002). The term allergy was first coined by Clemens von Pirquet in 1906 to distinguish 
between beneficial and harmful immune reactions (Roecken et al., 2004). However, 
allergy is a word that is as often misused as it is used correctly.  Many people will assume 
all intolerance reactions, such as allergic, pseudoallergic, idiosyncratic, or toxic, are 
allergic reactions. Today one defines allergy as an inappropriate and harmful immune 
response against exogenous substances (allergens), which are normally harmless (Arshad, 
2002). The chief actor in an allergic reaction to an allergen is the acquired, specific 
immune response. The initial exposure with a potential allergen may lead to sensitization 
of the exposed entity without producing any clinical symptoms. Antigen-specific 
lymphocytes and antibodies are produced. When the individual is exposed to the antigen 




Hypersensitivity is the abnormal or exaggerated response of the immune system, 
resulting in cellular and tissue damage (Arshad, 2002). Four or five types of 
hypersensitivity are often described. The four types of hypersensitivity reaction (Type I, 
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II, III, and IV) were expounded by Gell and Coombs (Gell and Coombs, 1963). Type V 
hypersensitivity (often used in Britain); termed “stimulatory” was later added to 
distinguish from Type II. The different types of hypersensitivity are not mutually 
exclusive as more than one type of immune response is often involved in 
hypersensitivity. 
 
1.1.3 Mechanism of Allergy – Type I (immediate) hypersensitivity 
 
The term “allergy” is basically used to refer to a type I immediate hypersensitivity 
reaction (Roitt et al., 1998). IgE antibodies mediate this reaction.  
 
Antigens (or allergens) enter the body through the respiratory and gastrointestinal mucosa 
and the skin. Subsequently, the antigen-presenting cells (APCs) engulf the antigens and, 
after processing, present these to the naïve T cells (Th0). In non-atopic individuals, this 
process will mount a low-grade immunological response and produce allergen specific IgG1 
and IgG4 antibodies (Kemeny et al., 1989). Their T cells respond to the antigen with a modest 
degree of proliferation and production of IFN-γ that is typical of Th1 cells (Romagnani, 1991; 
Ebner et al., 1995; Till et al., 1997). In atopic individuals, this process stimulates the 
production of Th2 cells, which then secrete cytokines, IL-4 and IL-13. These cytokines 
cause proliferation and switching of B cells to IgE-producing B and plasma cells, specific 
to the antigen (Pene et al., 1988; Finkelman et al., 1988; 
Punnonen et al., 1993; Emson et al., 1998). Some of these cells have a long life and are 
called memory cells. The IgE circulates in the blood in small quantities but mostly 
present in the tissues bound to high-affinity receptors (FcεR1) on the surface of mast cells 
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and low-affinity receptors (FcεR2) on eosinophils, macrophages and platelets (Roitt et 
al., 1998).  
 
Upon re-exposure to allergen, cross-linking of allergen specific IgE occurs. This early 
response causes mast cell degranulation and the secretion of mediators such as histamine, 
tryptase, heparin, prostaglandins, leukotrienes, and bradykinin (Kinet, 1999). These 
mediators cause vascular dilation, increased permeability and attract cells into the tissues, 
thus leading to inflammation. The symptoms of immediate hypersensitivity reactions include 
erythema and urticaria on the skin, coughing, wheezing, sneezing, rhinorrhea, blocked nose, 
watery eyes, and more serious conditions such as asthma and anaphylaxis. 
 
The late response takes place a few hours after the allergen exposure. Eosinophils are the 
most important cells at this stage but lymphocytes, mononuclear cells and neutrophils are 
also involved. Mast cells, lymphocytes and eosinophils secrete IL-3, IL-5, granulocyte-
macrophage colony-stimulating factor (GM-CSF) and chemokines to promote eosinophils 
proliferation, activiation and survivial (Arshad, 2002). Upon activation, eosinophils 
release pre-formed and newly synthesized mediators such as eosinophilic cationic protein 
(ECP), major basic protein (MBP), leukotrienes and prostaglandins to enhance 







1.2 Food allergy 
 
Recently, the World Allergy Organization (WAO) created a Nomenclature Review 
Committee to review the European Academy of Allergology and Clinical Immunology 
(EAACI) Nomenclature Position Statement (NPS) and to present a globally acceptable 
nomenclature for the field of allergy (Johansson et al., 2004). The appropriate term for 
food allergy is when immunologic mechanisms have been demonstrated. If IgE is 
involved in the reaction, the term IgE-mediated food allergy is appropriate. All other 
reactions should be referred to as non-allergic food hypersensitivity (Bruijnzeel-Koomen 
et al., 1995; Ortolani et al., 1999) 
 
Food allergy is a major public health issue and it is among the most frequent health 
complaints of our time. Up to 8% of children and 2% of adults in westernized countries 
suffer from allergic reactions against various foods (Beyer and Teuber, 2004). Children 
with atopic disorders tend to have a higher prevalence of food allergy; about 35% of 
children with moderate to severe atopic dermatitis have IgE-mediated food allergy 
(Eigenmann et al., 1998) and about 6% of children with asthma have food-induced 
wheezing (Novembre et al., 1988). There is limited data on food allergy in Singapore, but 
in a questionnaire survey done by schoolchildren in 1997 estimated the prevalence to be 
of 4 – 5% (Hill et al., 1999) 
 
Food allergy is a malfunction of the immune system in response to dietary antigens 
(Beyer and Teuber, 2004). It develops in genetically predisposed individuals when oral 
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tolerance fails to develop normally or break down (Sampson, 2003). The underlying 
immunologic mechanisms involved in oral tolerance induction have not been fully 
elucidated, but recent studies suggest that various antigen-presenting cells, especially 
intestinal epithelial cells and various dendritic cells, and regulatory T cells play a central 
role (Mowat, 2003). 
 
1.2.1 Food allergens 
 
Although hundreds of different foods are a part of the human diet, only a small number 
account for the vast majority of food allergic reactions. In young children, milk, eggs, 
peanuts, soybeans and wheat account for approximately 90% of hypersensitivity 
reactions whereas, in adults, peanuts, fish, shellfish and tree nuts account for 
approximately 85% of reactions (Krishna et al., 2001). Recently, due to the increased 
accessibility of fresh fruits and vegetables from various part of the world, there are more 
reported cases of allergic reaction to fruits (e.g. kiwi, apple, peach and pear) and 
vegetables (e.g. celery, carrot and lettuce) (Crespo and Rodriguez, 2003). The regional 
dietary habits and methods of food preparation also play a role in the prevalence of 
specific food allergies in various countries (Sampson, 2004). Processing of food may 
weaken or enhance allergenicity. For example, in the case of peanut allergy, dry roasting 
(180°C) of peanut have been shown to increase the allergenicity of peanut proteins 
(Maleki et al., 2000; Beyer et al., 2001; Maleki et al., 2003; Chung et al., 2003). Cross-
reactivity is also an important issue in food allergy. However, when we talk about cross-
reactivity, we have to distinguish sensitization from symptom elicitation. This is because 
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not all cross-reactive IgE antibodies give rise to clinical food allergy (Aalberse et al., 
2001, 1993; van Ree et al., 2004). Table 1 shows the pattern of cross-reactivity between 
food proteins and clinical cross-reactivity among members of plant and animal species. 
 
Table 1  
Cross-reactivity between food proteins and clinical cross-reactivity among members 





Sensitization to food allergens can occur in the gastrointestinal tract (considered 
traditional or class 1 food allergy) or as a consequence of an allergic sensitization to 
inhalant allergens (class 2 food allergy) (Breiteneder and Ebner, 2000). Food allergens 
are primarily water-soluble glycoproteins that have molecular weights ranging between 
10 to 70 kDa and generally stable to heat, acid and proteases (Sampson, 1999). As stated 
in a review by Breiteneder and Radauer, as more allergenic proteins are being identified, 
isolated, and characterized, it has become apparent that similar types of animal and plant 
proteins make up the vast majority of food allergens (Breiteneder and Radauer, 2004). 
 
1.3 Meat allergy 
 
Meat is a main source of proteins in western diets and it is an important food for children 
as its high content of polyamines is involved in the development of children’s 
gastrointestinal mucosa (Johnson, 1987). However, meat allergy has long been 
considered a rare pathology, occurring mainly in children (Restani et al., 1997). As the 
number of studies regarding the nature, epidemiology, and symptoms of meat allergy 
increases, it clearly indicates that current situations on meat allergy are under-reported 
and it may not be so rare. The prevalence of beef allergy ranges from 3% to 6.5% among 
children with atopic dermatitis and can be up to 20% in cow milk allergic children 
(Besler et al., 2001). Several studies reported an incidence of 1-2% of food induced 
anaphylactic reactions cause by ingestion of beef (Kanny et al., 1998; Biedermann et al., 
1999). Reports of allergy to pork are relatively rare. Challenge proven allergy to pork 
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meat ranges from 0.6% to 2.6% in food allergic individuals (Besler et al., 2001). Also, 
several anaphylactic and fatal reactions have been described (Pavel and Comanescu, 
1969; Wüthrich, 1996; Llatser et al., 1998; Drouet et al., 2001). Prevalence for lamb 
allergy has not been reported but anaphylactic reaction has been reported (Welt et al., 
2005). Cross-reactivity among various meats has also been reported (Fiocchi et al., 1995; 
Restani et al., 1997; Restani et al., 2002; Mamikoglu, 2005). Studies on pork meat 
allergy have revealed a high frequency of concomitant allergy to cat epithelium (pork-cat 
syndrome) (Drouet and Sabbah, 1996). Further investigations showed that serum albumin 
is the common allergen and that the frequency of sensitization among cat-allergic patients 
was 14% to 23% for cat serum albumin and 3% to 10% for pig serum albumin (Hilger et 
al., 1997). Immunoglobulins are also involved in cross-reactivity between meats from 
different animal species and in milk/meat co-sensitization (Ayuso et al., 2000; Belser et 
al., 2001b; Restani, 2002). The high degree of structural similarity between albumins and 
immunoglobulins suggests that patients sensitized by one species are likely to react to 
several different animal meats and epithelia (Mamikoglu, 2005).  
 
1.3.1 Meat-based allergens   
 
Currently, only limited information exists on meat allergens and their IgE-binding 
patterns in meat-allergic patients. The allergens are usually divided into specific groups 
based on their biochemical composition, sequence homology and molecular weight. The 
classification is based on the system of nomenclature as recommended by the World Health 
Organization/International Union of Immunological Societies (WHO/IUIS). The first three 
letters denotes the genus, followed by the first letter of the species name and an Arabic 
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numeral. The Arabic numeral indicates the chronological order in which the allergen was 
isolated. For example, Gal d 1 is first isolated from Gallus domesticus (chicken). Allergens 
from different species of the same or different genus which share the common 
biochemical properties are usually considered to belong to the same group (WHO/IUS, 
1994). However, the nomenclature for animal allergens is not well classified and 
established. Currently, very few animal meat-based allergens has been designated under 
the WHO/IUIS system of nomenclature. Only seven allergens from Bos 
taurus/domesticus (beef) have been listed (Table 2) and none from Sus scrofa (pork) and 
Ovis aries (mutton). 
 
Table 2 
Known allergen from Bos taurus listed on WHO/IUIS nomenclature system 
 
Species name Allergen name Biochemical ID or obsolete name MW kDa 
Bos taurus Bos d 2 Ag3, lipocalin 20
Bos d 3 Ca-binding S100 hom. 11
Bos d 4 alpha-lactalbumin 14.2
Bos d 5 beta-lactoglobulin 18.3
Bos d 6 serum albumin 67
Bos d 7 immunoglobulin 160
Bos d 8 caseins 20-30  
 
Most of the cases of meat allergy are due to bovine serum albumin (BSA) (Bos d 6) 
sensitization, as demonstrated by double blind placebo-controlled food challenges 
(DBPCFC) (Fuentes et al., 2004). This protein has been described as one of the most 
important allergens in beef and it is also one of the most widely studied and applied 
protein in biochemistry (Werfel et al., 1997; Tanabe et al., 2002). Its complete amino 
acid sequence and three-dimensional conformation has been determined (Hirayama et al., 
 10
1990; Holowachuk et al., 1991). The tertiary structure is made up of three domains, I, II, 
and III (1 – 190, 191 – 382, and 383 – 581) and it consists of nine separate disulfide-
bonded loops connected by peptide links of 11 – 26 residues (Brown, 1975; Brown, 1977; 
Peter et al., 1977). This tertiary structure and repeating pattern of disulfides is conserved 
among serum albumins from other species including human (Gelamo and Tabak, 2000). 
Tanabe et al. has observed nine IgE-binding epitopes and three T-cell epitopes that were 
found to induce T cell proliferation (Tanabe et al., 2002).  
 
Besides BSA, another major cross-reactive beef allergen is bovine gamma globulin 
(BGG) particularly the immunoglobulin G (IgG) (Bos d 7). This 160 kDa protein was 
detected in raw beef as an allergen in 83% of beef-allergic patients tested (Ayuso et al., 
2000). BGG is heat stable at 60°C but show reduced antigenicity at 100°C (Han, et al., 
2002). This is because heat treatment at 100°C results in heat-coagulation (precipitation) 
of the beef extract. Nevertheless, the precipitate is still able to induce IgE-binding with 
patients’ sera indicating the persistent antigenicity of the allergen (Han et al., 2002).  
 
There are also other meat-based proteins that have been reported in literatures but not 
listed under WHO/IUS. Among the muscle proteins, tropomyosin was found to be a weak 
meat allergen (Ayuso et al., 1999). Other beef proteins that appear to be allergenic are 
actin and the heat resistant myoglobin (Restani et al., 1997; Fuentes et al., 2004). For 
pork meat, allergens at molecular weights 67, 65, 51, 45, 43, 41, 40, 31, and 28 – 30 kDa 
have been reports in several literatures (Sabbah et al., 1994a; Sabbah et al., 1994b; Asero 
et al., 1997; Llatser et al., 1998; Benito et al., 2002; Atanaskovic-Marković et al., 2002). 
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Similarly, for chicken meat, allergens at molecular weights 150, 66, 50, 45, 33, 31, 28, 
27, 24, 23, 21, 20, 17, and 13 kDa have been reported (Cahen et al., 1998; Ayuso et al., 
1999).  
 
1.4 Trends in meat-based allergies 
 
In the 1980s, few reports in the literature had described hypersensitivity reactions to 
meats, the allergens involved, or the actual frequency of what was perceived to be a rare 
condition. Some nutritionists have even dubbed beef “allergy-safe”, whereas others have 
included it in hypoallergenic diets (Crawford, 1980). Today, we are beginning to realize 
that meat allergy may not as infrequent as previously thought. Many studies have been 
done on bovine proteins in relationship with cow’s milk allergy. For patients who suffer 
from multiple food allergies – including many infants and children with cow’s milk 
allergy – the removal of bovine proteins from the diet may pose a cascade of nutritional 
problems and it is not supported in current opinion (Fiocchi and Restani, 2002). 
 
It has been suggested that food allergy in childhood is an altogether different entity from 
food allergy in adults or adult-onset food allergy (Fiocchi et al., 2005). Evidence also 
suggests that beef allergy may involve two modalities whereby clinical reactivity to 
bovine proteins can be acquired depending on the timing of, and/or age at, sensitization 
(Ayuso et al., 2000; Fuentes et al., 2004). The suggestion is that in childhood bovine 
serum albumin (BSA) is the major allergen, whereas in adulthood immunoglobulins and 
myoglobin may be more or as important. The natural history of bovine protein allergy 
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proves that children outgrow their clinical symptoms, whereas adults do not and, this 
would also reflect different sensitization patterns (Fiocchi et al., 2005). 
 
Diagnosis of meat allergy remains as an important issue. The golden rule for diagnosis of 
food allergy is still the food challenge-based assessments particularly the double-blind, 
placebo-controlled food challenge (DBPCFC). The diagnostic accuracy of skin prick tests 
(SPTs) in IgE-mediated adverse reactions to bovine proteins has been reviewed by 
Fiocchi et al. In the literature, the positive predictive accuracies of skin prick tests vary 
between 69% and 100% and the negative predictive accuracies between 20% to 86% for 
cow milks (Fiocchi et al., 2002b). Caution should be exercised before ascribing in vitro 
assays such as immunoblots and Pharmacia UniCAP for diagnosis of food allergy. 
Studies have shown that no signification correlation was observed between RAST-
positivities to meat and serum albumin and the diameters of wheal in skin prick tests, thus 
underlining that not all sensitizing allergens are clinically relevant (Fiocchi et al., 1995). 
The relative roles of cross-reactivity and co-sensitization also limit the scope of inference 




The purpose of this study is to elucidate the underlining reasons for the observed paradox 
of high abundance of IgE-binding to meats antigens in sera of allergic patients but no 
clinical presentation of any allergic response present to these antigens. These data are 
intended for improved meat allergy diagnosis and also better understanding of oral tolerance 
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since IgE specific against meat antigens seen to be present without any clinical relevance. 
Meat allergy may even serve as a model to understand immunotherapy in its natural form. 
 
The specific aims are: 
 
1. Determine the prevalence of detectable specific IgE to meat antigens in the local 
population using an allergen immunoarray. 
2. Evaluate the cross-reactivity among various meat sources namely pork, beef, lamb, 
chicken and rabbit. 
3. Identify and characterize meat-based allergens from pork, beef and lamb using both 
proteomics and bioinformatics approaches. 
4. Clone and express putative allergens identified in previous study and assess IgE-
binding reactivity of all the recombinant allergens via immuno-dot blot. 
5. Investigate the presence of serum IgE binding cross-reactive carbohydrate 
determinants (CCDs) in meat antigens and it effects on IgE-binding upon 
deglycosylation. 
6. Evaluate the presence of blocking IgG antibodies in plasma inhibiting histamine 











CHAPTER 2: DOT IMMUNOARRAY SYSTEM FOR 




2.1.1 Techniques in allergy diagnosis 
 
As in other medical conditions, a complete history and physical examination is 
mandatory for the diagnosis and management of patients with allergic disease. 
Demonstrating the presence of antigen-specific IgE antibodies and histamine is crucial in 
establishing the diagnosis of allergic disease. There are various in vivo and in vitro 
diagnostic tests for confirming an allergic disease and identifying the allergen. 
 
There are many in vivo diagnostic tests available, for instance, skin prick test (SPT), 
prick-puncture test, modified prick test, prick-prick test, patch test, and intradermal test. 
Skin prick test is the most preferred method as it is quick, reliable, convenient and safe. 
Intradermal test although being more sensitive than skin prick test, is prone to false-
positive reactions and anaphylaxis may occur. The mechanism of these in vivo tests 
requires the allergen, when introduced into the skin, to react with the IgE antibodies 
bound to the mast cells and release histamine. The histamine induces wheal and erythema 
formation on the skin. The size of the reaction depends on the degree of sensitization, 
amount of standardized allergen injected, number and releasability of mast cells and the 
reactivity of dermal tissue to histamine. Skin prick test is regarded as positive when the 
wheal size (mean wheal diameter) is at least 3 mm, with a positive control of >3 mm, in 
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the absence of a reaction to negative control. Reactions are then scored from 0 to 4+ 
based on wheal and erythema size and the presence of pseudopodia. 
 
The most commonly used in vitro laboratory tests for diagnosis of allergic diseases are 
measurements of total or specific IgE antibodies. Immunoassay, using solid phase such as 
tube, sponges, beads or microtitre plate, are commonly used. These include 
radioallergosorbent (RAST), fluorescent allergosorbent (FAST), ADVIA Centaur®, 
AlaSTAT®, CARLA®, ENEA®, Hycor HY-TEC® and Pharmacia UniCAP® (Ricci et al., 
2003; Hamilton et al., 1999; Plebani et al., 1998; Nolthe and DuBuske, 1997). 
 
In in vitro immunoassays, immunosorbent matrices are utilized to bind to the allergens. 
Patient’s serum, containing unknown quantities of IgE is added, and the IgE binds to the 
allergens. A radiolabelled, fluorescence-labelled or enzyme conjugated anti-human IgE 
antibody is then added to detect the presence of IgEs. The intensity of radioactivity, 
fluorescence or colour is directly related to the concentration of IgE present in the 
patient’s serum. A standard curve is built in a parallel test with known quantities of the 
IgE antibodies to compare and quantify IgE present in the patient’s serum. 
 
2.1.2 Advantages of in vitro techniques 
 
In vitro techniques are usually employed when in vivo testing is for some reason not 
practical or possible. For instance, a patient had taken a medication that would preclude 
skin testing (e.g. antihistamines or related drugs). Or the patient suffers from extensive 
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skin disease and/or has a history of uncontrolled asthma, anaphylaxis, etc. in vitro testing, 
in these scenarios, will allow the patients to avoid coming in contact with the allergens 
thus reducing the risk of eliciting allergic reactions and the discomfort experienced 
during testing. Immunoassays are also useful when allergenic substances (e.g. latex, 
industrial chemicals) are not available as a licensed extract for in vivo testing (Dolen, 
2003).  
The in vivo tests such as food challenge and skin testing are usually applied and the 
results are usually recorded by trained and licensed clinicians and/or technician. Unlike in 
vitro testing, which do not require skilled hands, skin testing is a difficult technique and it 
requires training and experience to perform with both accuracy and consistency (Nelson, 
1994), and for interpretation of results (McCann and Ownby, 2002). Also, current 
specific IgE immunoassays are both qualitative and quantitative in nature. This provides 
additional information on the levels of specific IgE antibodies and its relevance in actual 
clinical situations. 
 
Sample usage for in vitro methods is also kept at a minimal. A single drop of serum is 
sufficient for multiple assays. With current advances in protein-chip array and allergen 
array technology, the amount of protein required per assay fall in range of pg/nl (Lebrun 
et al., 2005; Bacarese-Hamilton et al., 2005). This improvement in technology will 
greatly reduce the cost of current allergy testing. Currently, the average cost of a single in 
vitro test in Singapore ranges between S$18.00 to $25.00 (charges by the National 
University Hospital and Allergy Laboratories Pte. Ltd.) depending on the system used 
and type of allergens tested. 
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2.1.3 Limitations of in vitro techniques 
 
The limitations of in vitro techniques arise when there are discrepancies in results, the 
skin test is positive and the immunoassay is negative or vice versa. This discrepancy is 
usually thought more due to limitations of the immunoassay than to problems with skin 
testing (van der Zee et al., 1988). Immunoassays that lack sensitivity will produce many 
false negative results. Assay sensitivity can be improved by lowering the assay cutoff, but 
doing so can result in a loss of specificity (Dolen, 2003). Source materials that contain 
cross-reactive carbohydrate determinants (CCDs) with epitopes recognized by human IgE 
antibodies may produce clinically irrelevant false positive results (Mari et al., 1999; 
Foetisch et al., 2003; Ebo et al., 2004). 
Generally, specific IgE immunoassays are known for a lack of standardization (Williams 
et al., 2000; Szeinbach et al., 2001), even though there are published guidelines for assay 
design, performance, standardization, and quality assurance (Matsson, 1997). True 
standardization is probably not possible because of varying sources for raw allergenic 
materials (Dolen, 1995), differing methods for binding allergen to a detection matrix, and 
different detection systems. However, this can be overcome by implementing strict 
quality control measures such as incorporation of various positive and negative controls 
with repeats. Also, the anti-human IgE antibody used to recognize human IgE captured 







2.2 MATERIALS AND METHODS 
 
 
2.2.1 Patients and sera 
 
In total, 1096 consecutive sera from patients suspected of having allergies through 
clinical symptoms over a period of one year from 2001, were screened.  All sera were 
screened in duplicate. 
 
2.2.2 Skin Prick tests (SPTs) 
 
SPT tests: All tests are performed in the respiratory laboratory by an experienced 
technician using commercial allergen extracts and the GreerPick skin prick test device 
(Greer Laboratories, Lenoir North Carolina) and evaluated by an experienced paediatric 
allergist. A wheal diameter of 3 mm or more in excess of the negative control was 
considered a positive test result. The allergen extracts included in our panel are 
commercially produced by Greer (Greer Laboratories, Lenoir North Carolina), except for 
the B. tropicalis extract produced by the allergy and molecular immunology laboratory, 
National University of Singapore, Singapore. Our SPT panel includes: house dust mite 
mix (D. farinae 5000 AU/ml + D. pteronyssinus 5000 AU/ml, standardised.), Blomia 
tropicalis 0.2 mg protein/ml, 50% v/v glycerol, cockroach mix (Periplaneta americana, 
Blattella germanica), mixed feathers (chicken, duck, goose), canary feathers (Serinus 
canaria), kapok seeds, Alternaria alternata, Curvularia spicifera, Cladosporium 
herbarum, Aspergillus fumigatus, Candida albicans, cat hair (standardized cat hair, Felis 
catus domesticus 10,000 BAU/ml) and dog epithelia (Canis familiaris). Grass mix (9 
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grass mix, standardised), acacia, melaleuca, beefwood (Australian pine), oil palm, mango 
blossom, sage mix and weed mix. Food protein extracts include cow’s milk, soybean, egg 
whole, egg white, peanut, sesame seed, rice, beef, pork, chicken, wheat, fish mix and 
shellfish mix. 
 
2.2.3 Dotting apparatus 
 
 
The dotting apparatus used in the allergen array consist of a 384-pin MULTI-BLOT™ 
replicator (VP386) and colony copier (VP380) from V&P Scientific (California) as well 
as single well plates (NUNC, USA).  The replicator consists of 384 solid 1.19 mm 
diameter hydrophobic pins, designed to deliver 0.1 µl of liquid onto a membrane.  The 
colony copier registers the replicator to the membrane on a single well plate for high 
density arrays by using four holes located on the rear of the copier frame.  This results in 
an array of 1536 spots on a 7.5 × 11.5 cm membrane. Figure 1 shows examples of the 
dotting apparatus and the dotted membrane. 
 
Figure 1. 
Images of the dotting apparatus (A) and the membrane dotted with allergens (B) 
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2.2.4 Support materials and washing buffers 
 
The Trans-Blot nitrocellulose membrane (Bio-Rad, USA) was used as the solid phase 
support. Dotted membranes were blocked with phosphate buffered saline (PBS) (37mM 
NaCl, 8.1mM Na2HPO4, 2.7mM KCl, 1.4mM KH2PO4, pH 7.4) containing  0.1% of 
Tween 20 (0.1 % PBS-T) by placing them on an orbital shaker. Similarly, the blocked 
membranes were washed with 0.05% PBS-T. Immunoarray tested membranes were 
scanned using conventional scanners (Hewlett-Packard).  Dot intensities on the 
membranes were then measured using the Olympus MicroImage™ image analysis 
software (Media Cybernetics, 1999) by manually setting the threshold levels of the colour 
intensities.   
 
2.2.5 Allergen extracts 
 
Skin prick extracts from ALK-Abelló S.A. (Spain) and GREER Laboratories 
Incorporated (USA) were purchased.  However, certain skin prick extracts purchased did 
not meet the minimum requirement of 0.2 mg ml-1 in total protein concentration.  Thus, 
raw materials were purchased from local markets, Greer Laboratories Incorporated and 
Allergon AB (Sweden).  Table 4.1 shows the allergens studied.  All raw materials 
including the local allergens were then homogenized using a mortal and pestle after quick 
freezing with liquid nitrogen and suspended in PBS extraction buffer for 16 hrs at 4°C.  
The extracts were then centrifuged at 15,000 g for 15 minutes at 4°C.  Supernatants were 
collected and the pellets discarded.  Total protein concentration was then determined 
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using the BioRad protein assay kit (Bio-Rad Laboratories, USA) based on the Bradford 
method (Bradford, 1976). 
 
2.2.6 Allergen immunoarray for the detection of specific IgE 
 
Allergen extracts prepared at 0.2 mg ml-1 were filled into the 384-well plates.  
Membranes 7.5 × 11.5 cm in size were then placed onto single-well plates.  Each 
membrane after dotting will consist of three replicates of a full set of allergens.  The 
actual membrane size for a set of the allergen array was approximately 2.5 × 3.8 cm. 
Protein extracts were spotted at 1µg for each allergen on Trans-Blot nitrocellulose 
membrane (Bio-Rad, USA). After drying, membranes were blocked with 0.1% PBS-T at 
room temperature for 1 hour.  After washing with 0.05% PBS-T, the membranes were 
incubated with the respective patients’ sera. A total of 150µl of serum was diluted at 1:1 
(v/v) PBS and incubated overnight at 4°C.  Membranes were then washed followed by 
incubation with goat anti-human IgE ε-chain specific alkaline phosphatase conjugated 
antibody (Sigma, USA) at 1:1000 (v/v) dilution with PBS for 2.5 hours at room 
temperature.  Washing was then performed.  The positive binding of specific IgE to 
allergen was visualised by developing with BCIP/NBT (5-bromo-4chloro-3indolyl-
phosphate / nitro-blue tetrazolium) colour substrate kit (Promega, USA) in alkaline 
phosphatase buffer (100mM Tris-HCl [pH 9.0], 150mM NaCl, 1mM MgCl.2).  The 




2.2.7 Image analysis of immunoarray blots 
 
The reaction intensities were then measured using the Olympus MicroImage image 
analysis software (Media Cybernetics, USA). The images were processed through 
multiple morphological filters before the dot intensity readings were taken (Figure 4.1).  
First, the images were eroded using a 5 × 5 circle filter for a single pass to average out the 
colour of the dots.  The dots on each membrane were then fitted onto a grid with 48 by 32 
rings each with a diameter of 6 pixels by superimposition.  Then a mask of the grid was 
created.  The mask image was then filtered with a 5 × 5-circle single pass dilation 
followed by a 5 × 5-circle single pass closing to obtain solid circles.  The logic operation 
‘AND’ was performed (1st operand = eroded array image and 2nd operand = processed 
grid mask image).  The final image, a superimposition of the processed grid image onto 
the array image, resulted in only the areas dotted with allergens is in its original colour.  
The rest of the image was black in colour.  By using the command “automatic bright 
objects” which works automatically by setting the OD range of the image using the 
colour histogram, the dots were segmented from the background. Figure 2 shows the 









2.2.8 Allergen immunoarray validation 
 
Enzyme-linked immunosorbent assay (ELISA) was used to validate the allergen array 
results.  Sera samples were randomly chosen for validation. A total of 20ug of protein in 
carbonate/bicarbonate buffer (8mM Na2CO3, 17mM NaHCO3, pH9.6) were coated 
overnight onto each well (NUNC, USA) at 4°C.  Then the wells were washed 3 times 
with 0.05% PBS-T. Blocking was carried out using 0.1% PBS-T for 1 h at room 
temperature followed by washing.  25ul of patients’ sera were then diluted 1:1 (v/v) with 
PBS and incubated in wells for overnight at 4°C.  The wells were then washed and 
incubated with goat anti-human IgE conjugated with alkaline phosphatase (Sigma, USA) 
diluted 1:1000 (v/v) with PBS for 2 hours at room temperature. The wells were then 
washed 6 times before colour substrate p-Nitrophenyl phosphate disodium salt (pNPP) 
(Sigma, USA) was added and colour intensity read at 405ηm. For competitive inhibition 
ELISA, the patients’ sera were first incubated with the inhibitors (pork, beef, lamb, 
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chicken and rabbit extracts) at concentration 0.2, 0.1, 0.05, 0.025, and 0.0125 mg/ml 
overnight at 4ºC before being added into the respective wells. 
 
2.2.9 Statistical analyses 
 
Analyses were done using SPSS 11.5 for Windows (SPSS, USA).  Two standard 
deviations (SD) above negative reactions were used as the cut off points for positive 
results.  Subsequently, 4 SD and 8 SD were used as cut off points for medium and high 
reactions respectively. All concordances were based on positive and negative reactions.  
Spearman’s Correlation Test was used for all correlation analyses. Cluster Analysis was 














2.3 Results and Discussion 
2.3.1 Skin prick test 
 
A total of 50 patients from KK Women's and Children's Hospital were recruited for skin 
prick tests. Eighteen from the 50 have shown to possess relatively high level of specific 
IgEs to meat antigens, namely to pork and beef antigens. However, only two out of the 18 
patients showed positive skin prick test to beef and none to pork. This result indicates that 
majority of the patient with high specific IgEs to meat antigen did not exhibit any clinical 
response and the presence of these meat specific IgE have no clinical relevance.  
 
2.3.2 Allergen immunoarray 
2.3.2.1 Prevalence of meat-based allergy 
 
After the analysis of all 1096 sera (with a duplicate for each) the prevalence of specific 




Figure 3.  
Prevalence of allergy to meat and other animal products. The cut-offs for low, med 
and high reactions are at 2SD, 4SD and 8SD respectively. 
 
The sensitivity profile of the 1096 allergic patients can give an idea of the trends of 
sensitization towards different meat-based antigens in the local context. In this way, further 
studies on meat allergens can be concentrated on the species that seemed to be the most 
antigenic. Because strong reactors are more likely to elicit symptoms clinically hence only 
these were considered. From Figure 3, we can gather that the most common meat-based 
allergen sources were the red meats mainly pork, beef and mutton, which have shown to 
have high IgE-binding in 12.13%, 7.94% and 4.74% of patients respectively. This was 
followed by other animal products such as milk (3.92%) and egg (0.73%). The 
prevalence of specific IgE to beef and pork we noted were close to double the prevalence 
of beef and pork allergy reported by Besler et al., 2001. This could be due to the 
differences in population studied and the experimental method administered. The 
methods employed by Besler et al. involved RAST as well as skin prick test which took 
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into consideration clinical relevance of the specific IgE, thus the prevalence in their 
framework was expected to be lower. In the case of milk and egg allergy, the prevalence 
has been reported to be between 1 – 3 %, which was similar to what we have observed in 
our immunoarray screens (Hill and Hosking, 1995; Kagan, 2003). These parallel 
observations increased the confidence and reliability of the data as they generally 
followed expected trends.  Many other allergen sources such as plants, pollens, fungi, and 
insects were tested in the allergen immunoarray panel (listed in appendix I) but were not 
discussed in this study.  
 
2.3.2.2 IgE responses to pork among individuals (Malay Muslims) who do not 
consume pork  
 
We also evaluated if pork-specific IgE could be detected among individuals who have 
never consumed nor handled pork due to their religious beliefs (Malay Muslims), and 
evaluated if the presence of pork-specific IgE in these individuals were related to cross-
reactivity of pork with other vertebrate meats.  Forty-six sera from food allergic Malay 
Muslims were tested by dot blot for specific IgE antibodies to vertebrate meats (beef, 
lamb, pork, rabbit meat and chicken), and compared to the responses of 548 non-Muslim 
food allergic subjects (Chinese, Japanese, Caucasian and others). A total of 36.9% 
(17/46) of the Malay Muslims were found to have specific IgE to pork compared to 
46.3% (259/559) among the non-Muslim (Figure 4).  
 28
 
Figure 4.  
Percentage of individuals possessing pork-specific IgE in various races. 
 
When stratified by responses to beef, 88.2% (15/17) of pork-positive Malay Muslims 
were also positive to beef (69.9%, 181/259 of the pork-positive non-Muslims were also 
positive to beef (Figure 5). This strongly indicates possible existence of cross-reactive 
allergens within the meat of these vertebrates.  
 
Noticeably the Indian population had a lower IgE-binding frequency to meat antigens. 
This could be attributed to their diet as a significant proportion of Indians were 
vegetarians thus they may have possessed lower levels of specific IgE to meat antigens. 
Another perspective to why the Indian population had a lower IgE-binding frequency to 
meat antigens may be related to the “hygiene hypothesis”. Studies have shown that 
helminth infection can have a protective effect against atopic reactivity in a various 
settings in developing countries such as India and Venezuela (Lynch et al., 1987; Braun-
Fahrlander, 2002). The helminth infection protect from allergy and asthma either through 
the saturation of Fcε receptors on mast cells and basophils (by polyclonal IgE) or by 
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induction of IgG blocking antibodies (Lau and Matricardi, 2006). These confounding 
factors may have affected the production of IgE against allergens thus preventing allergy.  
 
Figure 5.  
Venn diagrams showing number and percentages of individuals possessing pork-
specific and/or beef-specific IgE. (A) Malay Muslims and (B) other races. 
 
 
2.3.3 Allergen immunoarray validation 
2.3.3.1 Performance of allergen immunoarray in terms of duplicates 
 
All 1096 sera screened on the allergen immunoarray were done in duplicates. Intra-
membrane concordances were evaluated by comparing the duplicate dots of the same 
allergen on a single membrane while inter-membrane concordances were evaluated using 
results obtained on duplicate membranes. Table 1 shows the inter-membrane and intra 
membrane concordances for meat-based and animal product allergens on the 
immunoarray. Generally, the immunoarray showed good intra-membrane and inter-
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membrane concordances. The intra-membrane concordances ranged from 89.57 to 
96.26% while the inter-membrane concordances, from 81.10 to 90.94%. The correlations 
of intensity values between duplicate dots (intra-membrane) of two selected species, pork 
and beef, are shown in Figure 6. The Spearman’s ranked order correlation coefficient (r) 
of 0.9358 and 0.9193 respectively showed that the intra-membrane correlation of pork 
and beef are strong and there was low variance between duplicates. Similarly, for the dots 
between membranes (inter-membrane), pork and beef showed strong correlation 
coefficient at 0.6746 and 0.6887 respectively. Both good intra- and inter-membrane 




Table 1.  
Intra-membrane and inter-membrane concordances 
 
Intra-membrane Concordance (%)  Inter-membrane Concordance (%)
Allergen Positive (+/+) Negative (-/-) Total  Positive (+/+) Negative (-/-) Total 
Beef 90.57 88.48 89.57 75.18 88.03 81.10 
Pork 95.18 91.88 93.90 83.65 97.89 88.98 
Sheep  90.61 92.40 91.54 81.48 94.96 87.80 
Chicken  90.41 94.46 92.72 77.78 90.41 85.04 
Rabbit meat 95.22 92.56 94.09 76.82 93.20 83.46 
Egg white 72.12 94.80 90.16 54.35 93.75 86.61 
Egg yolk 84.15 97.18 95.08 67.50 83.18 80.71 
Milk, cow  87.15 95.14 92.32 90.82 91.03 90.94 
Milk, goat  90.67 95.24 93.50 80.37 92.52 87.40 
Ovalbumin 94.12 96.92 96.26 74.65 97.27 90.94 
Ovomucoid 77.22 97.67 94.49 79.17 82.52 81.89 






Figure 6.  






Spearman’s Correlation Test analysis was used for the correlation studies.  All plots 
shown are significantly correlated with a minimum of p = 0.05.  
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2.3.3.2 Immunoarray vs ELISA 
 
For ELISA, a total of 3 allergens namely pork, beef and lamb were tested (Table 2). 
Varying degrees of concordances for pork (75.00%), beef (78.26%) and lamb (78.95%) 
were obtained. However, Spearman’s Correlation Test for the three allergens tested 
ranged from no correlation for beef (r = 0.0596) and lamb (r = 0.0647) to moderate 
correlation for pork (r = 0.432, p < 0.05) (Figure 7). The reason for the weak correlation 
is still unknown. However, we hypothesized that it was due presence of blocking IgG in 
the sera of the patient. The presence of blocking IgG inhibited the binding of IgE to the 
antigen. For ELISA (sera/antibody in excess), the amount of sera used was much more 
compared to dot-blot (antigen in excess), thus the effects of blocking IgG antibody were 
amplified resulting in the discordance between the two techniques. The effect of blocking 
IgG will be further discussed in Chapter 7. 
 
Table 2.  
Validation results between the immunoarray method versus the ELISA system. 
 
Concordance of immunoarray versus ELISA (%) 
Allergens tested (n = 24 to 76)  + / + - / -  + / -  - / + Total 
Pork  66.66 8.33 25.00 − 75.00 
Beef  73.91 4.35 11.59 10.14 78.26 




Figure 7.  
Correlation of the ELISA versus immunoarray system. Correlation coefficient, r was 
analyzed using Spearman’s Correlation Test. p values: p = 0.05*. 
 
 
2.3.3.3 Self inhibition 
 
Self inhibition was done to remove the ambiguity that the IgE-binding is due to non-
specific binding.  In self-inhibition ELISA, the serum is inhibited with the same proteins 
that the ELISA plate is coated with. Percentage inhibition is calculated by the formula:  
 
 (OD405 of positive control – OD405)  
______________________________         X 100%  
 
        OD405 of positive control  
 
Figure 8 illustrates a concentration-dependent response was observed when positive sera 
for pork, beef and mutton were self-inhibited respectively. This shows that sera that were 
screened positive by ELISA are indeed reacting to the proteins of interest, and it is not 




Figure 8.  
Graph showing self inhibition for pork (A), beef (B) and lamb (C). The sera were 





2.3.4.1 Prediction of pattern and potential for cross-reactivity 
 
After observing the results that have been obtained, certain patterns of relationships 
among the different food can be identified. This led to the suggestion of cross reactivity 
occurring in the study, where patients were frequently found to be sensitive to not just 
one, but several food belonging to the same group, especially if the proteins in them have 
epitope similarities. 
 
To give us an idea of the food groups that would usually cross-react, a Cluster 
Analysis using the SAS statistical programme has been done (Figure 9). The dendrogram 





Figure 9.  
Dendrogram showing relationships between the allergens used (Done courtesy of Ms 
Mavis Low). 
 
It was not unexpected to see that all the red meat were clustered together and most of the 
seafood were grouped together with members of the same phyla. To take it one step 
further, a few of these patterns which suggested cross-reactivities were singled out so that 
they could be more closely analyzed. In Figure 10, the cross-reactivity potential among 
the red meats can be observed.  Patients who are allergic to pork will most likely react to 
lamb and beef as well. 
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Figure 10.  
Correlation bi-plots between pork, beef and lamb. Correlation coefficient, r was 




2.3.4.2 Validation of cross-reactivity via cross inhibition ELISA 
 
Competitive cross inhibition ELISA was done to determine whether IgE-binding was due 
to cross-reactivity or co-sensitization from the different allergen sources. Figure 11 shows 
the results of ELISA plates coated with pork and incubated with sera that were pre-
incubated with pork, beef, lamb, rabbit and chicken. The results clearly indicated that the 
three sera tested elicited a similar concentration-dependent inhibition when pre-incubated 
with pork, beef and lamb. Close to 100% inhibition could be achieved with 0.2 mg/ml of 
inhibitor proteins (beef and lamb). Additionally, pork, beef and lamb do not cross-react 
with rabbit meat and chicken (except P3 which showed slight inhibition of close to 40% 
by rabbit meat). From the steepness of the curve, we can infer that beef is probably the 
primary sensitizer because it always attended close to 100% inhibition at a lower 
concentration of inhibitors. This can also explain why the Muslims have specific IgE to 
pork because they were primarily sensitized by beef. 
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Figure 11.  
Graph showing percentage inhibition against amount of protein (micrograms) 
inhibitors. Sera from three patients were inhibited with beef, mutton, pork, chicken, and 





To further validate the cross-inhibition results, the reserve was done whereby ELISA 
plates were coated with beef and lamb and tested with P1 sera pre-incubated with the 
inhibitors mentioned above. The outcome showed similar pattern of cross-reactivity 
among pork, beef and lamb (Figure 12). This reverse ELISA demonstrated that the three 
meats are indeed cross-reactive and also showed the pattern of cross-reactivity is 
reproducible. Another point to note was that the sera did not cross-react with chicken and 
rabbit also served as a control for steric hindrance. The fact that there was still a reaction 
when the sera are incubated with chicken protein showed that the reduced signals 
observed for sera incubated with beef or lamb were not due to steric hindrance.  
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Figure 12.  
Graph showing percentage inhibition against amount of protein (micrograms) 
inhibitors. The serum from P1 was inhibited with beef, mutton, pork, chicken, and rabbit 





The dot-blot immunoarray system has been shown to be an effective screening system of 
more than 150 types of allergens in duplicate simultaneously. The amount of serum 
required is 150 µl per assay and amount is less than 1 µl of serum for each allergen 
tested. This mass screening method provided useful insights to possible cross-reactivity 
patterns that may exist. The reliability and dependability of the immunoarray were verified 
by showing: i) good intra- and inter membrane concordances and correlations; ii) the 
presence of moderate to high concentrations of specific IgE towards well-known allergenic 
species such as milk and egg; iii) good concordance between results of immunoarray and 
ELISA. In this study, specific IgEs to meat-based allergens were detected in the patients’ 
sera samples. Highest number of IgE reactivity was found in the red meats namely pork, 
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beef and mutton. Self-inhibition ELISA demonstrated that the IgE binding to the meat 
antigen is a real phenomenon. However, the low occurrences of skin prick positive to 
meat antigens in patients with high level of specific to meats suggest that presences of 
these meat specific IgEs lack clinical relevance. Cross-reactivity among meat antigens 






































3.1.1 Establishment of food safety guidelines 
 
The safety evaluation of food, especially genetically modified food has become an 
important issue. The potential allergenicity and the potency of proteins in our food 
require apprehensive assessment. There is, however, no universal and reliable test system 
for the evaluation of the allergenic potency of food products and a case-by-case approach 
is suggested (Wal, 1999). The first systematic attempt to develop a structured approach to 
assessment of the allergenic potential of novel food proteins was jointly developed by the 
International Food Biotechnology Council (IFBC) and the International Life Science 
Institute (ILSI) Allergy and Immunology Institute and published in 1996 (Metcalfe et al., 
1996). The proposed IFBC/ILSI decision tree involves a range of test procedures, for 
example, structure analysis and amino acid sequence comparison, immunosorbent assays, 
skin prick tests, food challenges, study of physical and chemical properties like digestive 
and process (heat) stability, and consideration of the amount of the protein in the foods 
and consumption patterns. In 2001, a Food and Agriculture Organization (FAO) and 
World Health Organization (WHO) expert consultation modified the IFBC/ILSI decision 




Notably, a comparison of the amino acid sequence of the novel protein with those of 
known allergens is suggested as an introductory step for transgenes without a history 
of allergy. This is because any homology between the transgenic protein and known 
allergens is regarded as a risk for potential cross-reactivity and/or immunogenicity 
(FAO/WHO, 2001). Hence, a standard method for sequence comparison has been 
defined. Briefly, a protein is considered allergenic if it shares more than 35% sequence 
similarity (window of 80 residues) or an identity of at least six contiguous amino acids 
with a known allergen (FAO/WHO, 2001). With amino acid sequence comparisons 
currently a criterion for allergenicity assessment, there is a need for specialized allergen 
databases and better bioinformatics methods that could help to classify and predict the 
allergenicity of a given protein. 
 
3.1.2 Allergen databases 
 
The number of characterized protein allergens is increasing steadily because of advances 
in genomic, proteomics, and molecular biology techniques. Hence, there is a need for 
allergy-related databases to facilitate the collection, access, and use of these data. The 
Allergen Nomenclature Sub-Committee of the International Union of Immunological 
Societies (IUIS) maintains a list of certified protein allergens (http://www.allergen.org/). 
Some 500 protein allergens and 270 isoforms had been classified, as of September 2005. 
These numbers may not be a true representation of the total as many unlisted allergens 
can be found in the literatures. Also, the database lack detailed structural and functional 
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information of the characterized allergens. Therefore, in recent years, more number of 
specialized allergy-related databases has appeared. Major allergen-related data sources 
are listed in Table. 1. The number of allergen entries varies greatly among the databases; 
they range from 140 in BIFS to 4500 in ALLALLERGY. Malandain commended that 
many of the sequences in the databases did not correspond to allergens and many were 
unproven IgE-reactive sequences either ill-defined or present as US patent data (1035, 
among them 82% had less than 40 amino acids) (Malandain, 2004). After treating 
redundancy, only 1052 different allergen sequences was found, a result corresponding 
with data stored in Allergome, the currently most carefully updated allergen database 
(Malandain, 2004). 
 
Table 1. Major allergen-related data sources 
Database URL (http://)
IUIS www.allergen.org 






Asthma & Allergy cooke.gsf.de/asthmagen/main.cfm
Allergome www.allergome.org/
Informall www.foodallergens.info/








3.1.3 Allergenicity prediction 
 
Despite the great number of presently identified allergenic proteins, it is still not known 
why only few and particular proteins provoke allergic reactions. Thus, a method for 
allergenicity prediction would be beneficial, especially to prevent the chance of 
generating new allergenic food products by biotechnology methods. Bioinformatics, 
more specifically, sequence analysis methods have an important role in the identification 
and prediction of allergenicity (Hileman et al., 2002, Gendel, 2002). Based on current 
recommendations of the FAO/WHO Expert Consultation, as outlined in the Codex 
alimentarius (FAO/WHO, 2003), two allergenicity predictive webtools namely 
Allermatch™ [http://allermatch.org] and AllerPredict 
[http://sdmc.i2r.astar.edu.sg/Templar/DB/Allergen/Predict/Predict.html] were developed. 
However, the FAO/WHO criteria have been shown to lack full predictive capability 
(Kleter and Peijnenburg, 2002; Zorzet et al., 2002; Soeria-Atmadja et al., 2004). The six 
amino-acid identity rule is not practical because it produces a large number of false 
positive hits. The criterion of having a minimum 35% sequence similarity is on the other 
hand too stringent to find most true allergens.  
 
Analyses using protein motifs emerge as an alternative method for prediction of potential 
allergenicity (Stadler and Stadler, 2003). It involves the use of motif identification tool, 
such as MEME (Bailey and Elkan, 1994) to identify allergen motif. Subsequently, a 
query protein is predicted to be allergenic if its sequence matched an allergen motif with 
a high score. Similarly, Li et al. developed a motif approach allergenicity prediction 
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system based on a novel motif detecting tool using wavelet analysis (Li et al., 2004). 
Both motif-based prediction methods claimed to have achieved more than 90% precision 
and their motif-based system is a more superior alternative to the current FAO/WHO 
method. Using the entire Swiss-Prot as the query, both groups predicted around two 
thousand potential allergens. 
 
Structural comparison of allergenic proteins can be used to predict allergenic cross-
responses (Ipsen and Lowenstein, 1997), and eventually determine possible common 
characteristics of IgE recognition (Breiteneder and Ebner, 2000; Lascombe et al., 2000; 
Midoro-Horiuti et al., 1999; Soman et al., 2000; Wellhausen et al., 1996). The web-based 
Structural Database of Allergen Proteins (SDAP) [http://fermi.utmb.edu/SDAP/], which 
is currently the most ambitious of the molecular databases, was developed for this 
purpose (Ivanciuc et al., 2002; Ivanciuc et al., 2003a; Ivanciuc et al., 2003b). In addition 
to allergen sequences and structural links, this database has implemented some unique 
search capabilities to identify B- and T-cell epitopes and assess cross-reactivity with 
accompanying references. 
Besides computational allergenicity prediction, the FAO/WHO decision tree strategy has 
also introduced animal testing the focused on the prediction of the sensitizing potential of 
novel protein (FAO/WHO, 2001). However, despite increasing research efforts in recent 
years, validated and widely accepted animal models are not available yet (Knippels and 




3.1.4 Limitation of bioinformatics allergen prediction 
 
Bioinformatics is a fast and easy method when compared with the conventional allergen 
identification methods which require tedious laborious work. However, the accuracy of 
the allergenicity prediction by primary sequence comparison depends strictly on the 
quality of the data used for comparison. Hence, databases with accurate annotations and 
correct format of the sequences are essential for the outcome of the prediction. Also, 
prediction of novel allergens other then those with sequences deposited in the databases 
is not possible. Nevertheless, bioinformatics allergen prediction serves as an initial screen 
for putative candidates whereby actual characterization of the allergens still requires 
immunochemical assays. 
 
3.1.5 Expressed Sequence Tagging in genome studies  
 
Expressed Sequence Tagging was first proposed by Adams et al. as a means to rapidly 
increase the number of available sequences for the human genome project (Adams et al., 
1991). The basic strategy involves selecting cDNA clones at random and performing a 
single, automated, sequencing read from one or both ends of their inserts. They 
introduced the term expressed sequence tag (EST) to refer to this new class of sequence, 
which is characterized by being short (typically about 400–600 bases) and relatively 
inaccurate (around 2% error). These short sequences act as gene tags for identifying each 
cDNA clone through sequence search homology (e.g. BLAST) in simple nucleotide and 
protein databases.  
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Partial sequencing of cDNAs to generate expressed sequence tags (ESTs) has been 
demonstrated to be a rapid and efficient way to establish a detailed profile of genes 
expressed in a tissue or cell type or even in an organism (Adams et al., 1991; Adams et 
al., 1993a; Adams et al., 1993b). ].  In many cases, the information from a single 
sequencing reaction has been sufficient to assign a cDNA to a gene family based on 
sequence similarity (Waterston et al., 1992; McCombie et al., 1992; Okubo et al., 1992; 
Adams et al., 1993a; Khan et al., 1999), and provide a reliable and efficient place to start 
designing experiments to characterize gene function and tissue physiology.  
In many organisms, a large part of the genome comprise of nongenic DNA such as 
repeats, pseudogenes and other non-coding sequences, which makes genome analysis 
difficult and labour-intensive.  For instance, only 3% of the human genome codes for 
proteins, the function of the rest of the genome is unclear, but much of it may have no 
function.  The easiest way to access protein coding regions is thus to sequence cDNAs.  
The EST philosophy follows the argument that by solely sequencing the most important 
protein coding region, it give the largest return of biological information per base pair 
sequenced (Adams et al., 1991; Marra et al., 1999) and it is the most cost effective. With 
EST libraries available in public databases, the rate of identification of new allergens 
could be accelerated and new findings such as homologous allergens crossing diverse 








The sheer number of EST sequences is extraordinary, indeed for most organisms much 
larger than the number of genes. A major challenge is to make putative gene assignments 
for these sequences because many of these genes are not well defined and annotated. 
Computationally, this can be thought of as a clustering problem in which the sequences 
are vertices that may be coalesced into clusters by establishing connections among them 
(Pontius et al., 2003). 
 
UniGene is an experimental system for automatically partitioning GenBank sequences 
into a non-redundant set of gene-oriented clusters. Each UniGene cluster contains 
sequences that represent a unique gene, as well as related information such as the tissue 
types in which the gene has been expressed and map location. The UniGene Web site 
allows the user to view UniGene information on a per cluster, per sequence, or per library 
basis. UniGene is also the basis for three other NCBI resources: ProtEST 
[http://www.ncbi.nlm.nih.gov/UniGene/ProtEST/], a facility for browsing protein 
similarities; Digital Differential Display (DDD) 
[http://www.ncbi.nlm.nih.gov/UniGene/ddd.cgi?], for comparison of EST-based 
expression profiles; and HomoloGene [http://www.ncbi.nlm.nih.gov/HomoloGene/], 
which provides information about putative homology relationships. Therefore, Unigene 




3.2 MATERIALS AND METHODS 
3.2.1 Data mining and content 
 
Unigenes, nucleotide and protein sequences (in cases where Unigenes sequences are not 
available) from various species of animals were downloaded from National Center of 
Biotechnology Information (NCBI). Nucleotide sequences were used for goat and sheep 
while protein sequences were used for dog and cat instead. In total, 91,612 sequences 
have been downloaded (Sus scrofa (Pig) 19,590 unigenes, Bos taurus (Cow) 17,874 
unigenes, Gallus gallus (Chicken) 8,834 unigenes, Oncorhynchus mykiss (Trout) 13,156 
unigenes, Ovis aries (Sheep) 21,106 nucleotide sequences, Canis familiaris (Dog) 3,415 
protein sequences, Capra hircus (Goat) 2,476 nucleotide sequences, and Felis domesticus 
(cat) 5,161 protein sequences). 
 
3.2.2 Analysis of Sequence Similarity (Method 1) 
 
The flowchart in Figure 1 describes the method that was used for allergenicity prediction. 
The search method corresponds with FAO/WHO guidelines described above with more 
stringent cutoffs. Basically, a sequence homology search using BLASTX (Claverie, 
1992) with default parameters (matrix = Blosum 62, Gap open = 11, Gap extend = 1) 
against NCBI nr datadase was carried. This was done courtesy of Miss Lim Yun Ping 
from Singapore Biomedical Computing Resource (SBCR), Bioinformatics Institute (BII). 
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The BLAST output was manually inspected for matches holding the text “allergen” in the 
annotations. The results were then ranked according to their bit scores and E-values. If 
the alignment resulted in scores with bit scores above 100 and E-values less than a 
threshold of 1e -4, the query sequence is predicted to be allergenic. 
 
           
 
Figure 1.  







3.2.3 Allergenicity prediction using wavelet transform (Method 2) 
 
This was done courtesy of Dr Li Kuo Bin according to Li et al., 2004. Briefly, a reference 
database of 664 allergen proteins was constructed by searching four allergen-specific 
databases (IUIS, Swiss-Prot’s Allergen index, BIFS, and FARRP). Subsequently, 
clustering of these proteins into groups was done using ClustalW, PAM and T-Coffee 
software. Conserved motifs for each cluster were predicted using wavelet method and a 
profile for each predicted motif was built using HMMER package. Finally, putative 
allergens were predicted using HMMER and BLASTP based on a scoring system. 
 
3.2.4 Cataloging of BLAST output into functional categories 
 
For sequences with significant identities, a catalogue classifying them according to their 
putative biological functions was made. The categories in this catalogue were created 
based on the Mark Adam’s (1993a) classification of human brain cDNA library with 
minor modifications. These categories are: cell signaling, general metabolism, 
homeostasis, structural protein, chaperone/stress-related protein, protein synthesis, 







3.3 Results and Discussion 
3.3.1 Allergen prediction based on sequence homology 
 
The first main result of the work reported here is the analysis of the massive blast output 
of 91,612 sequences for homologues to know allergens. Careful evaluation was required 
to produce a thorough and accurate list of putative allergen for each species therefore 
substantial effort was put into this work. The arbitrary cut off values of bit scores above 
100 and E-values less than a threshold of 1e -4 were required to reduce the number of 
false positive. The number of putative allergens predicted based on sequence homology 
for each species is listed in Table 2. The actual list of sequence homology matches for 
each species with query description, subject description, bit score, E-value and region of 
amino acid homology is attached in appendix II - VIX.  From this result, we can deduce 
that the percentage of sequences that matched allergenic components fluctuate between 1 
– 2 % for each species (Figure 2) suggesting that the number of allergenic components 
within each species saturate around 2% of its genome. Previous EST libraries studies 
done on house dust mites have shown that allergenic components made up 4 to 6 percent 
of their genome (Ong, 2003). The percentage estimated using EST library was expected 
to be higher because the library consisted of multiple copies of the same genes whereby 
in our study we employed unique copy genes (unigenes) which significantly reduced the 









No. of putative allergens predicted for each species of animal based on sequence 
homology. 
 









Goat 25  
 
           
Figure 2.  
Relationship between the total numbers of Unigene, nucleotide or protein sequences 
used for each species (bars) and the percentage of these sequences that match 
allergens (lines). 
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3.3.1.1 Matched allergen profiles of the seven animal species 
 
 
Table 3 shows the type of plant, fungal, insect and animal allergen-homologues within 
the allergen homologous Unigene sequences. Majority of the unigenes were homologous 
to allergens from animal and insect. This was expected since the unigenes used were 
themselves of animal origin. In contrast, the unigenes homologous to allergens from plant 
origin was much lower. This illustrates the vast difference in allergen-type found between 
plants and animals hence suggesting that plant food allergens and animal food allergens 
are less likely cross-reactive.  Fungal allergens represented a significant proportion 
among the allergen-homologous unigenes found. They were mainly stress-related and 
metabolic proteins such as heat shock proteins, dehydrogenases, superoxide dismutases, 
thioedoxin, etc. There proteins were evolutionary highly conserved thus they were found 
in almost all the seven species of animal and most likely cross-reactive. Among the 
homologous insect and animal allergens, the most commonly found were tropomyosins, 
serum albumin, beta-lactoglobulin, alpha-lactalbumin, egg white proteins, phospholipase 
and dust mite proteins (Group 3, 8 and 13). These proteins were again highly conserved 




Unigenes of pig, cow, chicken, goat, sheep, dog, and cat found to be significantly homologous to allergens 
from various organisms. Ticks indicate the presence of allergen-homologous unigenes (not named) within the animal species. 
 
ALLERGEN TYPE ALLERGEN HOMOLOGUE EXAMPLES PIG COW CHICKEN GOAT SHEEP DOG CAT
Plant
Actinidain Act c 1 9 9 9 9
Calcium-binding allergen Ole e 8, Bet v 3 9 9 9
Enolase Hev b 9 9 9 9 9 9
Fungal
60S acidic ribosomal protein Cla h 12, Alt a 6 9 9 9 9 9
68 kDa allergen 9 9
Aldehyde dehydrogenase Alt a 10, Cla h 3 9 9 9 9
Alkyl hydroperoxide reductase Mal allergen 9 9 9
Heat shock 70 kDa protein Pen c 19, Cla h 4, Alt a 3 9 9 9 9 9 9
Heat shock protein 90 Asp f 12 9 9 9 9 9
Malate dehydrogenase Mal f 4 9 9 9 9
Peroxisomal membrane protein Mal f 2,  Asp f 3 9 9
Serine protease Tri s 4 9
Superoxide dismutase Asp f 6 9 9 9 9
Thioredoxin Cop c 2 9 9 9 9 9
Insect (Mite)
98kDa HDM allergen 9 9 9 9 9
Adenosine diphosphatase Aed a 1 9
Allergen A precursor 9
Allergen MAG29   9 9 9
Apolipophorin Der f 14 9
Arginine kinase Plo i 1 9 9 9 9
Calycin Bla g 4 9
Cysteine protease Eur m 1 9
Fatty acid-binding protein Lep d 13, Blo t 13 9 9 9 9 9
Gelsolin-like allergen Der f 16 9 9 9
Glutathione S-transferase Der p 8, Bla g 5 9 9 9 9 9 9
Hyaluronidase Pol a 2, Api m 2 9 9 9 9
Mite allergen Lep d 1.02                  9 9
Paramyosin Blo t 11 9 9 9 9
Phospholipase A1 1 precursor Dol m I, Ves v 1 9 9 9 9 9 9
Tropomyosin Blo t 10, Lep d 10, Per a 7 9 9 9 9 9 9
Trypsin Der f 3, Eur m 3 9 9 9 9 9 9
Venom allergen Dol m 5.01 9 9
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Table 3. (cont.) 
 
ALLERGEN TYPE ALLERGEN HOMOLOGUE EXAMPLES PIG COW CHICKEN GOAT SHEEP DOG CAT
Animal
Allergen dI chain C2A 9 9
Alpha, lactalbumin Bos d 4 9 9 9 9 9
Alpha-2u globulin Rat n 1 9 9 9 9
Arginine kinase Pen m 2 9 9 9
Beta-lactoglobulin Bos d 5 9 9 9 9 9 9
Bovine dander BDA20 9 9 9
Cat-1 Fed d 1 9
Lipocalin Equ c 1, Can f 1 9 9 9
Lysozyme C precursor Gal d 4 9 9
Ovalbumin Gal d 2 9 9 9 9
Ovomucoid Gal d 1 9 9 9 9 9
Parvalbumin Gad m 1, Sco j 1, Sal s 1 9 9
S100 calcium-binding protein A7 Bos d 3 9 9 9 9 9
Serum albumin Can f 3, Gal d 5, Bos d 6 9 9 9 9 9 9
Serum transferrin Gal d 3 9 9 9 9 9
Tropomyosin Hom a 1, Met e I, Cha f 1 9 9 9 9 9 9
Others





The summarized list of allergen homologues from the seven species of animals is listed in 
Table 4. This table provides the proportion of unigenes homologous to all matched 
known allergens and it provides insight to their abundance within the genome of each 
species. The three most abundant allergens were calcium binding protein, ovalbumin and 
paramyosin. Calcium-binding proteins contain a variable number of motifs, termed EF-
hands, which are made up of two perpendicularly placed alpha-helics and an inter-helical 
loop forming a single calcium-binding site (Valenta et al., 1998). Its main function is to 
transport calcium as well as to interact with a variety of ligands in a calcium-dependent 
manner. After parvalbumin, a three EF-hand fish allergen, calcium-binding allergens 
were discovered in pollens of trees, grasses and weeds and, recently, as autoallergens in 
man (Valenta et al., 1998). Although only a small percentage of atopic individuals 
display IgE reactivity to calcium-binding allergens, these allergens may be important 
because of their ability to cross-sensitize allergic individuals. Ovalbumin (a form of 
albumin) is member of a class of water-soluble, heat-coagulating proteins. Other 
examples of albumins include myogen of muscle, serum albumin of blood, lactalbumin of 
milk, legumelin of peas, and leucosin of wheat.  The main functions of albumin are 
protein transport and maintenance of homeostasis within the organism. Ovalbumin is a 
highly abundant (more than 50%) major allergenic protein of hen’s egg white. Due to 
ovalbumin’s resemblance with serum albumin, it was expected to observe high number of 
unigenes homologues to ovalbumin among the seven animal species. Paramyosin, like 
the tropomyosin and myosin, is a protein associated with associated with muscles. Both 
tropomyosin and paramyosin composed of two identical coiled-coil alphahelices (Tsai et 
al., 1999). Unlike tropomyosin, paramyosin is only found in invertebrates and the 
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distribution and functions of paramyosin are quite diverse (Tsai et al., 1999). The fact 
that many unigenes from the seven animal species were found to be homologues to 
paramyosin suggested that there are many variants or isoforms of paramyosin or 
tropomyosins present in vertebrates. Illustrated in Figure 3A – 3G are the pie-charts of 
the allergen homologues from individual animal species classified based on their 
biological function. Most of the allergens were involved in metabolism and homeostasis. 
Additionally, most of these allergen homologues were associated with stress response. 
Researchers have shown that certain allergic disorders such as eczema and asthma are 
regulated, in part, by hormones and brain chemicals released into the bloodstream in 
response to stress (Wright et al., 2005). For instance chaperons like heat shock proteins 
and thioredoxin play an important role in protein synthesis and in the protection of 
cellular structures during stress-related processes (Gruehn et al., 2003). Reduced and 
carboxymethylated bovine serum albumin (rcm-BSA) have been shown to elicit a stress 
response (Mifflin and Cohen, 1994). Expression of enzymes such as superoxide 
dismutases and phospholipases has also been shown to up-regulate during fungal 
infection (Rementeria et al., 2005). Another study done on Escherichia coli has 
demonstrated that temperature stress could cause the accumulation of stress proteins such 
as disaggregation chaperones (DnaK and ClpB), components of the RNA ribosomal 
proteins and enolases (Lethanh et al., 2005).
 58
Table 4. 
Summarized list allergen homologues from the seven species of animals 
 
Allergen matched Beef Pork Chicken Goat Sheep Dog Cat
21k allergen 2 0 0 0 1 0 0
60S acidic ribosomal protein 4 7 1 1 6 0 0
68 kDa allergen 1 2 0 0 0 0 0
98kDa HDM allergen 4 4 2 1 3 0 0
Actinidin 9 7 5 0 0 2 0
Aldehyde dehydrogenase 8 7 5 0 1 0 0
alkyl hydroperoxide reductase 3 2 1 0 0 0 0
allergen [Malassezia sympodialis]                      8 8 5 1 14 1 1
allergen Bos d 2.0103 1 0 0 0 0 0 0
Allergen Bla g 4 precursor 0 0 0 0 5 0 0
allergen dI chain C2A 1 0 0 1 0 0 0
allergen Lep d 1.02                                      1 0 1 0 0 0 0
allergen A precursor   0 1 0 0 0 0 0
Allergen MAG29   1 1 0 0 0 1 0
Allergen Mal f 2 0 1 0 0 0 0 0
alpha-2u globulin 1 3 1 0 0 1 0
Apyrase precursor 1 0 0 0 0 0 0
Arginine kinase 4 4 3 0 0 4 0
Beta-lactoglobulin precursor 1 2 0 6 6 6 14
C07A4.3 [Caenorhabditis elegans] 0 1 0 0 0 0 0
C10G8.3 [Caenorhabditis elegans] 0 0 1 0 0 0 0
calcium ion binding protein 23 26 7 0 2 1 0
Der f 3 mite allergen                                  9 12 6 1 0 12 2
Enolase 3 4 3 0 4 2 0
Fatty acid-binding protein 9 10 9 2 2 0 0
Fel d 1 0 0 0 0 0 0 17
gelsolin-like allergen 4 3 2 0 0 0 0
Glutathione S-transferase 3 7 6 1 8 1 0
group 14 allergen protein 0 0 1 0 0 0 0
Heat shock protein 9 11 6 2 5 3 0
Hyaluronidase 2 1 1 0 1 0 0
major allergenic protein Mal f 4 0 0 3 0 1 0 0
lactalbumin, alpha 1 1 0 2 3 2 0
Lysozyme C precursor 1 0 0 0 0 6 0
major allergen BDA20 3 1 0 1 0 0 0
Major allergen Can f 1 precursor 1 1 0 0 0 3 0
Minor allergen Can f 2 precursor 0 0 0 0 0 4 0
Major allergen Equ c 1 precursor 1 2 0 0 0 0 0
major allergenic protein Mal f 4 2 2 0 0 0 0 0
Mite group 1 allergen Eur m 1 precursor 0 0 0 1 0 0 0
Ovalbumin 21 18 7 0 2 0 2
Ovomucoid precursor 3 5 7 0 0 5 0
Ovotransferrin precursor 2 7 2 2 1 0 1
paramyosin allergen 13 5 19 0 0 0 2
Parvalbumin beta 0 0 3 0 0 0 2
Phospholipase A1 1 precursor 2 1 2 0 1 6 0
preproalbumin 0 0 0 0 0 1 0
Putative peroxiredoxin pmp20 1 2 0 0 0 0 4
Serum albumin precursor 5 4 2 0 1 11 0
Superoxide dismutase [Mn] 1 1 1 0 1 0 0
T05A10.5 [Caenorhabditis elegans] 1 1 0 0 0 0 0
Thioredoxin 4 4 4 1 1 0 0
tri s 4 allergen 0 1 0 0 0 0 0
Tropomyosin 5 6 5 2 1 1 0
venom allergen 1 2 2 0 0 0 0
Total 180 188 123 25 70 73 45
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Pie chart of the allergen homologues from dog classified based on their biological 
function
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3.3.1.2 Performance of allergen prediction by sequence homology 
 
 
The recall rate of the known allergen in each individual species was used as an indication 
of the method’s performance. For B. taurus (cow), there are currently 7 allergens (Bos d 
2 to Bos d 8) listed on WHO/IUIS and the system was able to recall 5 of the allergens 
(71.4%). For G. gallus (chicken), there are 5 allergens (Gal d 1 to Gal d 5) listed and the 
system was able to recall 4 of the allergens (80%). For C. familiaris (dog), there are 4 
allergens (Can f 1 to Can f 4) listed and 3 allergens were recalled (75%). For F. 
domesticus (cat), the number of successful recall was only 2 out of the listed 7 allergens 
(28%). This could be due to the quality and coverage of the sequences available on 
NCBI. 
 
3.3.2 Allergenicity prediction using wavelet transform     
 
 
This segment was done courtesy of Dr. Li Kuo Bin. All 664 reference allergens were 
used to predict putative allergen motifs. A total of 62 allergen motifs were predicted and 

















Table 5.  
Allergen motifs. The protein families were identified by using hmm search to search the 
Swiss-Prot with a profile HMM generated from the corresponding allergen motif. 
 
Motif 
identifiers Main protein families 
Motif 
identifiers Main protein families 
motif-1  Profilin motif-32  Lymphocyte antigen 75 precursor 
motif-2  Glutenin low molecular weight motif-33  Glutenin, high molecular weight 
motif-3  Agglutinin motif-34 Paramyosin 
motif-4  Glutenin high molecular weight motif-35  Glutenin, high molecular weight 
motif-5  Glutenin high molecular weight motif-36  Glutenin, high molecular weight 
motif-6  Beta-expansin motif-37  Enolase 
motif-7 Major mite fecal allergen motif-38  Glycinin 
motif-8  Profilin motif-39  Glycinin 
motif-9  Beta-fructofuranosidas motif-40  Gamma-gliadin B-I precursor 
motif-10  Seed allergenic protein motif-41  Calreticulin precursor 
motif-11  Profilin motif-42  Beta-conglycinin 
motif-12  Aspartic protease inhibitor motif-43  Glycinin precursor 
motif-13  Tropomyosin motif-44  Pollen allergen Amb a 5 
motif-14  
Tropomyosin; chlorophyll a-b binding 
proteins motif-45  Parvalbumin 
motif-15 Tropomyosin; heat shock protein motif-46  Globin 
motif-16  Gamma-gliadin motif-47  Superoxide dismutase 
motif-17  Profilin motif-48  
13S globulin seed storage protein 3 
precursor 
motif-18  Cysteine protease inhibitor motif-49  Profilin 
motif-19  Cysteine protease inhibitor motif-50  Profilin 
motif-20  Alpha/beta-gliadin motif-51  Allergen Pha a 1 precursor 
motif-21  Polygalacturonase motif-52  Beta-expansin 1 precursor 
motif-22  Gamma-gliadin precursor motif-53  Allergen Hol l 1 precursor 
motif-23  Polygalacturonase motif-54  Patatin T5 precursor 
motif-24  Polcalcin motif-55  Keratin 
motif-25  Patatin precursor motif-56 Phospholipase A1 
motif-26  Patatin precursor motif-57  Lipid-transfer protein 
motif-27  Aldehyde dehydrogenase motif-58  Melittin precursor 
motif-28  Hyaluronoglucosaminidase precursor motif-59  Pathogenesis-related protein 
motif-29  Alpha-amylase inhibitor motif-60  Glutenin, low molecular weight 
motif-30  
13S globulin seed storage protein 3 
precursor motif-61  Allergen Amb a 1.1 precursor 
motif-31  
13S globulin seed storage protein 3 








The downloaded unigenes, nucleotide and protein sequences from various species were 
put through the wavelet transform system for allergenic proteins prediction. The number 
of predicted allergens for each species varied from 34 proteins in beef to only 4 proteins 
in cat (Table 6). For example, tabulated in Table 7 is the list of putative allergens 
predicted in beef. The list was ranked based on the likelihood that the protein is allergenic 
as indicated by its E-values. The smaller is the E-value, the more likely the protein is 
allergenic. The potential allergens predicted from other species can be found in appendix 
X - XIV.  
 
                                            
Table 6.  
No. of putative allergens predicted for each species of animal using wavelet 
transform allergen prediction system. 
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An example of the list of putative allergens predicted in beef using wavelet transform   
   
Subject (hits) Subject Description Motif no. E-values
P00711 Alpha-lactalbumin precursor (Lactose synthase B protein) (Allergen Bos d 4). 17 5.30E-36
Q28133 Allergen Bos d 2 precursor (Dander major allergen BDA20) (Dermal allergen BDA20). 31 5.30E-13
P02769 Serum albumin precursor (Allergen Bos d 6) (BSA). 34 6.00E-11
P42918 Calreticulin, brain isoform 2 precursor (CRP55) (Calregulin) (HACBP). 41 7.50E-08
P52193 Calreticulin, brain isoform 1 precursor (CRP55) (Calregulin) (HACBP). 41 1.00E-07
P19120 Heat shock cognate 71 kDa protein. 15 1.80E-07
Q28050 S100 calcium-binding protein A7 (Allergen Bos d 3) (Dander minor allergen BDA11) (Dermal allergen BDA11) (Calcium-binding protein in amniotic fluid 2) (CAAF2). 10 1.90E-07
P34933 HEAT SHOCK 70 KD PROTEIN 3. 15 1.30E-06
P02663 Alpha-S2 casein precursor [Contains: Casocidin-I]. 16 1.80E-06
Q27975 HEAT SHOCK 70 KD PROTEIN 1 (HSP70-1). 15 6.70E-06
Q27965 HEAT SHOCK 70 KDA PROTEIN 2 (HSP70-2). 15 6.70E-06
P02754 Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5). 14 9.20E-06
P00792 Pepsin A precursor. 25 1.90E-05
P26882 40 kDa peptidyl-prolyl cis-trans isomerase (PPIase) (Rotamase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Estrogen receptor binding cyclophilin). 60 5.90E-05
Q09139 Fatty acid-binding protein, brain (B-FABP). 8 7.40E-05
Q9XSJ4 Alpha enolase (2-phospho-D-glycerate hydro-lyase) (Non-neural enolase) (NNE) (Enolase 1) (Phosphopyruvate hydratase). 42 9.80E-05
P04374 Peptidyl-prolyl cis-trans isomerase A (PPIase) (Rotamase) (Cyclophilin A) (Cyclosporin A-binding protein). 7 0.00011
P05786 Keratin, type II cytoskeletal 8 (Cytokeratin 8) (Cytokeratin A). 55 0.00021
P10790 Fatty acid-binding protein, heart (H-FABP) (Heart-type fatty acid-binding protein) (Mammary-derived growth inhibitor) (MDGI). 8 0.00023
P02662 Alpha-S1 casein precursor. 5 0.00044
P02668 Kappa casein precursor [Contains: Casoxin C; Casoxin 6; Casoxin A; Casoxin B; Casoplatelin]. 12 0.0011
Q29443 Serotransferrin precursor (Transferrin) (Siderophilin) (Beta-1-metal binding globulin). 27 0.0011
P48820 Ran-binding protein 2 (RanBP2) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (358 kDa nucleoporin) (P270). 7 0.0018
P02666 Beta casein precursor. 12 0.002
P48644 Aldehyde dehydrogenase 1A1 (Aldehyde dehydrogenase, cytosolic) (ALDH class 1) (ALHDII) (ALDH-E1). 28 0.0031
P25975 Cathepsin L precursor. 6 0.0037
P24627 Lactotransferrin precursor (Lactoferrin) [Contains: Lactoferricin B (Lfcin B)]. 28 0.0041
P80209 Cathepsin D precursor. 25 0.0045
P80311 Peptidyl-prolyl cis-trans isomerase B precursor (PPIase) (Rotamase) (Cyclophilin B) (S-cyclophilin) (SCYLP). 60 0.0045
Q9BGI1 Peroxiredoxin 5, mitochondrial precursor (Prx-V). 14 0.0059
Q02373 NADH-ubiquinone oxidoreductase PDSW subunit (Complex I-PDSW) (CI-PDSW). 16 0.023
P09867 Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) (Single-strand binding protein) (hnRNP core protein A1) (Unwinding protein 1) (UP1). 37 0.24
Q9TT96 Beta-1 adrenergic receptor (Beta-1 adrenoceptor) (Beta-1 adrenoreceptor). 51 0.26
P98107 E-selectin precursor (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2). 3 0.51
 68
3.3.2.1 Performance of allergenicity prediction using wavelet transform 
 
 
For individual species, the recall of its own known allergens was relatively high again 
with the exception in cat. For B. taurus (cow), 6 out of the 7 (85%) listed allergens were 
recalled. Similarly, in the case of G. gallus (chicken), 4 out of the 5 (80%) listed allergens 
were recalled. For C. familiaris (dog), 3 out of the 4 (75%) listed allergens listed were 
recalled and in lastly for F. domesticus (cat) only 2 out of the listed 7 allergens (28%). 
Again this was due to the quality and coverage of the sequences available on NCBI. 
 
 




In total, 197 distinct putative allergens were predicted by sequence homology from six 
species namely pig, cow, chicken, sheep, cat and dog. This number was obtained after 
filtering the repeated hits on the same allergen within each animal species. Similarly after 
filtering, the motif-based system predicted 90 distinct putative allergens from the same 
six animal species. The identities of the putative allergens predicted by both systems were 
quite dissimilar for each species (Table 8 - 13). The percentage of an allergen being 
predicted in both systems varies from 9.3 % in pig to 100 % in cat (Figure 4).  On 
average, only about 15 % of the allergens were predicted in both systems with the 
exception in cat. The only possible reason for the difference in output of the prediction 
has to be attributed to the difference in mode and parameter of search because the input 
information was entirely the same for both systems. We know from literatures that 
allergen prediction based on sequence homology were prone to false positive results 
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(Kleter and Peijnenburg, 2002; Zorzet et al., 2002; Soeria-Atmadja et al., 2004). On the 
other hand, motif-based allergen prediction may be too stringent and prone to false 
negative results. Therefore, the two systems serve to complement each other to increase 
the confidence level of the prediction. With the results from the two systems, we are 
confident that those putative allergens predicted in both systems are likely real allergens. 
These proteins are namely heat shock proteins, serum albumins, enolases, and 
dehydrogenases across the six animal species. The rest of the putative allergens that were 
not predicted in both systems remind as allergen candidates until farther studies to 
confirm their allergenicity. Results from later studies using the proteomics approach will 





Venn diagrams of putative allergens being predicted in both allergencity prediction 
systems for each animal species 
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Table 8. Comparison of predicted putative allergens in beef by both bioinformatics 
systems 
Allergen Method 1 Method 2
21k allergen [Anisakis simplex]                        9
40 kDa peptidyl-prolyl cis-trans isomerase  (Cyclophilin-related protein) 9
60S acidic ribosomal proteins 9
68 kDa allergen [Penicillium chrysogenum]               9
98kDa HDM allergen [Dermatophagoides farinae]          9
Actinidain precursor (Actinidin) (Allergen Act c 1) 9
Aldehyde dehydrogenase (ALDDH) 9 9
Alkyl hydroperoxide reductases 9
Allergen [Malassezia sympodialis]                      9
Allergen Bos d 2 precursor (Dander major allergen BDA20) (Dermal allergen BDA20). 9 9
Allergen dI chain C2A [Mus musculus] 9
Allergen Lep d 1.02                                      9
Allergen MAG29   9
Alpha-2u globulin PGCL1 [Rattus norvegicus]           9
Alpha-lactalbumin precursor (Lactose synthase B protein) (Allergen Bos d 4). 9 9
Alpha casein precursor. 9
Apyrase precursor  (Allergen Aed a 1) 9
Arginine kinase (AK) (Allergen Plo i 1)   9
Beta casein precursor. 9
Beta-1 adrenergic receptor (Beta-1 adrenoceptor) 9




Dust mite group 3 allergens 9
Enolase 1 (2-phosphoglycerate dehydratase 1) (2-phospho-D-glycerate hydro-lyase 1) (Allergen Hev b 9) 9 9
Enolase 2 (2-phosphoglycerate dehydratase 2) (2-phospho-D-glycerate hydro-lyase 2) (Allergen Hev b 9) 9
E-selectin precursor (Endothelial leukocyte adhesion molecule 1) (ELAM-1) 9
Fatty acid-binding protein 9 9
Gelsolin-like allergen Der f 16 [Dermatophagoides farinae] 9
Glutathione S-transferase (GST class-mu) (Major allergen Der p 8) (P dp 15) 9
Heat shock 70 KD protein 9 9
Heat shock protein 90 (Allergen Asp f 12) 9
Heterogeneous nuclear ribonucleoprotein A1 (Helix-destabilizing protein) 9
Hyalurononglucosaminidase precursor (Hyaluronidase) 9
Kappa casein precursor [Contains: Casoxin C; Casoxin 6; Casoxin A; Casoxin B; Casoplatelin]. 9
Keratin, type II cytoskeletal 8 (Cytokeratin 8) (Cytokeratin A). 9
Lactotransferrin precursor (Lactoferrin) [Contains: Lactoferricin B (Lfcin B)]. 9
Lysozyme C precursor (1,4-beta-N-acetylmuramidase C) (Allergen Gal d 4) (Gal d IV) 9
Major allergen BDA20 [Bos taurus] 9
Major allergen Can f 1 precursor (Allergen Dog 1) 9
Major allergen Equ c 1 precursor 9
major allergenic protein Mal f4 [Malassezia furfur]     9
NADH-ubiquinone oxidoreductase PDSW subunit (Complex I-PDSW) (CI-PDSW). 9
Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) 9
Ovomucoid precursor (Allergen Gal d 1) (Gal d I) 9
Paramyosin allergen [Blomia tropicalis]                 9
Paramyosin-like allergen [Dermatophagoides farinae]    9
Pepsin A precursor. 9
Peptidyl-prolyl cis-trans isomerase (Cyclophilin-related protein) 9
Peroxiredoxin 5, mitochondrial precursor (Prx-V). 9
Phospholipase A1 1 precursor (Allergen Dol m 1.01) (Dol m I) 9
Putative peroxiredoxin pmp20 (Thioredoxin reductase) (Peroxisomal membrane protein pmp20) (Allergen Asp f 3) 9
Ran-binding protein 2 (RanBP2) 9
S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] 9 9
Serum transferrin 9 9
Serum albumin precursor (Allergen Bos d 6) (BSA) 9 9
Superoxide dismutase [Mn], mitochondrial precursor (Allergen Asp f 6) 9
T05A10.5 [Caenorhabditis elegans] 9
Thioredoxin 9
Tropomyosins 9
Venom allergen 5.01 precursor 9
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Table 9. Comparison of predicted putative allergens in pork by both bioinformatics 
systems 
Allergen Method 1 Method 2
60S acidic ribosomal proteins 9
68 kDa allergen [Penicillium chrysogenum]               9
98kDa HDM allergen [Dermatophagoides farinae]          9
Actinidain precursor (Actinidin) (Allergen Act c 1) 9
Aldehyde dehydrogenase (ALDDH) 9
Alkyl hydroperoxide reductase/ Thiol specific antioxidant/ Mal allergen [Nitrosomonas europaea ATCC 19718] 9
Allergen [Malassezia sympodialis]                     9
Allergen A precursor [Psoroptes ovis]                   9
Allergen Bla g 5 [Blattella germanica]                  9
Allergen MAG29 9
Allergen Mal f 2 (MF1)  9
Allergen Pen m 2 [Penaeus monodon]                     9
Alpha-2-HS-glycoprotein precursor (Fetuin-A). 9
Alpha-2u globulin PGCL1 [Rattus norvegicus]           9 9
Alpha-lactalbumin precursor 9
Arginine kinase (AK) (Allergen Plo i 1) 9
Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5) 9
C07A4.3 [Caenorhabditis elegans] 9
Calcium-binding allergen Ole e 8 (PCA18/PCA23) 9
Cathepsin L precursor. 9
Cytochrome P450 3A29 (CYPIIIA29). 9
Dehydrogenase/reductase SDR family member 4 9
Dust mite group 3 allergens 9
Enolase 2 (2-phosphoglycerate dehydratase 2) (2-phospho-D-glycerate hydro-lyase 2) (Allergen Hev b 9). 9
Fatty acid-binding proteins 9 9
Fumarate hydratase, mitochondrial (Fumarase). 9
Gelsolin-like allergen Der f 16 [Dermatophagoides farinae] 9
Glutathione S-transferases 9
Heat shock 70 KD proteins 9 9
Heat shock protein 90 (Allergen Asp f 12) 9 9
Hyalurononglucosaminidase precursor (Hyaluronidase) (Allergen Pol a 2) 9
Inhibitor of carbonic anhydrase precursor. 9
Lactotransferrin precursor (Lactoferrin). 9
Major allergen BDA20 [Bos taurus]    9
Major allergen Can f 1 precursor (Allergen Dog 1) 9
Major allergen Equ c 1 precursor 9
Major allergenic protein Mal f4 [Malassezia furfur]    9
Malate dehydrogenase, mitochondrial precursor. 9
Membrane associated progesterone receptor component 1. 9
Myosin heavy chain, cardiac muscle beta isoform (MyHC-beta). 9
NADP-dependent malic enzyme (NADP-ME) (Malic enzyme 1). 9
Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) 9
Ovomucoid precursor (Allergen Gal d 1) (Gal d I) 9
Serum transferrin 9
Paramyosin allergen [Blomia tropicalis]                9
Paramyosin-like allergen [Dermatophagoides farinae]     9
Pepsin A precursor. 9
Phospholipase A1 1 precursor (Allergen Dol m 1.01) (Dol m I) 9
Putative peroxiredoxin pmp20 (Thioredoxin reductase)  (Allergen Asp f 3) 9
S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] 9
Serum albumin precursor. 9 9
Superoxide dismutase [Mn], mitochondrial precursor (Allergen Asp f 6) 9
T05A10.5 [Caenorhabditis elegans] 9
Thioredoxin (Allergen Cop c 2) 9
Tri s 4 allergen [Trichophyton schoenleinii] 9
Tropomyosins 9 9
venom allergen 5, LONg family member (lon-1) [Caenorhabditis elegans].    9
Von Ebner's gland protein precursor (VEG protein) (Lipocalin-1). 9
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Table 10. Comparison of predicted putative allergens in chicken by both 
bioinformatics systems 
Allergen Method 1 Method 2
40S ribosomal protein S27a. 9
60S acidic ribosomal protein P1 (Allergen Alt a 12) (Alt a XII). 9
98kDa HDM allergen [Dermatophagoides farinae]          9
Actinidain precursor (Actinidin) (Allergen Act c 1) 9
Aldehyde dehydrogenase 9 9
Alkyl hydroperoxide reductase/ Thiol specific antioxidant/ Mal allergen [Nitrosomonas europaea ATCC 19718] 9
Allergen [Malassezia sympodialis]                     9
Allergen Bla g 5 [Blattella germanica]                  9
Allergen Lep d 1.02                                      9
Allergen Pen m 2 [Penaeus monodon]                     9
Alpha-2u globulin PGCL1 [Rattus norvegicus]  9
Arginine kinase (AK) (Allergen Plo i 1) 9
Bromodomain adjacent to zinc finger domain 2B (Extracellular matrix protein F22). 9
C10G8.3 [Caenorhabditis elegans] 9
Calcium-binding allergens 9
Calretinin (CR). 9
Chromosome-associated kinesin KIF4A (Chromokinesin). 9
Der f 3 mite allergen                                  9
DNA topoisomerase II, alpha isozyme. 9
Enolase 1 (2-phosphoglycerate dehydratase 1) (2-phospho-D-glycerate hydro-lyase 1) (Allergen Hev b 9) 9 9
Enolase 2 (2-phosphoglycerate dehydratase 2) (2-phospho-D-glycerate hydro-lyase 2) (Allergen Hev b 9) 9 9
Fatty acid-binding proteins 9 9
Gamma enolase (2-phospho-D-glycerate hydro-lyase) (Neural enolase) (NSE). 9
Gelsolin-like allergen Der f 16 [Dermatophagoides farinae] 9
GENE X PROTEIN (OVALBUMIN-RELATED). 9
Gene Y protein (Ovalbumin-related). 9
Glutathione S-transferases 9
Group 14 allergen protein [Dermatophagoides pteronyssinus] 9
Heat shock 70 kDa proteins 9 9
Heat shock protein 90 9 9
Hyalurononglucosaminidase (Hyaluronidase) (Allergen Dol m 2) (Dol m II) 9
Keratin, type II cytoskeletal cochleal (Cytokeratin otokeratin). 9
Major allergenic protein Mal f4 [Malassezia furfur]    9
Dust mite group 3 allergens 9
Myosin heavy chain 9
Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) 9 9
Ovomucoid precursor (Allergen Gal d 1) (Gal d I) 9 9
Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) (Gal d III) (Serum transferrin) 9 9
Paramyosin allergen [Blomia tropicalis]                9
Paramyosin-like allergen [Dermatophagoides farinae]    9
Parvalbumins 9 9
Pepsin A precursor. 9
Peptidyl-prolyl cis-trans isomerase B precursor (PPIase) Cyclophilin-related protein 9
Phospholipase A1 precursor 9
Restin (Cytoplasmic linker protein-170) (CLIP-170). 9
S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] 9
Serum albumin precursor 9 9
Superoxide dismutase [Mn], mitochondrial precursor (Allergen Asp f 6) 9
Thioredoxin (Allergen Cop c 2) 9
Triosephosphate isomerase (TIM) (Triose-phosphate isomerase). 9
Tropomyosins 9 9
Venom allergens 9







Table 11. Comparison of predicted putative allergens in sheep by both 
bioinformatics systems 
Allergen Method 1 Method 2
21k allergen like family member (5F762) [Caenorhabditis elegans] 9
60S acidic ribosomal protein P1 (Allergen Alt a 12) (Alt a XII) 9
60S acidic ribosomal protein P1 (Allergen Cla h 12) (Cla h XII) 9
60S acidic ribosomal protein P2 (Minor allergen Alt a 6) (Alt a VI) 9
60S acidic ribosomal protein P2 (Minor allergen Fus c 1) 9
98kDa HDM allergen [Dermatophagoides farinae] 9
Aldehyde dehydrogenase (ALDDH) 9 9
allergen [Malassezia sympodialis] 9
Allergen Bla g 4 precursor (Bla g IV) 9
Alpha casein precursors 9
Beta casein precursor. 9
Beta-lactoglobulin precursor 9 9
Enolase 2 (2-phosphoglycerate dehydratase 2) (2-phospho-D-glycerate hydro-lyase 2) (Allergen Hev b 9) 9
Fatty acid-binding proteins 9
Glutathione S-transferase 9
Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) 9
Heat shock protein HSP1 (65 kDa IgE-binding protein) (Allergen Asp f 12) 9
Hyaluronoglucosaminidase precursor (Hyaluronidase) (Allergen Api m 2)(Api m II) 9
Interleukin-3 precursor (IL-3) (Mast-cell growth factor) (MCGF). 9
Keratin, type II 9
Alpha, lactalbumin [Bos taurus] 9 9
major allergenic protein Mal f4 [Malassezia furfur] 9
Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) 9
Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) (Gal d III) (Serum transferrin) 9
Phospholipase A1 1 precursor (Allergen Dol m 1.01) (Dol m I) 9
S100 calcium-binding protein A7 (psoriasin 1) (Dermal allergen BDA11) 9
Serum albumin precursor. 9 9
Superoxide dismutase [Mn], mitochondrial precursor (Allergen Asp f 6) 9


























Table 12. Comparison of predicted putative allergens in dog by both bioinformatics 
systems 
Allergen Method 1 Method 2
Actinidain precursor (Actinidin) (Allergen Act c 1) 9
Allergen [Malassezia sympodialis] 9
Allergen MAG29 9
Allergen Pen m 2 [Penaeus monodon] 9
Alpha-2u globulin PGCL1 [Rattus norvegicus] 9
Arginine kinase (AK) (Allergen Plo i 1) 9
Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5) 9
Calnexin precursor (pp90) 9
Der f 3 mite allergen 9
Enolase (2-phosphoglycerate dehydratase) (2-phospho-D-glycerate hydro-lyase) (Allergen Rho m 1) 9
Glutathione S-transferase (GST class-mu) (Major allergen Der p 8) (P dp 15) 9
Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) 9
Alpha, lactalbumin [Bos taurus] 9 9
Lysozyme C precursor (1,4-beta-N-acetylmuramidase C) (Allergen Gal d 4) (Gal d IV) 9
Major allergen Can f 1 precursor (Allergen Dog 1) 9 9
Minor allergen Can f 2 precursor (Allergen Dog 2) 9
Mite allergen Der f 3 precursor (Der f III) 9
Mite allergen Der p 3 precursor (Der p III). 9
Mite allergen Eur m 3 precursor 9
Occludin 9
Ovomucoid precursor (Allergen Gal d 1) (Gal d I) 9
Phospholipase A1 (Allergen Ves m 1) (Ves m I) 9
Phospholipase A1 precursor (Allergen Ves v 1) (Ves v I) 9
Preproalbumin (serum albumin) [Gallus gallus] 9
S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] 9
Serum albumin precursor (Allergen Can f 3) 9 9




Table 13. Comparison of predicted putative allergens in cat by both bioinformatics 
systems 
Allergen Method 1 Method 2
Allergen [Malassezia sympodialis] 9
Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5) 9
Chain A, Crystal Structure Of Fel d 1 9
Der f 3 mite allergen 9
Major allergen chain 1 precursor A - cat 9
Major allergen chain 1 precursor B - cat 9
Major allergen chain 2 precursor, short form - cat 9
Major allergen Fel dI chain 1 long form precursor - cat 9
Major allergen I 9
Major allergen I polypeptide chain 1 major form precursor (Allergen Fel d 1-A) 9 9
Major allergen I polypeptide chain 2 precursor (Allergen Fel d 1-B) (Fel d I-B) 9 9
Major cat allergen Fel d I beta chain - cat (fragment) 9
Ovomucoid precursor (Allergen Gal d 1) (Gal d I) 9
Paramyosin (Allergen Ani s 2) 9
Parvalbumin beta 2 (Major allergen Sal s 1) 9
Phospholipase A1 1 precursor (Allergen Dol m 1.01) (Dol m I) 9






Many allergen-homologous unigenes predicted based on sequence homology were found 
in each of eight animal species (pig, cow, chicken, goat, sheep, trout, dog and cat). Some 
of these are known allergens in the species concerned, but many more are putative new 
allergens. Many of these allergen-homologous unigenes are homologous to the same 
allergens across the eight animal species, implying that there is a possibility of cross-
reactivity among the different species, by means of pan-allergens. The motif-based system 
also predicted many putative allergens from six animal species (pig, cow, chicken, sheep, dog 
and cat). However, the lists of putative allergens predicted by both systems were quite varied. 
Nevertheless, both the systems have achieved high recall rates for the known allergens with 
each animal species. The two allergenicity predictive systems serve to complement each 
other and those putative allergens predicted in both systems are likely ‘true’ allergens. The 
detailed list of predicted homologous allergen equipped with regions of sequence homology 

















CHAPTER 4: IDENTIFICATION AND 
CHARACTERIZATION OF MEAT-BASED ALLERGENS 




Food allergies of Type-I hypersensitivity are IgE antibodies mediated and caused by 
certain proteins or glycoproteins, which are called food allergens. An analytical marker of 
allergens is the IgE-reactivity to these substances (Becker and Reese, 2001). The 
identification of food allergens is a priority in the management of food allergy, because 
of the need to obtain standardized extracts and pure allergens for diagnostic and 
therapeutic purposes (Pastorello and Trambaioli, 2001). It is thus important to develop 
methods for allergen extraction, separation and immunological detection methods to 
identify and characterize individual food allergens with minimum manipulation.  
 
4.1.1 Protein extraction from food sources 
 
Since a lot of different food sources are studied for their allergenic properties the first 
requirement for correct research procedure is to obtain good protein extracts, that is 
starting material with sufficiently high protein concentration and suitably low lipid and 
sugar content so as to allow for better protein separation (Pastorello and Trambaioli, 
2001). The optimization of the extraction procedure depends on the nature of source 
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material (e.g. lipids and carbohydrates content) and purpose (e.g. protease activity). The 
use of different extraction buffers will influence the outcome of protein extraction. For 
instance, the pH of the extraction buffer greatly influence the extract composition and 
antigen yield (Niemeijer et al., 1996). Buffers with solid polyvinylpolypyrrolidone 
(PVPP) and 2 mM ethyl-enediaminetetraacetic acid disodium salt (EDTA) added, 
inhibited reactions between protein and phenolic compounds, especially for plant food 
(Loomis, 1974). Some studies have focused on evaluating the effects on protein 
separation by various protein extraction and sample preparation methods (Carpentier et 
al., 2005; Natarajan et al., 2005; Saravanan and Rose, 2004). The results suggested that 
trichloroacetic acid (TCA) extraction method is one of the better methods for protein 
extraction. 
 
In the case of animal foods and/or meats, good extracts have often been achieved with 
simple grinding and incubation of the food in Phosphate Buffered Saline (PBS) solution 
to extract proteins contained in the raw materials (Asero et al., 1997; Llatser et al., 1998; 
Pastorello and Trambaioli, 2001). 
 
4.1.2 Methods used for protein separation and allergen isolation 
 
At present the most widely-used technique to identify allergenic molecules in raw 
extracts is one- and two-dimensional electrophoretic separation in sodium 
dodecylsulphate polyacrylamide gel (SDS-PAGE) followed by immunoblotting with 
allergenic patients’ serum. This method has been used for almost all allergenic proteins 
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reported in publications (Pastorello and Trambaioli, 2001). In some cases the allergenic 
proteins are directly eluted from the gel. This one-step purification protocol was used for 
isolation of Mal d 1, a major apple allergen (Vieths et al., 1995). Besides SDS-PAGE 
coupled with immunoblotting, chromatographic techniques are also widely used in 
allergen isolation and identification. Chromatographic techniques include ion-exchange 
(anionic and cationic), gel-flitration, reversed-phase, hydrophobic interaction, and affinity 
chromatography. These techniques are usually used in tandem for better purity and 
increased specificity of the desired allergenic protein. For instance, the egg white 
allergens, parvalbumin from fish, lipid transfer proteins (LTPs) from various plants, were 
isolated by ion-exchange chromatography followed by gel filtration (Aas and jebsen, 
1967; Elsayed and Aas, 1971; Anet et al., 1985; Hoffman, 1983; Ebbehøj et al., 1995; 
Pastorello et al., 1999; Pastorello et al., 2000; Pastorello et al., 1999). The famous 
profiling, a panallergen, was purified by affinity chromatography using a poly(L-proline) 
column (Valenta et al., 1991; Lindberg et al., 1988). 
 
4.1.3 Protein identification using Matrix-assisted laser desorption/ionization time-
of-flight mass spectrometry (MALDI-TOF MS) 
 
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), was first 
introduced in 1988 by Tanaka et al. and independently by Hillenkamp and Karas. For the 
past decade, it has become a widely accepted and versatile method for post-separation 
protein identification. Its ability to desorb high-molecular-weight thermolabile molecules, 
its high accuracy and sensitivity, combined with its wide mass range (1–300 kDa), make 
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MALDI-TOF MS a promising tool for the identification of biomolecules in complex 




The general principle of MALDI-Tof-MS revolves around the rapid photo-volatilization 
of a sample embedded in a UV-absorbing matrix followed by time-of-flight mass 




Figure 1.  
Principle of matrix-assisted laser desorption/ionization mass spectrometry. The 
analyte mixed with a saturated matrix solution forms crystals. The irradiation of this 
mixture by the laser induces the ionization of the matrix, desorption, transfer of protons 
from photo-excited matrix to analyte to form a protonated molecule (adapted from 










MALDI-TOF-MS identification of proteins is carried out by the peptide mass mapping or 
peptide mass fingerprinting technique. This protein identification is based on the accurate 
mass measurement of a group of peptides derived from a protein by sequence-specific 
proteolysis (Marvin et al., 2003). After proteolysis with a specific protease (e.g. trypsin), 
proteins of different amino acid sequence produce a series of peptides masses, which are 
subsequently detected by sensitive ion detectors. The spectrum of identified peptide 
masses is unique for individual protein and is known as a mass fingerprint. Searching the 
selected masses from the fingerprint against protein sequence databases (e.g. NCBI and 
SwissProt- TrEMBL) using software (e.g. Mascot and MS-fit) enables the identification 
of most proteins. Many proteomic data have been obtained using a combination of two-
dimensional polyacrylamide gel (2-D PAGE) and liquid chromatography (LC) with 
MALDI-TOF-MS. Recently, the technology of MS has improved to include tandem MS 
(MALDI-TOF-MS/MS), which provides actual amino acid sequences of the peptide 










4.2 MATERIALS AND METHODS 
4.2.1 Patients and sera 
 
The sera used in this study were selected from the previously pre-screened population 
mentioned in section 2.2.6. They were selected based on their IgE reactivity to the meat 
antigens and also the volume available for downstream studies. These sera were also 
confirmed by ELISA for their IgE reactivity towards the meat antigens. 
 
4.2.2 Protein extraction 
 
The crude extracts of pork, beef and lamb were extracted as described in section 2.2.3. 
Total protein concentration was then determined using the Bio-Rad protein assay kit 
(Bio-Rad, USA). TCA protein extraction method was also used in this study. Briefly, 10 
ml of TCA-acetone (90% acetone, 10% TCA, 0.07% DTT) was added to the tissue 
powder, which was grinded with liquid nitrogen. Samples were vortexed, incubated at –
20°C for 1 h, and centrifuged at 15,000 g for 15 min at 4°C. Protein pellets were washed 
3 times with acetone/DTT and subsequently lypholized and dissolved in lysis buffer. 
  
 
4.2.3 Gel Electrophoresis 
 
Meat extracts were separated by electrophoresis according to the protocols for 40% 
acrylamide/bis solutions, 37.5:1 (Bio-Rad, USA) given by Laemmli (1970). A total of 
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35µg of sample was loaded with sample buffer (62.5mM Tris-HCl, pH 6.8, 2% SDS, 
10% glycerol, 5% β-mercaptoethanol, and 0.01% bromophenol blue). For 2D 
electrophoresis, the first-dimension IEF was performed using either 7-cm or 17-cm IPG 
strips (Bio-Rad ReadyStrip IPG strips, pH 3-10) in the PROTEAN IEF System (Bio-Rad, 
USA). The 7-cm IPG strips were passively rehydrated  for 16 hrs with 125µl of 
rehydration buffer (9.5M urea, 4% CHAPS, 100 mM dithiothreitol, 0.2% bio-lytes pH 3–
10, 0.001% bromophenol blue) containing 75µg of protein whereas the 17-cm IPG strips 
were rehydrated with 350 µl of rehydration buffer containing 500 µg of protein. The IEF 
settings for 7-cm strips were 250 V rapid for 15 min, 8000 V gradient for 1 h, and 8000 
V rapid to a total of 20 kVh. The IEF settings for 17-cm strips were 250 V rapid for 1 hr, 
4000 V gradient for 3 hr, and 8000 V rapid to a total of 60 kVh. The focused strips were 
incubated with equilibration buffer 1 (50 mM Tris–HCl [pH 8.8], 6 M urea, 20% 
glycerol, 2% SDS, 0.002% bromophenol blue, 1% DTT) and equilibration buffer  2 
(50 mM Tris–HCl [pH 8.8], 6 M urea, 20% glycerol, 2% SDS, 0.002% bromophenol 
blue, 2.5% iodoacetamide) for 15 min each and subsequently placed onto 12% 
polyacrylamide gel. The strips were overlaid with agarose sealing solution (0.25M 
trisbase, 1.92 M glycine, 1% SDS, 1% agarose, 0.002% bromophenol blue). The 
electrophoresis was performed either using the Mini PROTEAN 3 cell unit or the 
PROTEAN II xi system (Bio-Rad, USA). The Bio-Rad 10 to 250kDa standard was used 





4.2.4 Protein visualization and image analysis 
 
Proteins were visualized either by Coomassie brilliant blue staining or by silver staining. 
For Coomassie blue staining, the gels were stained overnight in staining solution (20% 
methanol, 10% acetic acid, and 0.1% w/v Coomassie brilliant blue G-250 (Merck KGaA, 
Germany) and destained with destaining solution (10% methanol and 10% acetic acid). 
For silver staining, the gels were fixed for 1 hr in a fixing solution (50% methanol, 10% 
acedic acid), washed for 20 min in 30% ethanol and 20 min in Milli-Q water. After 
washing the gels were sensitized in 0.02% Na2S2O3 for 1 min and incubated in chilled 
silver stain (0.2% AgNO3, 0.02% formaldehyde) for 20 min.  The gels were then washed 
with Milli-Q water and developed in developing solution (3% Na2CO3, 0.0005% 
Na2S2O3, 0.05% formaldehyde) and stopped with 0.5% glycine solution. Stained gels 
were scanned and calibrated with Bio-RAD GS-700 Imaging Densitometer (Bio-Rad, 
USA). Image analysis was performed with PDQuest 2-D Analysis Software (Bio-Rad, 
USA). Spot detection was realized without spot editing. Spot matching for replicate gels 




Process of spots matching using the Bio-rad PDQuest software 
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4.2.5 Western Blotting Analysis 
 
1D and 2D gels were transferred overnight using 20V at 4ºC to Hybond ECL 
nitrocellulose membranes (Amersham Life Science, USA) using the Mini Trans-blot 
Electrophoretic Transfer Cell (BioRad). The transferred membranes were blocked with 
0.1% PBS-T at room temperature for 1 hour.  After washing with 0.05% PBS-T, the 
membranes were incubated overnight at 4°C with the respective patients’ sera. 
Membranes were then washed followed by incubation with goat anti-human IgE ε-chain 
specific alkaline phosphatase conjugated antibody (Sigma, USA) at 1:1000 (v/v) dilution 
with PBS for 2.5 hours at room temperature.  Washing was then performed.  The positive 
binding of specific IgE to allergen was visualised by developing with BCIP/NBT (5-
bromo-4chloro-3indolyl-phosphate / nitro-blue tetrazolium) colour substrate kit 
(Promega, USA) in alkaline phosphatase buffer. The membranes were then blot dried and 
scanned. 
 
4.2.6 In-gel digestion of protein bands and spots 
 
Protein bands and spots which were found positive on the Western blots were 
subsequently excised from the corresponding gels. Destaining was subsequently carried 
out with 50% acetonitrile (ACN) containing 50mM ammonium bicarbonate. Reduction 
and alkylation were later performed on the gels with 10mM DTT followed by 55mM 
iodoacetamide. Dehydration was performed by adding 100% ACN to the excised gels. 
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The gels were subsequently digested overnight at 37°C with 15µl (or till the whole gel is 
totally covered) sequencing grade porcine trypsin (Promega, USA) (12.5 ng/µl). The 
resulting tryptic fragments were then extracted with 50% ACN and 5% Trifluoroacetic 
acid (TFA). After vacuum drying, the peptides were re-dissolved in 1 µl matrix solution 
(5mg/ml of α-cyano-4-hydroxycinnamic acid [CHCA], 0.1%TFA, 50% ACN), and 
spotted onto a stainless steel MALDI target plate. 
 
4.2.7 MALDI TOF/TOF MS/MS analysis   
 
The samples on the MALDI target plates were analyzed using the ABI 4700 Proteomics 
Analyzer (Applied Biosystems, USA). For MS analysis, on average 1000 shots were 
accumulated for each sample. MS/MS analyses were performed using nitrogen, at 
collision energy of 1 kV and collision gas pressure of 3.0 × 10-7 Torr. A stop condition 
was used to ensure at least 2,000 to 10,000 shots were combined to obtain a good 
spectrum. MASCOT search engine (version 1.9; Matrix Science) was used to search for 
all of the tandem mass spectra. The GPS ExplorerTM software (Applied Biosystems, 
USA) was used to transform the spectrum files for MASCOT search engine for peptide 
and protein identifications. Cysteine carbamidomethylation, N-terminal acetylation, 
pyroglutamation, and methionine oxidation were selected as variable modifications. An 
error of one missing cleavage was allowed. Precursor error tolerance was set to less than 




4.3 Results and Discussion 
4.3.1 1-Dimensional SDS-PAGE and immunoblots 
 
Proteins were separated in 12% SDS-PAGE and either stained with Coomassie blue for 
total protein analysis or transferred onto membranes and immunolabeled with sera 
previously tested positive for meats on immunoarray to identify allergenic proteins of 
various meats (pork, beef and lamb). The IgE 1-DE immunoblots for various meat 
proteins using pre-screened patients’ sera confirmed the immunoarray results. Figure 3 
shows the SDS-PAGE and the results of the immunoblotting of pork for 8 patients and 
the control subject. IgE-binding proteins for pork meat were identified at >100, 67, 57, 50 
– 40, 37, 30 and 28kDa. The identified immunoreactive bands were comparable with 
results shown by Sabbah et al., 1994a, Sabbah et al., 1994b, Asero et al., 1997, Llatser et 
al., 1998, Benito et al., 2002, and Atanaskovic-Marković et al., 2002. For pig intestine 
and kidney, many IgE-binding proteins ranging from 200 to 15 kDa were seen. 
Especially noticeable were immunoreactive bands at 90, 50, and 30 kDa in both pig 
intestine and kidney. The control subject and blank control (secondary antibody only) 
showed no IgE-binding. The general pattern of IgE-binding was similar among the 8 
patients with variation only in IgE-binding intensity. Majority of the immunoreactive 








Figure 3.  
1-D SDS-PAGE and immunoblotting analysis of proteins from S. scrofa (pig) 
extract. Total protein: Coomassie stain for total protein analysis; Lane 1 (M): marker 
(kDa); Lane 2 (cM): commercial pork skin prick extract; Lane 3 (I): pig intestine PBS 
extract; Lane 4 (K): pig kidney PBS extract; Lane 5 (M): pork PBS extract. Immunoblots 
(1 – 8): 8 patients; Immunoblot 9: control subject; Immunoblot 10: blank control 






Figure 4 shows the SDS-PAGE and the immunoblots of beef for 10 patients and the 
control subjects. IgE-binding proteins were identified at 180, 160, 67, 50, 31, 28, and 23 
kDa. Among to two control patients tested, one (No. 12) showed IgE-binding suggesting 
that the particular control patient may not be a true negative patient. Nevertheless, the 
blank control (secondary antibody only) showed no IgE-binding. The identities of 
immunoreactive bands at 160 and 67 kDa are likely to be bovine gamma globulin (BGG) 
and bovine serum albumin respectively (Ayuso et al., 2000; Fuentes et al., 2004). The 
rest of the IgE-binding proteins are yet to be known. However, from the molecular 
weight, they are likely to be similar to those in pork. 
 
 
Figure 4. 1-D SDS-PAGE and immunoblotting analysis of proteins from B. 
taurus (cow) extract. Lane P: Coomassie stain for total protein analysis; Lane 1 – 10: 
immunoblots with 10 patients’ sera; Lane 11 and 12: immunoblots with 2 control 




Figure 5 shows the SDS-PAGE and the immunoblots of lamb for 10 patients and the 
control subjects. IgE-binding proteins were identified at >100, 75, 50 - 45, 37, 31, 28, and 
25 kDa. The control subjects and blank control (secondary antibody only) showed no 
IgE-binding. Again, the immunoreactive bands were of similar molecular weight to those 
in pork and beef suggesting similar allergenic proteins are present among various meat 




Figure 5. 1-D SDS-PAGE and immunoblotting analysis of proteins from O. 
aries (goat) extract. Lane P: Coomassie stain for total protein analysis; Lane 1 – 10: 
immunoblots with 10 patients’ sera; Lane 11 and 12: immunoblots with 2 control 






4.3.2 2-Dimensional SDS-PAGE and immunoblots 
 
For better separation and resolution to allow accurate identification of allergens and their 
isoforms, the proteins from pork, beef and lamb were separated by means of 2-D PAGE 
and immunoblotted using patients and control subjects sera. Figure 6 – 8, show the 
typical Coomassie blue stained 2-DE maps of pork, beef and lamb proteins in the pH 
range 3 – 10 respectively. The three meat sources showed similar electrophoric profile 
with an average of approximately 250 protein spots distributed over the separation range 
of pI 3 – 10 and molecular size range of 6.5 – 200 kDa. Identification of the IgE-
immunoreactive proteins for each patient was performed by matching the image of the 
Coomassie blue stained gel to the image of immunoblot membrane after 
immunodetection using PDQuest 2-D Analysis Software (Bio-Rad, USA). Both the 
reference gel and the gel for immunoblot were run under similar conditions side by side 
on the same day. Figure 9 – 11, show the 2-DE immunoblots patients and control subjects 
for pork, beef, and lamb respectively to give an overview of all identified allergenic 
proteins.  
 
After image analysis, an average of 25 distinct spots or regions from each species were 
selected as being IgE immunoreactive proteins, and these were excised for MALDI-TOF-
TOF analysis. The results of MALDI-TOF TOF identifications for pork, beef and lamb 






Figure 6. 2-DE separation of S. scrofa (pig) proteins. S. scrofa meat (pork) was 
extracted with TCA/acetone and dissolved in urea sample buffer before 2-D PAGE. First 
dimension: pH 3 – 10 NL; second dimension: 12% SDS-PAGE gel. Protein spots were 
visualized by Coomaisse blue staining. Isoelectric points and molecular weight (kDa) are 
indicated at the top and on the left side, respectively. An arrow with numeral indicates an 





Figure 7. 2-DE separation of B. taurus (cow) proteins. B. taurus meat (beef) was 
extracted with TCA/acetone and dissolved in urea sample buffer before 2-D PAGE. First 
dimension: pH 3 – 10 NL; second dimension: 12% SDS-PAGE gel. Protein spots were 
visualized by Coomaisse blue staining. Isoelectric points and molecular weight (kDa) are 
indicated at the top and on the left side, respectively. An arrow with numeral indicates an 







Figure 8. 2-DE separation of O. aries (goat) proteins.  O. aries meat (mutton) was 
extracted with TCA/acetone and dissolved in urea sample buffer before 2-D PAGE. First 
dimension: pH 3 – 10 NL; second dimension: 12% SDS-PAGE gel. Protein spots were 
visualized by Coomaisse blue staining. Isoelectric points and molecular weight (kDa) are 
indicated at the top and on the left side, respectively. An arrow with numeral indicates an 
IgE-binding spot identified by MALDI-TOF-TOF mass spectrometry.    
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Figure 9. 2-DE immnoblots of S. scrofa (pig) proteins. A blotting membrane was 
probed with serum IgE from patients (A – F) and from control subject as negative control 






        
Figure 10. 2-DE immnoblots of B. taurus (cow) proteins. A blotting membrane was 
probed with serum IgE from patients (A – D) and from control subject as negative control 







       
Figure 11. 2-DE immnoblots of O. aries (goat) proteins. A blotting membrane was 
probed with serum IgE from patients (A – C) and from control subject as negative control 






4.3.3 Protein identification by MALDI-TOF_TOF mass spectrometry 
 
The results from MALDI-TOF-TOF analysis for pork showed 25 out of 26 spots have 
significant homology (Mowse scores >75) with known peptide sequences from the 
database. Interestingly, many of the identified proteins are homologous to known 
allergens such as tropomyosins, heat shock proteins, serum albumin, IgG heavy chain, 
enolases, troponins, and transferrins. Most of the above mentioned identified proteins are 
highly conserved based on sequence homology and even structural conformation (except 
troponins), hence they are very likely to be cross-reactive. For instance, shown in Figure 
12, is the structural similarity among transferrins from pig, cow and the know allergen 
Gal d 3 which is an ovotransferrin. The prevalence of hypersensitivity reactions to 
homologous allergens from other origins that share IgE epitopes on molecules is likely to 







Allergen Gal d 3
Figure 12. Three-dimensional homology modeling of allergen Gal d 3 (ovotransferrin 
precursor-conalbumin) and other transferrins from (A) pig and (B) cow. They  show 
very high sequence and structural homology thus are candidate putative allergens. 
A
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Tropomyosins are highly conserved with approximately 75% sequence identity with 
other arthropod tropomyosins and they have been shown to be highly cross-reactive 
among shellfish and other invertebrate tropomyosins (Reese et al., 1997). These proteins 
are highly allergenic and hence have been termed pan allergens, and are responsible for a 
significant proportion of house dust mite and shellfish allergies. The purified natural 
protein has a molecular weight of 37 kDa (Aki et al., 1995; Reese et al., 1997), and the 
result 2-D immunoblotting demonstrated a similar molecular weight (Spot S1 at 
approximately 37 kDa) for porcine tropomyosin homologue (Figure 5). Spot S3, which 
was also identified as tropomyosin, could be a dimerized entity of tropomyosin at 
approximately 70 kDa. Structural study on tropomyosins have revealed a parallel two-
stranded alpha-helical coiled-coil structure with a remarkable core hence suggest the 
likelihood of forming dimers (Brown et al., 2001) 
 
Heat shock proteins (HSPs) are ubiquitously expressed highly conserved molecular 
chaperones that are classified based on their respective molecular masses. The HSP 
family includes: small HSPs (HSP25, HSP27, and HSP28 family), HSP40, HSP60, 
HSP70, HSP90 and HSP110 family. Unfortunately, HSPs are also common fungal 
allergens known to widely cross-reactive across the different families (Shen et al., 1997). 
Additionally, HSP70 are common allergens in barley, corn and hazel pollen (Chiung et 
al., 2000; Gruehn et al., 2003). Our 2-DE immunoblotting results have identified two 
spots S7 and S8 as heat shock protein 70 at the correct molecular weight. The fact that 
there were two or even more heat shock proteins present suggests that they are isoforms 
or variants of post-translational protein modification. To date, there are no studies done 
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on isoforms identification and post-translational protein modification with regards to 
meat (pork, beef, and mutton) proteome. However, considerable interest in milk 
proteomics in recent years because the occurrence of co- and post-translational protein 
modifications means that many gene products are present in milk as multiple protein 
forms (Natale et al., 2004). The spatial and temporal distribution of isoforms can play a 
crucial role in determining functionality whether in the context of development, 
maintenance of homeostasis or progression of allergic diseases (Natale et al., 2004). The 
difference in the two HSPs identified were likely due to glycosylation because spot S8 
was glucose-related.  
 
Enolase is another pan-allergen usually isolated among the molds (Breitenbach et al., 
1997; Simon-Nobbe et al., 2000) and recently also identified as a cross-reacting allergen 
in latex (Hevea. brasiliensis), Hev b 9 (Wagner et al., 2000). A typical molecular weight 
of enolase ranges from 47 to 55 kDa and the result from our 2-DE immunoblots have 
identified an enolase protein (Spot S20) at approximately 47 kDa. Troponin is a known 
allergen (Bla g 6) specifically found in cockroach Blatella germanica (Arruda et al., 
1995). Troponin is allergenic probably due to its association with tropomyosin which is a 
common pan-allergen. This is because troponin and tropomyosin forms a complex during 
the process of muscle contraction and relaxation hence they may have region of similar 
conformational or linear epitopes. The results of our 2-DE immunoblots have identified 
three troponin spots (Spot S21, S22, and S23) indicating the presence of isoforms or 
variants of post-translational protein modification. However, the molecular weights of the 
identified troponins (approximately 36 kDa) were of a larger size compared to a typical 
 101
troponin of approximately 30 kDa. The slight difference in molecular weight observed 
may be due the slight variations in ionic charges of the protein which will affect the speed 
of migration in the SDS-PAGE gel resulting in a shift in molecular weight. Another 
reason for the shift in molecular weight may be due to post-translational protein 
modification such as glycosylation and phosphorylation. For instance, an additional N-
glycan glycosylation caused a 3 kDa shift (Piva et al., 2002).  
 
The degree of overlap among the proteins identified by mass spectrometry was very high 
among the three animal species. A total of 13 out of 58 proteins (22%) were found in all 
three animal species and 35 proteins (60%) were found in at least two species. This high 
degree of overlap indicates that the compositions of allergenic components are vastly 
similar among the three species and they are most likely cross-reactive. One interesting 
observation was many of the proteins identified in mutton are related to glycolysis or 
Kerbs’ cycle pathway such as enolase, pyruvate dehydrogenase, fructose 1,6-
bisphosphate aldolase,  malate dehydrogenase and aconitase. Studies have shown that 
sensitization to microbial antigens was accompanied by the process of glycolysis and 
dehydrogenase activity (Pleshkova, 1978). Another study has shown that ovalbumin 
sensitized and challenged mice have a significant increase in nitrated protein and many of 
these proteins have been identified as the above mentioned enzymes involved in 
glycolysis and kerbs’ cycle (Ghosh et al., 2006). Therefore, these enzymes may have a 
role in the process of sensitization and/or inflammatory response. Additionally, enolase 
has been demonstrated to be an allergen (Hev b 9) in latex suggesting that the other 
enzymes were likely allergenic.
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Table 1.  
Identification of proteins fro 2-DE of S. scrofa (Pig) after in-gel trypsin digestion by MALDI-TOF-TOF and NCBI database 
searching. Missing spots were due to poor spectra, no significant matches, or keratin contaminations. 
 
Protein identified by MALDI TOF/TOF MS/MS   
Spot Calculated Protein identity Peptides Sequence MOWSE E-value NCBI Accession 
ID pI/Mr matched coverage (%) score number
S1 4.66/32931 Tropomyosin 2, beta 5 26 271 2.00E-19 gi|11875203 
S2 4.56/50913 PREDICTED: similar to RIKEN cDNA 1110030K22 13 19 212 1.6e-015  gi|62645352 
S3 4.71/32732 Tropomyosin 1, alpha 18 40 161 2e-010  gi|57281697 
S4 5.50/39199 Alpha-2-HS glycoprotein precursor (Fetuin-A) 10 30 85 0.0074 gi|231467
S5 5.3/42272 Actin skeletal muscle 14 23 171 2e-011  gi|217376 
S6 5.13/89917 Valosin-containing protein 34 44 231 2.00E-17 gi|47523626
S7 5.24/70989 Heat shock protein 70kDa 27 42 321 2.00E-26 gi|123647
S8 5.38/81568 Heat shock protein 70kDa (Glucose-related) 21 30 181 2.00E-12 gi|55632315
S9 5.92/71362 Serum albumin precusor 26 32 299 3.20E-24 gi|833798
S11 5.36/31573 Actin capping protein Z 11 29 105 7.90E-05 gi|45382141
S12 5.02/22521 Myosin light chain 11 38 162 1.6e-010  gi|33563264 
S13 5.36/31611 F-actin capping protein (CapZ beta) 13 34 99 0.00032  gi|1345668  
S14 5.61/45547 Aminoacylase I 13 28 110 2.50E-05 gi|1845
S15 5.03/20336 Glycerol-3-phosphate dehydrogenase 8 39 110 2.50E-05 gi|2149959
S16 6.49/22985 Heat shock 27kDa protein 1 19 46 368 4e-031  gi|55926209 
S17 6.82/52954 IgG heavy chain 10 25 94 0.00097 gi|47523192
S18 6.82/52954 IgG heavy chain 13 30 308 4.00E-25 gi|47523192
S19 6.82/52954 IgG heavy chain 7 12 133 1.30E-07 gi|47523192
S20 6.73/55735 Enolase 3 28 50 437 5e-038  gi|57086343 
S21 7.74/29811 Troponin T 11 32 122 1.6e-006  gi|46389787 
S22 7.74/29811 Troponin T 10 30 62 1.5 gi|46389787 
S23 7.74/29811 Troponin T 12 32 78 0.044 gi|46389787 
S24 9.12/55760 Titin immunoglobulin domain protein, myotilin 20 28 229 3.20E-17 gi|13529230
S25 9.3/35582 LIM  protein 16 29 152 1.6e-009  gi|47523806  
S26 6.73/78954 transferrin 35 47 603 1.3e-054  gi|833800 
PMF software: Mascot 
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Table 2.  
Identification of proteins fro 2-DE of B. taurus (cow) after in-gel trypsin digestion by MALDI-TOF-TOF and NCBI database 
searching. Missing spots were due to poor spectra, no significant matches, or keratin contaminations. 
 
Protein identified by MALDI TOF/TOF MS/MS   
Spot Calculated Protein identity Peptides Sequence MOWSE E-value NCBI Accession 
ID pI/Mr matched coverage (%) score number
S1 9.36/51598 Mitochondrial fatty acid beta-oxidation multienzyme complex 26 56 330 2.5E-27  gi|2832715  
S2 8.63/35509 Four and a half LIM domains 1 protein, isoform C 16 30 261 2E-20  gi|61826953 
S3 5.23/42376 Alpha actin 16 37 473 1.30E-41 gi|15825436
S4 8.08/86045 Aconitase 29 24 392 1.6E-033  gi|1351857 
S6 6.75/79870 Transferrin 32 41 440 2.5E-038  gi|2501351 
S8 6.44/47589 Enolase 1 13 23 189 2.00E-07 gi|27806645 
S10 5.46/49852 Bovine Mitochondrial Cytochrome Bc1 Complex 26 52 252 1.60E-19 gi|3891848 
S11 5.21/52587 Desmin 42 70 932 1.60E-87 gi|2959452 
S12 5.14/89977 Valosin-containing protein 23 31 106 2.00E-09 gi|17865351 
S13 5.37/112936 Beta-myosin heavy chain 50 43 447 5.00E-39 gi|49641
S14 5.38/81568 Heat shock 70kDa protein (glucose-related) 18 21 81 0.021 gi|55632315 
S15 5.82/71244 Albumin 15 18 79 0.033 gi|162648 
S18 4.68/32896 Tropomyosin 11 26 81 0.022 gi|19387215 
S19 9.45/36543 Succinate-CoA ligase 12 20 127 5.00E-07 gi|61553261 
S20 5.36/611249 Microtubule-actin crosslinking factor 46 8 79 0.029  gi|4887229
S22 4.97/51397 Bovine F1-Atpase, Chain E 28 56 598 4.00E-54 gi|3660252 





Table 3.  
Identification of proteins fro 2-DE of O. aries (goat) after in-gel trypsin digestion by MALDI-TOF-TOF and NCBI database 
searching. Missing spots were due to poor spectra, no significant matches, or keratin contaminations. 
 
Protein identified by MALDI TOF/TOF MS/MS   
Spot Calculated Protein identity Peptides Sequence MOWSE E-value NCBI Accession 
ID pI/Mr matched coverage (%) score number
S1 9.36/51598 Subunit beta of the mitochondrial fatty acid beta-oxidation multienzyme complex 19 39 172 1.6e-011  gi|2832715
S3 7.6/58393 Pyruvate kinase 26 38 305 7.90E-25 gi|2231167
S4 5.62/223764 Myosin heavy chain 30 17 109 3.2e-005  gi|21743235
S5 5.07/72473 Heat shock 70kDa protein (glucose-regulated protein) 25 35 185 7.90E-13 gi|38303969 
S7 4.97/51397 Bovine F1-Atpase 31 65 505 7.90E-45 gi|3660252
S8 5.21/52587 Desmin 22 49 210 2.50E-15 gi|2959452
S9 5.46/49866 Chain A, Cytochrome Bc1 Complex From Bovine 23 50 202 1.6e-014  gi|51247182 
S11 6.73/47337 Enolase 3, beta muscle  22 44 217 5.00E-16 gi|6679651
S14 5.38/39299 Pyruvate dehydrogenase 11 28 120 2.5e-006  gi|56090293
S15 8.64/44973 Phosphoglycerate kinase 25 56 333 1.30E-27 gi|52783777
S16 6.15/36700 Cytosolic malate dehydrogenase 16 37 212 1.6e-015  gi|61856478
S17 8.20/39586 Fructose 1,6-Bisphosphate Aldolase 22 59 269 3.20E-21 gi|6730621 
S18 9.01/45003 Aminotransferase 16 48 111 2.00E-05 gi|222979
S19 6.73/47337 Enolase 3, beta muscle 22 44 255 7.90E-20 gi|6679651 
S20 8.2/39586 Fructose-bisphosphate aldolase A (Muscle-type aldolase) 21 43 245 7.90E-19 gi|6730621
S24 8.3/39647 Fructose 1,6-Bisphosphate Aldolase 19 45 214 1.00E-15 gi|2781030 
S25 7.25/86045 Aconitase 28 30 240 2.5e-018  gi|1351857
 PMF software: Mascot 
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4.3.4 Comparison between bioinformatics and proteomics approach for allergen 
prediction and/or identification 
 
 
In total, the proteomics approach has identified 58 allergenic proteins from the three 
animal species (pig, cow and goat). Of the 58 proteins, 17 (30%) proteins were predicted 
and identified by both bioinformatics and proteomics approaches (Figure 13). 
Additionally, out of the 17 proteins, 15 (88%) proteins were predicted in both the motif-
based and sequence homology based prediction systems. This result demonstrates that 
when a protein is predicted as a putative allergen in both prediction systems, it is highly 
credible that the particular protein is allergenic. The remaining two proteins [tropomyosin 
in cow (M1) and alpha-2-HS glycoprotein precursor (Fetuin-A) in pig (M2)] were 
predicted one each by the two prediction systems. This indicates that one prediction 
system alone is still deficient and the combination of the two systems significantly 
increases the confidence level of the prediction. Nevertheless, predictive systems are still 
entry level whereby it still requires the proteomics tools to determine IgE-binding to 











Venn diagram showing the comparison between bioinformatics and proteomics 










In this study, we are able to identify 58 allergens from cow, pig and goat. Many of them 
are homologous to well-known allergens such heat shock proteins, tropomyosins, 
dehydrogenases, serum albumins and transferrins. The composition of allergenic 
components is very similar among the three animal species indicating that these similar 
allergenic components contribute to the cross-reactivity among the three species. The 
allergens identified by the proteomics approach also confirm that those putative allergens 
predicted by both allergen prediction systems are indeed allergenic hence increasing the 




























CHAPTER 5: MOLECULAR CLONING AND 
IMMUNOGLOBULIN E (IGE) REACTIVITY OF 




5.1.1 Usage of recombinant allergens for research and diagnosis 
 
Currently, allergists still rely on natural allergenic products that were obtained from crude 
extracts for the diagnosis and treatment of allergic diseases. The natural extracts however 
are heterogeneous in nature containing many non-allergenic proteins, carbohydrates, 
lipids and other macromolecules. The allergens produced from natural sources vary in 
composition and content. Natural products are also at risk of being contaminated with 
allergens from other sources and can contain proteolytic enzymes (van der Veen et al., 
1996). The enzymes may be allergenic or non-allergenic, but in either case can cause 
degradation and loss of potency when administered together with other allergens during 
diagnosis or immunotherapy (Nelson et al., 1996). 
 
Recombinant DNA technology facilitates the characterization and analysis of the 
allergenic proteins; it also provides the basis for producing allergens and their derivatives 
for both diagnostic application and immunotherapy (Valenta, 2002; Schmid-
Grendelmeier and Crameri, 2001). Further advantages of recombinant allergens and their 
derivatives include the production of preparations of consistent pharmaceutical quality; 
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the avoidance of problems of natural extract standardization; the inclusion of optimal 
concentrations of the important allergens; the exclusion of non-allergenic proteins; the 
avoidance of the possible risk of contamination by allergens from other sources; and 
exclusion of the risk of introducing infectious agents (Cromwell et al., 2004). 
 
Beside diagnostic applications, purified allergens (natural or recombinant) are also 
essential research tools to investigate the cellular mechanisms of immediate 
hypersensitivity and the molecular basis of inflammatory reactions (Chapman et al., 
2000). For instance, the IgE binding capacity, T cell responses and cytokine profiles of 
allergens such as the birch pollen Bet v 1 (Ferreira et al., 1993; Ferreira et al., 1996; 
Ferreira et al., 1997) and some peanut allergens (Rabjohn et al., 1999; Burks et al., 1995) 
have been studied using recombinant proteins. The three-dimensional structure of 
allergens can be determined using recombinant protein as an alternative source to its 
natural counterpart. For example, the structure of the fully immunoreactive birch pollen 
allergen Bet v 1 has been solved by both nuclear magnetic resonance (NMR) and X-ray 
crystallography (Gajhede et al., 1996). 
 
5.1.2 Criteria for the production and characterization of recombinant allergens 
for clinical applications 
 
The choice of expression system is essential for the production of recombinant allergen. 
Escherichia coli is the most commonly used host for proteins expression when post-
transcriptional modifications (e.g. glycosylation) is not necessary. Glycosylated proteins 
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can be produced in several eukaryotic expression systems (Schmidt and Hoffman, 2002) 
such as the yeast Pichia pastoris, Baculovirus in host insect cells, mammalian cells, and 
various plants including the tobacco plant Nicotiana benthamiana (Breiteneder et al., 
2001) and barley (Horvath et al., 2000), but this is not to say that the glycosylation will 
be comparable with that of the natural glycoprotein.  
 
Another important issue is solubility and correct folding of the recombinant allergen. For 
E.coli expression system, high-level expression of correctly folded and soluble proteins 
may be achieved for some allergens, but others may be expressed as insoluble inclusion 
bodies. Additionally, problems of aggregation may arise during the refolding process due 
to exposure of hydrophobic residues in unfolded or intermediate states. Therefore, an in 
vitro solubilisation/refolding strategy has to be established to recover the recombinant 
allergen in a soluble and correctly folded form. Correct folding of the recombinant 
protein can be inferred from similar circular dichroism (CD) spectrum profile, reactivity 
and/or activity as the native protein.  
 
The final and most important criterion is safety issues on usage of recombinant allergens. 
There are potential risks associated with contaminants derived from the host cells. Such 
contaminants could conceivably have immunopathological effects and nucleic acid 
contaminants pose theoretical risks, including the possibility that they could be integrated 
into the host genome. Recombinant products derived from plant, insect and animal host 
cells, or from systems including animal products, pose an additional risk of viral infection 
(Cornwell et al., 2004). Nevertheless, since 1991, recombinant allergens such as Bet v 1 
and Bet v 2 were successfully used for in vitro diagnosis of pollen allergy (Valenta et al., 
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1991). Later, the first skin test with recombinant allergen (fungus Aspergillus fumigatus Asp 
f I/a) was described (Moser et al., 1992). Several important allergens form various sources 
are now commercially available for diagnosis purposes, these include mite group 1, 2, 5 and 
7 allergens, cat Fel d 1 and albumin, cockroach Bla g 1, 2, 4 and 5 allergens, birch pollen Bet 





















5.2 MATERIALS AND METHODS  
5.2.1 Bacterial strains 
 
XL1-Blue  [N1]∆(mcrA) 183∆(mcrCB–hsdSMR-mrr)173 endA1 supE44 thi-1recA1 gyr 
1A96 relA1 lac [F’ proAB lacIqZ ∆M15 Tn10 (Tetr)] 
 
BL21 (DE3) F- ompT hsdSB(r-Bm-B) gal dcm (DE3) pLysS 
 
5.2.2 mRNA extraction 
 
Fresh pork and beef were purchased from a local market. One gram of fresh meat tissue 
was ground in a baked overnight mortar filled with liquid nitrogen. After grinding, RNA 
isolation was performed using TRIZOL Reagent (Gibco-BRL, USA) according to the 
manufacturer’s protocol. The purity of the RNA was judged by electrophoresis separation 
and spectrophotometer. 
 
5.2.3 Molecular cloning of recombinant allergens 
5.2.3.1 Bioinformatics analysis 
  
The full-length nucleotide and protein sequences of the putative allergens listed in Table 





List of putative allergens to be cloned 
 
Sus scrofa Bos taurus
Tropomyosin 1 alpha chain (Tropo 1) Enolase 1 (ENO 1)
Tropomyosin 3 (Tropo 3) Aldehyde dehydrogenase (ADH)
Myosin light chain (Myo_L) Heat shock protein 70 kDa (bHSP70)
Troponin T fast skeletal muscle type (TRNT)
Heat shock protein 70 (pHSP70)
90-kDa heat shock protein alpha (HSP90)
 
All nucleotide and amino acid sequences were analyzed and aligned using DNAMAN 
version 4.15 by Lynnon BioSoft. Prediction of the signal peptide cleavage site was 
analyzed using the software SignalP v1.1 (Nielsen et al., 1997). N- glycosylation site 
prediction was done using NetNGlyc 1.0 Server (Blom et al., 2004) using artificial neural 
networks to examine the sequence context of Asn-Xaa-Ser/ Thr sequences. Specific 
primers (Table 2) were designed at both ends of the sequence excluding the signal 
peptide. Oligonucleotide properties were calculated using the webtool Oligonucleotide 












List of specific forward and reverse conserved primers used for PCR amplification 
of desire gene 
 
Types/Names of primer Oligonucleotide primer sequence
Tropo 1 Forward 5'-ATGGACGCCATCAAGAAGAAG-3'
Tropo 1 Reverse 5'-TTATATGGAAGTCATATCGTTG-3'
Tropo 3 Forward 5'-ATGGCTGGAATCACCACCATCG-3'




TRNT Reverse 5'-TTACTTCCACCTTCCGCCAACCTTG-3' 
pHSP70 Forward 5'-ATGGCGAAGAGCGTGGCCATCG-3'
pHSP70 Reverse 5'-CTAATCCACCTCCTCGATGGTG-3'
ENO 1 Forward 5'-ATGTCCATCCTGAAGGTCCACG-3'
ENO 1 Reverse 5'-TTACTTGGCCAACGGGTTTCTGAAG-3'
ADH Forward 5'-ATGTCGTCCTCAGCCATGCC-3' 
ADH Reverse 5'-TTATGAGTTCTTCTGAGAAATTTTGA-3'
bHSP70 Forward 5'-ATGGCGAAAAACATGGCTATCG-3'
bHSP70 Reverse 5'-CTAATCCACCTCCTCAATGGTGGG-3'  




5.2.3.2 RT-PCR to isolate full length clones of putative meat allergens 
 
1 µg of total RNA was used for first strand cDNA synthesis using iScript cDNA 
synthesis kit (Bio-Rad, USA). The second strand of cDNA was synthesized by the use of 
specific forward and reverse conserved primers (Table 2) designed based on known 
sequence published from NCBI. PCR amplification was carried out using Expand long-
template Taq DNA polymerase (Roche, USA). The PCR mixture contained 5 µl of 10× 
PCR buffer, 1 µl of 10 mM dNTP, 0.5 µl of 50 µM forward and reverse primer, 0.5 µl of 
Taq DNA polymerase, 41 µl of ddH2O, and 1.5 µl of cDNA template. The PCR cycling 
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profile was as follow: initial denaturation at 94 °C for 15 sec, followed by 32 cycles at 94 
°C for 15 sec, 50 °C for 25 sec, 68 °C for 2 min and final extension at 68 °C for 7 min. 
PCR was carried out in PTC-100TM Programmable Thermal Controller (MJ Research, 
Inc., USA). The PCR product was analyzed on 1.0% agarose gel. The DNA products 
with the appropriate size were excised and purified from the gel using QIAquick Gel 
Extraction Kit (QIAGEN Inc., USA) as according to manufacturer’s instruction. 
 
5.2.3.3 Cloning of PCR product into pGEMT®-Easy Vector  
 
The extracted PCR products were ligated using pGEM®-T Easy Vector system 
(Promega, USA) following manufacturer’s instruction. Briefly, One µl (~50 ng insert 
DNA) was ligated with 0.5 µl  pGEM_-T Easy vector in 8.5 µl reaction mixture 
containing 5 µl 2x Rapid ligation buffer, 1 µl of T4 DNA ligase and 2.5 µl sterile 
deionized water. The mixture was incubated at 4 °C overnight and was subsequently used 
to transform E. coli XL1-Blue competent cells. 
 
5.2.3.4 Transformation of E. coli strain XL1-Blue 
 
Competent cells were prepared according to Sambrook and Russel (2001). For 
transformation, 100 µl of competent cells (XL1-Blue) were added to the ligation mixture 
and placed on ice for 40 min. The mixture was heat-shocked for 2 min at 42 oC and 
cooled on ice for 2 min. After adding 1 ml Luria-Bertani (LB) broth, the mixture was 
incubated for 45 min in a 37 oC shaker at 200 rpm. The bacterial culture was plated on 
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LB agar containing 100 µg/ml ampicillin, 80 µg/ml of 5-bromo-4-chloro-3-indolyl-beta-
D galactopyranoside (Xgal) and 0.5mM of isopropyl 1-thio-β-Dgalactoside (IPTG). The 
plates were incubated overnight at 37 °C. 
 
5.2.3.5 Colony Screening 
 
Colonies were picked and employed as template in PCR screening to detect correct insert 
in the transformed cells. Clone specific vector primer i.e. SP6 and T7 were used. PCR 
was carried using Taq DNA polymerase (Fermentas, USA) according to manufacturer’s 
instruction. Gel electrophoresis was performed to confirm the insert according with the 
expected size. Listed in Table 3 are the universal primers used for colony screening. 
 
Table 3. 
List of universal primers used for colony screening 
 




pET32 Reverse 5’-TAGCAGCCGGATCTCAGTGGT-‘3  
 
5.2.3.6 Culture of E. coli and Plasmid Extraction 
 
Only colonies with the correct insert were selected for inoculation overnight in 5 ml of 
LB broth at 37 °C with continuous shaking at 200 rpm. E. coli cultures were then 
centrifuged at 3000 x g for 15 min to obtain the cell pellet. Plasmid was extracted from 
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the cells using the QIAprep Miniprep kit (QIAGEN Inc., USA) according to 
manufacturer’s instruction. 
 
5.2.3.7 Ligation Independent Cloning (LIC) of putative allergens into pET32a (+) 
expression vector 
 
LIC kit (Novagen, USA) was applied according to the manufacturer’s protocol for 
directional cloning without the need of restriction enzyme digestion or ligation reaction. 
PCR products of putative or identified allergens with complementary overhangs to 
EK/LIC vector were created by building appropriate 5’ extension into the primers (Table 
4).  The 5’ of the primer was incorporated into the following sequence: 
Sense primer: 5’- GAC GAC GAC AGG ATX* -insert specific sequence-3’ 
Antisense primer: 5’-GAG GAG AAG CCC GGT- insert specific sequence-3’  














List of Ek-LIC forward and reverse primers 
Types/Names of primer Oligonucleotide primer sequence
Ek-LIC Tropo 1 Forward 5'-GACGACGACAAGATGGACGCCATCAAGAAG-3'
Ek-LIC Tropo 1 Reverse 5'-GAGGAGAAGCCCGGTTTATATGGAAGTCAT-3'
Ek-LIC Tropo 3 Forward 5'-GACGACGACAAGATGGCTGGAATCACCACC-3'
Ek-LIC Tropo 3 Reverse 5'-GAGGAGAAGCCCGGTCTACATCTCATTCAG-3'
Ek-LIC Myo_L Forward 5'-GACGACGACAAGATGTCCTTCAGTGCTGAC-3'
Ek-LIC Myo_L Reverse 5'-GAGGAGAAGCCCGGTTTAGATAGACATGATG-3'
Ek-LIC TRNT Forward 5'-GACGACGACAAGATGTCGGACGAGGAAGTAG-3'
Ek-LIC TRNT Reverse 5'-GAGGAGAAGCCCGGTTTACTTCCACCTTCC-3'
Ek-LIC pHSP70 Forward 5'-GACGACGACAAGATGGCGAAGAGCGTGGCC-3'
Ek-LIC pHSP70 Reverse 5'-GAGGAGAAGCCCGGTCTAATCCACCTCCTC-3'
Ek-LIC ENO 1 Forward 5'-GACGACGACAAGATGTCCATCCTGAAGGTC-3'
Ek-LIC ENO 1 Reverse 5'-GAGGAGAAGCCCGGTTTACTTGGCCAACGGGTTTC-3'
Ek-LIC ADH Forward 5'-GACGACGACAAGATGTCGTCCTCAGCCATG-3'
Ek-LIC ADH Reverse 5'-GAGGAGAAGCCCGGTTTATGAGTTCTTCTGAGAAATTTTG-3'
Ek-LIC bHSP70 Forward 5'-GACGACGACAAGATGGCGAAAAACATGGCTATC-3'
Ek-LIC bHSP70 Reverse 5'-GAGGAGAAGCCCGGTCTAATCCACCTCCTCAATGG-3'
Ek-LIC HSP90 Forward 5'-GACGACGACAAGATGCCCGAGGAGACCCAG-3'
Ek-LIC HSP90 Reverse 5'-GAGGAGAAGCCCGGTTCAGTCCACTTCCTCCATGC-3'
 
 
PCR amplification was carried out as described in section 5.2.3 using specific LIC 
forward and reverse primers for individual allergen. The PCR product was analyzed on 
1.0% agarose gel and subjected to gel extraction. The extracted PCR products were 
treated with T4 DNA polymerase in the presence of the appropriate dATP to generate the 
specific vector-compatible overhangs as indicated by the manufacturer’s protocol. The 
inserts were then annealed into the Ek/LIC pET32a (+) expression vector according to the 
manufacturer’s instructions with minor modifications. Briefly, 1 µl of Ek/LIC vector was 
added to 2 µl of T4 DNA polymerase treated Ek/LIC insert and incubated at 22 °C for 5 
min. Subsequently, 1 µl of 25 mM EDTA was added to the mixture and incubate at 22 °C 
for another 5 min.  
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The constructed pET32a (+) expression vectors were transformed (mentioned in section 
5.2.5) into E. coli strain BL21 (DE3) and the plates were incubated overnight at 37 °C. 
After a round of colony screening (mentioned in section 5.2.6) with pET forward and 
reverse primers, clones with the correct size were sent for DNA sequencing. 
 
5.2.4 DNA sequencing  
5.2.4.1 Automated sequencing 
DNA sequencing reactions were performed as suggested in the ABI PrismTM Dye 
Terminator cycle sequencing ready reaction kits (Perkin Elmer, USA) which involved a 
20 µl mixture reaction containing 2 µl Big Dye TM , 3 µl of 2.5 X Sequencing Buffer 
(Perkin Elmer, USA), 300 ng PCR products and 3.2 pmole primer. Thermal cycling 
profile was set for denaturation at 96 °C for 30 sec, annealing at 50 °C for 15 sec, 
extension at 60 °C for 4 min and repeated for 25 cycles.  
 
5.2.4.2 Purification of Automated sequencing products 
 
Following cycle sequencing, 2 µl of 3M sodium acetate (pH4.6), 2 µl of 125 mM EDTA 
and 50 µl of absolute ethanol were added to the reaction mixture and incubated on ice for 
10 minutes, followed by centrifugation for 20 min at 13,000 x g. The pellet was then 
washed twice with 500 µl 70% ethanol and centrifuged for 5 min each time. The pellet 




5.2.4.3 Automated DNA sequencing analysis 
 
The purified extension products were subjected to sequence analysis on an ABI Prism 
377 DNA sequencer (Applied Biosystems, USA). The DNA sequencing service was 
provided by the Department of Biological Sciences, National University of Singapore 
(NUS). 
 
5.2.5 Expression and purification of recombinant allergens 
5.2.5.1 Sample induction and expression 
 
Clones that are of the correct size and have been sequence confirmed were cultured 
overnight in 5 ml of LB broth at 37 °C with continuous shaking at 200 rpm. The cultures 
were then transferred into fresh 200ml LB broth with 100 µg/ml ampicillin and grown to 
OD600 at approximately 0.6. Thereafter, a final concentration of 0.5 mM of isopropyl-
beta-D-thiogalactopyranoside (IPTG) was added to the bacterial cultures and incubated 
for another 4 hrs at 37 °C with continuous shaking at 200 rpm. The cells were harvested 
by centrifugation at 5000 x g for 10 min at 4 °C and re-suspended in 10 ml of binding 
buffer (w/o urea) containing 5 mM imidazole, 0.5M NaCl, 20 mM Tris-HCl, pH 7.9. The 
re-suspened cells were sonicated on ice for 5 x 1 min or until the lysates become slightly 
clear. Both the inclusion bodies and the cell lysates were separated from the supernatant 
by centrifuging at 15,000 x g for 30 min in 4 °C. The recombinant protein’s degree of 
solubility was evaluated by SDS-PAGE for both supernatant and pellet. For protein in 
inclusion bodies, the pellet was dissolved in 1× binding buffer with 6 M urea. 
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5.2.5.2 Affinity purification of recombinant protein with pET-32a (+) His-Tag 
system  
 
His-tagged recombinant proteins were then purified with affinity chromatography by 
using the His•Bind resin and buffer kit (Novagen, USA) according to the manufacturer’s 
instructions. Briefly, the supernatants from either soluble or insoluble proteins were 
loaded onto approximately 10 ml of charged Ni-NTA resin (Novagen) packed in columns 
(Bio-Rad, USA). The bound proteins were washed 10 x with wash buffer (60 mM 
imidazole, 0.5 M NaCl and 20 mM Tris-HCl, pH 7.9) and eluted with 15 ml of elution 
buffer (0.5 M imidazole, 0.5 M NaCl and 20 mM Tris-HCl, pH 7.9). In the case of 
insoluble proteins, 6 M urea was added in the washing and elution buffers. The purified 
proteins were then quantified by the Bio-Rad protein assay (Bio-Rad, USA).  
 
5.2.6 Recombinant proteins immunoarray 
5.2.6.1 Patients and sera 
 
A total of 80 sera from the previously pre-screened population mentioned in section 2.2.6 
were selected for recombinant allergen screening. Positive (70) and negative (10) sera 
were selected based on positivity or negativity to meat crude proteins via allergen 







The procedure for the recombinant proteins immunoarray was essentially the same as 
described in the previous section 2.2.4. 
 
5.3 Results and Discussion 
 
5.3.1 Characterization of recombinant proteins 
5.3.1.1 General Bioinformatics analysis of putative allergen sequences 
 
A total of nine full-length nucleotide and protein sequences were obtained from NCBI 
database. Detailed bioinformatics analyses of the putative allergens are summarized in 
(Table 5). Prediction of the signal peptide cleavage site is based on the (-3, -1) rule as 
suggested by von Heijne (1986) and analysed using the software SignalP v1.1 (Nielsen et al., 
1997). All the nine putative allergens do not have signal peptides and most of them possess 











Detailed bioinformatics analyses of the putative allergens 
 
Putative CDS CDS Est. MW Calculated Signal Glycosylation cDNA sequence 
allergen (bp)  (amino acids) (Daltons) pI Peptide sites diagram
Tropo 1 855 284 32693 4.67 No No Figure 1
Tropo 3 747 248 29000 4.75 No No Figure 2
Myo_L 453 150 16711 4.63 No Yes Figure 7
TRNT 753 250 29795 7.74 No Yes Figure 5
pHSP70 1926 641 70019 5.6 No Yes Figure 11
ENO 1 1305 434 47223 6.44 No Yes Figure 10
ADH 1506 501 54771 6.24 No Yes Figure 8
bHSP70 1926 641 70152 5.68 No Yes Figure 12





Tropomyosin belongs to a family of highly conserved proteins with multiple isoforms 
found in both muscle and non-muscle cells of all species of vertebrates and invertebrates. 
Its native structure consists of two parallel alpha-helical tropomyosin molecules that are 
wound around each other to form a coiled-coil dimer of approximately 66 kDa (Reese et 
al.,1999). The basic function of tropomyosin is regulation of muscle contraction and 
relaxation.  
 
Tropomyosins are potent allergens. Many species especially arthropods are sources of the  
allergenic tropomyosins that can sensitize and induce IgE-mediated allergic reactions in 
humans. Due to its high sequence homology, tropomyosins have been shown to be the 
common allergens in the extracts of crustaceans, mollusks, insects (dust mites, 
cockroaches, moths, etc) and meat exhibiting cross-reactivity among these organisms 
(Martinez, et.al., 1997; Asturias, et al., 1999; Ayuso et al., 1999). A total of eight 
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tropomyosin epitopes were known based on studies on Pen I 1 from Shrimp (Shanti et al., 
1993), Pen a 1 (Penaeus azetus) by Reese et al.,1997, and Oyster Cra g 1 (Ishikawa et al., 
1998) (Table). Thus, tropomyosins from Sus scrofa were cloned to determine their IgE-
binding reactivity. Full length sequence genes of Tropo 1 (Figure1) and Tropo 3 (Figure 
2) comprised of 855 bp and 747 bp encoding polypeptides of 284 and 248 amino acids 
respectively. Tropo 1 and Tropo 3 have relatively high sequence homology with overall 
identity at 60.55% (Figure 3). Also, the likely sites of IgE-binding epitopes were 
predicted based on the eight known tropomyosin epitopes. 
 
 
>X66274 (Sus scrofa Tropomyosin 1 alpha chain (Alpha-tropomyosin)-cardiac)  
 
1         ATGGACGCCATCAAGAAGAAGATGCAAATGCTCAAGCTCGACAAGGAGAACGCCTTGGAT 
1          M  D  A  I  K  K  K  M  Q  M  L  K  L  D  K  E  N  A  L  D   
61        CGAGCGGACGAGGCGGAGGCCGATAAGAAGGCGGCAGAGGACAGGAGCAAGCAGCTGGAA 
21         R  A  D  E  A  E  A  D  K  K  A  A  E  D  R  S  K  Q  L  E   
121       GATGAGCTGGTGTCGCTGCAAAAGAAGCTCAAGGCCACCGAAGATGAACTGGACAAATAT 
41         D  E  L  V  S  L  Q  K  K  L  K  A  T  E  D  E  L  D  K  Y   
181       TCCGAGGCTCTCAAAGATGCCCAGGAGAAGCTGGAGCTGGCGGAGAAAAAGGCCACCGAT 
61         S  E  A  L  K  D  A  Q  E  K  L  E  L  A  E  K  K  A  T  D   
241       GCTGAAGCCGATGTAGCTTCTCTGAACAGACGCATCCAACTGTTTGAGGAAGAGCTGGAC 
81         A  E  A  D  V  A  S  L  N  R  R  I  Q  L  F  E  E  E  L  D   
301       CGTGCCCAGGAGCGACTGGCAACAGCTTTACAGAAACTTGAGGAGGCTGAGAAGGCAGCA 
101        R  A  Q  E  R  L  A  T  A  L  Q  K  L  E  E  A  E  K  A  A   
361       GATGAGAGTGAGAGAGGCATGAAAGTCATTGAAAGCCGAGCCCAAAAGGATGAGGAGAAA 
121        D  E  S  E  R  G  M  K  V  I  E  S  R  A  Q  K  D  E  E  K   
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421       ATGGAAATTCAGGAGATCCAGCTGAAAGAAGCCAAGCACATTGCTGAGGATGCCGACCGC 
141        M  E  I  Q  E  I  Q  L  K  E  A  K  H  I  A  E  D  A  D  R   
481       AAGTATGAAGAGGTGGCCCGTAAGCTGGTCATCATTGAGAGTGACCTGGAACGTGCCGAG 
161        K  Y  E  E  V  A  R  K  L  V  I  I  E  S  D  L  E  R  A  E   
541       GAGCGGGCTGAACTCTCAGAAGGCAAATGTGCCGAGCTTGAAGAAGAGTTGAAAACTGTG 
181        E  R  A  E  L  S  E  G  K  C  A  E  L  E  E  E  L  K  T  V   
601       ACGAACAACTTGAAGTCACTGGAGGCTCAGGCTGAGAAGTACTCACAGAAGGAAGACAAA 
201        T  N  N  L  K  S  L  E  A  Q  A  E  K  Y  S  Q  K  E  D  K   
661       TATGAAGAAGAGATCAAGGTCCTTTCTGACAAGCTGAAGGAGGCTGAAACTCGGGCCGAG 
221        Y  E  E  E  I  K  V  L  S  D  K  L  K  E  A  E  T  R  A  E   
721       TTTGCAGAGAGGTCAGTAACTAAATTGGAGAAAAGCATTGATGACTTAGAAGACGAGCTG 
241        F  A  E  R  S  V  T  K  L  E  K  S  I  D  D  L  E  D  E  L   
781       TACGCTCAGAAACTGAAGTACAAAGCCATCAGCGAGGAGCTGGACCACGCTCTCAACGAT 
261        Y  A  Q  K  L  K  Y  K  A  I  S  E  E  L  D  H  A  L  N  D   
841       ATGACTTCCATATAA 
281        M  T  S  I  *   
 
Figure 1.  
Nucleotide and deduced amino acid sequence of Tropo 1. The predicted initiation Met 
start and stop codon (TAA) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in green are likely regions of tropomyosin IgE-binding 
epitopes based on previously known epitopes. Underlined is the tropomyosin signature at 
amino acid position 232 – 240. 
 
 
>NM_001001632 ( Sus scrofa tropomyosin 3 (TPM3)  
 
1         ATGGCTGGAATCACCACCATCGAGGCGGTGAAGCGCAAGATCCAGGTTTTGCAGCAGCAG 
1          M  A  G  I  T  T  I  E  A  V  K  R  K  I  Q  V  L  Q  Q  Q   
61        GCCGATGATGCAGAGGAGAGGGCCGAGCGCCTCCAGCGGGAAGTGGAGGGGGAAAGGCGG 
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21         A  D  D  A  E  E  R  A  E  R  L  Q  R  E  V  E  G  E  R  R   
121       GCCCGGGAACAGGCTGAGGCTGAGGTGGCCTCCTTGAACCGTAGGATCCAGCTGGTTGAA 
41         A  R  E  Q  A  E  A  E  V  A  S  L  N  R  R  I  Q  L  V  E   
181       GAGGAGCTGGACCGCGCTCAAGAGCGCCTGGCCACTGCCCTGCAAAAGCTGGAGGAAGCT 
61         E  E  L  D  R  A  Q  E  R  L  A  T  A  L  Q  K  L  E  E  A   
241       GAGAAAGCTGCTGATGAGAGCGAGAGAGGTATGAAGGTCATTGAAAACCGAGCCTTAAAA 
81         E  K  A  A  D  E  S  E  R  G  M  K  V  I  E  N  R  A  L  K   
301       GATGAGGAAAAAATGGAACTCCAGGAAATCCAACTCAAAGAAGCTAAGCACATTGCAGAA 
101        D  E  E  K  M  E  L  Q  E  I  Q  L  K  E  A  K  H  I  A  E   
361       GAGGCAGATAGGAAGTATGAAGAGGTGGCTCGTAAGTTGGTGATTATTGAGGGAGACTTG 
121        E  A  D  R  K  Y  E  E  V  A  R  K  L  V  I  I  E  G  D  L   
421       GAACGCACAGAGGAGCGAGCTGAGCTGGCAGAGTCCCGTTGCCGAGAGATGGATGAGCAG 
141        E  R  T  E  E  R  A  E  L  A  E  S  R  C  R  E  M  D  E  Q   
481       ATCAGACTGATGGACCAGAATCTGAAGTGTCTGAGTGCTGCTGAAGAAAAGTACTCTCAA 
161        I  R  L  M  D  Q  N  L  K  C  L  S  A  A  E  E  K  Y  S  Q   
541       AAAGAAGACAAATATGAGGAAGAGATAAAGATTCTCACTGACAAACTCAAGGAGGCAGAG 
181        K  E  D  K  Y  E  E  E  I  K  I  L  T  D  K  L  K  E  A  E   
601       ACCCGGGCCGAGTTTGCCGAGAGATCGGTAGCCAAGCTGGAAAAGACAATTGATGACTTG 
201        T  R  A  E  F  A  E  R  S  V  A  K  L  E  K  T  I  D  D  L   
661       GAAGATAAACTGAAATGCACCAAAGAGGAGCACCTCTGTACACAAAGGATGCTGGACCAG 
221        E  D  K  L  K  C  T  K  E  E  H  L  C  T  Q  R  M  L  D  Q   
721       ACTCTGCTCGACCTGAATGAGATGTAG 
241        T  L  L  D  L  N  E  M  *   
 
Figure 2.  
Nucleotide and deduced amino acid sequence of Tropo 3. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in green are likely regions of tropomyosin IgE-binding 
epitopes based on previously known epitopes. Underlined is the tropomyosin signature at 
amino acid position 196 – 204.  
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    40Tropo 1
    15Tropo 3
MDAIKKKMQMLKLDKENALDRADEAEADKKAAEDRSKQLE
M.A........GI...TTI....EA.V.K.....R.K.IQ
    79Tropo 1
    42Tropo 3
DELVSLQKKLKATED.ELDKYSEALKDAQEKLELAEKKAT
...V.LQQ..QA.DDAE.ER.AERLQ..RE.VE.GERRAR
   118Tropo 1
    82Tropo 3
D.AEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEK
EQAEAEVASLNRRIQLVEEELDRAQERLATALQKLEEAEK
   158Tropo 1
   122Tropo 3
AADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAEDA
AADESERGMKVIENRALKDEEKMELQEIQLKEAKHIAEEA
   198Tropo 1
   162Tropo 3
DRKYEEVARKLVIIESDLERAEERAELSEGKCAELEEELK
DRKYEEVARKLVIIEGDLERTEERAELAESRCREMDEQIR
   237Tropo 1
   201Tropo 3
TVTNNLKSLEAQA.EKYSQKEDKYEEEIKVLSDKLKEAET
LMDQNLKCLSA.AEEKYSQKEDKYEEEIKILTDKLKEAET
   276Tropo 1
   240Tropo 3
RAEFAERSVTKLEKSIDDLEDELYAQKLKYKAISEE.LDH
RAEFAERSVAKLEKTIDDLEDKLKCTKEEH.LCTQRMLDQ
   283Tropo 1




Figure 3.  
Multiple sequence alignments between Tropo 1 and Tropo 3. Amino acid with 100% 
identity colored in black and more than 50% homology colored in blue. Dots have been 
introduced to maximize the alignments. 
 
 
Total Sus scrofa RNA was used to amplify the cDNA coding for the tropomyosins using 
gene specific primers designed based on the known sequences. Various steps for cloning 
and agarose gel electrophoresis results were shown in Figure 4. Cloning and agarose gel 
electrophoresis results for other putative allergens are shown in appendix XV – XXII. 
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Figure 4. 
Molecular cloning of Tropo 1. (A) RNA extraction: Agarose (1%) gel showing the 
total RNA extraction of meat from Sus scrofa using Trizol reagent in Lane 1. Distinct 
double bands were observed indicating integrity of the 28s and 18s RNA, however, there 
was an accumulation of 5S RNA. Nevertheless, the RNA was used for cDNA synthesis. 
(B) PCR amplification of target tropomyosin gene with gene specific primers using 
Expand long-template Taq DNA polymerase. Amplicons in Lane 1 and 2 corresponds to 
correct expected size of ~900 bp. PCR amplicons from both lanes were extracted and 
purified using QIA quick Gel extraction Kit (Qiagen) and ligated to pGEMT-Easy vector 
followed by transformation into XL-1 blue non-expression host. (C) Colony screening of 
PCR inserts in pGEMT vector using SP6 and T7 primers: A total of 10 colonies were 
screened for insert. Only five lanes were showed here (Lane: 1 to 5). Only 5 out of 10 
clones showed the presence of insert with expected size of ~900 bp. (D): PCR 
amplification of target gene from pGEM-T plasmids with correct insert using 
designed LIC primer adaptors. Purified pGEM-T plasmid from clone 1 (Lane 1 of Fig 
C) was used. The PCR amplified band was gel extracted, and purified. The final digested 
DNA fragment was ligated into pET-32a (+) expression vector (Novagen, USA) using T4 
DNA ligase (Invitrogen, USA) and transformed into XL1-Blue non-expression host cell. 
(E): Colony screening of pET32a ligated insert in transformed XL 1-blue non-
expression host strain using LIC primers. Lane 1 to 5 corresponds to 5 clones chosen with 
the correct size of insert. (F): Sub cloning of ligated Pet Vector plasmid into BL-21 
(DE3) (Novagen, USA) expression host. Again, colony screening was performed (lane 1 
to 5). The clones were subsequently sequenced from both ends to check for correct 
reading frame. Clone 2 and Clone 4 were selected for protein expression. Glycerol stocks 




Troponin is a protein complex that confers calcium sensitivity to muscle cells which is 
pivotal for muscle contraction (Wikipedia, 2006). It is found in both skeletal muscle and 
cardiac muscle, but the specific versions of troponin differ between types of muscle. 
Troponin is a component of thin filaments (along with actin and tropomyosin), and is the 
protein to which calcium binds that is essential for muscle contraction and relaxation 
regulation. Troponin has three subunits, TnC, TnI, and TnT. When calcium is bound to 
specific sites on TnC, the structure of the thin filament changes in such a manner that 
myosin (a molecular motor organized in muscle thick filaments) attaches to thin filaments 
and produces force and/or movement (Wikipedia, 2006). In the absence of calcium, 
tropomyosin interferes with this action of myosin, and therefore muscles remain relaxed. 
 
Troponin has been identified as an allergen in cockroach Blatella germanica (Arruda et 
al., 1995). The identified cockroach allergen Bla g 6 is a troponin C whereas the putative 
allergen from Sus scrofa is a troponin T (TRNT). Both troponins are calcium-binding 
proteins which may be related to other calcium-binding allergen such as Bet v 3, Bos d 3 
and Ole e 3. However, Bla g 6, Bet v 3, Bos d 3, and Ole e 3 showed weak overall 
sequence identity of 17.00%, 16.02%, 13.55% and 11.07% to TRNT respectively (Figure 
6). 
 
The full length sequence genes TRNT comprised of 753 bp encoding a 250 amino acid 




>NP_001001863 (Troponin T fast skeletal muscle type)  
 
1         ATGTCGGACGAGGAAGTAGAACACGTCGAGGAAGAGTACGAGGAGGAAGAAGAGGCCCAG 
1          M  S  D  E  E  V  E  H  V  E  E  E  Y  E  E  E  E  E  A  Q   
61        GAGGAAGAGGAAGTTCAAGAAGAGGAGAAGCCGAGACCCAAACTCACTGCTCCTAAGATC 
21         E  E  E  E  V  Q  E  E  E  K  P  R  P  K  L  T  A  P  K  I   
121       CCGGAAGGGGAGAAAGTCGACTTTGATGACATCCAGAAGAAGCGCCAGAATAAGGACCTT 
41         P  E  G  E  K  V  D  F  D  D  I  Q  K  K  R  Q  N  K  D  L   
181       ATGGAGCTGCAGGCCCTCATCGACAGCCACTTCGAGGCTCGGAAGAAGGAGGAAGAGGAG 
61         M  E  L  Q  A  L  I  D  S  H  F  E  A  R  K  K  E  E  E  E   
241       CTGGTCGCTCTCAAGGAGAGAATCGAGAAGCGCCGTGCCGAGAGAGCCGAGCAGCAGAGG 
81         L  V  A  L  K  E  R  I  E  K  R  R  A  E  R  A  E  Q  Q  R   
301       ATCCGGGCTGAGAAGGAGCGGGAGCGCCAGAACAGGCTGGCGGAGGAGAAGGCCCGGCGG 
101        I  R  A  E  K  E  R  E  R  Q  N  R  L  A  E  E  K  A  R  R   
361       GAGGAGGAGGAAGCCAAGAGAAGGGCAGAGGACGACCTGAAGAAAAAGAAGGCGCTGTCC 
121        E  E  E  E  A  K  R  R  A  E  D  D  L  K  K  K  K  A  L  S   
421       TCCATGGGCGCCAACTACAGCAGCTACCTGGCCAAGGCCGAYCAGAAGCGAGGCAAGAAG 
141        S  M  G  A  N  Y  S  S  Y  L  A  K  A  D  Q  K  R  G  K  K   
481       CAGACGGCCCGGGAGATGAAGAAGAAGGTGCTGGCCGAGCGGAGGAAGCCCCTCAACATC 
161        Q  T  A  R  E  M  K  K  K  V  L  A  E  R  R  K  P  L  N  I   
541       GACCACCTCAGTGAGGACAAGCTGAGGGACAAGGCCAAGGAGCTCTGGGACGCCCTGTAC 
181        D  H  L  S  E  D  K  L  R  D  K  A  K  E  L  W  D  A  L  Y   
601       CARCTGGAGATTGACAAGTTCGAGTACGGGGAGAAGCTGAAGCGCCAGAAATACGACATC 
201        Q  L  E  I  D  K  F  E  Y  G  E  K  L  K  R  Q  K  Y  D  I   
661       ATCAACCTCAGAAGCCGCATCGACCAGGCCCAGAAGCACAGCAAGAAGGCCGGGACGACG 
221        I  N  L  R  S  R  I  D  Q  A  Q  K  H  S  K  K  A  G  T  T   
 131
721       CCCAAGGGCAAGGTTGGCGGAAGGTGGAAGTAA 
241        P  K  G  K  V  G  G  R  W  K  * 
 
Figure 5.  
Nucleotide and deduced amino acid sequence of TRNT. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in red is the predicted N-glycosylation site. 
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    40TRNT
    11Bla g 6
    28Bet v 3
     0Bos d 3






    69TRNT
    51Bla g 6
    68Bet v 3
     2Bos d 3






   109TRNT
    90Bla g 6
   108Bet v 3
    40Bos d 3






   146TRNT
   100Bla g 6
   135Bet v 3
    55Bos d 3






   186TRNT
   135Bla g 6
   169Bet v 3
    87Bos d 3






   226TRNT
   163Bla g 6
   204Bet v 3
   101Bos d 3






   250TRNT
   163Bla g 6
   204Bet v 3
   101Bos d 3








Multiple sequence alignments between TRNT, Bla g 6, Bet v 3, Bos d 3 and Ole e 3. 
Amino acid with 100% identity colored in black, 75% homology colored in pink and 
50% homology colored in blue... Dots have been introduced to maximize the alignments 
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5.3.1.4 Myosin-light chain 
 
Myosin protein is a heteropolymer composed of two heavy chains (approximately 
200,000 MW) and two pair of light chains. The light chain pair have been termed 
essential light chain 1 (25,000 MW) and regulatory light chain 2 (19,000 MW). The light 
chains that associate with each heavy chain in the neck region are calmodulin or 
calmodulin-like proteins. Light chains may provide structural support in neck domains 
and in some cases have a regulatory role. Another study has suggested that the essential 
light chain could form a link between thin and thick filaments to modulate the 
actomyosin interaction. The myosin light chain may play an important role in modulating 
the kinetics of catalytic activity in myosin which is mainly determined by the heavy chain 
structure (Sugiura et al., 2002). 
 
Although currently no allergen has been classified as a myosin-light chain, our studies 
have shown that this protein is potentially allergenic. The possible account that myosin 
light chain could be allergenic may be related to its association with actin, which has 
been shown to bind IgE with meat allergic patients’ sera (Bourne et al., 2005). Cross-
linking of myosin from fast muscle with actin leads to, amongst others, the formation of a 
Myosin light chain -1F-actin complex (Andreev and Borejdo, 1995). The formation of 
Myosin light chain – 1F-actin complex indicates that myosin light chain may share 
similar conformational or linear epitopes with actin hence eliciting an immune response. 
Thus the myosin light chain cDNA clone was constructed by PCR from S. scrofa cDNA. 
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The cloned myosin light chain (Myo_L) comprised of 453 bp encoding a 150 amino acid 
protein (Figure 7). There are three N-glycosylation sites predicted in Myo_L. 
 
>NM_214374 (Sus scrofa myosin light chain (MYL1) 
 
1         ATGTCCTTCAGTGCTGACCAGATTGCTGAATTCAAGGAGGCATTTCTCCTCTTTGACAGA 
1          M  S  F  S  A  D  Q  I  A  E  F  K  E  A  F  L  L  F  D  R   
61        ACAGGCGAATGCAAGATCACCCTAAGCCAGGTTGGTGATGTCCTTCGGGCTCTGGGCACA 
21         T  G  E  C  K  I  T  L  S  Q  V  G  D  V  L  R  A  L  G  T   
121       AATCCCACCAATGCAGAGGTCAAGAAGGTTCTGGGAAACCCCAGCAATGAAGAGATGAAT 
41         N  P  T  N  A  E  V  K  K  V  L  G  N  P  S  N  E  E  M  N   
181       GCCAAGAAAATTGAGTTTGAACAATTCCTGCCTATGCTGCAAGCTATTTCCAACAACAAG 
61         A  K  K  I  E  F  E  Q  F  L  P  M  L  Q  A  I  S  N  N  K   
241       GACCAGGGAAGCTATGAAGACTTTGTTGAGGGTCTGCGTGTCTTTGACAAGGAAGGCAAT 
81         D  Q  G  S  Y  E  D  F  V  E  G  L  R  V  F  D  K  E  G  N   
301       GGTACAGTCATGGTGACTGAACTTCGTCATGTTCTAGCTACACTAGGTGAAAAGATGAAA 
101        G  T  V  M  V  T  E  L  R  H  V  L  A  T  L  G  E  K  M  K   
361       GAGGAAGAAGTGGAAGCCCTGATGGCAGGTCAAGAAGACTCCAATGGCTGCATCAACTAT 
121        E  E  E  V  E  A  L  M  A  G  Q  E  D  S  N  G  C  I  N  Y   
421       GAAGCCTTTGTCAAGCACATCATGTCTATCTAA 
141        E  A  F  V  K  H  I  M  S  I  * 
 
Figure 7.  
Nucleotide and deduced amino acid sequence of Myo_L. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 




5.3.1.5 Aldehyde dehydrogenase 
 
Aldehyde dehydrogenases have been found in nearly every form of living thing. Their 
primary role in humans and other mammals is protecting the body from toxic compounds 
called aldehydes. Aldehyde dehydrogenase, often in tandem with alchohol 
dehydrogenase, acts in detoxifying a wide variety of organic compounds, toxins and 
pollutants hence it is also classify as a stress response protein. The bovine aldehyde 
dehydrogenase displayed high sequence homology to known aldehyde dehydrogenase 
fungal allergens from Alternaria alternate (Alt a 10) and Cladosporium herbarum (Cla h 
3) at 49.3% and 50.5% respectively (Figure 9). 
 
Thus, the aldehyde dehydrogenase cDNA clone (ADH) was constructed by PCR from B. 
taurus cDNA. The ADH sequence comprised of 1506 bp encoding a 501 amino acid 
protein (Figure 8). The PROSITE program (Hoffman et al., 1999) detected a conserved 
glutamic acid and cysteine residues in the sequence which was implicated in the catalytic 
activity of mammalian aldehyde dehydrogenase. One N-glycosylation site was also 
predicted in ADH.  
 
> NM_174239 (Bos taurus aldehyde dehydrogenase 1 family, member A1 
(ALDH1A1)  
 
1         ATGTCGTCCTCAGCCATGCCAGACGTACCTGCCCCACTCACCAATTTGCAGTTTAAATAT 
1          M  S  S  S  A  M  P  D  V  P  A  P  L  T  N  L  Q  F  K  Y   
61        ACTAAGATCTTCATAAACAATGAATGGCATAGTTCAGTGAGTGGTAAGAAATTTCCAGTC 
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21         T  K  I  F  I  N  N  E  W  H  S  S  V  S  G  K  K  F  P  V   
121       TTTAATCCTGCAACTGAGGAGAAACTCTGTGAGGTGGAAGAAGGAGATAAGGAGGATGTT 
41         F  N  P  A  T  E  E  K  L  C  E  V  E  E  G  D  K  E  D  V   
181       GACAAAGCAGTGAAGGCTGTAAGACAAGCTTTTCAGATTGGCTCTCCATGGCGTACTATG 
61         D  K  A  V  K  A  V  R  Q  A  F  Q  I  G  S  P  W  R  T  M   
241       GATGCTTCAGAGAGAGGACGGCTGTTAAACAAGTTGGCTGACTTAATTGAAAGAGATCAT 
81         D  A  S  E  R  G  R  L  L  N  K  L  A  D  L  I  E  R  D  H   
301       CTGCTCCTGGCGACAATGGAGGCAATGAATGGTGGAAAACTATTTTCCAATGCATATCTG 
101        L  L  L  A  T  M  E  A  M  N  G  G  K  L  F  S  N  A  Y  L   
361       ATGGATTTAGGAGGCTGCATAAAAACACTACGCTACTGTGCAGGCTGGGCTGACAAGATC 
121        M  D  L  G  G  C  I  K  T  L  R  Y  C  A  G  W  A  D  K  I   
421       CAGGGCCGCACAATACCCATGGATGGAAACTTTTTTACATATACAAGAAGTGAGCCTGTT 
141        Q  G  R  T  I  P  M  D  G  N  F  F  T  Y  T  R  S  E  P  V   
481       GGTGTGTGTGGCCAAATCATTCCTTGGAATTTCCCATTGCTCATGTTCCTCTGGAAGATA 
161        G  V  C  G  Q  I  I  P  W  N  F  P  L  L  M  F  L  W  K  I   
541       GGGCCTGCCCTTAGCTGCGGAAACACAGTGGTTGTCAAACCAGCAGAGCAAACCCCTCTG 
181        G  P  A  L  S  C  G  N  T  V  V  V  K  P  A  E  Q  T  P  L   
601       ACTGCTCTTCACATGGGATCTTTAATAAAAGAGGCAGGGTTTCCTCCTGGAGTAGTGAAT 
201        T  A  L  H  M  G  S  L  I  K  E  A  G  F  P  P  G  V  V  N   
661       ATTGTCCCTGGTTATGGGCCTACTGCAGGGGCAGCCATTTCTTCTCACATGGATGTAGAC 
221        I  V  P  G  Y  G  P  T  A  G  A  A  I  S  S  H  M  D  V  D   
721       AAAGTGGCCTTCACAGGATCGACAGAGGTTGGCAAACTGATCAAAGAAGCTGCTGGGAAA 
241        K  V  A  F  T  G  S  T  E  V  G  K  L  I  K  E  A  A  G  K   
781       AGCAATCTGAAAAGGGTGTCCCTGGAACTCGGGGGAAAGAGTCCTTGCATTGTGTTTGCT 
261        S  N  L  K  R  V  S  L  E  L  G  G  K  S  P  C  I  V  F  A   
841       GATGCCGACTTGGACAATGCTGTTGAATTTGCACACCAAGGAGTATTCTATCACCAGGGC 
281        D  A  D  L  D  N  A  V  E  F  A  H  Q  G  V  F  Y  H  Q  G   
901       CAGTGTTGTATAGCTGCATCCCGTCTCTTTGTAGAAGAATCAATTTACGATGAGTTTGTT 
301        Q  C  C  I  A  A  S  R  L  F  V  E  E  S  I  Y  D  E  F  V   
 137
961       CGAAGGAGTGTTGAGCGGGCGAAAAAGTATGTTCTTGGAAATCCTCTGACCCCAGGAGTC 
321        R  R  S  V  E  R  A  K  K  Y  V  L  G  N  P  L  T  P  G  V   
1021      AGTCAAGGCCCTCAGATTGATAAAGAACAATATGAAAAAATACTTGACCTCATTGAAAGT 
341        S  Q  G  P  Q  I  D  K  E  Q  Y  E  K  I  L  D  L  I  E  S   
1081      GGGAAGAAGGAGGGGGCCAAGCTGGAATGTGGCGGAGGCCCTTGGGGGAATAAAGGCTAC 
361        G  K  K  E  G  A  K  L  E  C  G  G  G  P  W  G  N  K  G  Y   
1141      TTTATCCAACCCACAGTTTTCTCTGATGTTACTGATGATATGCGCATTGCCAAAGAGGAG 
381        F  I  Q  P  T  V  F  S  D  V  T  D  D  M  R  I  A  K  E  E   
1201      ATATTTGGACCTGTGCAGCAAATCATGAAGTTTAAGTCTTTAGATGATGTAATCAAGAGA 
401        I  F  G  P  V  Q  Q  I  M  K  F  K  S  L  D  D  V  I  K  R   
1261      GCAAACAATACTTTCTATGGGTTATCTGCAGGAATATTTACCAATGATATTGATAAAGCC 
421        A  N  N  T  F  Y  G  L  S  A  G  I  F  T  N  D  I  D  K  A   
1321      ATCACAGTCTCCTCTGCTTTGCAGTCTGGAACCGTGTGGGTGAACTGCTATAGTGTGGTA 
441        I  T  V  S  S  A  L  Q  S  G  T  V  W  V  N  C  Y  S  V  V   
1381      TCTGCCCAGTGCCCCTTTGGTGGATTCAAGATGTCTGGAAATGGTCGAGAACTGGGAGAA 
461        S  A  Q  C  P  F  G  G  F  K  M  S  G  N  G  R  E  L  G  E   
1441      TATGGTTTCCATGAATACACAGAAGTCAAGACGGTCACAATCAAAATTTCTCAGAAGAAC 
481        Y  G  F  H  E  Y  T  E  V  K  T  V  T  I  K  I  S  Q  K  N   
1501      TCATAA 
501        S  * 
 
Figure 8.  
Nucleotide and deduced amino acid sequence of ADH. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in red is the predicted N-glycosylation site. Underlined are 
the conserved glutamic acid site and cysteine site which are located at amino acid 
positions 268 - 275 and 296 - 307 respectively. 
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    40ADH
    37Alt a 10




    80ADH
    77Alt a 10




   120ADH
   115Alt a 10




   160ADH
   154Alt a 10




   200ADH
   194Alt a 10




   240ADH
   234Alt a 10




   280ADH
   274Alt a 10




   320ADH
   314Alt a 10




   360ADH
   353Alt a 10




   400ADH
   393Alt a 10




   440ADH
   433Alt a 10




   480ADH
   473Alt a 10




   500ADH
   495Alt a 10




                                  
Figure 9.  
Multiple sequence alignments between ADH, Alt a 10 and Cla h 3. Amino acid with 
100% identity colored in black and more than 50% homology colored in blue. Dots have 






Enolase is an enzyme that is required for glycolysis. Enolase catalyzes the conversion of 
2-phosphoglycerate (2PG) to phosphoenolpyruvate (PEP), the penultimate step in the 
conversion of glucose to pyruvate (Wikipedia, 2006). The enzyme is a member of an 
enzyme superfamily (the enolase superfamily), whereby a group of evolutionarily related 
enzymes share similar reaction mechanisms but function on different substrates (with 
altered substrate affinity) and in different biochemical context. There are basically five 
distinct enolase isozymes, namely alpha enolase is ubiquitous in the cytoplasm of cells, 
beta is associated with muscle tissue and gamma is neuronal specific (Wikipedia, 2006). 
 
Enolase is a phylogenetically conserved enzyme in terms of amino acid sequence. It is 
well known as a pan-allergen among the molds (Breitenbach et al., 1997; Simon-Nobbe 
et al., 2000) and recently also identified as a cross-reacting allergen in latex (Hevea. 
brasiliensis), Hev b 9 (Wagner et al., 2000). Thus, enolase from Bos taurus is likely to be 
allergenic due to its high sequence homology. 
 
The Bos taurus enolase (ENO 1) comprised of 1305 bp encoding a 434 amino acid 






>NM_174049 (Bos taurus enolase 1 (ENO1) 
1         ATGTCCATCCTGAAGGTCCACGCCAGAGAGATCTTTGACTCTCGTGGGAATCCCACCGTT 
1          M  S  I  L  K  V  H  A  R  E  I  F  D  S  R  G  N  P  T  V   
61        GAGGTTGATCTCTTCACCGCGAAAGGTCTCTTCAGAGCTGCTGTGCCCAGTGGCGCTTCA 
21         E  V  D  L  F  T  A  K  G  L  F  R  A  A  V  P  S  G  A  S   
121       ACTGGAATCTATGAGGCCCTGGAGCTCCGGGACAATGATAAGACGCGCTACATGGGGAAG 
41         T  G  I  Y  E  A  L  E  L  R  D  N  D  K  T  R  Y  M  G  K   
181       GGTGTCTCAAAGGCTGTTGAGCACATCAATAAAACTATTGCGCCTGCCCTGGTTAGCAAG 
61         G  V  S  K  A  V  E  H  I  N  K  T  I  A  P  A  L  V  S  K   
241       AAGTCGAACGTCGTGGAGCAGGAGAAGATCGACAAGCTGATGATAGAGATGGATGGCACA 
81         K  S  N  V  V  E  Q  E  K  I  D  K  L  M  I  E  M  D  G  T   
301       GAAAAAAAATCTAAGTTTGGTGCGAACGCCATCCTGGGCGTGTCCCTGGCTGTCTGCAAA 
101        E  K  K  S  K  F  G  A  N  A  I  L  G  V  S  L  A  V  C  K   
361       GCTGGTGCTGTGGAGAAGGGGGTGCCCCTCTACCGCCACATCGCCGACTTGGCTGGCAAT 
121        A  G  A  V  E  K  G  V  P  L  Y  R  H  I  A  D  L  A  G  N   
421       GCTGAGGTCATCCTGCCAGTTCCGGCTTTCAATGTCATCAACGGTGGCTCTCATGCTGGC 
141        A  E  V  I  L  P  V  P  A  F  N  V  I  N  G  G  S  H  A  G   
481       AACAAGCTGGCCATGCAGGAGTTTATGATCCTTCCTGTTGGGGCCGAAAACTTCCGGGAG 
161        N  K  L  A  M  Q  E  F  M  I  L  P  V  G  A  E  N  F  R  E   
541       GCCATGCGCATCGGAGCAGAGGTTTACCACAACCTGAAGAATGTCATCAAGGAGAAATAT 
181        A  M  R  I  G  A  E  V  Y  H  N  L  K  N  V  I  K  E  K  Y   
601       GGGAAGGATGCCACCAACGTGGGAGATGAGGGCGGCTTTGCCCCCAACATCCTGGAGAAC 
201        G  K  D  A  T  N  V  G  D  E  G  G  F  A  P  N  I  L  E  N   
661       AAAGAAGCCCTGGAGCTGCTGAAGAATGCCATCGGCAAGGCTGGCTACAGCGACAAGGTC 
221        K  E  A  L  E  L  L  K  N  A  I  G  K  A  G  Y  S  D  K  V   
721       GTCATCGGCATGGACGTAGCTGCCTCTGAGTTCTACAGGTCGGGCAAGTATGACCTGGAC 
241        V  I  G  M  D  V  A  A  S  E  F  Y  R  S  G  K  Y  D  L  D   
781       TTCAAGTCGCCCGATGACCCCAGCAGGTACATCACACCCGACGAGCTGGCCAACCTGTAC 
 141
261        F  K  S  P  D  D  P  S  R  Y  I  T  P  D  E  L  A  N  L  Y   
841       AAGTCCTTCATCAGGGACTACCCAGTGGTGTCTATCGAAGATCCCTTCGACCAAGATGAC 
281        K  S  F  I  R  D  Y  P  V  V  S  I  E  D  P  F  D  Q  D  D   
901       TGGGAAGCTTGGCAGAAGTTCACTGCCAGCGCAGGGATCCAGGTGGTGGGGGATGATCTC 
301        W  E  A  W  Q  K  F  T  A  S  A  G  I  Q  V  V  G  D  D  L   
961       ACGGTGACAACCCCAAAGACGATCGCCAAGGGCGTGAACGAAAAATCCTGCAACTGCCTC 
321        T  V  T  T  P  K  T  I  A  K  G  V  N  E  K  S  C  N  C  L   
1021      CTGCTGAAAGTCAACCAGAATGGCTCTGTGACCGAGTCTCTTCAGGGGTGCAAGCTGGCC 
341        L  L  K  V  N  Q  N  G  S  V  T  E  S  L  Q  G  C  K  L  A   
1081      CATGCCAACGGGTGGGGCGTCATGGTTTCTCATCGTTCGGGGGAGACTGATGATACCTTC 
361        H  A  N  G  W  G  V  M  V  S  H  R  S  G  E  T  D  D  T  F   
1141      ATCGCTGAACTGGTGGTGGGGCTGTGCACTGGGCAGATCAAGAATGGTCCCCCTTGCCGT 
381        I  A  E  L  V  V  G  L  C  T  G  Q  I  K  N  G  P  P  C  R   
1201      ACTGAGCGCTTGGCCAAGTACAACCAGATCCTCAGAATTGAAGAGGAATTGGGCAGCAAG 
401        T  E  R  L  A  K  Y  N  Q  I  L  R  I  E  E  E  L  G  S  K   
1261      GCTAAGTTTGCCGGCAGGAACTTCAGAAACCCGTTGGCCAAGTAA 
421        A  K  F  A  G  R  N  F  R  N  P  L  A  K  * 
 
Figure 10. 
Nucleotide and deduced amino acid sequence of ENO 1. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in red are the predicted N-glycosylation sites. 








5.3.1.7 Heat shock proteins 
 
Heat shock proteins (HSPs) are a group of proteins whereby expressions are up-regulated 
when the cells are exposed to elevated temperatures. This dramatic up-regulation of the 
heat shock proteins plays a key role in heat shock/stress response. Other factors that 
trigger production of high levels of heat shock proteins include exposure to different 
kinds of environmental stress conditions, such as infection, inflammation, exposure of the 
cell to toxins (ethanol, arsenic, trace metals and ultraviolet light, among many others), 
starvation, hypoxia (oxygen deprivation), nitrogen deficiency (in plants), or water 
deprivation (Wikipedia, 2006) . Heat shock proteins are also molecular chaperones for 
protein molecules which play an important role in protein-protein interactions such as 
folding and assisting in the establishment of proper protein conformation (shape) and 
prevention of unwanted protein aggregation (Wikipedia, 2006). This essential role is also 
known as protein maintenance.  
 
Besides its essential role in stress response and protein maintanence, HSPs are also 
common fungal allergens known to widely cross reactive across the different families 
(Shen et al., 1997). Additionally, HSP70 are also common allergens in barley, corn and 
hazel pollen (Chiung et al., 2000; Gruehn et al., 2003). Thus, three heat shock proteins 
namely pHSP70, bHSP70 and HSP90 from both Sus scrofa and Bos taurus were cloned 
to determine their IgE-binding reactivity 
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The pHSP70 (Figure 11), bHSP70 (Figure 12)and HSP90 (Figure 13)cDNAs comprised 
of 1926 bp, 1926 bp and 2202 bp, which encoded a polypeptide of 641, 641, and 733 
amino acids respectively. All the three heat shock proteins possessed N-glycosylation 
sites and the heat shock protein signature sequences.  
 
>AY466608 (Sus scrofa heat shock protein 70.2 (hsp70.2)  
 
1         ATGGCGAAGAGCGTGGCCATCGGCATCGACCTGGGCACCACGTACTCGTGCGTGGGGGTG 
1          M  A  K  S  V  A  I  G  I  D  L  G  T  T  Y  S  C  V  G  V   
61        TTCCAGCACGGCAAGGTGGAGATCATCGCCAACGACCAGGGCAACCGCACCACCCCCAGC 
21         F  Q  H  G  K  V  E  I  I  A  N  D  Q  G  N  R  T  T  P  S   
121       TACGTGGCCTTCACGGACACCGAGCGGCTGATCGGCGATGCGGCCAAGAACCAGGTGGCG 
41         Y  V  A  F  T  D  T  E  R  L  I  G  D  A  A  K  N  Q  V  A   
181       CTGAACCCGCAGAACACGGTGTTTGACGCGAAGCGGCTGATCGGGCGCAAGTTCGGCGAC 
61         L  N  P  Q  N  T  V  F  D  A  K  R  L  I  G  R  K  F  G  D   
241       CCGGTGGTGCAGGCGGACATGAAGCACTGGCCCTTCCGGGTGATCAACGACGGGGACAAG 
81         P  V  V  Q  A  D  M  K  H  W  P  F  R  V  I  N  D  G  D  K   
301       CCCAAGGTGCAGGTGAGCTACAAGGGCGAGACCAAGGCGTTCTACCCGGAGGAGATCTCG 
101        P  K  V  Q  V  S  Y  K  G  E  T  K  A  F  Y  P  E  E  I  S   
361       TCGATGGTGCTGACCAAGATGAAGGAGATCGCCGAGGCGTACCTGGGCCACCCGGTGAGC 
121        S  M  V  L  T  K  M  K  E  I  A  E  A  Y  L  G  H  P  V  S   
421       AACGCGGTGATCACGGTGCCGGCCTACTTCAACGACTCGCAGCGGCAGGCCACCAAGGAT 
141        N  A  V  I  T  V  P  A  Y  F  N  D  S  Q  R  Q  A  T  K  D   
481       GCGGGGGTGATCGCGGGGCTGAACGTGCTGCGGATCATCAACGAGCCCACGGCGGCGGCC 
161        A  G  V  I  A  G  L  N  V  L  R  I  I  N  E  P  T  A  A  A   
541       ATCGCCTACGGCCTGGACAGGACGGGCAAGGGGGAGCGCAACGTGCTGATCTTCGACCTG 
181        I  A  Y  G  L  D  R  T  G  K  G  E  R  N  V  L  I  F  D  L   
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601       GGCGGGGGCACGTTCGACGTGTCCATCCTGACGATCGACGACGGCATCTTCGAGGTGAAG 
201        G  G  G  T  F  D  V  S  I  L  T  I  D  D  G  I  F  E  V  K   
661       GCCACGGCGGGGGACACGCACCTGGGCGGCGAGGACTTCGACAACAGGCTGGTGAACCAC 
221        A  T  A  G  D  T  H  L  G  G  E  D  F  D  N  R  L  V  N  H   
721       TTCGTGGAGGAGTTCAAGAGGAAGCACAAGAAGGACATCAGCCAGAACAAGCGGGCGGTG 
241        F  V  E  E  F  K  R  K  H  K  K  D  I  S  Q  N  K  R  A  V   
781       AGGCGGCTGCGCACGGCCTGCGAGCGGGCCAAGAGGACCCTGTCGTCCAGCACACAGGCC 
261        R  R  L  R  T  A  C  E  R  A  K  R  T  L  S  S  S  T  Q  A   
841       AGCCTGGAGATCGACTCCCTGTTCGAGGGCATCGACTTCTACACGTCCATCACCCGGGCG 
281        S  L  E  I  D  S  L  F  E  G  I  D  F  Y  T  S  I  T  R  A   
901       CGCTTCGAGGAGCTGTGCTCGGACCTGTTCCGCAGCACCCTGGAGCCGGTGGAGAAGGCT 
301        R  F  E  E  L  C  S  D  L  F  R  S  T  L  E  P  V  E  K  A   
961       CTGCGCGACGCGAAGCTGGACAAGGCCCAGATCCACGACCTGGTGCTGGTGGGGGGCTCG 
321        L  R  D  A  K  L  D  K  A  Q  I  H  D  L  V  L  V  G  G  S   
1021      ACGCGCATCCCCAAGGTGCAGAAGCTGCTGCAGGACTTCTTCAACGGGCGCGACCTCAAC 
341        T  R  I  P  K  V  Q  K  L  L  Q  D  F  F  N  G  R  D  L  N   
1081      AAGAGCATCAACCCGGACGAGGCGGTGGCGTATGGGGCGGCGGTGCAGGCGGCCATCCTG 
361        K  S  I  N  P  D  E  A  V  A  Y  G  A  A  V  Q  A  A  I  L   
1141      ATGGGCGACAAGTCGGAGAACGTGCAGGACCTGCTGCTGCTGGACGTGGCCCCGCTGTCG 
381        M  G  D  K  S  E  N  V  Q  D  L  L  L  L  D  V  A  P  L  S   
1201      CTGGGGCTGGAGACGGCCGGCGGCGTGATGACGGCGCTGATCAAGCGCAACTCCACCATC 
401        L  G  L  E  T  A  G  G  V  M  T  A  L  I  K  R  N  S  T  I   
1261      CCCACCAAGCAGACGCAGATCTTCACCACGTACTCGGACAACCAGCCGGGCGTGCTGATC 
421        P  T  K  Q  T  Q  I  F  T  T  Y  S  D  N  Q  P  G  V  L  I   
1321      CAGGTGTACGAGGGCGAGAGGGCCATGACGCGGGACAACAACCTGCTGGGGCGCTTCGAG 
441        Q  V  Y  E  G  E  R  A  M  T  R  D  N  N  L  L  G  R  F  E   
1381      CTGAGCGGCATCCCGCCGGCCCCGCGGGGGGTGCCCCAGATCGAGGTGACCTTCGACATC 
461        L  S  G  I  P  P  A  P  R  G  V  P  Q  I  E  V  T  F  D  I   
1441      GACGCCAACGGCATCCTGAACGTCACGGCGACGGACAAGAGCACGGGCAAGGCCAACAAG 
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481        D  A  N  G  I  L  N  V  T  A  T  D  K  S  T  G  K  A  N  K   
1501      ATCACCATCACCAACGACAAGGGCCGGCTGAGCAAGGAGGAGATCGAGCGCATGGTGCAG 
501        I  T  I  T  N  D  K  G  R  L  S  K  E  E  I  E  R  M  V  Q   
1561      GAGGCGGAGAAGTACAAAGCGGAGGACGAGATCCAGCGCGAGAGGGTGTCGGCCAAGAAC 
521        E  A  E  K  Y  K  A  E  D  E  I  Q  R  E  R  V  S  A  K  N   
1621      GCGCTGGAGTCGTACGCCTTCAACATGAAGAGCGCCGTGGAGGATGAGGGGCTCAAGGGC 
541        A  L  E  S  Y  A  F  N  M  K  S  A  V  E  D  E  G  L  K  G   
1681      AAGATCAGCGAGGCGGACAAGAAGAAGGTGCTGGACAAGTGTCAGGAGGTGATTTCCTGG 
561        K  I  S  E  A  D  K  K  K  V  L  D  K  C  Q  E  V  I  S  W   
1741      CTGGACGCCAACACGCTGGCCGAGAAGGACGAGTTTGAGCACAAGAGGAAGGAGCTGGAG 
581        L  D  A  N  T  L  A  E  K  D  E  F  E  H  K  R  K  E  L  E   
1801      CAGGTGTGTAACCCCATCATCAGCGGACTGTACCAGGGGGCGGGTGGCCCCGGGGCTGGC 
601        Q  V  C  N  P  I  I  S  G  L  Y  Q  G  A  G  G  P  G  A  G   
1861      GGCTTTGGGGCTCAGGCCCCCAAAGGGGGCTCTGGGTCTGGCCCCACCATCGAGGAGGTG 
621        G  F  G  A  Q  A  P  K  G  G  S  G  S  G  P  T  I  E  E  V   
1921      GATTAG 
641        D  * 
 
Figure 11.  
Nucleotide and deduced amino acid sequence of pHSP70. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in red are the predicted N-glycosylation sites. Underlined 
are the three heat shock hsp70 proteins family signatures at amino acid positions 9 – 16, 








>AY662497 (Bos taurus heat shock protein 70 kDa) 
 
1         ATGGCGAAAAACATGGCTATCGGCATCGACCTGGGCACCACCTACTCCTGCGTAGGGGTG 
1          M  A  K  N  M  A  I  G  I  D  L  G  T  T  Y  S  C  V  G  V   
61        TTCCAGCACGGCAAGGTGGAGATCATCGCCAACGACCAGGGCAACCGCACCACCCCCAGC 
21         F  Q  H  G  K  V  E  I  I  A  N  D  Q  G  N  R  T  T  P  S   
121       TACGTGGCCTTCACCGATACCGAGCGGCTCATCGGGGATGCGGCCAAGAGCCAGGTGGCG 
41         Y  V  A  F  T  D  T  E  R  L  I  G  D  A  A  K  S  Q  V  A   
181       CTGAACCCGCAGAACACGGTGTTCGACGCGAAGCGCCTGATCGGCCGCAAGTTCGGAGAC 
61         L  N  P  Q  N  T  V  F  D  A  K  R  L  I  G  R  K  F  G  D   
241       CCGGTGGTGCAGTCGGACATGAAGCACTGGCCTTTCCGCGTCATCAACGACGGAGACAAG 
81         P  V  V  Q  S  D  M  K  H  W  P  F  R  V  I  N  D  G  D  K   
301       CCTAAGGTGCAGGTGAGCTACAAAGGGGAGACCAAGGCGTTCTACCCGGAGGAGATCTCG 
101        P  K  V  Q  V  S  Y  K  G  E  T  K  A  F  Y  P  E  E  I  S   
361       TCGATGGTGCTGACCAAGATGAAGGAGATCGCCGAGGCGTACCTGGGCCACCCGGTGACC 
121        S  M  V  L  T  K  M  K  E  I  A  E  A  Y  L  G  H  P  V  T   
421       AACGCGGTGATCACCGTGCCGGCCTACTTCAACGACTCGCAGCGGCAGGCCACCAAGGAC 
141        N  A  V  I  T  V  P  A  Y  F  N  D  S  Q  R  Q  A  T  K  D   
481       GCGGGGGTGATCGCGGGGCTGAACGTGCTGAGGATCATCAACGAGCCCACGGCCGCCGCC 
161        A  G  V  I  A  G  L  N  V  L  R  I  I  N  E  P  T  A  A  A   
541       ATCGCCTACGGCCTGGACAGGACGGGCAAGGGGGAGCGCAACGTGCTCATCTTTGATCTG 
181        I  A  Y  G  L  D  R  T  G  K  G  E  R  N  V  L  I  F  D  L   
601       GGAGGGGGCACGTTCGACGTGTCCATCCTGACGATCGACGACGGCATCTTCGAGGTGAAG 
201        G  G  G  T  F  D  V  S  I  L  T  I  D  D  G  I  F  E  V  K   
661       GCCACGGCCGGGGACACGCACCTGGGCGGGGAGGACTTCGACAACAGGCTGGTGAACCAC 
221        A  T  A  G  D  T  H  L  G  G  E  D  F  D  N  R  L  V  N  H   
721       TTCGTGGAGGAGTTCAAGAGGAAGCACAAGAAGGACATCAGCCAGAACAAGCGGGCCGTG 
241        F  V  E  E  F  K  R  K  H  K  K  D  I  S  Q  N  K  R  A  V   
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781       AGGCGGCTGCGCACCGCATGCGAGCGGGCCAAGAGAACCTTGTCGTCCAGCACCCAGGCC 
261        R  R  L  R  T  A  C  E  R  A  K  R  T  L  S  S  S  T  Q  A   
841       AGCCTGGAGATCGACTCCCTGTTCGAGGGCATCGACTTCTACACGTCCATCACCAGGGCG 
281        S  L  E  I  D  S  L  F  E  G  I  D  F  Y  T  S  I  T  R  A   
901       CGGTTCGAGGAGCTGTGCTCCGACCTGTTCCGGAGCACCCTGGAGCCCGTGGAGAAGGCG 
301        R  F  E  E  L  C  S  D  L  F  R  S  T  L  E  P  V  E  K  A   
961       CTACGCGACGCCAAGCTGGACAAGGCGCAGATCCACGACCTGGTCCTGGTGGGGGGCTCC 
321        L  R  D  A  K  L  D  K  A  Q  I  H  D  L  V  L  V  G  G  S   
1021      ACCCGCATCCCCAAGGTGCAGAAGCTGCTGCAGGACTTCTTCAACGGGCGCGACCTCAAC 
341        T  R  I  P  K  V  Q  K  L  L  Q  D  F  F  N  G  R  D  L  N   
1081      AAGAGCATCAACCCCGACGAGGCGGTGGCGTACGGGGCGGCGGTGCAGGCGGCCATCCTG 
361        K  S  I  N  P  D  E  A  V  A  Y  G  A  A  V  Q  A  A  I  L   
1141      ATGGGGGACAAGTCGGAGAACGTGCAGGACCTGCTGTTGCTGGACGTGGCTCCCCTGTCG 
381        M  G  D  K  S  E  N  V  Q  D  L  L  L  L  D  V  A  P  L  S   
1201      CTGGGACTGGAGACGGCCGGAGGCGTGATGACCGCCCTGATCAAGCGCAACTCCACCATC 
401        L  G  L  E  T  A  G  G  V  M  T  A  L  I  K  R  N  S  T  I   
1261      CCCACGAAGCAGACGCAGATCTTCACCACCTACTCGGACAACCAGCCGGGCGTGCTGATC 
421        P  T  K  Q  T  Q  I  F  T  T  Y  S  D  N  Q  P  G  V  L  I   
1321      CAGGTGTACGAGGGCGAGAGGGCCATGACGCGGGACAACAACCTGCTGGGGCGCTTCGAG 
441        Q  V  Y  E  G  E  R  A  M  T  R  D  N  N  L  L  G  R  F  E   
1381      TTGAGCGGCATCCCGCCGGCCCCGCGGGGGGTGCCCCAGATCGAGGTGACCTTCGACATC 
461        L  S  G  I  P  P  A  P  R  G  V  P  Q  I  E  V  T  F  D  I   
1441      GACGCCAATGGCATCCTGAACGTCACGGCCACGGACAAGAGCACGGGCAAGGCCAACAAG 
481        D  A  N  G  I  L  N  V  T  A  T  D  K  S  T  G  K  A  N  K   
1501      ATCACCATCACCAACGACAAGGGCCGGCTGAGCAAGGAGGAGATCGAGCGCATGGTGCAG 
501        I  T  I  T  N  D  K  G  R  L  S  K  E  E  I  E  R  M  V  Q   
1561      GAGGCGGAAAAGTACAAGGCGGAGGACGAGGTCCAGCGCGAGAGGGTGTCTGCCAAGAAC 
521        E  A  E  K  Y  K  A  E  D  E  V  Q  R  E  R  V  S  A  K  N   
1621      GCGCTGGAGTCATACGCCTTCAACATGAAGAGCGCCGTGGAGGATGAGGGGCTGAAGGGC 
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541        A  L  E  S  Y  A  F  N  M  K  S  A  V  E  D  E  G  L  K  G   
1681      AAGATCAGCGAGGCGGACAAGAAGAAGGTGCTGGACAAGTGCCAGGAGGTGATTTCCTGG 
561        K  I  S  E  A  D  K  K  K  V  L  D  K  C  Q  E  V  I  S  W   
1741      CTGGACGCCAACACCTTGGCGGAGAAGGACGAGTTTGAGCACAAGAGGAAGGAGCTGGAG 
581        L  D  A  N  T  L  A  E  K  D  E  F  E  H  K  R  K  E  L  E   
1801      CAGGTGTGTAACCCCATCATCAGCAGACTGTACCAGGGGGCGGGCGGCCCCGGGGCTGGC 
601        Q  V  C  N  P  I  I  S  R  L  Y  Q  G  A  G  G  P  G  A  G   
1861      GGCTTTGGGGCTCAGGGCCCTAAAGGGGGCTCTGGGTCTGGCCCCACCATTGAGGAGGTG 
621        G  F  G  A  Q  G  P  K  G  G  S  G  S  G  P  T  I  E  E  V   
1921      GATTAG 
641        D  * 
 
Figure 12. 
Nucleotide and deduced amino acid sequence of bHSP70. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in red are the predicted N-glycosylation sites. Underlined 
are the three heat shock hsp70 proteins family signatures at amino acid positions 9 – 16, 












>NM_213973 (90-kDa heat shock protein (HSP90) 
  
1         ATGCCCGAGGAAACCCAGACCCAAGACCAGCCGATGGAGGAGGAGGAGGTGGAGACGTTC 
1          M  P  E  E  T  Q  T  Q  D  Q  P  M  E  E  E  E  V  E  T  F   
61        GCCTTCCAGGCGGAAATCGCCCAGTTGATGTCGTTGATCATCAACACTTTCTACTCGAAC 
21         A  F  Q  A  E  I  A  Q  L  M  S  L  I  I  N  T  F  Y  S  N   
121       AAGGAGATCTTTCTGAGGGAGCTCATTTCCAACTCGTCCGATGCTTTGGACAAGATCAGA 
41         K  E  I  F  L  R  E  L  I  S  N  S  S  D  A  L  D  K  I  R   
181       TACGAAAGCCTGACGGATCCCAGTAAACTAGACTCCGGGAAAGAGCTGCACATTAATCTC 
61         Y  E  S  L  T  D  P  S  K  L  D  S  G  K  E  L  H  I  N  L   
241       ATTCCGAACAAGCAAGACCGGACCCTCACGATAGTGGACACCGGCATCGGCATGACCAAG 
81         I  P  N  K  Q  D  R  T  L  T  I  V  D  T  G  I  G  M  T  K   
301       GCCGACTTGATCAATAACCTTGGTACGATCGCCAAGTCTGGGACCAAGGCGTTCATGGAG 
101        A  D  L  I  N  N  L  G  T  I  A  K  S  G  T  K  A  F  M  E   
361       GCTTTGCAGGCCGGTGCCGATATCTCGATGATTGGCCAGTTCGGTGTCGGCTTCTACTCT 
121        A  L  Q  A  G  A  D  I  S  M  I  G  Q  F  G  V  G  F  Y  S   
421       GCGTACCTGGTCGCTGAGAAAGTGACCGTTATCACCAAACACAACGATGACGAGCAGTAT 
141        A  Y  L  V  A  E  K  V  T  V  I  T  K  H  N  D  D  E  Q  Y   
481       GCCTGGGAGTCTTCTGCAGGAGGATCTTTCACCGTTAGGACAGACACAGGAGAACCTATG 
161        A  W  E  S  S  A  G  G  S  F  T  V  R  T  D  T  G  E  P  M   
541       GGTCGTGGAACAAAGGTTATTCTACATCTGAAAGAAGACCAAACTGAGTACTTGGAAGAA 
181        G  R  G  T  K  V  I  L  H  L  K  E  D  Q  T  E  Y  L  E  E   
601       AGGAGAATAAAGGAGATTGTGAAGAAACACTCTCAGTTTATTGGCTACCCCATTACTCTC 
201        R  R  I  K  E  I  V  K  K  H  S  Q  F  I  G  Y  P  I  T  L   
661       TTCGTGGAGAAGGAACGTGATAAAGAAGTCAGTGACGACGAGGCGGAAGAAAAGGAAGAC 
221        F  V  E  K  E  R  D  K  E  V  S  D  D  E  A  E  E  K  E  D   
721       AAAGAGGAAGAAAAGGAGAAAGAAGAGAAGGAATCTGAGGATAAACCGGAGATAGAAGAT 
241        K  E  E  E  K  E  K  E  E  K  E  S  E  D  K  P  E  I  E  D   
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781       GTTGGTTCTGATGAAGAGGAAGAAGAAAAGAAGGATGGTGACAAGAAGAAGAAGAAGAAG 
261        V  G  S  D  E  E  E  E  E  K  K  D  G  D  K  K  K  K  K  K   
841       ATCAAGGAGAAGTATATTGATCAAGAGGAACTCAACAAGACAAAGCCTATCTGGACCAGA 
281        I  K  E  K  Y  I  D  Q  E  E  L  N  K  T  K  P  I  W  T  R   
901       AACCCCGATGACATCACTAATGAAGAGTACGGGGAGTTCTATAAGAGCTTGACCAATGAC 
301        N  P  D  D  I  T  N  E  E  Y  G  E  F  Y  K  S  L  T  N  D   
961       TGGGAGGATCACTTGGCTGTGAAGCACTTTTCAGTCGAAGGGCAGTTGGAGTTCAGAGCC 
321        W  E  D  H  L  A  V  K  H  F  S  V  E  G  Q  L  E  F  R  A   
1021      CTTCTTTTCGTCCCAAGACGCGCTCCTTTCGACTTATTTGAAAACAGAAAGAAGAAGAAC 
341        L  L  F  V  P  R  R  A  P  F  D  L  F  E  N  R  K  K  K  N   
1081      AACATCAAGCTGTATGTTCGCAGAGTGTTCATCATGGACAACTGCGAGGAGCTCATCCCT 
361        N  I  K  L  Y  V  R  R  V  F  I  M  D  N  C  E  E  L  I  P   
1141      GAGTATCTGAATTTCATTAGAGGCGTGGTGGACTCTGAGGATCTTCCTCTGAACATTTCT 
381        E  Y  L  N  F  I  R  G  V  V  D  S  E  D  L  P  L  N  I  S   
1201      CGTGAGATGTTGCAACAAAGCAAAATTTTGAAAGTCATCAGGAAGAATCTGGTCAAGAAA 
401        R  E  M  L  Q  Q  S  K  I  L  K  V  I  R  K  N  L  V  K  K   
1261      TGCTTGGAGCTCTTTACTGAATTGGCCGAAGATAAAGAGAATTACAAGAAGTTCTATGAG 
421        C  L  E  L  F  T  E  L  A  E  D  K  E  N  Y  K  K  F  Y  E   
1321      CAGTTCTCTAAAAATATTAAGCTTGGAATACATGAAGATTCTCAAAATCGGAAGAAGCTT 
441        Q  F  S  K  N  I  K  L  G  I  H  E  D  S  Q  N  R  K  K  L   
1381      TCCGAGCTGTTGAGGTACTACACTTCTGCTTCTGGCGACGAGATGGTTTCCCTCAAGGAC 
461        S  E  L  L  R  Y  Y  T  S  A  S  G  D  E  M  V  S  L  K  D   
1441      TATTGCACCAGAATGAAGGAGAACCAGAAACACATCTATTACATCACAGGTGAGACCAAG 
481        Y  C  T  R  M  K  E  N  Q  K  H  I  Y  Y  I  T  G  E  T  K   
1501      GACCAGGTGGCCAACTCGGCCTTCGTGGAACGTCTGCGGAAGCACGGCCTGGAGGTGATC 
501        D  Q  V  A  N  S  A  F  V  E  R  L  R  K  H  G  L  E  V  I   
1561      TACATGATCGAGCCCATCGATGAGTACTGTGTGCAGCAGCTGAAGGAGTTTGAGGGGAAG 
521        Y  M  I  E  P  I  D  E  Y  C  V  Q  Q  L  K  E  F  E  G  K   
1621      ACCTTAGTGTCAGTCACCAAAGAGGGCCTGGAGCTCCCGGAAGATGAAGAGGAGAAGAAG 
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541        T  L  V  S  V  T  K  E  G  L  E  L  P  E  D  E  E  E  K  K   
1681      AAACAGGAGGAGAAGAAGACAAAGTTTGAAAACCTCTGCAAGATCATGAAGGACATCTTG 
561        K  Q  E  E  K  K  T  K  F  E  N  L  C  K  I  M  K  D  I  L   
1741      GAGAAGAAAGTCGAAAAGGTGGTTGTGTCGAACCGGTTGGTGACCTCACCGTGCTGCATT 
581        E  K  K  V  E  K  V  V  V  S  N  R  L  V  T  S  P  C  C  I   
1801      GTCACAAGCACATACGGCTGGACAGCAAACATGGAGAGAATCATGAAGGCTCAAGCCCTG 
601        V  T  S  T  Y  G  W  T  A  N  M  E  R  I  M  K  A  Q  A  L   
1861      AGAGACAACTCGACAATGGGTTACATGGCAGCAAAGAAGCACCTGGAGATAAATCCAGAC 
621        R  D  N  S  T  M  G  Y  M  A  A  K  K  H  L  E  I  N  P  D   
1921      CATTCCATCATCGAGACCCTGAGGCAAAAGGCAGAGGCGGACAAGAACGACAAGTCCGTG 
641        H  S  I  I  E  T  L  R  Q  K  A  E  A  D  K  N  D  K  S  V   
1981      AAGGATCTGGTCATCCTGCTGTACGAAACCGCTCTGCTGTCTTCTGGCTTCAGCCTGGAA 
661        K  D  L  V  I  L  L  Y  E  T  A  L  L  S  S  G  F  S  L  E   
2041      GATCCCCAGACGCACGCCAACAGGATCTACAGGATGATCAAACTTGGTCTTGGTATTGAT 
681        D  P  Q  T  H  A  N  R  I  Y  R  M  I  K  L  G  L  G  I  D   
2101      GAGGACGACCCCACCGCCGACGACAGCAGCGCTGCTGTGACGGAGGAGATGCCACCCCTG 
701        E  D  D  P  T  A  D  D  S  S  A  A  V  T  E  E  M  P  P  L   
2161      GAAGGGGACGACGACACGTCCCGCATGGAGGAAGTCGATTAG 
721        E  G  D  D  D  T  S  R  M  E  E  V  D  *   
 
Figure 13.  
Nucleotide and deduced amino acid sequence of HSP90. The predicted initiation Met 
start and stop codon (TAG) is in red. Highlighted in yellow are the forward and reverse 
primer sequences. Highlighted in red are the predicted N-glycosylation sites. Underlined 






5.3.2 Expression and purification of recombinant allergens 
 
The different clones encoding for the potential allergens were sub-cloned into the 
expression plasmid pET 32a and the proteins were expressed as His-tagged proteins. The 
pET System was chosen as it is a powerful system developed for cloning and expression 
of recombinant proteins in E. coli. The yield of the desired protein can comprise more 
than 50% of the total cell protein after a few hours of induction. 
 
SDS-PAGE analysis showed the successful expression and purification for all of the 
recombinant proteins except HSP90 (Figure 14). Despite optimization by changing 
induction temperature and concentration of IPTG, HSP90 was still unable to be 
expressed. Thus, HSP90 was excluded in subsequent experiments. The molecular weights 
of the expressed recombinant fusion proteins were estimated by adding the molecular 
weight of each protein of interest with the molecular weight of fusion protein (17.3 kD). 
The molecular weight of fusion protein was obtained by estimated the molecular weight 
of deduce amino acids of fusion protein coding sequences in vector DNA. The molecular 
weight of the allergen of interest and its predicted mass after fusion with the fusion 







Table 6.  
Estimated molecular weight of the expressed allergen with the fusion protein. 
 
Putative allergen Estimated MW cloned (kD) Predicted MW together with
fusion protein (kD)
Tropo 1 32.7 50




ENO 1 47.2 64.5
ADH 54.7 72
bHSP70 70.1 87.4  
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Figure 14.   
SDS-PAGE analyses of expression (A) and purification (B) of the recombinant 
allergens. 
 
5.3.3 Recombinant proteins immunoarray 
 
Sera from 70 atopic patients that positively react to meat crude extracts in the previous 
allergen immunoarray analysis and 10 negative sera were tested in the recombinant 
proteins immunoarray to determine IgE reactivity to putative meat-based recombinant 
proteins. Various positive controls such as IgE standards and negative controls such as 
PBS buffer, elution buffer and E. coli proteins were added in the panel of screens. An 





Figure 15.  
Recombinant proteins immunoarray plate format and immunodot blots. (A) The 
plate format of the recombinant immunoarray where highlighted in blue, yellow and 
green are the controls, crude proteins and recombinant proteins respectively. (B) An 
example of the immunodot blots labeled +ve sera, -ve sera and blank (secondary antibody 
only). Dots in purple indicate positive IgE-binding.  
 
 
5.3.3.1 Prevalence of IgE-binding of crude and recombinant proteins 
 
Figure 16 shows the IgE-binding capacity (%) to both crude and recombinant proteins. 
As expected, close to 90% of the pre-screened sera reacted to any one type of meat (beef, 
lamb or pork) and these results strongly ascertain the reproducibility of the allergen 
immunoarray results. Majority of the meat reactive sera showed IgE-binding to BSA 
(49.3%), which is a major allergen in beef allergy (Fuentes et al., 2004). However, the 
IgE-binding frequency was relatively low for the recombinant proteins ranging from 
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8.75% to 18.75%. This could be due to improper folding of the recombinant protein and 
also the lack of post-translation protein modification in an E. coli (prokaryotic) system. 
The lack of post-translation protein modification as glycosylation, phosphorylation or 
even the proper formation of disulphide bonds may lead to mis-folded protein and 
aggravate the formation of proteins in inclusion bodies which render them insoluble. 
Additionally, IgE-binding to certain proteins, especially glycoproteins, may occur at or be 
influenced by the glycosyl side-chains, which are known as cross-reactive carbohydrate 
determinants (CCD) (Mari et al., 1999; Mari, 2002). It is also well-known that allergens 
which are glycoproteins in particular can increase the antibodies titer (Thomas and Smith, 
2002). Hence, this could be the reason why there was a marked reduction in IgE-binding 
for the recombinant proteins produced in E. coli.  
 
 
Figure 16.  
Percentage of IgE-binding frequency of crude and recombinant proteins 
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On the other hand, CCDs are also known to reduce the specificity and diagnostic value of in 
vivo assays, and may be counter-productive in immunotherapy (Thomas and Smith, 2002; 
Vieths et al., 2001). Therefore, we need to better understand the significances of CCDs in 
order to increase the sensitivity and specificity of allergy diagnosis especially in vitro 
diagnosis techniques. The effect of CCDs will be discussed farther in Chapter 6. 
 
5.4 Conclusion 
A total of nine allergens from S. scrofa (Tropomyosin 1 alpha chain, Tropomyosin 3, 
Myosin light chain, Troponin T fast skeletal muscle type, and Heat shock protein 70 kDa) 
and B. taurus (Enolase 1, Aldehyde dehydrogenase, and Heat shock protein 70 kDa) were 
successfully cloned, produced and purified as recombinant proteins. Their identities were 
confirmed by molecular weight and by DNA sequencing. Results from the recombinant 
proteins immunoarray showed relatively low IgE-binding in the 80 patients’ sera tested. 
The low IgE-binding frequency could be due to the lack of post translational protein 
modification which resulted in the lost of CCDs and/or the improper folding of the 










CHAPTER 6: INVESTIGATIONS ON THE CROSS-
REACTIVE CARBOHYDRATE DETERMINANTS (CCD) 




The role of carbohydrates in allergy has been much discussed in recent years and is still 
controversial. Glycans often play important physiological roles e.g. in resistance to 
proteolytic degradation, transduction of information between cells and intercellular 
adhesion through ligand–receptor interactions (Gesundheit et al., 1987; Ashwell and 
Harford, 1982; Potskaldy et al., 1986). Indications for glycosylation can be deduced from 
the protein sequence. The sequence motif Asn-X (except of Pro)-Ser /Thr indicates 
probable N- glycosylation sites. (The prediction of O-linked glycans is much more 
difficult and less reliable. They are built up of only a few monosaccharide units and seem 
to be less important for the elucidation of allergy) (Petersen and Mundt, 2001). 
 
In clinical relevance, due to the widespread occurrence of structurally similar CCDs in 
plants and invertebrates, IgE to carbohydrates often leads to false-positive diagnostic 
results when only the IgE binding to extracts or allergens (CAP, RAST, FAST, and 
immunoblot) but do not show clinical symptomology (Mari et al., 1999; van der Veen et 
al., 1997; van Ree, 1999). Many glycoproteins, such as bromelain, are monovalent 
glycoconjugates thus unable to cross-link IgE antibodies bound to the receptors of mast 
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cells and basophils to elicit clinical symptoms (Paschinger et al., 2005). However, there 
are also many glycoproteins with more than one N-linked glycan [eg, horseradish 
peroxidase (HRP)] or 3 potential glycoprotein allergens (eg, β-fructofuranosidase, 
polygalacturonase 2A and pectinesterase) that we have recently identified in tomato fruit 
extract (Westphal et al., 2003; Foetisch et al., 2001). Until now, there are no conclusive 
evidences to indicate that whether or not natural multivalent glycoproteins are able to 
induce histamine release and/or contribute to clinical symptoms.  
 
The IgE-binding carbohydrates are often N-glycans carrying α(1,3)-fucose (linked to the 
proximal N-acetyl glucosamine) and/or β(1,2)-xylose (linked to the core mannose) 
commonly found in pollen and plant food glycoproteins (Ebo et al., 2004; Faye and 
Chrispeels, 1988). These are features absent in mammals and are, therefore, 
immunogenic (Wilson, 2002). The prevalence of anti-CCD IgE has been estimated to be 
10–15% in patients with grass pollen allergy (van Ree and Aalberse, 1993) and increases 
up to 60%in patients with concomitant sensitization to pollen from trees, grasses and 
weeds (Mari et al., 1999). Invertebrate glycoproteins, present in hymenoptera venom, 
also bear IgE-binding α(1,3)-fucose-containing CCD (Tretter et al., 1993). About one in 
four honeybee–bumblebee venom and one in 10 yellow jacket venom allergic patients 
have been shown to be anti-CCD IgE positive (Kochuyt, 2000). 
 
Besides CCDs, profilin is another protein that is known to elicit false-positive IgE-
binding without clinical relevance. Profilins, a family of actin-binding proteins, are 
ubiquitous in eukaryotic cells and probably function as mediators of membrane–
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cytoskeleton signaling (Ebo et al., 2004). Profilins are present in pollen (e.g. birch, 
mugwort, timothy grass), fruit (e.g. apple, cherry), vegetables (e.g. celery, peanut, carrot) 
and natural rubber latex (Vieths et al., 2002; Valenta et al., 1992; Vallier et al., 1995). 
The clinical role of profilins is still not clear. For instance, the birch profilin has been 
demonstrated to be a highly efficient sensitizer, but sensitization to birch profilin is rarely 
associated with symptoms (Pauli et al., 1996; Wensing et al., 2002) 
 
6.2 MATERIALS AND METHODS 
6.2.1 Patients and sera 
 
A total of seven sera from the previously pre-screened population mentioned in section 
2.2.6 were selected for investigation for presence of cross-reactive carbohydrate 
determinants (CCDs). The sera were selected on the basis that the patients have relatively 
high levels of specific IgE to meat antigens.  
 
6.2.2 Protein extraction 
 
The crude extracts of beef and pork were extracted as described in section 2.2.3. Total 






6.2.3 Enzymatic deglycosylation procedures 
 
`Crude meat extracts from beef and pork were enzymatically deglycosylation with  
E-DEGLY kit (Sigma, USA) according to manufacturer’s protocol with slight 
modifications. Briefly, 10 µl of 5X Reaction Buffer and 2.5 µl of Denaturation Solution 
were added to 100 µg of protein sample and incubated at 4 °C for 24 hrs. After which, 2.5 
µl of TRITON X-100 solution was added along with 1 µl each of the PNGase F, O-
Glycosidase, α-2(3,6,8,9) Neuraminidase,  β(1-4)Galactosidase and β−N-
Acetylglucosaminidase. The sample was incubated at 37 °C for 3 hrs and analyzed by 
SDS-PAGE for deglycosylation.  
 
6.2.4 Immunoassays 
6.2.4.1 Western blot analysis 
 
The procedure for western blot was essentially the same as described in the previous 
section 4.2.5. Basically, the non-deglycosylated extracts and deglycosylated extracts were 
separated by 1D SDS-PAGE side by side for ease of profile comparison. The proteins 







6.2.4.2 Enzyme-linked immunosorbent assay (ELISA)  
 
The procedure for enzyme-linked immunosorbent assay (ELISA) was similar as 
described in section 2.2.7.  
 
 
6.3 Results and Discussion 
6.3.1 Deglycosylation experiments 
 
The deglycosylation procedure in crude extracts can only be interpreted, when 
monoclonal antibodies are available for identification of the glycoprotein and the mixture 
contains only a few glycoproteins (Petersen and Mundt, 2001). However, in this study, 
monoclonal antibodies are not available thus we have to assume that the changes in 
protein profile on the SDS-PAGE were due to the deglycosylation process. Figure 1 
illustrates the deglycosylated SDS-PAGE gel for pork and beef with noticeable changes 
in protein profile after deglycosylation. 
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Figure 1.  
Protein separation of non-deglycosylated and deglycosylated pork and beef crude 
extracts. M: marker; ND: non-deglycosylated; N: deglycosylated. Indicated in arrows are 
















6.3.2.1 Western blot analysis 
 
 
Results of immunoblotting after SDS-PAGE with patients’ sera disclosed significant 
reduction in IgE-binding before and after deglycosylation. Reduction in IgE-binding is 
especially noticeable for high molecular weight reactive bands (<100 kDa) in both 
species’ deglycosylated extracts with the exception in Patient 1 (Figure 2). One reactive 
band at approximately 52 kDa was retained in both non-deglycosylated and 
deglycosylated pork extract suggesting that the particular band has no carbohydrate 
moieties (Figure 2A). Based on previous experiment done in chapter four, the identity of 
this reactive band is IgG heavy chain. Computational N-glycosylation prediction using 
NetNGlyc 1.0 revealed that the potential of glycosylation for this protein is low with only 
one N-glycosylation site at amino acids 322 – 324. For patient 3 and 5, two additionally 
bands at 27 and 25 kDa were observed in the deglycosylated pork extracts (Figure 2A). 
These bands are likely reactive bands that were partially deglycosylated. In the case of 
beef western analysis, the patients showed relatively similar pattern in IgE-binding and 
no particular reactive band was retained in both non-deglycosylated and deglycosylated 
extracts (Figure 2B). Patient 6 and 7 even have total abolishment of IgE-binding in the 
beef deglycosylated extract and this clearly indicates that majority of the IgEs were 









Figure 2.  
Immunodetection after SDS-PAGE of pork (A) and beef (B) extracts (non-
deglycosylated and deglycosylated) with patients’ sera. M: marker; ND: non-
deglycosylated; N: deglycosylated. In both blots, membranes 1 – 7 were IgE 
immunoblots using 7 patients’ sera. Membranes 8 were negative serum and membranes 9 







ELISA was done to validate the results of the immunoblots. Figure 3 shows significant 
reduction in IgE-binding in deglycosylated extracts for individual patient. Sera from 
Patient 5 – 7 have reduced IgE-binding to basal level similar to that of the negative serum 
and blank. This result again confirm that majority of the IgEs were binding only to the 






Figure 3.  
ELISA validation of IgE-binding for non-deglycosylated and deglycosylated pork 




Physicians often rely on in vitro quantification of specific IgE to confirm the diagnosis of 
IgE-mediated allergic diseases. The patients are usually tested with allergenic extracts or 
molecules and those that show high IgE reactivity are assumed as the sensitizers. 
However, a positive specific IgE reaction may not always result in clinical presentation of 
allergic symptoms.  The immunochemical cross-reactivity among different allergens 
sharing homologous epitopes has been identified as one of the main reasons for clinical 
irrelevant IgE and the most likely explanation for the lack of clinical presentation by 
some of these cross-reactive IgE antibodies may be related to epitope valency and low 
affinity (Ebo et al., 2004). Ubiquitous structures such as CCDs present on glycoproteins 
of mainly plants and hymenoptera venom have been known to induce the syntheses of 
IgE antibodies that lack biological activity (Ebo et al., 2004). The most relevant 
carbohydrate determinants for IgE reactivity is the α(1,3) fucosylation to the innermost 
N-acetylglucosamine and probably also the β(1,2) xylosylation to the trimannosyl core 
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residue (Faye and Chrispeels, 1988). These carbohydrate determinants are highly 
immunogenic in man (Ebo et al., 2004). The primary aim of this study is to investigate 
whether the high prevalence of IgE-binding to meat antigens is due to CCDs present on 
the antigens. Since this is the first study on mammalian-based CCDs and no unique 
marker for mammalian CCD reactivity is available, we have to rely on deglycosylation 
and reduction in IgE-binding to identified CCD sensitization in patients’ sera with high 
IgE-binding to meat antigens.  
 
Our data clearly show that deglycosylation reduces IgE-bindng in all seven patients 
tested. However, we have yet to identify the carbohydrate moieties where the anti-
carbohydrate antibodies bind. Nevertheless, from the immunoarray screen results, we 
were able to deduce that the carbohydrate moieties were different from that of bromelain 
and horseradish peroxidase (standard control markers for CCDs). This was because the 
frequency of IgE binding for the meat namely pork and beef showed weak correlation 
with the two markers of CCDs (Figure 4). This indicates that the CCDs in mammalian 
meat or even vertebrates are unique and distinct from those found in plants. Further 
inhibition studies could be done by using neoglycoconjugates: bovine serum albumin 
carrying various forms of glycopeptides, N-glycans, or O-glycans to identify the actual 








    
 
Figure 4 
Correlation bi-plots between meat antigens (pig and cow) and CCDs markers 






Besides inhibition studies, the detection and characterization of carbohydrate structures 
of glycoproteins can be achieved using a technique called hydrazinolysis, which is a 
starting point for detailed analysis of the carbohydrate structure. Hydrazinolysis basically 
involves acetone treatment followed by chromatographic procedures to purify the 
carbohydrate chains. Mass spectrometry is used to evaluate the monosaccharide 
composition and the exact carbohydrate structure can then be identified by NMR 
analysis. Oxford Glycosystem can also be used to determine the carbohydrate moieties by 
glycan sequencing followed by comparison with a glycan database to identify the 
particular structure.  
 
 
6.4 Conclusion  
 
This study confirms the presence of CCDs in crude meat antigens. Deglycosylation assay 
showed mark reduction in IgE-binding in both western blots and ELISA. Weak IgE-
binding correlation between meat antigens and CCDs markers (bromelain and 
horseradish peroxidase) suggests that the carbohydrate moieties present in meat antigens 
are distinct from those present in plant. Further studies are required to identify and 
characterize in order to classify and understand this new form of mammalian CCD, which 












CHAPTER 7: BLOCKING IMMUNOGLOBULIN G (IGG) 
ANTIBODIES IN MEAT ALLERGY 
 
7.1 INTRODUCTION 
7.1.1 Specific immunotherapy (SIT) 
 
Specific immunotherapy (SIT) is an established treatment for selected allergic diseases 
including pollen, bee venom and dust mite allergy (Hardy et al., 2004). While the clinical 
efficacy of SIT is well-documented, the molecular mechanisms require further 
clarification. Current evidence suggests that specific immunotherapy effect several 
aspects of the immune system, including modulation of allergen-specific B cell and T cell 
responses. Studies on the effect of immunotherapy have demonstrated reduced basophil 
reactivity to allergens (Kimura et al., 1985), reductions in mucosal recruitment of 
inflammatory cells (Wilson et al., 2001), deviation of Th2 cytokine responses to allergens 
in favour of Th1 responses (Secrist et al., 1993; Jutel et al., 1995; McHugh et al., 1995; 
Akoum et al., 1996) and the induction of IL-10 producing regulatory T cells (Akdis et al., 
1998; Bellinghausen et al., 1998; Francis et al., 2003). In addition, changes in levels of 
serum antibody in response to immunotherapy have been described, mostly as increases 
in allergen-specific IgG antibodies, particularly the IgG4 isotype (Muller et al., 1989; 
McHugh et al., 1990; Ewan et al., 1993; Michils et al., 1997; van Neerven et al., 1999; 
Wachholz et al., 2003) 
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7.1.2 Concept of blocking IgG antibodies 
 
Classical experiments performed by Cooke et al. in 1935 to investigate the protective 
mechanisms underlying allergen-specific immunotherapy demonstrated that allergen-
specific IgG antibodies, termed blocking antibodies, can antagonize the cascade of 
allergic inflammation resulting from allergen recognition by IgE antibodies. The 
importance of such antibodies is still being debated. In general, SIT increases the level of 
allergen-specific IgG1 and IgG4 and these antibody concentrations are related to 
improvements in clinical outcome (Djurup and Osterballe, 1984; Moss et al., 1987; 
Gehlhar et al., 1999; Jutel et al., 2003). Frequently, however, successful SIT is not 
associated with a decreased concentration of allergen-specific IgE antibodies (Moss et 
al., 1987; Jutel et al., 1995; Gehlhar et al., 1999; Jutel et al., 2003), although this is not 
always the case (Gleich et al., 1982; Benjaponpitak et al., 1999; Flicker and Valenta, 
2003).  
 
One way in which IgG may block IgE-mediated mechanisms is by inhibiting basophile 
histamine release by either direct competition with IgE for allergen binding or possibly 
by the binding of IgE-allergen-IgG complexs to the lower affinity IgG receptor (FcεRIIb) 
with resulting co-aggregation with the high affinity IgE receptor (FcεRI) and the 
consequent inhibition of IgE receptor triggering (Coggeshall, 1998; Ravetch and Bolland, 
2001; Zhu et al., 2002). Another mechanism of blocking antibodies is via inhibition of 
IgE facilitated allergen presentation by B cells to allergen –specific T cells. This results 
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in reduced T cell proliferation and cytokine production by specific T cells (van Neeren et 
al., 1999; Wachholz et al., 2003; van Neeren et al., 2004) 
 
7.2 MATERIALS AND METHODS 
7.2.1 Patients and sera 
 
A total of 25 sera from the previously pre-screened population mentioned in section 2.2.6 
were selected for specific IgG screening. Positive and negative sera were selected based 
on positivity or negativity to meat crude proteins via allergen immunoarray screening 
performed previously. Eventually, plasma and peripheral blood mononuclear cells 
(PBMCs) from two patients with both high levels of meat specific IgE and IgG antibodies 
were collected. 
 
7.2.2 Allergen immunoarray for the detection of specific IgG 
 
The procedure for allergen immunoarray was essentially the same as described in the 
previous section 2.2.4 except the secondary antibody used was goat anti-human IgG -
chain specific alkaline phosphatase conjugated antibody (Sigma, USA) diluted at 1:5000 






7.2.3 Plasma preparation 
 
Whole blood samples were collected in EDTA vacutainer tubes (Becton-Dickinson, 
USA). Invert the tubes to mix the samples well with the anticoagulant. Centrifuge the 
samples at 2000 x g for 15 minutes at room temperature. After centrifugation, the plasma 
was removed and stored in aliquots of 500 µl at -20 °C until use. The remaining cells 
were used for peripheral blood mononuclear cells isolation. 
 
 
7.2.4 Isolation of peripheral blood mononuclear cells (PBMCs) 
 
Peripheral blood mononuclear cells were isolated by Ficoll-Hypaque centrifugation 
(Amersham Pharmacia, USA). Basically, the 3 ml of remaining cells from previous 
section was diluted with 3 ml of PBS. The 6 ml of diluted cells was subsequently overlaid 
with 3 ml of Ficoll- Hypaque solution and centrifuged for 15 min at 750 x g with no 
brakes. The upper layer was removed and the buffy coat containing the PBMCs was 
transferred into a fresh 15 ml tube (Figure 1). The cells were washed twice by adding 10 
ml of RPMI 1640 medium (Sigma, USA) and centrifuged for 10 min at 750 x g at room 
temperature. The cells pellet were re-suspended in growth medium (RPMI 1640 medium 
containing 10% fetal calf serum (FCS) and 0.01% (w/v) each of penicillin and 
streptomycin) and checked for cell viability and number. Cell viability was visualized 
with Trypan blue dye (Sigma, USA) (1:2 dilution with PBS) and cell number was 
determined with a hemacytometer (). The isolated PBMCs were diluted with culture 
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medium to 1 x 106 cells/ml either for storage at -80 °C with 10% dimethyl sulphoxide 










Typical diagram showing Ficoll- Hypaque separation of whole blood sample. 
Samples are separated based on density after centrifugation 
 
7.2.5 Immunoaffinity depletion of IgG from plasma 
 
Plasma instead of serum was used in this experiment because the process of blood 
coagulation triggers sticky platelets to release histamine (Masini et al., 1998). Thus, to 
prevent presence of endogenous histamine in serum, plasma samples were used. All 
plasma samples were centrifuged multiple times at 13,000 x g for 5 min to remove all 
clotted protein and lipid. IgG was depleted by loading 1 ml plasma aliquots onto 5 ml of 
Protein G PLUS-Agarose beads (Calbiochem, Germany) filled column (Bio-Rad, USA). 
The Protein G beads were used because it has high affinity for IgG antibodies and no 
affinity to IgE antibodies. The IgG depleted plasma was recovered from the flow-through 
and stored at -20 °C until use. Depletion of IgG was analyzed by SDS-PAGE. As a 
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control, PBS was loaded onto Protein G agarose column as above to exclude the 
contaminants from Protein G agarose. 
 
7.2.6 Preparation of meat antigens 
 
The crude extracts of pork, beef and chicken was prepared as described in section 2.2.3. 
To ensure the samples were sterile and free from contaminants, all extracts were syringe 
filtered at 0.22 (Milipore, USA). 
 
7.2.7 Histamine-release assay 
 
Crude extracts from pork, beef and chicken were diluted with PBS to concentrations 10-4, 
10-3, 10-2, 10-1 or 1 mg/ml. Based on prior knowledge that the patients did not have IgE 
reactivity to chicken, thus, chicken was used as a negative non-allergen control. The 
PBMCs were first checked for cell viability with Trypan blue dye (Sigma) before 
aliquoting about 1 x 105 cell/tube in duplicates for histamine release assay. Tubes 
containing 1 x 105 cells each were centrifuged at 750 x g for 10 min to remove the culture 
medium. The each tube containing cells was then co-incubated with 100 µl of plasma 
(either with or without IgG) with different concentration of various crude extracts or PBS 
control. The samples were incubated at 37 °C for 1 hr to induce histamine release from 
basophilic granulocytes. The released histamine in the supernatant was subsequently 
determined using the histamine enzyme immunoassay kit (SPI-BIO, France) according to 
the manufacturer’s instructions. The principle of the histamine enzyme immunoassay 
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(EIA) is based on the competition between unlabelled derivatized histamine and 
acetylcholinesterase (AChE) linked to histamine (tracer) for limited anti-histamine 
antibody sites (Figure 2). Other controls in the assay include the tests for endogenous 
histamine in the plasma and the extracts itself. Therefore, the final analyzed result would 
involve subtracting the reading from various controls namely the PBS extract control and 














Figure 2.   






7.3 Results  and Discussion   
7.3.1 Allergen immunoarray for the detection of specific IgG 
 
A total of 25 sera with differential IgE-binding to pork, beef and lamb were analyzed for 
their level of specific IgG to the three meats. The reason for choosing sera with 
differential IgE-binding was to observe the distribution of specific meat IgG among 
patients with different atopy background and not only restricting to those with high level 
of specific IgE to meat. The levels of specific IgG for beef, pork and lamb were 
significantly higher (p < 0.001) than their respective specific IgE level (Figure 3). 
Interestingly, there seemed to be an inverse correlation for the levels of IgE and IgG 
antibodies. However, statistical analysis showed that the correlation is not significant (p < 
0.326) thus we are unable to draw any conclusions. Nevertheless, the presence of specific 
meat IgG in such a high magnitude (>10000 fold) implies that the patients may have high 
abundance of blocking IgG antibodies which can antagonize the cascade of allergic 
inflammation resulting from allergen recognition by IgE antibodies.  
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Figure 3. Comparison between levels of meat specific IgEs and IgGs. A total of 25 
sera were screened for meat specific IgG antibodies. (Conversion for IgE is 1 IU = 
2.4ng/protein; for IgG is 1 IU = 0.8147 mg). The difference in magnitude between IgG 
and IgE is more than 10000 times. 
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7.3.2 Immunoaffinity depletion of IgG from plasma 
 
The IgG antibodies were removed from plasma using the Protein G PLUS-Agarose 
beads. Figure 4 shows the SDS-PAGE of the flow-through with IgG antibodies depleted 
from two patients’ plasma. The molecular weight of IgGs (IgG1, IgG2, IgG3 and IgG4) 
ranges from 140 – 170 kDa (Gergely, 1967). The bands at molecular weights 140 – 170 
kDa corresponding to molecular weights of IgG antibodies were removed in the IgG 
depleted plasma. Also, one additional band was noticed at approximately 30 kDa in the 
IgG depleted plasma. This band is probably due to contamination from the protein G 
agarose resin as its molecular weight corresponds with the molecular weight of protein G 
(Bjorck and Kronvall, 1984). Nevertheless, PBS was loaded onto the Protein G agarose 
column as control to exclude the contaminants from Protein G agarose in subsequent 
experiment. ELISA was also used to confirm the removal of IgG from the plasma 
samples (Figure 5).       
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Figure 4.  
SDS-PAGE of plasma and IgG depleted plasma from two patients. Lane 1: marker; 
Lane 2: Patient 1 IgG depleted plasma; Lane 3: Patient 1 plasma; Lane 4: Patient 2 IgG 
depleted plasma; Lane 5: Patient 2 plasma. Boxed region indicates the removal of IgG 
between 140 – 170 kDa when compared to non-IgG depleted plasma. 
 
 
                         
Figure 5.  




7.3.3 Histamine-release assay 
 
When plasma (with or with IgG) co-incubated with allergen extracts were tested for the 
ability to trigger histamine release from human PBMCs, only samples with IgG depleted 
induced significant histamine release. This is especially prominent when IgG deplete 
samples were challenged with beef extract (Figure 6A and 6B)). A dose-response 
increase in histamine release was observed in both patients. On the other hand, in the case 
of plasma with IgG, only trace amount of histamine (< 2 ng/ml) was released when 
challenged with 1.0 mg/ml of beef extract. This strongly indicates the presence of IgG 
inhibits histamine release from human PBMCs. For pork, only trace amount of histamine 
(≤ 1 ng/ml) was released when challenged with 0.1 and 1.0 mg/ml of pork extract co-
incubated with IgG depleted plasma from P1 (Figure 6C). No histamine was released 
from samples co-incubated with plasma containing IgG. The difference in levels of 
histamine release between pork and beef antigens may indicate that beef antigens are 
more potent allergens and the presence of IgG play a more significant role in inhibiting 




                
             
Figure 6.  
Histamine release from PBMCs induced by either pork or beef extracts from two 
patients (P1 and P2). PBMCs were co-incubated with plasma (blue bars) or IgG 
depleted plasma (red bars). (A) Histamine release induced by beef extract with P1 
plasma. (B) Histamine release induced by beef extract with P2 plasma. (C) Histamine 
release induced by pork extract with P1 plasma. 
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From this study, we can infer that the protective role of “blocking” IgG is the crucial 
factor which determines whether a patient develops allergic symptoms. Similarly in the 
case of SIT, increase in allergen-specific “blocking” IgG is one of the immunological 
mechanisms associated with successful SIT. The induction of IgG antibodies with 
blocking activity may have a protective role not only through the inhibition of allergen-
induced, IgE-mediated release of inflammatory mediators from mast cells and basophils, 
but also through the inhibition of IgE-facilitated antigen presentation to T cells 
(Wachholz and Durham, 2004). Besides quantitative level of IgG, the qualitative changes 
such as affinity of IgG are also important in the allergen-specific IgG antibody response 
which retards allergic response (Svirshchevskaya et al., 2004). The production of IgG, 
particularly the IgG4 subclass, is regulated by IL-10 which in turn reduce IL-4-induced 
IgE synthesis, while increasing allergen-specific γ4 transcription and IgG4 production by 
B cells with an elevated IgG4:IgE ratio. Although SIT has no effect on antibody affinity 
of allergen-specific IgE, IgG1 or IgG4, study have shown that  allergic patients with high-
affinity IgG1 and IgG4 antibodies report less symptoms than patients with low affinity 
antibodies (Jakobsen et al., 2005). The mechanism of “blocking” IgG has yet to be fully 
resolved as studies are still ongoing to confirm whether the increase in IgG correlates 
well or not with reduce clinical symptoms. In the case whereby increases in IgG failed to 
predict the clinical response, it was hypothesized that the IgG may reflect high allergen 
exposure rather than play a causal role in successful immunotherapy (Muller et al., 1989; 




Besides the blocking effect of IgG, the affinity and specificity of IgE also might play a 
role in histamine release. Recently, a strong correlation was found between the affinity of 
the IgE for its antigen and the sensitivity of the histamine release (Foetisch et al., 2003). 
Therefore the IgE antibody affinities to Der p 2 varied approximately 30-fold among 21 
patients with mite allergy (Mita et al., 2000). Thus, in our case, the affinity of specific 
IgE for beef may be higher than that of pork resulting in a higher degree of histamine 
release since in PBMCs challenged with beef. 
 
In the future, we hope to look at the effect on “blocking” IgG on T-cell proliferation and 
cytokine production. We would also like to explore the mechanism of “blocking” IgG 
antibodies by deciphering the methods of clearance and inhibition of the allergens. We 
hypothesize that the specific IgG antibodies are either involved in formation of IgG 
antibody-allergen complex for direct clearance from the immune system or the complex 




In conclusion, we have shown that patients with high level of specific IgEs to meat 
antigen also have high if not higher level of meat specific IgGs indicating the presence of 
“blocking” IgG antibodies. IgG antibodies are successful depleted from plasma sample 
using protein G agarose resin. The PBMCs co-incubated with plasma sample with IgG 
depleted and the allergen has been shown to elicit histamine release suggesting that the 
presence of IgG antibodies inhibits histamine release. The in vitro inhibition of histamine 
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release by IgG antibodies also explains why there was a low prevalence of skin prick 
positive patients to meat antigens even though they themselves have high level of meat 
specific IgEs. In summary, the observed paradox of high abundance of IgE-binding to 
meats antigens but no clinical presentation to these antigens is due to the presence of 
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Appendix I. Allergens dotted onto the array. 























Acacia auriculiformis (acacia)c, Agrostis alba (bent grass)a, Agropyron repens (quack grass)a, Alnus glutinosa (black alder)a, Alopecurus 
prantesis  (foxtail, meadow)a, Ambrosia artemisiifolia (annual ragweed)d, Amaranthus hybridus (careless weed)d, Ambrosia trifida (tall 
ragweed)a, Acer negundo (box elder)d, Anthxanthum odoratum   (sweet vernal grass)a, Atriplex polycarpa (allscale)d, Arecastrum romanzo 
ffianum  (queen palm)d, Artemisia vulgaris (common mugwort)a, Avena sativa (cultivated oats)a, Baccharis halimifolia (eastern baccharis)d, 
Betula verrucosa (white birch)d, Bromus mollis  (spear grass)a, Brassica spp. (brassica pollen)d, Carpinus betulus (hornbeam)a, Casuarina 
equisetifolia (Australian pine)d, Calluna vulgaris  (heather)f, Chenopodium album  (lamb's quarter)a, Chrysanthemum leucanthemum  (ox 
eye daisy)a, Corylus avellana (hazel)f, Cryptomeria japonica (Japanese cedar)d, Cupressus arizonica (Arizona cypress)f, Cupressus 
sempervirens  (Italian cypress)f, Cynodon dactylon (Bermuda grass)d, Dahlia cultorum (dahlia)a, Dactylis glomerata (orchard grass)f, 
Elaeis guineensis (oil palm)c, Eucalyptus globules (bluegum)d, Fagus sylvatica (European beech)f, Festuca prantesis (meadow fescue)f, 
Fraxinus excelsior (ash)a, Holcus lanatus (velvet grass)a, Hordeum vulgare (cultivated barley)a, Humulus lupulus (hops)a, Juniperus 
asheisabinoides (mountain cedar)d, Ligustrum vulgare (common privet)f, Lolium perenne (perennial rye grass)f, Medicago sativa (alfalfa)a, 
Olea europea (olive)f, Parietaria judaica (wall pellitory)f, Populus deltoides  (eastern cottonwood)d, Phragmites communis (reed)f, 
Philadelphus coronarius  (syringa)a, Phlenum pratesense(Timothy grass)b, Pinus radiata (pine)a, Platanus acerfolia (plane tree)d, Plantago 
lanceolata (English plantain)a, Populus nigra (black poplar)a, Poa pratensis   (Kentucky bluegrass)f, Podocarpus polystachyus  (sea teak)d, 
Pinus strobus (eastern white pine)d, Populus trichocarpa (black cottonwood)d, Quercus alba (white oak)d, Quercus ilex (live oak)f, Quercus 
robur (red oak)a, Robinia pseudoacacia (false acacia)a, Rumex acetosella (sorrell)a, Salsola kali (Saltwalt or Russian thistle)a, Sambucus 
nigra (European elder)a, Salix viminalis (willow)a, Secale cereale (cultivated rye)a, Schinus molle (pepper tree)d, Sorghum halepense 
(Johnson grass)d, Solidago virgaurea (golden rod)a, Syringa vulgaris (lilac)a, Tamarix gallica (salt cedar)d, Taraxacum officinale 
(dandelion)a, Tilia cordata (linden)a, Triticum aestivum/sativum (cultivated wheat)a, Ulmus americana (American elm)d, Ulmus minor 
(English elm)a, Urtica dioica (nettle)f, Zea mays (corn)d 
 
Alternaria alternatad, Aspergillus flavus d, Aspergillus fumigatus a, Aspergillus niger c, Aspergillus terreus d, Botrytis cinerea f, Candida 
albicans d, Cladosporium cladosporioides c, Cladosporium fulvum a, Cladosporium herbarum c, Corenyspora cassicola c, Curvularia 
brachysporac, Curvularia fallaxc, Curvularia inequalisc, Curvularia lunatac, Curvularia pallescencesc, Curvularia spiciferaa, 
Drechslerea/Bipolaris sorokiana c, Fusarium moniliforme a, Fusarium solani d, Malazessia furfur c, Mucor mucedo a, Penicillium 
brevicompactum f, Penicillium chrysogenum d, Penicillium expansum a, Penicillium notatum c, Penicillium roqueforti a, Rhizopus nigricans 
a, Saccharomyces cerevisae a, Stemphylium botryosum f, Trichoderma viride d, Trichophyton mentagrophytes f, Trichophyton rubrum d, 
Ustilago triticif 
Allergen sources: aALK-Abelló S.A., bGREER Laboratories Incorporated, clocal sources, draw materials from GREER Laboratories 
Incorporated, eraw materials for Allergon AB and gSigma.  
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Acarus siroc, Austroglycyphagus  geniculatus c, Blomia tropicalis c, Dermatophagoides farinae c, Dermatophagoides pteronyssinus c, 
Glycophagus domesticus c, Lepidoglyphus destructor c, Suidasia medanensis c, Tyrophagus putrescentiae c 
 
budgerigar  (Melopsittacus undulatus)a, cat  (Felis domesticus)e, cow  (Bos taurus) a, dog  (Canis familiaris) a, feather mix (chicken and 
duck) (Pullus gallinaceus and Anas platyrhynchas)a, goose  (Anser anser) a, goat  (Capra hircus)b, guinea pig  (Cavia porcellus) a, hamster  
(Cricetus cricetus) a, horse  (Equus caballus) a and rabbit  (Oryctolagus cuniculus) a 
 
banana prawn  (Penaeus merguiensis)c, beef (Bos taurus)b, caseinb, chicken  (Pullus gallinaceus) a, cockles (Anadara granosa)c, egg white a, 
egg yolk a, mackerel fish  (Scomberomorus sp.)b, milk, cow  (Bos taurus) a, milk, goat  (Capra hircus) a, mud crab  (Scylla olivacea)c, 
mussels (Perna viridis)c, ovalbumin a, ovomucoid a, pork (Sus scrofa)a, rabbit (Oryctolagus cuniculus)a, salmon fish (Oncorhynchus sp.)d, sea 
bream fish (Nemipterus furcosus)c, selar fish (Atule mate)c, sheep (Ovis aries)b, squid (Photololigo duvaucelii)c, swimming crab (Portunus 
pelagicus)c, tiger prawn (Penaeus monodon)c, tuna fish (Thunnus sp.)d 
 
apple (Malus domestica)b, banana (Musa hybrids)c, broccoli (Brassica oleracea var. botrytis)b, cabbage (Brassica oleracea var. capitata)b, 
cacao (Theobroma cacao)a, carrot (Daucus carota)c, chard (Beta vulgaris var. cicla)a, corn flour (Zea mays)a, garlic (Allium sativum)a, 
gliadine (Triticum aestivum)a, hazelnut (Corylus avellana)a, kiwi (Actinidia chinensis)c, orange (Citrus sinensis)c, peach (Prunus persica)a, 
peanut (Arachys hypogaea)a, potato (Solanum tuberosum)c, rice flour (Oryza sativa)a, soya bean (Glycine max)c, spinach (Spinacia 
oleraceaa,  strawberry (Fragaria vesca)c, sunflower seed (Helianthus annuus)a, tofu (Glycine max)c, walnut (Junglans regia)a, wheat flour 
(Triticum aestivum)a 
 
American cockroach (Periplaneta americana)b, fire ant (Solenopsis invicta)b, German cockroach (Blatella germanica)b, mosquito (Culicidae 
sp.)b, oriental cockroach (Blatta orientalis)a 
 
honeybee (Apis mellifera)b, hornet (Dolichovespula spp.)b, wasp (Polistes spp.)b, yellowjacket (Vespula spp.)b 
 
horseradish peroxidase g, latexb, bromelaing 
 
NIBSC IgE standard (positive control), bovine serum albumin (protein control)g, extraction buffer (negative control) 
Allergen sources: a ALK-Abelló S.A., bGREER Laboratories Incorporated, clocal sources, draw materials from GREER Laboratories 
Incorporated, eraw materials for Allergon AB and gSigma 
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Appendix II. Detail lists of sequence homology matches for beef with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology. 
 
Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Bt#S15645050 sp|P02769| Serum albumin precursor (Allergen Bos d 6) (BSA) homeostasis 1216 0 592/607 (97%) 592/607 (97%) highly homologous
Bt#S12073040 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 860 0 highly homologous
Bt#S11933280 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 845 0 highly homologous
Bt#S14887313 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 687 0 354/694 (51%) 470/694 (67%) highly homologous
Bt#S15645044 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 684 0 362/696 (52%) 471/696 (67%) highly homologous
Bt#S12072680 sp|Q9LEI9| Enolase 2 metabolism 549 1.00E-155 289/443 (65%) 346/443 (78%) highly homologous
Bt#S16822592 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 529 1.00E-148 269/444 (60%) 335/444 (75%) highly homologous
Bt#S12072842 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 492 1.00E-138 248/478 (51%) 329/478 (68%) highly homologous
Bt#S12002881 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 436 1.00E-120
Bt#S12072372 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 365 2.00E-99 190/421 (45%) 280/421 (66%) IKLYVRRVFITDD, SRETLQQ, LAKLLR, NMERIMKAQA, KKTFEI
Bt#S12377745 ref|NP_777186.1| major allergen BDA20 [Bos taurus] transport protein 353 2.00E-96 172/172 (100%) 172/172 (100%) highly homologous
Bt#S12072572 sp|P02754| Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5) homeostasis 316 2.00E-85 158/161 (98%) 158/161 (98%) highly homologous
Bt#S12373715 sp|Q9LEJ0| Enolase 1 metabolism 300 2.00E-80 156/231 (67%) 181/231 (78%) highly homologous
Bt#S12073013 ref|NP_776803.1| lactalbumin, alpha [Bos taurus] homeostasis 276 2.00E-73 131/142 (92%) 131/142 (92%) highly homologous
Bt#S12072260 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1)   metabolism 274 2.00E-72 152/330 (46%) 211/330 (63%) DLFDPII, QQQLIDDHFLF, FLVWVNEEDHLR, CPSNLGT
Bt#S12072749 sp|P50635| Apyrase precursor (ATP-diphosphatase) metabolism 263 6.00E-69 172/540 (31%) 274/540 (50%) LGNHEFD
Bt#S14905395 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19) Chaparone/stress-related 262 5.00E-69 125/183 (68%) 153/183 (83%) highly homologous
Bt#S12072373 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 258 2.00E-67 141/378 (37%) 209/378 (55%) FDGLDLDWEYPG, WVGYDD
Bt#S12073064 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1)   metabolism 255 2.00E-66 148/341 (43%) 202/341 (59%) QQQLIDDHFLF, FLVWVNEEDH, CPTNLGT, VHIKLP
Bt#S15812499 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 249 8.00E-65 137/366 (37%) 207/366 (56%) FDGLDL
Bt#S11933200 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 243 1.00E-62 165/489 (33%) 250/489 (51%) FDGLDL, WVGYDD
Bt#S12072246 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 242 1.00E-62 131/389 (33%) 218/389 (56%) SALAMV, VLVNAI, KPVQMM, ADHPFLF 
Bt#S12072666 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 226 6.00E-58
Bt#S17487029 sp|Q95182| Major allergen Equ c 1 precursor transport protein 220 2.00E-56 111/173 (64%) 130/173 (75%) highly homologous
Bt#S14837289 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 213 2.00E-54 108/240 (45%) 158/240 (65%) LELGGKSP
Bt#S14561797 sp|P46419| Glutathione S-transferase (GST class-mu) metabolism 213 6.00E-54 97/199 (48%) 138/199 (69%) ILGYWDIRG, WLNEKF, LGLDFPNLPY
Bt#S12072465 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 208 1.00E-53 101/101 (100%) 101/101 (100%) highly homologous
Bt#S11933345 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 198 8.00E-49 100/157 (63%) 113/157 (71%) NFRALCTGEKGFG, FHRVIPDF, PGLLSMAN, SQFFIT , KHVVFG
Bt#S15341477 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 196 7.00E-55 94/123 (76%) 99/123 (80%) highly homologous
Bt#S12072771 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 195 1.00E-48 101/165 (61%) 114/165 (69%) DVVPKT, NFRALCTGEKG, GLLSMANAG, NTNGSQFFITTV, LDGKHVVFG
Bt#S12072795 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 195 5.00E-48 119/363 (32%) 192/363 (52%) ELVPVP, LLHVKG
Bt#S14866901 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 190 2.00E-47 95/163 (58%) 118/163 (72%) DVVPKTA, FADENF, PGLLSMAN, WLDGKHVVFG
Bt#S11932912 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 190 4.00E-47 97/214 (45%) 138/214 (64%) CGGCWAFSA, DYWIVKNSW
Bt#S11933051 sp|Q92450| Superoxide dismutase [Mn] metabolism 189 1.00E-46 96/203 (47%) 128/203 (63%) KFNGGGHINHS, WEHAYYLQY, IWNVINW
Bt#S16972488 sp|P46419| Glutathione S-transferase (GST class-mu) metabolism 188 8.00E-47 84/199 (42%) 134/199 (67%) LGYWDIRG, LDFPNLPY 
Bt#S12072533 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 185 1.00E-45
Bt#S12073122 sp|P49275| Mite allergen Der f 3 precursor metabolism 185 8.00E-46 99/247 (40%) 138/247 (55%) HFCGGS, DSCQGDSGGPV, GIVSWGYGCA
Bt#S12373623 sp|Q25456| Tropomyosin (Allergen Met e 1) (Met e I)  structural protein 178 1.00E-43 94/191 (49%) 128/191 (67%) ADRKYDEVARKL, ELEEEL, NNLKSLE, RAEFAERSV
Bt#S15971742 sp|Q9U6V9| Hyalurononglucosaminidase precursor metabolism 177 4.00E-43 110/324 (33%) 169/324 (52%) FMEETLKL, LFPSVY, PQLGNL
Bt#S15645043 sp|P00698| Lysozyme C precursor (1,4-beta-N-acetylmuramidase C) metabolism 174 3.00E-42 79/148 (53%) 109/148 (73%) STDYGI, WWCNDG
Bt#S15460514 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 173 6.00E-42 118/361 (32%) 179/361 (49%) PVQHRE
Bt#S12072768 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 172 5.00E-42 87/158 (55%) 106/158 (67%) TGEKGFGY, SMANAG, TNGSQFFITTV, WLDGKHV 
Bt#S12073038 sp|Q08169| Hyalurononglucosaminidase precursor metabolism 172 1.00E-41 113/338 (33%) 170/338 (50%) nil
Bt#S12072261 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 169 1.00E-40
Bt#S14878741 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19) Chaparone/stress-related 165 4.00E-46
Bt#S17486502 ref|NP_777186.1| major allergen BDA20 [Bos taurus] transport protein 163 2.00E-39 81/156 (51%) 108/156 (69%) EGGPLR
Bt#S12072961 ref|NP_240013.1| alkyl hydroperoxide reductase metabolism 159 1.00E-37 83/172 (48%) 110/172 (63%) DFTFVCPTE, GLALRG, GEVCPA
Bt#S14769516 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 157 7.00E-37
Bt#S12072754 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 157 1.00E-36
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Bt#S12072270 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 156 5.00E-37 81/175 (46%) 111/175 (63%) DFTFVCPTE, GEVCPA
Bt#S12072400 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 156 2.00E-36 112/379 (29%) 188/379 (49%) nil
Bt#S12373644 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1)   metabolism 154 1.00E-36 77/167 (46%) 108/167 (64%) CPTNLGT, VYDISN 
Bt#S12069906 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 148 6.00E-35
Bt#S12069907 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 146 3.00E-34
Bt#S12373656 sp|O44119| Tropomyosin (Allergen Hom a 1) structural protein 143 3.00E-33 78/168 (46%) 106/168 (63%) AADESER, EVARKL, NNLKSLE, RAEFAERSV  
Bt#S11933075 gb|AAA99805.1| Der f 3 mite allergen                                  metabolism 141 2.00E-32
Bt#S12072960 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 141 2.00E-32 75/180 (41%) 106/180 (58%) DFTFVCPTE, GEVCPA
Bt#S11965762 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 138 6.00E-32 72/212 (33%) 124/212 (58%) KPVQMM
Bt#S12072401 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 137 3.00E-31
Bt#S12072361 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 136 6.00E-31
Bt#S11972834 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 135 6.00E-31
Bt#S12378832 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 135 2.00E-30
Bt#S12377802 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 134 9.00E-31 64/174 (36%) 104/174 (59%) KPVQMM
Bt#S12072762 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 132 3.00E-29
Bt#S12065996 sp|P49064| Serum albumin precursor (Allergen Fel d 2) homeostasis 132 7.00E-30 58/125 (46%) 82/125 (65%) NRRPCFS, VDETYVP, TEEQLKTV
Bt#S12072765 gb|AAA99805.1| Der f 3 mite allergen                                  metabolism 129 2.00E-28
Bt#S14846682 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 126 4.00E-28 65/186 (34%) 106/186 (56%) ADHPFLF
Bt#S12378774 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 124 4.00E-28 57/126 (45%) 87/126 (69%) GQCCCAGS, ESIYDKF
Bt#S15184002 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 115 3.00E-24
Bt#S12375436 sp|P35747| Serum albumin precursor (Allergen Equ c 3) homeostasis 115 9.00E-25 64/180 (35%) 90/180 (50%) FTFHAD
Bt#S14870192 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 114 1.00E-24
Bt#S12378278 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 112 9.00E-25 61/145 (42%) 89/145 (61%) nil
Bt#S12372716 sp|P39674| Allergen MAG29   Chaparone/stress-related 112 4.00E-24 49/74 (66%) 63/74 (85%) LAEKDEFEH, VCNPII
Bt#S11933030 sp|Q06478| Phospholipase A1 1 precursor (Allergen Dol m 1.01) metabolism 112 4.00E-23 77/276 (27%) 127/276 (46%) SLGAHA, GLDPAGP
Bt#S12072353 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]    structural protein 110 2.00E-22 153/731 (20%) 320/731 (43%) nil
Bt#S12072399 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 109 2.00E-22 96/388 (24%) 173/388 (44%) nil
Bt#S11963276 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 104 1.00E-21
Bt#S12044428 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 103 2.00E-21
Bt#S12072611 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 102 4.00E-21 47/105 (44%) 69/105 (65%) ATWCGPC
Bt#S12073098 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 101 1.00E-20 48/125 (38%) 74/125 (59%) STFKNTEI
Bt#S12073097 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 99 5.00E-20 52/127 (40%) 80/127 (62%) STFKNTEI
Bt#S14887281 sp|P46419| Glutathione S-transferase (GST class-mu) metabolism 96 9.00E-19 62/207 (29%) 99/207 (47%) nil
Bt#S14885468 sp|P49275| Mite allergen Der f 3 precursor metabolism 94 2.00E-18
Bt#S12072302 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 93 1.00E-17
Bt#S12375811 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 92 9.00E-18
Bt#S12072282 sp|O43099| Putative peroxiredoxin pmp20 (Thioredoxin reductase) structural protein 91 3.00E-17 56/176 (31%) 85/176 (48%) PGAFTP 
Bt#S12072858 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 90 5.00E-17
Bt#S17479898 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 89 7.00E-17
Bt#S12072243 sp|P42037| 60S acidic ribosomal protein P2 (Minor allergen Alt a 6) protein synthesis 89 1.00E-17 48/115 (41%) 62/115 (53%) SVGIEAD, DMGFGLFD
Bt#S17485445 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19) Chaparone/stress-related 88 1.00E-16 49/159 (30%) 80/159 (50%) nil
Bt#S12373902 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 87 4.00E-16
Bt#S14903074 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]     unknown 86 3.00E-22 54/128 (42%) 79/128 (61%) EVVKAK, GAGSATLSMAYA
Bt#S14876172 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 86 5.00E-16 43/136 (31%) 76/136 (55%) nil
Bt#S14885930 sp|Q06478| Phospholipase A1 1 precursor (Allergen Dol m 1.01) metabolism 86 5.00E-16 51/149 (34%) 80/149 (53%) SLGAHISGFAG
Bt#S17486445 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 86 5.00E-16 43/119 (36%) 70/119 (58%) LGEEFEE
Bt#S12072759 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 84 5.00E-15
Bt#S12378546 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 84 3.00E-15
Bt#S17484852 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 84 2.00E-15 48/137 (35%) 76/137 (55%) GEEFEE
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Bt#S12059808 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 82 4.00E-15
Bt#S12072859 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 82 9.00E-15 nil
Bt#S15645006 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 82 2.00E-14 48/137 (35%) 72/137 (52%)
Bt#S12065896 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 80 6.00E-14 AIKKKMQ, LNRRIQL
Bt#S12041279 sp|O18416| Tropomyosin (Allergen Der p 10)    structural protein 80 4.00E-14 58/209 (27%) 85/209 (40%) TGQIKTGAPCRSERLAKYNQL, RIEEELG
Bt#S14838136 sp|Q9LEJ0| Enolase 1 metabolism 80 2.00E-14 38/45 (84%) 40/45 (88%) nil
Bt#S11932968 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 79 1.00E-13 45/131 (34%) 77/131 (58%)
Bt#S12072330 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 78 4.00E-13 GEEFEE
Bt#S14874248 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 78 1.00E-13 45/131 (34%) 77/131 (58%) nil
Bt#S12072807 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 77 5.00E-12 91/391 (23%) 157/391 (40%)
Bt#S12072308 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 77 1.00E-12 STFKNTEI
Bt#S11937254 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 77 2.00E-13 37/89 (41%) 56/89 (62%) QDCFNE
Bt#S17483233 ref|NP_803230.1| allergen dI chain C2A [Mus musculus] unknown 76 3.00E-13 38/93 (40%) 51/93 (54%)
Bt#S12072667 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 76 3.00E-12 VGHYTQ 
Bt#S12378420 sp|P10736| Venom allergen 5.01 precursor (Antigen 5 form 2) metabolism 76 9.00E-14 47/132 (35%) 68/132 (51%) nil
Bt#S14561803 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 76 1.00E-13 44/130 (33%) 69/130 (53%)
Bt#S14902851 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 75 9.00E-13 NGTGGKSIY
Bt#S14878999 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 74 7.00E-17 35/59 (59%) 39/59 (66%)
Bt#S12072476 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 74 2.00E-12 DHPFLF
Bt#S14847131 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 72 8.00E-12 39/104 (37%) 52/104 (50%)
Bt#S12373387 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 72 8.00E-12
Bt#S12072818 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 70 8.00E-11
Bt#S12072861 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 69 1.00E-10 nil
Bt#S17486673 ref|NP_777186.1| major allergen BDA20 [Bos taurus] transport protein 69 6.00E-11 42/155 (27%) 77/155 (49%) KPKATE, EGPKLVVSTQT 
Bt#S11906978 sp|P02769| Serum albumin precursor (Allergen Bos d 6) (BSA) homeostasis 69 2.00E-11 41/75 (54%) 44/75 (58%)
Bt#S14886676 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 68 1.00E-10 EGGPLRNYYR, LEKYQQLNSERGVPNENIENLIKTDNCPP
Bt#S17485312 pir||B59225 allergen Bos d 2.0103 [imported] - bovine                  transport protein 67 1.00E-10 51/126 (40%) 63/126 (50%) LGEEFEE
Bt#S12073100 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 67 2.00E-10 38/127 (29%) 62/127 (48%) nil
Bt#S12376903 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 66 5.00E-10 32/90 (35%) 51/90 (56%) ADHPFLF
Bt#S11931473 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 66 3.00E-10 39/149 (26%) 81/149 (54%) VGHYTQ
Bt#S12378419 ref|NP_509802.1| T05A10.5 [Caenorhabditis elegans] metabolism 65 3.00E-10 34/75 (45%) 40/75 (53%) LFAKAL, SDDDMGFGLFD 
Bt#S14835144 sp|P50344| 60S acidic ribosomal protein P1 (Allergen Cla h 12) protein synthesis 65 7.00E-10 42/113 (37%) 51/113 (45%) nil
Bt#S12072562 prf||2118249B allergen Lep d 1.02                                      unknown 64 4.00E-09 36/110 (32%) 56/110 (50%)
Bt#S16058522 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 62 1.00E-07
Bt#S14879707 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 62 8.00E-09 nil
Bt#S11906148 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 61 8.00E-09 41/166 (24%) 74/166 (44%) nil
Bt#S14870498 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 60 2.00E-08 31/91 (34%) 53/91 (58%) SVGIEAD, KLASVP
Bt#S11894291 sp|P42037| 60S acidic ribosomal protein P2 (Minor allergen Alt a 6) protein synthesis 60 2.00E-09 29/56 (51%) 39/56 (69%) nil
Bt#S12072915 sp|Q9NFZ4| Tropomyosin (Allergen Lep d 10)    structural protein 59 6.00E-07 49/233 (21%) 107/233 (45%) nil
Bt#S14882439 sp|P49064| Serum albumin precursor (Allergen Fel d 2) homeostasis 58 2.00E-07 42/172 (24%) 72/172 (41%)
Bt#S14881268 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 58 1.00E-07
Bt#S11978542 sp|P42041| Aldehyde dehydrogenase (ALDDH) (Allergen Alt a 10) metabolism 57 9.00E-08
Bt#S12072722 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]     unknown 56 2.00E-06 nil
Bt#S12072244 ref|NP_671747.1| alpha-2u globulin PGCL1 [Rattus norvegicus]           homeostasis 56 6.00E-07 38/156 (24%) 74/156 (47%) nil
Bt#S14879787 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 55 1.00E-06 48/174 (27%) 81/174 (46%)
Bt#S12062724 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 55 6.00E-07 WLDGKHVVFG
Bt#S12371599 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 54 3.00E-06 26/50 (52%) 30/50 (60%) FHKYSG
Bt#S12007486 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 54 2.00E-06 32/100 (32%) 52/100 (52%)
Bt#S12375345 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 54 2.00E-14 nil
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Bt#S14844653 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 54 7.00E-07 25/80 (31%) 45/80 (56%) nil
Bt#S13584272 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 53 9.00E-07 23/41 (56%) 26/41 (63%)
Bt#S14872311 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 53 4.00E-06 43/164 (26%) 79/164 (48%)
Bt#S17484640 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 52 1.00E-05
Bt#S12073034 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 51 1.00E-04 nil
Bt#S12072631 sp|O18873| Major allergen Can f 1 precursor (Allergen Dog 1) transport protein 51 4.00E-05 TSETPK
Bt#S15828154 sp|Q9UB83| Tropomyosin (Major allergen Per a 7) structural protein 51 5.00E-05 39/158 (24%) 71/158 (44%)
Bt#S11989097 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]           metabolism 50 3.00E-04 31/84 (36%) 34/84 (40%)
Bt#S12072484 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 50 1.00E-04 nil
Bt#S12072508 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 50 5.00E-05 GCGGNANRF
Bt#S12072417 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 50 2.00E-05 29/81 (35%) 46/81 (56%) nil
Bt#S12070644 dbj|BAC77154.1| 21k allergen [Anisakis simplex]                        unknown 49 4.00E-05 27/64 (42%) 35/64 (54%)
Bt#S14879262 gb|AAB34785.1| 68 kDa allergen [Penicillium chrysogenum]               metabolism 49 5.00E-05 35/100 (35%) 46/100 (46%)
Bt#S12378066 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 49 6.00E-05 nil
Bt#S11882487 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 49 3.00E-05
Bt#S14877298 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 49 1.00E-04 53/225 (23%) 102/225 (45%) PVCGTDGVTY
Bt#S12072905 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 49 8.00E-05
Bt#S13584198 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 49 2.00E-05 18/41 (43%) 27/41 (65%)
Bt#S12072720 emb|CAA09883.1| allergen [Malassezia sympodialis]                      signal transduction 48 6.00E-04 FHKYSG
Bt#S14884075 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 48 1.00E-04
Bt#S12072466 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 48 6.00E-05 26/81 (32%) 43/81 (53%)
Bt#S12043764 sp|P43187| Calcium-binding allergen Bet v 3 (Bet v III) signal transduction 48 9.00E-05 nil
Bt#S14905591 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 47 2.00E-04 LFAKAL
Bt#S12072412 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 47 5.00E-05 27/91 (29%) 47/91 (51%)
Bt#S14882897 sp|P49148| 60S acidic ribosomal protein P1 protein synthesis 47 2.00E-04 26/61 (42%) 36/61 (59%) LFDPIIED
Bt#S12376787 sp|P78983| Heat shock 70 kDa protein (Allergen Alt a 3) Chaparone/stress-related 47 2.00E-08 TWCGPC
Bt#S14855781 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1)   metabolism 47 3.00E-07 20/31 (64%) 24/31 (77%)
Bt#S14846535 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 47 2.00E-04 21/50 (42%) 29/50 (58%)
Bt#S17482076 dbj|BAC77154.1| 21k allergen [Anisakis simplex]                        unknown 46 5.00E-04
Bt#S12375538 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 46 8.00E-04 FVDWIE
Bt#S14902829 sp|Q9M7R0| Calcium-binding allergen Ole e 8 (PCA18/PCA23). signal transduction 46 7.00E-04 nil
Bt#S14886698 sp|P49275| Mite allergen Der f 3 precursor metabolism 45 2.00E-04 18/25 (72%) 18/25 (72%)










Appendix III. Detail lists of sequence homology matches for pork with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology. 
Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Ssc#S6091528 sp|P02769| Serum albumin precursor (Allergen Bos d 6) (BSA) homeostasis 1032 0 483/604 (79%) 543/604 (89%) highly homologous
Ssc#S6091475 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 815 0 406/640 (63%) 498/640 (77%) highly homologous
Ssc#S6091477 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 745 0 377/618 (61%) 475/618 (76%) highly homologous
Ssc#S6091427 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 707 0 362/700 (51%) 484/700 (69%) highly homologous
Ssc#S6091238 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 701 0 354/700 (50%) 479/700 (68%) highly homologous
Ssc#S6091718 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 657 0 349/715 (48%) 471/715 (65%) highly homologous
Ssc#S6090900 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 529 1.00E-149 269/444 (60%) 335/444 (75%) highly homologous
Ssc#S6089974 sp|P19121| Serum albumin precursor (Alpha-livetin) (Allergen Gal d 5) homeostasis 493 1.00E-138 239/614 (38%) 367/614 (59%) YEIARRHP, YEYSRRHP, NRRPCFS
Ssc#S6090444 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 445 1.00E-123 259/772 (33%) 422/772 (54%) nil
Ssc#S6090711 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 365 3.00E-99 190/421 (45%) 279/421 (66%) IKLYVRRVFITDD, KGVVDS, LAKLLR, NMERIMKAQA, KKTFEI
Ssc#S6077154 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19) Chaparone/stress-related 346 6.00E-96
Ssc#S14768430 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 319 3.00E-86     
Ssc#S6091740 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]    unknown 270 8.00E-71 149/294 (50%) 198/294 (67%) highly homologous
Ssc#S16767837 sp|Q9LEI9| Enolase 2 metabolism 256 2.00E-67 126/179 (70%) 149/179 (83%) highly homologous
Ssc#S17511701 sp|Q9LEI9| Enolase 2 metabolism 248 5.00E-65 123/178 (69%) 147/178 (82%) highly homologous
Ssc#S6089598 sp|Q9NAS5| Tropomyosin (Allergen Ani s 3). structural protein 246 5.00E-64 134/280 (47%) 177/280 (63%) highly homologous
Ssc#S6091381 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 244 3.00E-63 137/378 (36%) 214/378 (56%) WVGYDD
Ssc#S6090433 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 240 6.00E-62 167/489 (34%) 246/489 (50%) FDGLDL, WVGYDD
Ssc#S6091242 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 219 9.00E-56 126/345 (36%) 190/345 (55%) CWAFSA
Ssc#S6091086 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 217 4.00E-55 131/340 (38%) 182/340 (53%) YWIVKNSW
Ssc#S17525633 sp|P02754| Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5) homeostasis 215 5.00E-55 108/167 (64%) 133/167 (79%) highly homologous
Ssc#S6091512 sp|P02754| Beta-lactoglobulin precursor (Beta-LG) (Allergen Bos d 5) homeostasis 214 1.00E-54 107/167 (64%) 132/167 (79%) highly homologous
Ssc#S6090496 sp|Q95182| Major allergen Equ c 1 precursor transport protein 212 8.00E-54 106/172 (61%) 131/172 (76%) IEENGSM, NIIDLTKI
Ssc#S6091491 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 208 4.00E-52 121/366 (33%) 199/366 (54%) nil
Ssc#S6091341 sp|O18873| Major allergen Can f 1 precursor (Allergen Dog 1) transport protein 207 1.00E-52 97/153 (63%) 130/153 (84%) highly homologous
Ssc#S6090478 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 206 7.00E-52 115/307 (37%) 172/307 (56%) nil
Ssc#S6091747 ref|NP_776803.1| lactalbumin, alpha [Bos taurus] homeostasis 204 1.00E-51 95/142 (66%) 111/142 (78%) highly homologous
Ssc#S17525050 sp|Q9LEI9| Enolase 2 metabolism 199 2.00E-50 98/135 (72%) 113/135 (83%) highly homologous
Ssc#S17510611 sp|Q9LEI9| Enolase 2 metabolism 196 4.00E-49 95/121 (78%) 108/121 (89%) highly homologous
Ssc#S6072833 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 196 2.00E-49 99/221 (44%) 137/221 (61%) CWAFSA, LISLSEQ, CGIATM
Ssc#S17513259 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 191 8.00E-48 99/217 (45%) 133/217 (61%) LELGGKSP
Ssc#S17518674 sp|Q92450| Superoxide dismutase [Mn] metabolism 189 4.00E-47 95/203 (46%) 125/203 (61%) KFNGGGHINHS, WEHAYYLQY, IWNVINW
Ssc#S6081972 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 187 2.00E-46 97/232 (41%) 146/232 (62%) VLVNAI
Ssc#S6090009 sp|Q9U6V9| Hyalurononglucosaminidase precursor metabolism 184 7.00E-45 109/331 (32%) 167/331 (50%) NGGIPQ , FMQETLKL 
Ssc#S6091332 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 180 5.00E-44 115/380 (30%) 202/380 (53%) nil
Ssc#S17515670 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 175 7.00E-43 88/158 (55%) 106/158 (67%) TGEKGFGY, SMANAG, TNGSQFFITTV, WLDGKHVVFG
Ssc#S17510471 sp|P46419| Glutathione S-transferase (GST class-mu) metabolism 174 2.00E-42 80/191 (41%) 125/191 (65%) LDFPNLPY, FPNLKA
Ssc#S6074566 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 165 8.00E-40 85/167 (50%) 116/167 (69%) ANMERIMKA
Ssc#S6090480 sp|P49275| Mite allergen Der f 3 precursor (Der f III) metabolism 164 1.00E-57 76/90 (84%) 81/90 (90%) highly homologous
Ssc#S17524919 sp|P02769| Serum albumin precursor (Allergen Bos d 6) (BSA) homeostasis 164 8.00E-39 96/242 (39%) 139/242 (57%) LTAAHC
Ssc#S17518399 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19) Chaparone/stress-related 159 4.00E-37 105/382 (27%) 184/382 (48%) nil
Ssc#S6091317 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 159 3.00E-38
Ssc#S17511369 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 154 1.00E-42 77/167 (46%) 108/167 (64%) CPSNLGT, VYDISN
Ssc#S17526670 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 151 7.00E-36 75/125 (60%) 89/125 (71%) TGEKGFGY, SMANAG, TNGSQFFITTV, WLDGKHVVFG
Ssc#S17519014 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 149 4.00E-35
Ssc#S6090124 sp|O97370| Mite allergen Eur m 3 precursor metabolism 148 2.00E-34 92/241 (38%) 128/241 (53%) LTAAHCV, DSCQGDSGGP, GIVSWG 
Ssc#S6090257 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 147 5.00E-34 108/379 (28%) 187/379 (49%) nil
Ssc#S6090888 sp|P49275| Mite allergen Der f 3 precursor (Der f III) metabolism 143 6.00E-33
Ssc#S6090178 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 143 1.00E-32 90/244 (36%) 129/244 (52%) CQGDSGGP, GIVSWG 
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Ssc#S6091834 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 141 3.00E-32 116/392 (29%) 197/392 (50%) nil
Ssc#S6090504 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 140 7.00E-33 66/94 (70%) 85/94 (90%) highly homologous
Ssc#S17512167 sp|P39675| Mite allergen Der f 3 precursor (Der f III) metabolism 139 3.00E-32 78/162 (48%) 99/162 (61%) GGKDSCQGDSGGPVV, GIVSWGYGCA
Ssc#S6090943 sp|O44119| Tropomyosin (Allergen Hom a 1)   structural protein 138 1.00E-31 79/213 (37%) 111/213 (52%) VAALNRRIQ, AEEADRKY, EVARKL
Ssc#S17508597 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 133 3.00E-30 63/144 (43%) 100/144 (69%) PFGGYK
Ssc#S17511216 sp|P49822| Serum albumin precursor (Allergen Can f 3)       homeostasis 132 4.00E-29
Ssc#S17524777 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 132 6.00E-30 70/168 (41%) 94/168 (55%) EEGPKL
Ssc#S6091419 gb|AAA99805.1| Der f 3 mite allergen                                  metabolism 132 3.00E-30 66/151 (43%) 100/151 (66%) DFELLC
Ssc#S6081806 gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon]                     structural protein 131 7.00E-38 65/110 (59%) 80/110 (72%) LLSMAN, TNGSQFFITT
Ssc#S14765627 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 131 1.00E-29 70/157 (44%) 94/157 (59%) HNDNKTFLVW, NEEDHLR, VHIKLP
Ssc#S16769360 sp|P49275| Mite allergen Der f 3 precursor (Der f III) metabolism 125 4.00E-28 68/192 (35%) 105/192 (54%) HFCGGS, GDSGGP
Ssc#S6090453 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 125 3.00E-27 97/383 (25%) 186/383 (48%) nil
Ssc#S6072984 sp|P42041| Aldehyde dehydrogenase (ALDDH) (Allergen Alt a 10) metabolism 118 7.00E-26 55/122 (45%) 82/122 (67%) EEIFGPV, PFGGYK
Ssc#S6072240 sp|O44119| Tropomyosin (Allergen Hom a 1) structural protein 116 1.00E-27 58/135 (42%) 85/135 (62%) AEEADRKY, EVARKL, RAEFAERSV
Ssc#S6091320 sp|Q06478| Phospholipase A1 1 precursor (Allergen Dol m 1.01) metabolism 110 1.00E-22 77/276 (27%) 126/276 (45%) GLDPAGP, GYSLGAHA
Ssc#S6055440 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 107 2.00E-22 55/90 (61%) 61/90 (67%) LLSMAN, SQFFIT, KHVVFG
Ssc#S17507675 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 105 4.00E-22 47/72 (65%) 58/72 (80%) PGLLSMAN, GPNTNGSQFF, WLDGKHVVFGEV
Ssc#S17513373 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 103 2.00E-21 58/127 (45%) 78/127 (61%) STFKNTEI
Ssc#S17526046 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 103 2.00E-21 63/188 (33%) 100/188 (53%) nil
Ssc#S16764840 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 103 2.00E-21 58/127 (45%) 78/127 (61%) STFKNTEI
Ssc#S14890189 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 100 2.00E-20 47/125 (37%) 75/125 (60%) STFKNTEI
Ssc#S17526117 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 100 3.00E-20 47/125 (37%) 75/125 (60%) STFKNTEI
Ssc#S6090271 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 100 2.00E-20 63/200 (31%) 105/200 (52%) AKLLRY
Ssc#S17515904 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 100 3.00E-20 44/95 (46%) 64/95 (67%) ATWCGPC
Ssc#S6090227 ref|NP_777186.1| major allergen BDA20 [Bos taurus]    transport protein 99 3.00E-20 54/157 (34%) 84/157 (53%) nil
Ssc#S6090217 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 96 7.00E-19
Ssc#S6089956 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 96 6.00E-19 53/122 (43%) 77/122 (63%) CPSNLGT
Ssc#S16514177 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 96 4.00E-19 50/153 (32%) 77/153 (50%) nil
Ssc#S16515301 ref|NP_671747.1| alpha-2u globulin PGCL1 [Rattus norvegicus] homeostasis 96 5.00E-19 63/218 (28%) 110/218 (50%) nil
Ssc#S17510722 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 95 1.00E-18 49/85 (57%) 60/85 (70%) YGLAAAV, AGTVWVN, PFGGYK, GRELGE
Ssc#S6090499 sp|O43099| Putative peroxiredoxin pmp20 (Thioredoxin reductase) metabolism 94 2.00E-18 57/176 (32%) 87/176 (49%) PGAFTP 
Ssc#S17526279 sp|O43099| Putative peroxiredoxin pmp20 (Thioredoxin reductase) metabolism 93 4.00E-18 56/176 (31%) 86/176 (48%) PGAFTP 
Ssc#S6057638 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 91 1.00E-17 50/93 (53%) 62/93 (66%) GPNTNGS
Ssc#S16517353 sp|O44119| Tropomyosin (Allergen Hom a 1)    structural protein 89 6.00E-17 64/194 (32%) 85/194 (43%) ICNYGPAGN
Ssc#S17526881 ref|NP_741138.1| venom allergen 5, LONg family member (lon-1) metabolism 89 5.00E-17 52/144 (36%) 80/144 (55%) RKYEEVARKL 
Ssc#S17527194 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 87 3.00E-16
Ssc#S17526951 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 87 2.00E-16
Ssc#S6054734 sp|P42037| 60S acidic ribosomal protein P2 (Minor allergen Alt a 6) protein synthesis 86 1.00E-25 43/91 (47%) 60/91 (65%) GEVCPA
Ssc#S6076895 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 86 2.00E-16 47/115 (40%) 62/115 (53%) GNTSPSA, SVGIEAD
Ssc#S16767408 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 85 5.00E-16 45/138 (32%) 70/138 (50%) nil
Ssc#S17526356 ref|NP_671747.1| alpha-2u globulin PGCL1 [Rattus norvegicus]           homeostasis 85 1.00E-15 50/136 (36%) 74/136 (54%) nil
Ssc#S17526677 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 84 1.00E-15 43/113 (38%) 70/113 (61%) nil
Ssc#S17527193 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 82 3.00E-15
Ssc#S17506573 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 80 4.00E-14
Ssc#S6085810 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 80 4.00E-14
Ssc#S17509918 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 80 4.00E-14
Ssc#S14900653 ref|NP_741138.1| venom allergen 5, LONg family member (lon-1) metabolism 79 4.00E-14 52/158 (32%) 69/158 (43%) CNYGPAGN
Ssc#S6084992 sp|Q9M7R0| Calcium-binding allergen Ole e 8 (PCA18/PCA23) signal transduction 78 3.00E-14 42/106 (39%) 64/106 (60%) nil
Ssc#S16767712 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 78 1.00E-13 39/123 (31%) 65/123 (52%) nil
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Ssc#S17501675 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 77 1.00E-13
Ssc#S14765758 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 77 3.00E-13 45/131 (34%) 76/131 (58%) GKEFEED, RTLSTFRN  
Ssc#S6081386 sp|O97370| Mite allergen Eur m 3 precursor  metabolism 77 2.00E-13 41/84 (48%) 55/84 (65%) GDSGGP
Ssc#S6055999 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 77 2.00E-13 44/130 (33%) 69/130 (53%) GEKVKTVV, EGDNK 
Ssc#S6089848 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 77 5.00E-20 36/60 (60%) 41/60 (68%) EKGFGY, GKSIYG
Ssc#S17526279 sp|P56577| Allergen Mal f 2 (MF1)  metabolism 76 5.00E-13 35/75 (46%) 46/75 (61%) DFTFVCPTE
Ssc#S16516418 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 76 4.00E-13
Ssc#S6091287 sp|O18598| Glutathione S-transferase (GST class-sigma) metabolism 76 5.00E-13 41/120 (34%) 62/120 (51%) PGAFTP
Ssc#S16515479 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 76 8.00E-13 60/195 (30%) 96/195 (49%) nil
Ssc#S6053690 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 75 3.00E-13 39/94 (41%) 60/94 (63%) nil
Ssc#S17527544 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 74 1.00E-12 36/63 (57%) 46/63 (73%) AGTVWVN, PFGGYK, GRELGE
Ssc#S16516911 sp|O97370| Mite allergen Eur m 3 precursor  metabolism 74 2.00E-12 36/67 (53%) 47/67 (70%) CQGDSGGP
Ssc#S6091286 gb|AAB72147.1| allergen Bla g 5 [Blattella germanica]                  metabolism 73 6.00E-12 59/195 (30%) 95/195 (48%) nil
Ssc#S14767224 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 72 9.00E-12 35/114 (30%) 64/114 (56%) nil
Ssc#S16516041 sp|P46419| Glutathione S-transferase (GST class-mu) metabolism 72 6.00E-12 32/87 (36%) 54/87 (62%) nil
Ssc#S6053232 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 72 5.00E-12 39/127 (30%) 65/127 (51%) nil
Ssc#S16514502 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 72 6.00E-12 42/128 (32%) 71/128 (55%) nil
Ssc#S6091224 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 72 7.00E-12
Ssc#S16765201 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 72 3.00E-11 76/384 (19%) 163/384 (42%) nil
Ssc#S6081229 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 71 1.00E-11
Ssc#S6061469 sp|P42037| 60S acidic ribosomal protein P2 (Minor allergen Alt a 6) protein synthesis 70 6.00E-12 36/62 (58%) 44/62 (70%) KLASVP 
Ssc#S17504676 ref|NP_509707.1| C07A4.3 [Caenorhabditis elegans] unknown 70 3.00E-11 44/150 (29%) 76/150 (50%) HNEYRQK
Ssc#S17503360 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 69 6.00E-11
Ssc#S6090938 emb|CAD23374.1| tri s 4 allergen [Trichophyton schoenleinii] metabolism 68 9.00E-10 58/243 (23%) 107/243 (44%) GSTGFGQ
Ssc#S17526971 sp|P50344| 60S acidic ribosomal protein P1 (Allergen Cla h 12) protein synthesis 67 2.00E-10 42/113 (37%) 52/113 (46%) LFAKAL, SDDDMGFGLFD
Ssc#S17526972 sp|P50344| 60S acidic ribosomal protein P1 (Allergen Cla h 12) protein synthesis 67 2.00E-10 42/113 (37%) 52/113 (46%) LFAKAL, SDDDMGFGLFD
Ssc#S17527394 sp|P50344| 60S acidic ribosomal protein P1 (Allergen Cla h 12) protein synthesis 67 2.00E-10 42/113 (37%) 52/113 (46%) LFAKAL, SDDDMGFGLFD
Ssc#S17527395 sp|P50344| 60S acidic ribosomal protein P1 (Allergen Cla h 12) protein synthesis 67 2.00E-10 42/113 (37%) 52/113 (46%) LFAKAL, SDDDMGFGLFD
Ssc#S17513058 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 66 4.00E-10
Ssc#S16768146 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 65 1.00E-09
Ssc#S6091057 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 65 5.00E-10 44/108 (40%) 54/108 (50%) GDSGG, GLVSWG, GIYTRV 
Ssc#S6072210 sp|P50344| 60S acidic ribosomal protein P1 (Allergen Cla h 12) protein synthesis 65 2.00E-09
Ssc#S6061819 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 65 9.00E-10
Ssc#S17506578 sp|P39675| Mite allergen Der f 3 precursor (Der f III) metabolism 65 1.00E-09 37/128 (28%) 71/128 (55%) nil
Ssc#S16512438 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 65 8.00E-10 35/90 (38%) 50/90 (55%) nil
Ssc#S17526921 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 65 1.00E-09 42/113 (37%) 52/113 (46%) ESDDDMGFGLFD
Ssc#S14889738 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 64 2.00E-09 33/91 (36%) 54/91 (59%) nil
Ssc#S17526498 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 64 2.00E-09
Ssc#S17526761 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 63 3.00E-09
Ssc#S17526114 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 62 4.00E-09
Ssc#S17526115 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 62 5.00E-09 44/171 (25%) 70/171 (40%) nil
Ssc#S17525077 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 62 5.00E-09 44/171 (25%) 70/171 (40%) nil
Ssc#S16771069 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]           metabolism 61 2.00E-08 39/120 (32%) 59/120 (49%) WVGYDD
Ssc#S6081164 sp|P49275| Mite allergen Der f 3 precursor (Der f III) metabolism 60 4.00E-08 38/139 (27%) 66/139 (47%) WVLTAAH, DNDIAL
Ssc#S14889469 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 60 2.00E-08 26/59 (44%) 38/59 (64%) nil
Ssc#S6053822 sp|O97370| Mite allergen Eur m 3 precursor  metabolism 59 3.00E-08 29/69 (42%) 40/69 (57%) QGDSGGP
Ssc#S6090725 gb|AAK61827.1| allergen A precursor [Psoroptes ovis]                   unknown 59 2.00E-07 35/112 (31%) 53/112 (47%) nil
Ssc#S17514592 sp|P42041| Aldehyde dehydrogenase (ALDDH) (Allergen Alt a 10) metabolism 58 1.00E-07
Ssc#S14900438 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 58 4.00E-12 40/138 (28%) 70/138 (50%) nil
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Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Ssc#S6074621 gb|AAB72147.1| allergen Bla g 5 [Blattella germanica]                  metabolism 58 3.00E-08 30/91 (32%) 52/91 (57%) nil
Ssc#S17514843 gb|AAA99805.1| Der f 3 mite allergen                                   metabolism 58 1.00E-07
Ssc#S17526817 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 57 3.00E-07 54/217 (24%) 102/217 (47%) nil
Ssc#S17509917 sp|O18598| Glutathione S-transferase (GST class-sigma) metabolism 57 3.00E-12 26/60 (43%) 42/60 (70%) HAVVARDD
Ssc#S6091335 ref|NP_671747.1| alpha-2u globulin PGCL1 [Rattus norvegicus] homeostasis 57 2.00E-07 41/161 (25%) 74/161 (45%) nil
Ssc#S6054592 sp|P39674| Allergen MAG29 Chaparone/stress-related 56 3.00E-07 52/189 (27%) 88/189 (46%) nil
Ssc#S6014546 sp|O18598| Glutathione S-transferase (GST class-sigma) metabolism 56 4.00E-07
Ssc#S16518057 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 56 2.00E-06 63/277 (22%) 117/277 (42%) nil
Ssc#S17501633 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 56 6.00E-13 46/169 (27%) 81/169 (47%) nil
Ssc#S6091678 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]     unknown 56 2.00E-07 26/57 (45%) 38/57 (66%) VCNPII
Ssc#S17527560 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 55 5.00E-07
Ssc#S16517598 sp|Q9M7R0| Calcium-binding allergen Ole e 8 (PCA18/PCA23) signal transduction 54 2.00E-06
Ssc#S6090814 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 52 2.00E-06 20/41 (48%) 28/41 (68%) PVCGTDGVTY
Ssc#S17526077 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 52 1.00E-05 59/220 (26%) 102/220 (46%) nil
Ssc#S16770867 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 52 7.00E-06
Ssc#S6090946 ref|NP_509802.1| T05A10.5 [Caenorhabditis elegans] unknown 51 2.00E-05 28/102 (27%) 50/102 (49%) nil
Ssc#S16512766 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 51 6.00E-06 29/67 (43%) 33/67 (49%) nil
Ssc#S17526404 sp|Q9NAS5| Tropomyosin, muscle (Allergen Ani s 3)   structural protein 50 2.00E-05 31/110 (28%) 46/110 (41%) nil
Ssc#S17525633 sp|Q95182| Major allergen Equ c 1 precursor transport protein 50 5.00E-05 30/141 (21%) 64/141 (45%) nil
Ssc#S17514554 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 50 3.00E-05 29/81 (35%) 46/81 (56%) nil
Ssc#S17527413 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 50 2.00E-05 31/157 (19%) 79/157 (50%) nil
Ssc#S14889652 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 50 2.00E-05 29/81 (35%) 46/81 (56%) nil
Ssc#S6076164 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 49 1.00E-04 22/66 (33%) 42/66 (63%) nil
Ssc#S6059348 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 49 2.00E-04 33/103 (32%) 49/103 (47%) nil
Ssc#S6084107 gb|AAB34785.1| 68 kDa allergen [Penicillium chrysogenum]               metabolism 49 7.00E-05 32/99 (32%) 46/99 (46%) nil
Ssc#S6091507 gb|AAB34785.1| 68 kDa allergen [Penicillium chrysogenum]               metabolism 49 1.00E-05 29/74 (39%) 37/74 (50%) ADHPFLF
Ssc#S6074301 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 48 1.00E-04 23/50 (46%) 32/50 (64%) nil
Ssc#S17526070 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 48 2.00E-04 21/71 (29%) 39/71 (54%) nil
Ssc#S17518044 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 48 3.00E-05 25/75 (33%) 43/75 (57%) nil
Ssc#S6052752 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 48 7.00E-05 25/81 (30%) 43/81 (53%) FHKYSG
Ssc#S6090612 sp|Q9M7R0| Calcium-binding allergen Ole e 8 (PCA18/PCA23) signal transduction 47 1.00E-04 30/82 (36%) 46/82 (56%) nil
Ssc#S6052231 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 47 4.00E-04 48/260 (18%) 110/260 (42%) nil
Ssc#S17516187 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 47 8.00E-05 19/33 (57%) 26/33 (78%) nil
Ssc#S14893538 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 47 2.00E-04 18/50 (36%) 29/50 (58%) nil
Ssc#S17526542 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 47 3.00E-04 28/90 (31%) 53/90 (58%) FHKYSG
Ssc#S16517063 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 47 3.00E-04 30/97 (30%) 48/97 (49%) nil
Ssc#S6084171 sp|Q9NAS5| Tropomyosin, muscle (Allergen Ani s 3)   structural protein 46 5.00E-04 59/266 (22%) 110/266 (41%) nil
Ssc#S6029777 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 46 3.00E-04 28/90 (31%) 52/90 (57%) FHKYSG
Ssc#S6074754 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 46 7.00E-04 24/61 (39%) 35/61 (57%) nil
Ssc#S6091596 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 45 5.00E-04 35/134 (26%) 58/134 (43%) nil
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Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Gga#S7088995 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 1419 0 686/705 (97%) 688/705 (97%) highly homologous
Gga#S7088912 sp|P19121| Serum albumin precursor (Alpha-livetin) (Allergen Gal d 5) homeostasis 1262 0 615/615 (100%) 615/615 (100%) highly homologous
Gga#S7088142 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 852 0
Gga#S7089514 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 744 0
Gga#S7088619 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 728 0 371/386 (96%) 371/386 (96%) highly homologous
Gga#S7088538 sp|Q9LEJ0| Enolase 1 metabolism 595 1.00E-169 315/442 (71%) 363/442 (82%) highly homologous
Gga#S7087857 sp|Q9LEI9| Enolase 2 metabolism 583 1.00E-165 306/444 (68%) 360/444 (81%) highly homologous
Gga#S7088537 sp|Q9LEJ0| Enolase 1 metabolism 547 1.00E-154 290/442 (65%) 342/442 (77%) highly homologous
Gga#S7088879 sp|P40292| Heat shock protein 90 (Heat shock protein hsp1) Chaparone/stress-related 512 1.00E-143 260/445 (58%) 325/445 (73%) highly homologous
Gga#S7088128 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 511 1.00E-143 257/476 (53%) 337/476 (70%) highly homologous
Gga#S7087329 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 488 1.00E-136 248/478 (51%) 330/478 (69%) highly homologous
Gga#S7086749 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 479 1.00E-133 241/477 (50%) 318/477 (66%) highly homologous
Gga#S7086560 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 467 1.00E-129
Gga#S7089425 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 452 1.00E-126 210/210 (100%) 210/210 (100%) highly homologous
Gga#S7086621 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 450 1.00E-124
Gga#S7087643 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 442 1.00E-122
Gga#S7088770 sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) homeostasis 428 1.00E-118 266/706 (37%) 379/706 (53%) highly homologous
Gga#S7087480 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 369 1.00E-100 235/757 (31%) 378/757 (49%) KCSSLEK
Gga#S7088958 gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon]                     metabolism 275 1.00E-72 150/340 (44%) 209/340 (61%) LSSLEGE, QQKLIDDHFLF, HNDNKTFLVWVNEEDHLR
Gga#S7087899 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 271 3.00E-71 146/409 (35%) 233/409 (56%) nil
Gga#S7088730 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 263 8.00E-69
Gga#S10817582 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 258 2.00E-67 145/400 (36%) 216/400 (54%)
Gga#S10817582 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]          metabolism 258 2.00E-67 145/400 (36%) 216/400 (54%) DWEYPGS
Gga#S7042222 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)   Chaparone/stress-related 257 3.00E-67 125/180 (69%) 149/180 (82%) TKDNNLLGKF, LTGIPPAPRGVPQIEVTFD, NKITITNDKGRLSK, EAEKYKAEDEA
Gga#S7089575 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 256 8.00E-67 146/337 (43%) 201/337 (59%) QQQLIDDHFLF, KTFLVW, CPTNLGT, VYDISN 
Gga#S7089006 gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon]                     metabolism 255 1.00E-66 147/340 (43%) 198/340 (58%) QQQLIDDHFLF, HNDNKTFLVW, NEEDHLR, VHIKLP 
Gga#S7089219 sp|Q9NAS5| Tropomyosin, muscle (Allergen Ani s 3) structural protein 239 6.00E-62 128/282 (45%) 180/282 (63%) MDAIKKKMQ, AEEADRKYDEVARKL, LKEAETRAEFAERSV
Gga#S7048071 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]    unknown 222 7.00E-61 116/193 (60%) 140/193 (72%) highly homologous
Gga#S7088010 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 209 3.00E-52 127/363 (34%) 193/363 (53%) LVPVPK
Gga#S7089351 gb|AAM64112.1| gelsolin-like allergen Der f 16 [Dermatophagoides farinae] structural protein 204 5.00E-51 123/361 (34%) 185/361 (51%) LLHVKGKK 
Gga#S7088077 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 199 6.00E-52
Gga#S7088756 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 198 3.00E-49 115/385 (29%) 203/385 (52%) nil
Gga#S6758316 emb|CAA09884.1| allergen [Malassezia sympodialis]                     structural protein 192 7.00E-48 96/163 (58%) 118/163 (72%) DVVPKTA, FADENF, PGLLSMAN, WLDGKHVVFG 
Gga#S7087325 sp|Q92450| Superoxide dismutase [Mn] metabolism 188 2.00E-46 95/198 (47%) 121/198 (61%) KFNGGGHINH, WEHAYYLQY, IWNVINW 
Gga#S7089362 sp|O44119| Tropomyosin (Allergen Hom a 1)  structural protein 187 9.00E-46 107/282 (37%) 147/282 (52%) AIKKKMQ, LNRRIQL, AEEADRKYDEVARKL, NNLKSLE, RAEFAERSV 
Gga#S7007685 sp|Q9N2R3| Tropomyosin (Allergen Cha f 1) (Cha f I)   structural protein 178 2.00E-43 105/238 (44%) 144/238 (60%) AIKKKMQ, AEGEVAALNRRIQL, AEEADRKY
Gga#S7024633 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 176 9.00E-43 77/193 (39%) 118/193 (61%) HDGECK, PVCGTDG, TYDNEC, VCGTDGVTY 
Gga#S7088303 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 176 9.00E-43 115/365 (31%) 184/365 (50%) nil
Gga#S7088670 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 174 2.00E-42 119/391 (30%) 191/391 (48%) nil
Gga#S7020852 sp|P46419| Glutathione S-transferase (GST class-mu) metabolism 172 2.00E-42 81/182 (44%) 122/182 (67%) GPAPDFD, LGLDFPNLPY, LGYWDI
Gga#S7088640 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 163 4.00E-39
Gga#S6955753 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 160 4.00E-38
Gga#S7040668 sp|P42041| Aldehyde dehydrogenase (ALDDH) (Allergen Alt a 10) metabolism 149 8.00E-35 73/147 (49%) 96/147 (65%) EEIFGPV, ALRAGTVWVN, PFGGYK
Gga#S7088968 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 147 9.00E-34 105/381 (27%) 180/381 (47%) nil
Gga#S7088301 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 147 1.00E-33
Gga#S7087868 sp|P02769| Serum albumin precursor (Allergen Bos d 6) (BSA) homeostasis 143 9.00E-33 109/463 (23%) 196/463 (42%) nil
Gga#S6752375 sp|Q91483| Parvalbumin beta 2 (Major allergen Sal s 1)   homeostasis 140 2.00E-32 66/102 (64%) 87/102 (85%) AADSFN, DQDKSGFIEE, AETKAFLA, DGDGKIGV
Gga#S7046462 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 136 1.00E-41 68/99 (68%) 74/99 (74%) KPGLLSMANAGP, TNGSQFFITTV, LDGKHVVFG
Gga#S16073703 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 135 1.00E-30
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Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Gga#S12377738 gb|AAA99805.1| Der f 3 mite allergen                                  metabolism 131 3.00E-29
Gga#S7051840 sp|P49275| Mite allergen Der f 3 precursor (Der f III) metabolism 122 3.00E-38 71/183 (38%) 93/183 (50%) HFCGGS, KGYPGVYT
Gga#S7088024 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 120 3.00E-25
Gga#S7089676 sp|P59747| Parvalbumin beta (Allergen Sco j 1) homeostasis 119 5.00E-26 56/108 (51%) 77/108 (71%) SGFIEE, DGDGKIG
Gga#S16508721 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 117 9.00E-26 63/141 (44%) 85/141 (60%) nil
Gga#S7087864 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 116 1.00E-23 176/835 (21%) 348/835 (41%) nil
Gga#S6937106 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 110 3.00E-23 65/211 (30%) 113/211 (53%) AVITVPAYFN
Gga#S7088951 sp|Q06478| Phospholipase A1 1 precursor (Allergen Dol m 1.01) metabolism 109 2.00E-22 78/274 (28%) 128/274 (46%) GHSLGAH, GLDPAGP, 
Gga#S7087186 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]    structural protein 106 4.00E-21
Gga#S7021690 sp|O18598| Glutathione S-transferase (GST class-sigma) metabolism 104 3.00E-21 47/97 (48%) 66/97 (68%) PSYKLTY
Gga#S6967219 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 103 5.00E-21
Gga#S7006405 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 103 6.00E-21
Gga#S16575233 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 102 8.00E-21 53/126 (42%) 75/126 (59%) STFKNTEI, FKLGEEF
Gga#S7050592 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 102 1.00E-20 53/126 (42%) 75/126 (59%) STFKNTEI, FKLGEEF
Gga#S6767541 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II) homeostasis 98 3.00E-19 51/135 (37%) 77/135 (57%) ANSGISS, ADHPFLF
Gga#S14760878 sp|P39675| Mite allergen Der p 3 precursor (Der p III)  metabolism 94 2.00E-18
Gga#S7023254 sp|O97370| Mite allergen Eur m 3 precursor  metabolism 91 2.00E-17 58/197 (29%) 98/197 (49%) LTAAHCV, GDSGGP  
Gga#S7046109 sp|Q9M7R0| Calcium-binding allergen Ole e 8 (PCA18/PCA23) signal transduction 91 4.00E-17
Gga#S7087231 pir||B37330 venom allergen III - red imported fire ant metabolism 89 4.00E-16 60/183 (32%) 87/183 (47%) YLVCNY
Gga#S7087199 sp|P35781| Venom allergen 5.01 (Antigen 5-1) (Ag5-1) metabolism 89 1.00E-16 60/178 (33%) 88/178 (49%) DEVKDY, HYTQMVWA, YLVCNY
Gga#S7035521 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 86 2.00E-17 43/107 (40%) 63/107 (58%) STFKNTEI, FKLGEEF
Gga#S7030500 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 85 2.00E-15 44/126 (34%) 71/126 (56%) GEEFEE
Gga#S7089649 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 84 4.00E-14
Gga#S7041077 sp|Q90YK9| Parvalbumin beta (Allergen Gad m 1)   homeostasis 83 6.00E-15 46/107 (42%) 60/107 (56%) SGFIEEEEELK
Gga#S7089204 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 81 7.00E-14 107/459 (23%) 204/459 (44%) nil
Gga#S6760447 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 81 3.00E-14
Gga#S6755446 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 81 2.00E-14
Gga#S7022623 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 77 4.00E-29 38/76 (50%) 48/76 (63%) DFTFVCPTE, GEVCPA
Gga#S16508680 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 76 1.00E-13 34/77 (44%) 48/77 (62%) nil
Gga#S7014316 gb|AAB72147.1| allergen Bla g 5 [Blattella germanica]                  metabolism 74 4.00E-12 54/194 (27%) 102/194 (52%) nil
Gga#S7086812 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 73 2.00E-11 83/381 (21%) 167/381 (43%) nil
Gga#S7089578 ref|NP_671747.1| alpha-2u globulin PGCL1 [Rattus norvegicus]  homeostasis 73 1.00E-11 41/148 (27%) 67/148 (45%) nil
Gga#S7088757 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 73 9.00E-12 51/188 (27%) 74/188 (39%) nil
Gga#S7089243 sp|O18598| Glutathione S-transferase (GST class-sigma) metabolism 72 3.00E-11 57/208 (27%) 107/208 (51%) nil
Gga#S7050015 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 72 1.00E-11 38/132 (28%) 74/132 (56%) GEEFEED  
Gga#S7088830 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 70 3.00E-10
Gga#S6910547 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 69 1.00E-10 46/108 (42%) 57/108 (52%) nil
Gga#S7087904 gb|AAB72147.1| allergen Bla g 5 [Blattella germanica]                  metabolism 69 1.00E-10 47/163 (28%) 84/163 (51%) nil
Gga#S7087705 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 69 5.00E-10 81/407 (19%) 164/407 (40%) nil
Gga#S6829946 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 67 3.00E-10 33/90 (36%) 55/90 (61%) nil
Gga#S7046376 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) (Cla h IV) Chaparone/stress-related 65 9.00E-18
Gga#S7089336 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 64 2.00E-08
Gga#S6943084 sp|P49148| 60S acidic ribosomal protein P1 (Allergen Alt a 12) protein synthesis 64 4.00E-09 35/62 (56%) 42/62 (67%) LFAKAL
Gga#S7089207 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 62 6.00E-08 81/386 (20%) 159/386 (41%) nil
Gga#S7046470 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 62 7.00E-09
Gga#S7045877 sp|P40108| Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) metabolism 62 5.00E-11 50/178 (28%) 82/178 (46%) KEEIFGP
Gga#S14761110 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 60 1.00E-08
Gga#S6922012 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 59 1.00E-07 34/70 (48%) 38/70 (54%) TGEKGF, TGGKSIYG, DFMLQGGDFT
Gga#S7087550 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 59 1.00E-06 72/309 (23%) 133/309 (43%) QENTEL 
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Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Gga#S16567772 sp|Q9NAS5| Tropomyosin, muscle (Allergen Ani s 3)    structural protein 59 1.00E-07 33/159 (20%) 84/159 (52%) nil
Gga#S7050535 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 59 6.00E-08 30/101 (29%) 57/101 (56%) nil
Gga#S14753739 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 58 1.00E-07 27/57 (47%) 33/57 (57%) nil
Gga#S7086605 gb|AAM21322.1| group 14 allergen protein [Dermatophagoides pteronyssinus] metabolism 57 3.00E-06 84/361 (23%) 143/361 (39%) nil
Gga#S7088409 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 57 2.00E-06
Gga#S7089429 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) (Gal d I) homeostasis 57 8.00E-08 24/24 (100%) 24/24 (100%) NKCNFCNAVVESNGTLTLSHFGKC
Gga#S7087161 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 57 1.00E-07 33/130 (25%) 67/130 (51%) nil
Gga#S6773814 sp|O18598| Glutathione S-transferase (GST class-sigma) metabolism 56 7.00E-07 49/153 (32%) 73/153 (47%) nil
Gga#S7088954 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]     unknown 55 4.00E-06
Gga#S7087511 gb|AAK39511.1| paramyosin-like allergen [Dermatophagoides farinae]     structural protein 55 8.00E-06
Gga#S7089062 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) [Bos taurus] signal transduction 55 8.00E-07 29/91 (31%) 52/91 (57%) nil
Gga#S7026285 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 55 2.00E-06 34/106 (32%) 56/106 (52%) nil
Gga#S7035595 prf||2118249B allergen Lep d 1.02                                      unknown 54 5.00E-06 30/106 (28%) 53/106 (50%) nil
Gga#S7089017 sp|Q9M7R0| Calcium-binding allergen Ole e 8 (PCA18/PCA23) signal transduction 54 6.00E-06 47/172 (27%) 78/172 (45%) nil
Gga#S6920649 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 53 5.00E-06
Gga#S7086632 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaparone/stress-related 53 2.00E-05
Gga#S6928896 sp|P49369| Phospholipase A1 precursor (Allergen Ves v 1) (Ves v I) metabolism 52 1.00E-05 22/58 (37%) 32/58 (55%) nil
Gga#S7087316 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]     unknown 51 4.00E-05
Gga#S14762459 sp|P49371| Hyalurononglucosaminidase (Hyaluronidase) (Allergen Dol m 2) metabolism 51 2.00E-05 45/170 (26%) 60/170 (35%) nil
Gga#S7088064 sp|Q9NAS5| Tropomyosin, muscle (Allergen Ani s 3) structural protein 51 6.00E-05
Gga#S7088883 ref|NP_173866.1| calcium ion binding [Arabidopsis thaliana] signal transduction 49 2.00E-04
Gga#S7036572 ref|NP_504417.1| C10G8.3 [Caenorhabditis elegans] unknown 49 2.00E-04
Gga#S6944910 sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) metabolism 49 2.00E-04
Gga#S6930035 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) (Bt6) metabolism 48 2.00E-04 26/75 (34%) 40/75 (53%) nil














Appendix V. Detail lists of sequence homology matches for trout with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology. 
Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Omy#S15341035 sp|P02789| Ovotransferrin precursor (Conalbumin) homeostasis 645 0.00E+00 354/701 (50%) 461/701 (65%) highly homologous
Omy#S15341314 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)  chaparone/stress-related 409 1.00E-113
Omy#S15341215 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 378 1.00E-103 218/681 (32%) 367/681 (53%)
Omy#S18160274 sp|Q9LEJ0| Enolase 1 metabolism 313 2.00E-84 171/252 (67%) 194/252 (76%) Highly homologous
Omy#S18097301 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)  Chaparone/stress-related 312 3.00E-84 159/250 (63%) 188/250 (75%) highly homologous
Omy#S18098044 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]   unknown 258 8.00E-68 148/253 (58%) 174/253 (68%) Highly homologous
Omy#S15341258 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 251 3.00E-65 147/364 (40%) 206/364 (56%) DPIIED, QQQLIDDHFLF, KTFLVWVNEEDHLR, CPTNLGT
Omy#S15330950 sp|Q9NAS5| Tropomyosin, muscle (Allergen Ani s 3) structural protein 232 4.00E-60 125/225 (55%) 157/225 (69%) highly homologous
Omy#S18163682 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)  chaparone/stress-related 227 2.00E-58 109/159 (68%) 135/159 (84%) Highly homologous
Omy#S18098124 sp|P40108| Aldehyde dehydrogenase (ALDDH)  metabolism 221 1.00E-56 117/256 (45%) 158/256 (61%) KKEPIGVC, GNTVVLK, LELGGKSP 
Omy#S15340856 sp|P00785|  Actinidain precursor (Actinidin) metabolism 220 6.00E-56
Omy#S15241444 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 220 2.00E-56 106/157 (67%) 120/157 (76%) DVVPKTA, FHRVIP, QGGDFT, NGTGGKSIYG, LSMANAGPNTNGSQFFI, WLDGKHVVFG
Omy#S18101805 sp|Q9LEI9| Enolase 2 metabolism 220 2.00E-56 105/143 (73%) 123/143 (86%) highly homologous
Omy#S15302100 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 214 2.00E-54 101/157 (64%) 116/157 (73%) highly homologous
Omy#S18093011 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 209 4.00E-53 100/157 (63%) 113/157 (71%) highly homologous
Omy#S18102422 sp|Q92450| Superoxide dismutase [Mn] metabolism 207 1.00E-52 100/194 (51%) 129/194 (66%) FNGGGHINH, QGSGWGWL, WEHAYYLQY, IWNVINW
Omy#S18100439 sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) chaparone/stress-related 194 2.00E-48 104/250 (41%) 150/250 (60%) nil
Omy#S18100604 sp|Q9LEJ0| Enolase 1 metabolism 192 7.00E-48 93/132 (70%) 115/132 (87%) Highly homologous
Omy#S18151560 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 188 8.00E-47 96/163 (58%) 116/163 (71%) highly homologous
Omy#S18160728 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)  chaparone/stress-related 186 4.00E-46 96/194 (49%) 133/194 (68%) LTGIPPAPRGVPQIEVTF, NKITITND, LESYAYSLKN 
Omy#S15341266 sp|P00698| Lysozyme C precursor metabolism 186 4.00E-46 78/127 (61%) 104/127 (81%) NTQATNRNTDGSTDYGI, DGRTPG, AWVAWR 
Omy#S15298097 gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon]                     metabolism 184 1.00E-45 100/249 (40%) 143/249 (57%) QQKLIDDHFLF, KTFLVWVNEEDHLR, CPTNLGT
Omy#S15279465 sp|P42041| Aldehyde dehydrogenase (ALDDH)  metabolism 184 1.00E-45 95/210 (45%) 125/210 (59%) LFINNE, ATGNTVV, AEQTPL, GFPPGV
Omy#S15314908 sp|Q91482| Parvalbumin beta 1 (Major allergen Sal s 1) homeostasis 183 3.00E-45 94/109 (86%) 96/109 (88%) highly homologous
Omy#S15276554 sp|P00785|  Actinidain precursor (Actinidin) metabolism 181 2.00E-44
Omy#S15263229 sp|Q91483| Parvalbumin beta 2 (Major allergen Sal s 1)...   homeostasis 180 2.00E-44 92/108 (85%) 93/108 (86%) highly homologous
Omy#S15289021 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 179 4.00E-44 88/147 (59%) 105/147 (71%) NFRALCTG, GTGGKSIYG, PGLLSMAN, SQFFIT
Omy#S15296653 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 179 4.00E-44 99/269 (36%) 155/269 (57%) SALAMV, VLVNAI
Omy#S15317026 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 178 5.00E-44 89/165 (53%) 113/165 (68%) LCTGEKG, LLSMAN, TNGSQFFITT 
Omy#S15300801 sp|P49275| Mite allergen Der f 3 precursor metabolism 178 1.00E-43
Omy#S15261700 sp|Q91483| Parvalbumin beta 2 (Major allergen Sal s 1)...   homeostasis 178 7.00E-44 92/108 (85%) 93/108 (86%) highly homologous
Omy#S15299978 sp|O61379| Tropomyosin (Allergen Pan s 1) structural protein 175 7.00E-43 98/217 (45%) 127/217 (58%) NRRIQL
Omy#S18101278 sp|P00785|  Actinidain precursor (Actinidin) metabolism 171 2.00E-41 87/208 (41%) 111/208 (53%) YWIVKNSW
Omy#S15299885 gb|AAA99805.1| Der f 3 mite allergen                                  metabolism 170 3.00E-41
Omy#S18097897 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 166 3.00E-40 84/173 (48%) 112/173 (64%) DFTFVCPTE, GEVCPA
Omy#S18098073 sp|P39675| Mite allergen Der p 3 precursor  metabolism 164 1.00E-39
Omy#S15298319 sp|P39675| Mite allergen Der p 3 precursor  metabolism 161 1.00E-38
Omy#S15253908 pdb|1FSK| B Chain B, Fab Fragment of IgG antibody  158 1.00E-37 86/217 (39%) 123/217 (56%) LTQSPKS, TLTIS+VQAED 
Omy#S15289106 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 158 1.00E-37 84/185 (45%) 110/185 (59%) QQQLIDDHFL, KTFLVWVNEEDHLR, CPTNLGT
Omy#S15295934 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 157 2.00E-37 81/140 (57%) 93/140 (66%) TGEKGFGY,  GKSIYG, LSMANAG, TNGSQFFITT, WLDGKHVVFG 
Omy#S15340985 sp|P02789| Ovotransferrin precursor (Conalbumin) homeostasis 156 8.00E-37 107/355 (30%) 156/355 (43%) GDVAFVKHTT
Omy#S15291877 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 153 4.00E-36 80/174 (45%) 109/174 (62%) DFTFVCPTE, GEVCPA
Omy#S15328178 sp|Q870B9| Enolase metabolism 149 5.00E-55 72/125 (57%) 97/125 (77%) highly homologous
Omy#S15340913 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 146 6.00E-34 74/167 (44%) 104/167 (62%) DFTFVCPTE, GEVCPA
Omy#S15297807 sp|P39674| Allergen MAG29 chaparone/stress-related 146 4.00E-34 66/101 (65%) 85/101 (84%) DIERMV, VCNPIITKLYQ
Omy#S18092321 sp|Q91483| Parvalbumin beta 2 (Major allergen Sal s 1)...   homeostasis 146 2.00E-34 75/108 (69%) 83/108 (76%) highly homologous
Omy#S15344074 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 145 3.00E-33
Omy#S18163799 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 145 5.00E-34
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Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Omy#S15301263 sp|P49275| Mite allergen Der f 3 precursor metabolism 142 7.00E-33
Omy#S15286468 sp|P49275| Mite allergen Der f 3 precursor metabolism 142 5.00E-33
Omy#S18150128 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 140 2.00E-32
Omy#S15239535 ref|NP_842456.1| Alkyl hydroperoxide reductase metabolism 138 1.00E-31 72/170 (42%) 102/170 (60%) DFTFVCPTE, GEVCPA
Omy#S15297133 gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon]                     metabolism 137 6.00E-39 81/192 (42%) 113/192 (58%) nil
Omy#S18148000 sp|P40292| Heat shock protein HSP1 Chaparone/stress-related 137 2.00E-31 70/155 (45%) 104/155 (67%) NMERIMKAQA
Omy#S15261218 sp|P00785|  Actinidain precursor (Actinidin) metabolism 136 3.00E-31
Omy#S15300863 sp|P49275| Mite allergen Der f 3 precursor metabolism 136 5.00E-31
Omy#S15324732 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 135 9.00E-31 65/102 (63%) 78/102 (76%) highly homologous
Omy#S15300340 sp|P40292| Heat shock protein HSP1 chaparone/stress-related 135 1.00E-30 72/155 (46%) 101/155 (65%) ANMERIMKAQALRD, 
Omy#S15329061 gb|AAA99805.1| Der f 3 mite allergen                                  metabolism 127 1.00E-28
Omy#S18163842 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)  chaparone/stress-related 125 7.00E-28
Omy#S18165126 pdb|1FSK| B Chain B, Fab Fragment of IgG antibody  124 2.00E-27 68/151 (45%) 93/151 (61%) DFTLTIS, PPSSEQL, SSTLTL
Omy#S15296242 sp|P40292| Heat shock protein HSP1 chaparone/stress-related 124 3.00E-27 64/136 (47%) 90/136 (66%) ANMERIMKAQA 
Omy#S15320563 sp|P49275| Mite allergen Der f 3 precursor metabolism 119 5.00E-26
Omy#S18145010 sp|Q9NFZ4| Tropomyosin (Allergen Lep d 10) structural protein 119 4.00E-26 60/109 (55%) 81/109 (74%) KLKEAE, RAEFAERSV
Omy#S18145976 sp|P42041| Aldehyde dehydrogenase (ALDDH)  metabolism 117 2.00E-25 54/116 (46%) 80/116 (68%) EEIFGPV, PFGGYK
Omy#S18104480 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                structural protein 117 2.00E-29
Omy#S18153844 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 116 3.00E-39 TNGSQFFITT, LCTGEKG, DFMLQGGDF
Omy#S15287234 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)  chaparone/stress-related 116 4.00E-25 65/135 (48%) 86/135 (63%) NKITITNDKGRLSKE, EAEKYK
Omy#S18159676 sp|P00785|  Actinidain precursor (Actinidin) metabolism 113 3.00E-24
Omy#S15315310 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 113 3.00E-24
Omy#S15316954 sp|Q9N2R3| Tropomyosin (Allergen Cha f 1) structural protein 111 1.00E-23 56/127 (44%) 83/127 (65%)
Omy#S15319952 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 110 3.00E-23 68/220 (30%) 118/220 (53%) MLVLLPDE
Omy#S15252829 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 107 2.00E-22 52/123 (42%) 78/123 (63%) STFKNTEI, FKLGEEF
Omy#S18160812 sp|Q06478| Phospholipase A1 1 precursor metabolism 106 4.00E-22 68/213 (31%) 108/213 (50%) SLGAHISGF, LDPAGP
Omy#S15281917 sp|Q9M7R0| Calcium-binding allergen Ole e 8 signal transduction 105 1.00E-21
Omy#S15297301 ref|NP_173866.1| polcalcin (calcium-binding pollen allergen) signal transduction 105 1.00E-21
Omy#S15310703 sp|Q90YK9| Parvalbumin beta (Allergen Gad m 1) homeostasis 104 1.00E-21 54/107 (50%) 71/107 (66%) DQDKSG, LFLQNFS
Omy#S18158866 emb|CAA09884.1| allergen [Malassezia sympodialis]                     unknown 102 4.00E-21
Omy#S18092374 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 102 6.00E-21 48/115 (41%) 73/115 (63%) STFKNTEI, FKLGEEF
Omy#S15340855 sp|Q06478| Phospholipase A1 1 precursor metabolism 102 3.00E-20 78/283 (27%) 122/283 (43%) SLGAHV, GLDPAGP
Omy#S15274427 sp|P59747| Parvalbumin beta (Allergen Sco j 1) homeostasis 98 1.00E-19 52/106 (49%) 61/106 (57%) GSFDHKKFF, SGFIEEEELK, DAETKAFL  
Omy#S15301757 emb|CAA09883.1| allergen [Malassezia sympodialis]                      unknown 95 1.00E-18 48/107 (44%) 70/107 (65%) PGAFTP, ELKSKGV, VNDAFVM
Omy#S18102363 sp|P42037| 60S acidic ribosomal protein P2 protein synthesis 95 1.00E-18 48/113 (42%) 63/113 (55%) LGGNTSPS, SVGIEA, GKDINE, DMGFGLFD
Omy#S15320006 sp|Q92260| Heat shock 70 kDa protein (Allergen Pen c 19)   chaparone/stress-related 94 2.00E-18 46/69 (66%) 54/69 (78%) TKDNNLL, LTGIPPAP, QIEVTFD
Omy#S18096761 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) chaparone/stress-related 94 2.00E-18 42/92 (45%) 63/92 (68%) nil
Omy#S18161350 sp|Q25456| Tropomyosin (Allergen Met e 1) structural protein 94 3.00E-18 55/107 (51%) 65/107 (60%) LERAEERAE, NNLKSLE, RAEFAERSV
Omy#S18152048 emb|CAA09883.1| allergen [Malassezia sympodialis]                      unknown 93 6.00E-18 49/121 (40%) 74/121 (61%) PGAFTP, NDAFVM
Omy#S15258008 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) chaparone/stress-related 91 2.00E-17 43/104 (41%) 65/104 (62%) ATWCGPC
Omy#S15275396 sp|P40292| Heat shock protein HSP1 chaparone/stress-related 90 3.00E-17 48/107 (44%) 72/107 (67%) nil
Omy#S18151973 sp|P59747| Parvalbumin beta (Allergen Sco j 1) homeostasis 89 7.00E-18 44/73 (60%) 49/73 (67%) nil
Omy#S15266961 sp|P42037| 60S acidic ribosomal protein P2 protein synthesis 87 1.00E-16 46/114 (40%) 61/114 (53%) LESVGIEAD, DMGFGLFD
Omy#S15276631 ref|NP_173866.1| polcalcin (calcium-binding pollen allergen)   signal transduction 85 1.00E-15
Omy#S18102906 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 84 1.00E-15 41/125 (32%) 67/125 (53%) STFKNTE
Omy#S18095855 sp|P40108| Aldehyde dehydrogenase (ALDDH)   metabolism 83 4.00E-15
Omy#S15298004 emb|CAA09884.1| allergen [Malassezia sympodialis]                      unknown 82 1.00E-14 48/102 (47%) 60/102 (58%) nil
Omy#S18094395 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 81 2.00E-14 42/128 (32%) 74/128 (57%) GEEFEE  
Omy#S15297826 sp|P39675| Mite allergen Der p 3 precursor   metabolism 80 5.00E-15
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Omy#S18099206 sp|P42037| 60S acidic ribosomal protein P2 protein synthesis 80 5.00E-14 37/61 (60%) 51/61 (83%) LGGNTSPS, SVGIEA, GKDINE
Omy#S15311381 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 78 1.00E-13 42/107 (39%) 58/107 (54%) EIKFKL
Omy#S18095529 sp|P00785|  Actinidain precursor (Actinidin) metabolism 75 9.00E-13
Omy#S15281065 sp|P39675| Mite allergen Der p 3 precursor   metabolism 75 7.00E-13
Omy#S15289030 sp|P40292| Heat shock protein HSP1 Chaparone/stress-related 75 1.00E-13 41/103 (39%) 66/103 (64%) nil
Omy#S18160615 gb|AAM83103.1| paramyosin allergen [Blomia tropicalis]                 structural protein 75 3.00E-13
Omy#S18094587 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]           metabolism 73 6.00E-22 38/99 (38%) 60/99 (60%) NVMTYD
Omy#S15296122 sp|Q9NFZ4| Tropomyosin (Allergen Lep d 10) structural protein 73 3.00E-12 35/57 (61%) 45/57 (78%) KLKEAE, RAEFAERSV
Omy#S18101599 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 72 6.00E-12 41/134 (30%) 77/134 (57%) GEEFEE
Omy#S15291492 sp|Q9NFZ4| Tropomyosin (Allergen Lep d 10) structural protein 72 7.00E-12 36/66 (54%) 46/66 (69%) RAEFAERSV
Omy#S15330831 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 71 2.00E-11
Omy#S15298184 sp|Q9M7R0| Calcium-binding allergen Ole e 8 signal transduction 70 3.00E-11
Omy#S15301789 sp|P39675| Mite allergen Der p 3 precursor   metabolism 70 8.00E-12 33/64 (51%) 42/64 (65%) VSWGYGCA
Omy#S15337042 sp|O18598| Glutathione S-transferase metabolism 70 5.00E-11
Omy#S15291988 sp|Q9M7R0| Calcium-binding allergen Ole e 8 signal transduction 69 6.00E-11
Omy#S15336377 gb|AAB72147.1| allergen Bla g 5 [Blattella germanica]                  metabolism 69 5.00E-11 50/162 (30%) 76/162 (46%) nil
Omy#S15296648 sp|P49275| Mite allergen Der f 3 precursor metabolism 69 1.00E-10
Omy#S15292324 sp|P00785|  Actinidain precursor (Actinidin) metabolism 68 2.00E-10
Omy#S15329842 sp|P00785|  Actinidain precursor (Actinidin) metabolism 68 1.00E-10 46/152 (30%) 70/152 (46%) nil
Omy#S18150434 emb|CAD23374.1| tri s 4 allergen [Trichophyton schoenleinii]           metabolism 68 2.00E-10 56/229 (24%) 96/229 (41%)
Omy#S15291186 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 67 3.00E-10
Omy#S18164789 ref|XP_135574.1| similar to Major urinary protein 6 precursor          unknown 67 4.00E-10 47/181 (25%) 86/181 (47%) nil
Omy#S15298379 prf||2118249B allergen Lep d 1.02                                      unknown 66 9.00E-10 41/128 (32%) 64/128 (50%) nil
Omy#S18160554 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 66 4.00E-10 36/83 (43%) 50/83 (60%) DPIIED
Omy#S15309334 sp|P49148| 60S acidic ribosomal protein P1 protein synthesis 65 9.00E-10 42/110 (38%) 52/110 (47%) DMGFGLFD
Omy#S15238745 sp|P00785|  Actinidain precursor (Actinidin) metabolism 64 2.00E-09
Omy#S18157610 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 64 2.00E-09 37/128 (28%) 68/128 (53%) nil
Omy#S18092678 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 64 2.00E-09 33/77 (42%) 47/77 (61%) STFKNTEI
Omy#S18147957 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 64 2.00E-09 34/101 (33%) 58/101 (57%) LSTFRN, GEEFEE
Omy#S15316324 ref|XP_135574.1| similar to Major urinary protein 6 precursor          unknown 64 4.00E-09 40/154 (25%) 75/154 (48%) nil
Omy#S18093730 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 63 4.00E-09
Omy#S15299468 sp|P39675| Mite allergen Der p 3 precursor   metabolism 62 2.00E-10
Omy#S18162445 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 60 4.00E-08 33/130 (25%) 61/130 (46%) nil
Omy#S15273089 gb|AAM64112.1| gelsolin-like allergen Der f 16 structural protein 60 3.00E-08 40/133 (30%) 66/133 (49%) nil
Omy#S15298661 sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) metabolism 60 1.00E-08 35/91 (38%) 46/91 (50%) CPTNLGT
Omy#S18149611 sp|P42039| 60S acidic ribosomal protein P2 protein synthesis 60 5.00E-08 26/66 (39%) 43/66 (65%) GKDINE
Omy#S18094102 sp|O97370| Mite allergen Eur m 3 precursor transport protein 59 7.00E-08
Omy#S18095061 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 59 9.00E-08 28/88 (31%) 51/88 (57%) nil
Omy#S18165005 gb|AAM64112.1| gelsolin-like allergen Der f 16 structural protein 59 1.00E-07 39/136 (28%) 67/136 (49%) nil
Omy#S15259426 sp|P42037| 60S acidic ribosomal protein P2 protein synthesis 59 1.00E-10 27/46 (58%) 37/46 (80%) LGGNTSPS, SVGIEA
Omy#S18147972 ref|XP_135574.1| similar to Major urinary protein 6 precursor unknown 59 1.00E-07 31/103 (30%) 53/103 (51%) nil
Omy#S18145916 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 57 1.00E-07 33/126 (26%) 64/126 (50%) nil
Omy#S15280016 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) chaparone/stress-related 56 6.00E-07
Omy#S15299958 sp|Q9M7R0| Calcium-binding allergen Ole e 8 signal transduction 55 1.00E-06
Omy#S15301794 ref|NP_173866.1| polcalcin (calcium-binding pollen allergen) signal transduction 55 1.00E-06
Omy#S15272111 gb|AAB34785.1| 68 kDa allergen [Penicillium chrysogenum]               unknown 54 1.00E-06 31/88 (35%) 49/88 (55%) nil
Omy#S15278000 sp|P00785|  Actinidain precursor (Actinidin) metabolism 54 3.00E-06 29/74 (39%) 43/74 (58%) KYGKSY
Omy#S15278259 sp|P00785|  Actinidain precursor (Actinidin) metabolism 54 4.00E-06 29/74 (39%) 43/74 (58%) KYGKSY
Omy#S15259662 sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) metabolism 54 2.00E-06 33/124 (26%) 63/124 (50%) nil
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Appendix V. Detail lists of sequence homology matches for trout with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology (cont.). 
 
Query Subject (hits) Subject Description Functional category Bit Score E-value Identities Positives 6 amino acid homology
Omy#S18159014 ref|XP_135574.1| similar to Major urinary protein 6 precursor          unknown 54 4.00E-06 37/154 (24%) 72/154 (46%) nil
Omy#S15250021 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]           metabolism 53 5.00E-06 25/56 (44%) 36/56 (64%) nil
Omy#S15325049 sp|Q9M7R0| Calcium-binding allergen Ole e 8 signal transduction 52 1.00E-05
Omy#S18159084 sp|O18598| Glutathione S-transferase metabolism 52 2.00E-10 32/98 (32%) 50/98 (51%) nil
Omy#S18149744 sp|P01005| Ovomucoid precursor (Allergen Gal d 1) homeostasis 52 1.00E-05 23/63 (36%) 33/63 (52%) nil
Omy#S15325715 gb|AAM64112.1| gelsolin-like allergen Der f 16 structural protein 51 2.00E-05 28/77 (36%) 42/77 (54%) nil
Omy#S18150484 sp|P46419| Glutathione S-transferase metabolism 51 2.00E-05 34/137 (24%) 66/137 (48%) nil
Omy#S15340590 ref|NP_505373.1| 21k allergen like (5J634) unknown 50 3.00E-05 44/155 (28%) 65/155 (41%) nil
Omy#S15287595 ref|NP_173866.1| polcalcin (calcium-binding pollen allergen)   signal transduction 50 2.00E-05
Omy#S18157215 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) signal transduction 50 2.00E-05 27/83 (32%) 50/83 (60%) nil
Omy#S15311702 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) signal transduction 50 2.00E-05 27/83 (32%) 49/83 (59%) nil
Omy#S18163138 sp|Q9M7R0| Calcium-binding allergen Ole e 8 signal transduction 49 9.00E-05 42/130 (32%) 63/130 (48%) IDTDKDGF
Omy#S15336978 sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) metabolism 49 1.00E-04 26/57 (45%) 33/57 (57%) EIKFKL
Omy#S15318302 sp|P01012| Ovalbumin (Plakalbumin) (Allergen Gal d 2) homeostasis 49 1.00E-05 24/75 (32%) 37/75 (49%)
Omy#S15321446 gb|AAD25927.1| major allergenic protein Mal f4 [Malassezia furfur]     unknown 48 2.00E-04
Omy#S15253358 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) signal transduction 48 9.00E-05 26/83 (31%) 49/83 (59%) nil
Omy#S15299946 sp|Q9UW02| Thioredoxin (Allergen Cop c 2) .    chaparone/stress-related 48 2.00E-04
Omy#S18093805 gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae]           metabolism 47 9.00E-05 28/51 (54%) 33/51 (64%) nil
Omy#S18096822 sp|O24171| Profilin 3 (Pollen allergen Ole e 2) structural protein 47 4.00E-04 47/143 (32%) 69/143 (48%) MSWQSYV
Omy#S15272298 ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1)   signal transduction 47 2.00E-04 26/83 (31%) 47/83 (56%) FHKYSG
Omy#S18150137 sp|Q91482| Parvalbumin beta 1 (Major allergen Sal s 1) homeostasis 46 7.00E-04 27/73 (36%) 39/73 (53%) nil
Omy#S18161972 gb|AAD32205.1| putative allergen protein [Prunus armeniaca]            unknown 46 5.00E-04 42/148 (28%) 62/148 (41%) nil
Omy#S18162187 gb|AAM64112.1| gelsolin-like allergen Der f 16 structural protein 45 2.00E-04 23/65 (35%) 39/65 (60%) nil
Omy#S15288908 ref|NP_173866.1| polcalcin (calcium-binding pollen allergen)  signal transduction 45 9.00E-04














Appendix VI. Detail lists of sequence homology matches for sheep with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology. 
 
 
Query Hit Hit Description Function Bit-score E-value Identity Positivity 6 amino acid homology
gi|1386|emb|X17055.1|OASERALB[1386] gi|1351907|sp|P02769|ALBU_BOVIN[1351907] Serum albumin precursor (Allergen Bos d 6) Homeostasis 1181 0.0 561/607 (92%) 588/607 (96%) Highly homologous
gi|527681|gb|U12761.1|OAU12761[527681] gi|729320|sp|P40108|DHAL_CLAHE[729320] Aldehyde dehydrogenase (ALDDH) (Allergen Cla h 3) Metabolism 494 e-138  248/478 (51%) 330/478 (69%) Highly homologous
gi|1315|emb|X04520.1|OALGLBR[1315] gi|125910|sp|P02754|LACB_BOVIN[125910] Beta-lactoglobulin precursor (Beta-LG) Homeostasis 323 3e-87 159/167 (95%) 165/167 (98%) Highly homologous
gi|1309|emb|X06367.1|OALACA[1309] gi|27805979|ref|NP_776803.1|[27805979] lactalbumin, alpha [Bos taurus] Homeostasis 262 6e-69 123/142 (86%) 126/142 (88%) Highly homologous
gi|602293|gb|U17988.1|OAU17988[602293] gi|5815436|gb|AAD52672.1|AF178772_1[5815436] 98kDa HDM allergen [Dermatophagoides farinae] Metabolism 235 2e-60 145/421 (34%) 226/421 (53%) FDGLDL, WVGYDD  
gi|37576791|gb|AY392761.1|[37576791] gi|5815436|gb|AAD52672.1|AF178772_1[5815436] 98kDa HDM allergen [Dermatophagoides farinae] Metabolism 231 2e-59 132/366 (36%) 199/366 (54%) FDGLDL 
gi|31084950|gb|CD286907.1|[31084950] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 231 7e-60 112/157 (71%) 124/157 (78%) TGEKGFGY, QGGDFT , NGTGGKSIYG ,LSMANAGPNTNGSQFFI ,WLDGKHVVFG
gi|31085783|gb|CD287740.1|[31085783] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 223 2e-57 108/153 (70%) 120/153 (78%) TGEKGFGY , QGGDFT , NGTGGKSIYG , LSMANAGPNTNGSQFFI , WLDGKHVVF
gi|885600|gb|U16719.1|OAU16719[885600] gi|5815436|gb|AAD52672.1|AF178772_1[5815436] 98kDa HDM allergen [Dermatophagoides farinae] Metabolism 222 2e-56 140/421 (33%) 220/421 (52%) FDGLDL, WVGYDD, 
gi|33180696|gb|CF117600.1|[33180696] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 219 2e-56 106/147 (72%) 117/147 (79%) TGEKGFGY , QGGDFT  , NGTGGKSIYG , LSMANAGPNTNGSQFFI , WLDGKHVVFG
gi|31085773|gb|CD287730.1|[31085773] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 219 2e-56 108/157 (68%) 120/157 (76%) TGEKGFGY , QGGDFT  , NGTGGKSIYG , LSMANAGPNTNGSQ , LDGKHVVFG
gi|31087233|gb|CD289190.1|[31087233] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 200 3e-50 97/136 (71%) 106/136 (77%) QGGDFT , NGTGGKSIYG , GPNTNGSQFFI , WLDGKHVVFG
gi|29893401|gb|AY251270.1|[29893401] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 176 1e-43 84/110 (76%) 91/110 (82%) TGEKGFGY, QGGDFT, NGTGGKSIYG , LSMANAGPNTNGSQFFI , WLDGKHVVFG
gi|31086436|gb|CD288393.1|[31086436] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 174 1e-42 78/141 (55%) 106/141 (75%) ILGYWDIRG , WLNEKF , LGLDFPNLPY 
gi|18699095|gb|AF411974.1|[18699095] gi|14423735|sp|Q9U6V9|HUGA_POLAN[14423735] Hyaluronoglucosaminidase precursor Metabolism 174 4e-42 105/335 (31%) 170/335 (50%) LFPSVY
gi|33177820|gb|CF116165.1|[33177820] gi|14423687|sp|Q9LEI9|ENO2_HEVBR[14423687] Enolase 2 Metabolism 172 2e-42 81/113 (71%) 96/113 (84%) DLYKSF, VSIEDPFDQDDWE , VTNPKR, LLLKVNQIGSVTES, SHRSGETEDTFIADL 
gi|31086489|gb|CD288446.1|[31086489] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 165 4e-40 76/154 (49%) 106/154 (68%) WLNEKF , LGLDFPNLPY 
gi|31086018|gb|CD287975.1|[31086018] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 162 1e-39 73/133 (54%) 98/133 (73%) WLNEKF , LGLDFPNLPY , ILGYWDIRG 
gi|31086149|gb|CD288106.1|[31086149] gi|729764|sp|P40918|HS70_CLAHE[729764] Heat shock 70 kDa protein (Allergen Cla h 4) Chaperone/stress-related 161 5e-39 74/97 (76%) 88/97 (90%) GIDLGTTYSCVG, EIIANDQGNRTTPS, VAFTDTERLIGD, AKNQVA, NTVFDAKRLIGR
gi|33182088|gb|CF118296.1|[33182088] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 160 1e-38 76/110 (69%) 86/110 (78%) NFRALCTGEKGFG, FHRVIPDF, PGLLSMAN, SQFFIT
gi|31085538|gb|CD287495.1|[31085538] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 156 1e-37 71/133 (53%) 95/133 (71%) WLNEKF, LGLDFPNLPY 
gi|7331112|gb|AF233075.1|AF233075[7331112] gi|14423687|sp|Q9LEI9|ENO2_HEVBR[14423687] Enolase 2 Metabolism 153 1e-36 79/110 (71%) 87/110 (79%) HAGNKLAMQEFMILPVGASSF, GAEVYHHLK, DATNVGDEGGFAP, KVVIGMDVAASEFY 
gi|33181791|gb|CF118146.1|[33181791] gi|2851483|sp|P40292|HS82_ASPFU[2851483] Heat shock protein HSP1 Chaperone/stress-related 145 3e-34 74/149 (49%) 103/149 (69%) ANMERIMKAQALRD 
gi|31084868|gb|CD286825.1|[31084868] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 144 6e-34 65/132 (49%) 91/132 (68%) LGYWDIRG,  LDFPNLPY 
gi|7274395|gb|AF233351.1|AF233351[7274395] gi|4587985|gb|AAD25927.1|AF084828_1[4587985] major allergenic protein Mal f4 [Malassezia furfur] Unknown 144 6e-34 80/137 (58%) 95/137 (68%) ISNPVNST, AEVFKK, FGVTTL, NVPVIGGH, EVVKAK 
gi|31084662|gb|CD286619.1|[31084662] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 143 1e-33 63/129 (48%)  90/129 (69%) LGYWDIRG, LDFPNLPY 
gi|20799497|gb|AF483003.1|[20799497] gi|14423687|sp|Q9LEI9|ENO2_HEVBR[14423687] Enolase 2 Metabolism 142 3e-43 69/94 (73%) 80/94 (85%) VSLAVCK, LAMQEFMILPVGASSF, GAEVYH
gi|33179463|gb|CF116982.1|[33179463] gi|2851483|sp|P40292|HS82_ASPFU[2851483] Heat shock protein HSP1 Chaperone/stress-related 131 4e-30 60/103 (58%) 84/103 (81%) KLGIHED, IYYITGES , QLKEFDGK 
gi|31084020|gb|CD285977.1|[31084020] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 121 3e-31 55/102 (53%) 72/102 (70%) WLNEKF, LGLDFPNLPY 
gi|31086912|gb|CD288869.1|[31086912] gi|12231036|sp|Q92450|SODM_ASPFU[12231036] Superoxide dismutase [Mn] Metabolism 115 3e-25 52/91 (57%) 69/91 (75%) KFNGGGHINHS
gi|31085365|gb|CD287322.1|[31085365] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 114 6e-25 56/75 (74%) 60/75 (80%) TGEKGFGY , QGGDFT, NGTGGKSIYG
gi|11610598|dbj|AB052168.1|[11610598] gi|27805979|ref|NP_776803.1|[27805979] lactalbumin, alpha [Bos taurus] Homeostasis 114 6e-24 50/52 (96%) 50/52 (96%) FHTSGYDTQAIVQNNDSTEYGLFQINNKIWCKDDQNPHS, NICNISCD
gi|1812|emb|X68308.1|OOLPLIP[1812] gi|548449|sp|Q06478|PA11_DOLMA[548449] Phospholipase A1 1 precursor (Allergen Dol m 1.01) Metabolism 112 3e-23 77/276 (27%) 127/276 (46%) GLDPAGP
gi|31086186|gb|CD288143.1|[31086186] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 105 2e-39 50/70 (71%) 57/70 (81%) LSMANAGPNTNGSQFFI , WLDGKHVVFG
gi|397946|emb|Z25864.1|OATHIORD[397946] gi|11135375|sp|Q9UW02|THIO_COPCM[11135375] Thioredoxin (Allergen Cop c 2) Chaperone/stress-related 102 4e-21 47/105 (44%) 69/105 (65%) ATWCGPC
gi|33178709|gb|CF116609.1|[33178709] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 101 3e-21 51/97 (52%) 59/97 (60%) TGEKGFGY  
gi|31085791|gb|CD287748.1|[31085791] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 97.4 6e-20 61/114 (53%) 68/114 (59%) LSMANAGPNTNGSQFFI 
gi|1217|emb|X07005.1|OABLG2[1217] gi|125910|sp|P02754|LACB_BOVIN[125910] Beta-lactoglobulin precursor (Beta-LG) Homeostasis 93.2 2e-18 45/48 (93%) 48/48 (100%) SLAMAASDISLLDAQSAPLRVYVEELKPTPEG, LEILLQKW
gi|45126132|emb|CQ772360.1| gi|125910|sp|P02754|LACB_BOVIN[125910] Beta-lactoglobulin precursor (Beta-LG) Homeostasis 93.2 8e-17 45/48 (93%) 48/48 (100%) SLAMAASDISLLDAQSAPLRVYVEELKPTPEG, LEILLQKW
gi|31086320|gb|CD288277.1|[31086320] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 86.7 5e-40 40/51 (78%) 42/51 (82%) TGEKGFGY , QGGDFT  , NGTGGKSIYG 
gi|7288117|dbj|AB040058.1|[7288117] gi|27805979|ref|NP_776803.1|[27805979] lactalbumin, alpha [Bos taurus] Homeostasis 84 8e-16 41/44 (93%) 43/44 (97%) MMSFVSLLLVGILFHATQAEQLTKCEVF, YGGVSLPE
gi|33178236|gb|CF116373.1|[33178236] gi|41688715|sp|Q8TFM9|RLA2_FUSCU[41688715] 60S acidic ribosomal protein P2 (Minor allergen Fus c 1) Protein sysnthesis 82.4 2e-15 39/62 (62%) 52/62 (83%) SVGIEAD 
gi|31086798|gb|CD288755.1|[31086798] gi|2851483|sp|P40292|HS82_ASPFU[2851483] Heat shock protein HSP1 Chaperone/stress-related 82 7e-15 44/113 (38%) 73/113 (64%) RIMKAQA , KKTFEI
gi|31085577|gb|CD287534.1|[31085577] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis]  Unknown 80.9 9e-21 37/45 (82%) 38/45 (84%) TGEKGFGY , QGGDFT, NGTGGKSIY
gi|33180730|gb|CF117617.1|[33180730] gi|42559584|sp|Q23939|TPM_DERFA[42559584] Tropomyosin (Allergen Der f 10) Structural protein 80.9 5e-15 41/105 (39%) 62/105 (59%) MEAIKKKMQ 
gi|2318025|gb|AF012019.1|AF012019[2318025] gi|1351295|sp|P02789|TRFE_CHICK[1351295] Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) Homeostasis 80.1 1e-14 35/61 (57%) 44/61 (72%) FDEYFS, GCAPGS  
gi|33182374|gb|CF118439.1|[33182374] gi|1173071|sp|P42037|RLA2_ALTAL[1173071] 60S acidic ribosomal protein P2 (Minor allergen Alt a 6) Protein sysnthesis 79.3 2e-14 38/62 (61%) 50/62 (80%) VGIEAD 
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gi|31085636|gb|CD287593.1|[31085636] gi|2851483|sp|P40292|HS82_ASPFU[2851483] Heat shock protein HSP1 Chaperone/stress-related 77 2e-22 43/134 (32%) 76/134 (56%) AKLLRY
gi|31086791|gb|CD288748.1|[31086791] gi|37078092|sp|Q870B9|ENO_RHORB[37078092] Enolase Metabolism 67.4 1e-10 30/46 (65%) 39/46 (84%) DSRGNPTVEV, VPSGASTG
gi|26000691|gb|AY157617.1|[26000691] gi|14423698|sp|Q17284|FABP_BLOTA[14423698] Fatty acid-binding protein (Allergen Blo t 13) Metabolism 67.4 3e-09 31/58 (53%) 40/58 (68%) STFKNTEI 
gi|31084308|gb|CD286265.1|[31084308] gi|1710589|sp|P50344|RLA1_CLAHE[1710589] 60S acidic ribosomal protein P1 (Allergen Cla h 12) Protein sysnthesis 67 2e-10 42/113 (37%) 52/113 (46%) LFAKAL, SDDDMGFGLFD
gi|31084215|gb|CD286172.1|[31084215] gi|1710589|sp|P50344|RLA1_CLAHE[1710589] 60S acidic ribosomal protein P1 (Allergen Cla h 12) Protein sysnthesis 66.6 2e-10 42/113 (37%) 52/113 (46%) LFAKAL, SDDDMGFGLFD
gi|31086627|gb|CD288584.1|[31086627] gi|1710589|sp|P50344|RLA1_CLAHE[1710589] 60S acidic ribosomal protein P1 (Allergen Cla h 12) Protein sysnthesis 66.6 1e-10 42/113 (37%) 52/113 (46%) LFAKAL , SDDDMGFGLFD
gi|33178800|gb|CF116653.1|[33178800] gi|1350779|sp|P49148|RLA1_ALTAL[1350779] 60S acidic ribosomal protein P1 (Allergen Alt a 12) Protein sysnthesis 62 7e-09 34/62 (54%) 42/62 (67%) LFAKAL   
gi|33181640|gb|CF118070.1|[33181640] gi|4138173|emb|CAA09884.1|[4138173] allergen [Malassezia sympodialis] Unknown 56.6 1e-07 26/48 (54%) 36/48 (75%) WLDGKHVVFG
gi|33182193|gb|CF118349.1|[33182193] gi|129293|sp|P01012|OVAL_CHICK[129293] Ovalbumin (Plakalbumin) (Allergen Gal d 2) Homeostasis 55.8 2e-07 40/131 (30%) 62/131 (47%) AMVYLGA
gi|27127169|gb|AF473547.1|[27127169] gi|14423714|sp|Q9U5P1|FABP_LEPDS[14423714] Fatty acid-binding protein (Allergen Lep d 13) Metabolism 54.3 8e-07 26/49 (53%) 32/49 (65%) STFKNTEI 
gi|33178677|gb|CF116593.1|[33178677] gi|27807077|ref|NP_777021.1|[27807077] S100 calcium-binding protein A7 (psoriasin 1) Signal transduction 52.8 2e-06 31/94 (32%) 51/94 (54%) FHKYSG 
gi|1219|emb|X07006.1|OABLG3[1219] gi|125910|sp|P02754|LACB_BOVIN[125910] Beta-lactoglobulin precursor (Beta-LG) Homeostasis 51.6 6e-06 24/24 (100%) 24/24 (100%) ENGECAQKKIIAEKTKIPAVFKID
gi|7595909|gb|AF241828.1|AF241828[7595909] gi|17565876|ref|NP_504413.1|[17565876] 21k allergen like family member (5F762) Unknown 46.2 0.002 25/61 (40%) 34/61 (54%) GNKNNF
gi|31086544|gb|CD288501.1|[31086544] gi|1170095|sp|P46419|GTM1_DERPT[1170095] Glutathione S-transferase (GST class-mu) Metabolism 45.8 2e-04 20/35 (57%) 26/35 (74%) ILGYWDIRG 
gi|4836365|gb|AF117693.1|AF117693[4836365] gi|125910|sp|P02754|LACB_BOVIN[125910] Beta-lactoglobulin precursor (Beta-LG) Homeostasis 45.4 3e-04 20/22 (90%) 22/22 (100%) FDKALKALPMHI, FNPTQLE
gi|1214|emb|X07004.1|OABLG1[1214] gi|125910|sp|P02754|LACB_BOVIN[125910] Beta-lactoglobulin precursor (Beta-LG) Homeostasis 42.4 0.003 19/22 (86%) 20/22 (90%) IVTQTMKGLDIQKV 
gi|31087172|gb|CD289129.1|[31087172] gi|1705483|sp|P54962|BLG4_BLAGE[1705483] Allergen Bla g 4 precursor (Bla g IV) Metabolism 37 0.24 16/20 (80%) 17/20 (85%) VLATDYENYA
gi|33179271|gb|CF116886.1|[33179271] gi|1705483|sp|P54962|BLG4_BLAGE[1705483] Allergen Bla g 4 precursor (Bla g IV) Metabolism 37 0.21 16/20 (80%) 17/20 (85%) VLATDYENYA
gi|31085828|gb|CD287785.1|[31085828] gi|1705483|sp|P54962|BLG4_BLAGE[1705483] Allergen Bla g 4 precursor (Bla g IV) Metabolism 37 0.18 16/20 (80%) 17/20 (85%) VLATDYENYA
gi|31087082|gb|CD289039.1|[31087082] gi|1705483|sp|P54962|BLG4_BLAGE[1705483] Allergen Bla g 4 precursor (Bla g IV) Metabolism 35.4 0.39 15/20 (75%) 16/20 (80%) VLATDYENYA

















Appendix VII. Detail lists of sequence homology matches for goat with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology. 
 
Query Hit Hit Description Function Bit-score e-value Identity Positivity 6 animo acid homology
gi|6063528|dbj|AB033604.1| gi|729764|sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) Chaperone/stress-related 833 0 415/610 (68%) 489/610 (80%) Highly homologous
gi|1280044|gb|U53857.1| gi|1351295|sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) Homeostasis 672 0 356/696 (51%) 465/696 (66%) Highly homologous
gi|556806|emb|X78902.1| gi|1351295|sp|P02789| Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) Homeostasis 667 0 355/696 (51%) 463/696 (66%) Highly homologous
gi|437751|emb|Z19569.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 324 2.00E-87 160/167 (95%) 164/167 (98%) Highly homologous
gi|967|emb|X58471.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 324 1.00E-87 160/167 (95%) 164/167 (98%) Highly homologous
gi|23957583|gb|AF548366.1| gi|2851483|sp|P40292| Heat shock protein HSP1 Chaperone/stress-related 305 1.00E-81 145/191 (75%) 168/191 (87%) LNKTKPIWTRNP , NDWEDHLAVKHFSVEGQLEFRA , RAPFDLFE , KNNIKLYVRRVFI , GVVDSEDLPLN , FSKNIKLGIHED
gi|979|emb|X05149.1| gi|27805979|ref|NP_776803.1| lactalbumin, alpha [Bos taurus] Homeostasis 263 2.00E-69 124/142 (87%) 127/142 (89%) Highly homologous
gi|19526602|gb|AY081150.1| gi|5815436|gb|AAD52672.1| 98kDa HDM allergen [Dermatophagoides farinae] Metabolism 249 1.00E-64 138/366 (37%) 206/366 (56%) FDGLDL 
gi|31088464|gb|CD051781.1| gi|28195402|ref|NP_777186.1| major allergen BDA20 [Bos taurus] Transport 238 1.00E-61 113/172 (65%) 134/172 (77%) AQETPAEIDPSK , KIVEGGPLR , AKGTSFT , KYQQLNSERG , PNENIE
gi|1292783|emb|Z71867.1| gi|4138173|emb|CAA09884.1| allergen [Malassezia sympodialis] Unknown 202 1.00E-51 97/127 (76%) 103/127 (81%) TGEKGFGY , QGGDFT  , NGTGGKSIYG , LSMANAGPNTNGSQFFI , WLDGKHVVFG
gi|8489486|gb|AF247645.1| gi|1170095|sp|P46419| Glutathione S-transferase (GST class-mu) Metabolic 184 1.00E-45 85/185 (45%) 123/185 (66%) LGLDFPNLPY 
gi|164106|gb|M63868.1| gi|27805979|ref|NP_776803.1| lactalbumin, alpha [Bos taurus] Homeostasis 114 1.00E-23 50/52 (96%) 50/52 (96%) Highly homologous
gi|39939389|gb|AY466498.1| gi|14423698|sp|Q17284| Fatty acid-binding protein (Allergen Blo t 13) Metabolism 103 1.00E-21 49/125 (39%) 75/125 (60%) STFKNTEI 
|1292789|emb|Z71861.1| gi|11135375|sp|Q9UW02| Thioredoxin (Allergen Cop c 2) Chaperone/stress-related 102 2.00E-21 47/105 (44%) 69/105 (65%) ATWCGPC
gi|601887|dbj|D43752.1| gi|1314736|gb|AAA99805.1| Der f 3 mite allergen  Metabolic 99.4 3.00E-20 62/156 (39%) 81/156 (51%) GDSGGP
gi|494966|emb|Z33881.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 95.1 2.00E-17 46/48 (95%) 48/48 (100%) Highly homologous
gi|31088632|gb|CD051949.1| gi|14423714|sp|Q9U5P1| Fatty acid-binding protein (Allergen Lep d 13) Metabolism 81.3 1.00E-14 46/121 (38%) 74/121 (61%) STFKNTE
gi|31088724|gb|CD052041.1| gi|14423976|sp|Q9NAS5| Tropomyosin (Allergen Ani s 3) Structural 61.6 9.00E-09 30/52 (57%) 40/52 (76%) LKEAET , AEFAERSV 
gi|31088725|gb|CD052042.1| gi|14423976|sp|Q9NAS5| Tropomyosin (Allergen Ani s 3) Structural 61.6 9.00E-09 30/52 (57%) 40/52 (76%) LKEAET , AEFAERSV 
gi|1292801|emb|Z71876.1| gi|1350779|sp|P49148| 60S acidic ribosomal protein P1 (Allergen Alt a 12) Protein synthesis 60.5 8.00E-09 33/61 (54%) 41/61 (67%) LFAKAL   
gi|31088838|gb|CD052155.1| gi|45331208|ref|NP_987098.1| allergen dI chain C2A [Mus musculus] Unknown 55.8 3.00E-07 27/65 (41%) 38/65 (58%) QDCFNE     
gi|31088468|gb|CD051785.1| gi|14424447|sp|P25780| Mite group 1 allergen Eur m 1 precursor (Eur m I) Metabolic 50.1 6.00E-05 20/50 (40%) 31/50 (62%) YWIVRNSW   
gi|619077|emb|Z47079.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 43.5 0.002 20/20 (100%) 20/20 (100%) VYVEELKPTPEGDLEILLQK
gi|437753|emb|Z19570.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 42 0.003 19/22 (86%) 20/22 (90%) IVTQTMKGLDIQKV 















Appendix VIII. Detail lists of sequence homology matches for dog with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid. 
Query Hit Hit Description Function Bit-score E-value Identity Positivity 6 amino acid homology
gi|13124699|sp|P49822| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 1248 0 608/608 (100%) 608/608 (100%) Highly homologous
gi|22531688|dbj|BAC10663.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 1246 0 606/608 (99%) 608/608 (100%) Highly homologous
gi|6687188|emb|CAB64867.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 1246 0 606/608 (99%) 608/608 (100%) Highly homologous
gi|3319897|emb|CAA76841.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 1193 0 579/584 (99%) 580/584 (99%) Highly homologous
gi|32813265|dbj|BAC79353.1| gi|729764|sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) Chaperone / stress-related 916 0 458/640 (71%) 543/640 (84%) Highly homologous
gi|32813271|dbj|BAC79356.1| gi|729764|sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) Chaperone / stress-related 916 0 458/640 (71%) 543/640 (84%) Highly homologous
gi|17298186|dbj|BAB78505.1| gi|729764|sp|P40918| Heat shock 70 kDa protein (Allergen Cla h 4) Chaperone / stress-related 904 0 455/640 (71%) 540/640 (84%) Highly homologous
gi|2147092|pir||I46986 gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 538 e-152 264/265 (99%) 264/265 (99%) Highly homologous
gi|22218072|dbj|BAC07513.1| gi|45383974|ref|NP_990592.1| preproalbumin (serum albumin) [Gallus gallus] Homeostasis 514 e-144 245/613 (39%) 374/613 (61%) ARRHPFLYAP , EYSRRH , YANRRPCF
gi|3121746|sp|O18874| gi|3121746|sp|O18874| Minor allergen Can f 2 precursor (Allergen Dog 2)             Unknown 371 e-102 180/180 (100%) 180/180 (100%) Highly homologous
gi|29292270|emb|CAD82910.1| gi|3121746|sp|O18874| Minor allergen Can f 2 precursor (Allergen Dog 2) Unknown 371 e-102 180/180 (100%) 180/180 (100%) Highly homologous
gi|2598976|gb|AAC48795.1| gi|3121746|sp|O18874| alpha-2u globulin PGCL1 [Rattus norvegicus] Homeostasis 371 e-102 180/180 (100%) 180/180 (100%) Highly homologous
gi|29292274|emb|CAD82912.1| gi|3121746|sp|O18874| Minor allergen Can f 2 precursor (Allergen Dog 2). Unknown 364 e-100 177/179 (98%) 177/179 (98%) Highly homologous
gi|29292272|emb|CAD82911.1| gi|3121746|sp|O18874| Minor allergen Can f 2 precursor (Allergen Dog 2) Unknown 358 3.00E-98 172/173 (99%) 173/173 (100%) Highly homologous
gi|3121745|sp|O18873| gi|3121745|sp|O18873| Major allergen Can f 1 precursor (Allergen Dog 1). Unknown 348 3.00E-95 174/174 (100%) 174/174 (100%) Highly homologous
gi|29292148|emb|CAD82909.1| gi|3121746|sp|O18874| Major allergen Can f 1 precursor (Allergen Dog 1) Unknown 348 2.00E-95 174/174 (100%) 174/174 (100%) Highly homologous
gi|2598974|gb|AAC48794.1| gi|3121745|sp|O18873| Major allergen Can f 1 precursor (Allergen Dog 1) Unknown 348 3.00E-95 174/174 (100%) 174/174 (100%) Highly homologous
gi|633938|gb|AAB30434.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 296 4.00E-79 131/263 (49%) 186/263 (70%) VHKECC , EDKEVCK , YEYSRRHPE
gi|125303|sp|P05123| gi|25453077|sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1). Metabolic 283 8.00E-75 157/341 (46%) 219/341 (64%) DLFDPII, QQQLIDDHFLF , NKTFLVW , NEEDHLR
gi|89027|pir||A24686 gi|25453077|sp|Q95PM9| Arginine kinase (AK) (Allergen Plo i 1) Metabolic 275 1.00E-72 154/330 (46%) 211/330 (63%) DLFDPII , QQQLIDDHFLF , NKTFLVW , NEEDHLR
gi|125292|sp|P05124| gi|27463265|gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon] Homeostasis 275 1.00E-72 154/340 (45%) 208/340 (60%) LFDPIIED , LIDDHFLF , HNDNKTFLVW , NEEDHLR , VHIKLP 
gi|320114|pir||B24686 gi|27463265|gb|AAO15713.1| allergen Pen m 2 [Penaeus monodon] Homeostasis 253 5.00E-66 146/340 (42%) 197/340 (57%) LFDPIIED , LIDDHFLF , HNDNKTFLVW , NEEDHLR , VHIKLP 
gi|27497538|gb|AAO13009.1| gi|113285|sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) Metabolic 238 2.00E-61 126/303 (41%) 181/303 (59%) CWAFSA
gi|8699209|gb|AAF78600.1| gi|4138173|emb|CAA09884.1| allergen [Malassezia sympodialis] Unknown 225 3.00E-58 109/154 (70%) 121/154 (78%) TGEKGFGY , QGGDFT , NGTGGKSIYG , LSMANAGPNTNGSQFFI , WLDGKHVVFG
gi|10185020|emb|CAC08809.1| gi|113285|sp|P00785| Actinidain precursor (Actinidin) (Allergen Act c 1) Metabolic 223 7.00E-57 130/342 (38%) 192/342 (56%) CWAFSA  , WIVKNSW   
gi|423167|pir||S33877 gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 220 9.00E-57 100/162 (61%) 138/162 (85%) QKVAGTW , AMAASDISLLD , APLRVY
gi|462472|sp|P33685| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 220 9.00E-57 100/162 (61%) 138/162 (85%) QKVAGTW , AMAASDISLLD , APLRVY
gi|448346|prf||1916447D gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 220 9.00E-57 100/162 (61%) 138/162 (85%) QKVAGTW , AMAASDISLLD , APLRVY
gi|1082934|pir||S33878 gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 213 2.00E-54 95/160 (59%) 134/160 (83%) QKVAGTW , AMAASDISLLD , APLRVY , 
gi|462474|sp|P33686| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 213 2.00E-54 95/160 (59%) 134/160 (83%) QKVAGTW , AMAASDISLLD , APLRVY
gi|448347|prf||1916447E gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 213 2.00E-54 95/160 (59%) 134/160 (83%) QKVAGTW , AMAASDISLLD , APLRVY
gi|136411|sp|P06872| gi|2507248|sp|P49275| Mite allergen Der f 3 precursor (Der f III) Metabolic 189 5.00E-47 100/248 (40%) 144/248 (58%) HFCGGS , DSCQGDSGGPVV , GIVSWGYGCA , NFVDWI
gi|67552|pir||TRDG gi|2507248|sp|P49275| Mite allergen Der f 3 precursor (Der f III) Metabolic 189 5.00E-47 100/248 (40%) 144/248 (58%) HFCGGS , DSCQGDSGGPVV , GIVSWGYGCA , NFVDWI
gi|27923790|sp|Q9N2G9| gi|27805979|ref|NP_776803.1| lactalbumin, alpha [Bos taurus] Homeostasis 187 3.00E-47 83/127 (65%) 98/127 (77%) FHTSGYDTQ , YGLFQI, WCKDDQN , KKILDK , YWLAHK , LCSEKL
gi|7959046|dbj|BAA95930.1| gi|27805979|ref|NP_776803.1| lactalbumin, alpha [Bos taurus] Homeostasis 187 3.00E-47 83/127 (65%) 98/127 (77%) FHTSGYDTQ , YGLFQI , WCKDDQN  , KKILDK , YWLAHK , LCSEKL
gi|136406|sp|P06871| gi|729315|sp|P39675| Mite allergen Der p 3 precursor (Der p III). Metabolic 174 2.00E-42 96/239 (40%) 133/239 (55%) GGKDSCQGDSGGPV  
gi|67551|pir||TRDGC gi|729315|sp|P39675| Mite allergen Der p 3 precursor (Der p III). Metabolic 174 2.00E-42 96/239 (40%) 133/239 (55%) GGKDSCQGDSGGPV  
gi|117612|sp|P04813| gi|729315|sp|P39675| Mite allergen Der p 3 precursor (Der p III). Metabolic 158 1.00E-37 84/231 (36%) 132/231 (56%) GDSGGP , VGIVSWG 
gi|108088|pir||A21195 gi|729315|sp|P39675| Mite allergen Der p 3 precursor (Der p III). Metabolic 158 1.00E-37 84/231 (36%) 132/231 (56%) GDSGGP , VGIVSWG 
gi|1085423|pir||S48641 gi|126608|sp|P00698| Lysozyme C precursor Metabolic 157 4.00E-38 69/130 (53%) 90/130 (69%) ESNFNTQA 
gi|20150098|pdb|1I56|A gi|126608|sp|P00698| Lysozyme C precursor Metabolic 157 4.00E-38 69/130 (53%) 90/130 (69%) ESNFNTQA 
gi|9257149|pdb|1QQY|A gi|126608|sp|P00698| Lysozyme C precursor Metabolic 157 4.00E-38 69/130 (53%) 90/130 (69%) ESNFNTQA 
gi|8928188|sp|P81708| gi|126608|sp|P00698| Lysozyme C precursor Metabolic 157 4.00E-38 69/130 (53%) 90/130 (69%) ESNFNTQA 
gi|13787135|pdb|1EL1|B gi|126608|sp|P00698| Lysozyme C precursor Metabolic 157 4.00E-38 69/130 (53%) 90/130 (69%) ESNFNTQA 
gi|684994|gb|AAB31794.1| gi|126608|sp|P00698| Lysozyme C precursor  IV) Metabolic 157 4.00E-38 69/130 (53%) 90/130 (69%) ESNFNTQA 
gi|4454073|emb|CAA05126.1| gi|1314736|gb|AAA99805.1| Der f 3 mite allergen Metabolic 145 1.00E-33 87/240 (36%) 128/240 (53%) LTAAHC , GDSGGP
gi|482952|pir||B32410 gi|14423685|sp|O97370| Mite allergen Eur m 3 precursor. Metabolic 139 9.00E-32 95/252 (37%) 135/252 (52%) LTAAHCV   , VSWGYGC   
gi|136423|sp|P19236| gi|14423685|sp|O97370| Mite allergen Eur m 3 precursor Metabolic 139 9.00E-32 95/252 (37%) 135/252 (52%) LTAAHCV , VSWGYGC    
gi|3318843|pdb|1RP1| gi|1709545|sp|P51528| Phospholipase A1 (Allergen Ves m 1) Metabolic 112 1.00E-23 79/259 (30%) 116/259 (44%) LIGHSLGAHV
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gi|126316|sp|P06857| gi|1709545|sp|P51528| Phospholipase A1 (Allergen Ves m 1) Metabolic 112 2.00E-23 80/261 (30%) 117/261 (44%) LIGHSLGAHV
gi|164048|gb|AAA30885.1| gi|1709545|sp|P51528| Phospholipase A1 (Allergen Ves m 1) Metabolic 110 6.00E-23 79/261 (30%) 117/261 (44%) LIGHSLGAHV
gi|67162|pir||LIDG gi|1709545|sp|P51528| Phospholipase A1 (Allergen Ves m 1) Metabolic 110 6.00E-23 79/261 (30%) 117/261 (44%) LIGHSLGAHV
gi|124847|sp|P01002| gi|124757|sp|P01005|I Ovomucoid precursor (Allergen Gal d 1) Homeostasis 102 2.00E-21 50/119 (42%) 68/119 (57%) RPLCGSD 
gi|476547|pir||TIDGS gi|124757|sp|P01005|I Ovomucoid precursor (Allergen Gal d 1) Homeostasis 102 2.00E-21 50/119 (42%) 68/119 (57%) RPLCGSD 
gi|163944|gb|AAA30840.1| gi|1709545|sp|P51528| Phospholipase A1 (Allergen Ves m 1) Metabolic 99.4 1.00E-19 74/238 (31%) 104/238 (43%) LIGHSLGAHV
gi|3914452|sp|Q28278| gi|1314736|gb|AAA99805.1| Der f 3 mite allergen Metabolic 95.1 6.00E-19 58/155 (37%) 81/155 (51%) GDSGGP
gi|1304048|dbj|BAA07808.1| gi|1314736|gb|AAA99805.1| Der f 3 mite allergen Metabolic 95.1 6.00E-19 58/155 (37%) 81/155 (51%) GDSGGP
gi|38374003|gb|AAR19224.1| gi|1314736|gb|AAA99805.1| Der f 3 mite allergen Metabolic 87.4 1.00E-16 52/171 (30%) 87/171 (50%) DSCQGDSGGP
gi|543068|pir||A48292 gi|37078092|sp|Q870B9| Enolase Metabolic 85.5 7.00E-15 48/84 (57%) 60/84 (71%) VPSGASTG , TIAPALI  
gi|402558|emb|CAA48914.1| gi|37078092|sp|Q870B9| Enolase Metabolic 85.5 7.00E-15 48/84 (57%) 60/84 (71%) VPSGASTG , TIAPALI  
gi|3288714|dbj|BAA31256.1| gi|729970|sp|P39674| Allergen MAG29 Chaperone / stress-related 71.2 5.00E-12 41/67 (61%) 42/67 (62%) VCNPIIT , SGPTIEEVD
gi|229545|prf||753699A gi|124757|sp|P01005| Ovomucoid precursor (Allergen Gal d 1) Homeostasis 68.2 4.00E-11 38/135 (28%) 63/135 (46%) PICGTD  
gi|423181|pir||S29749 gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3) Homeostasis 53.5 1.00E-06 24/24 (100%) 24/24 (100%) Highly homologous
gp-4 gi|124757|sp|P01005| Ovomucoid precursor (Allergen Gal d 1) Homeostasis 52 4.00E-06 19/41 (46%) 27/41 (65%) NECLLC    
gi|68720|pir||TIDGA gi|124757|sp|P01005| Ovomucoid precursor (Allergen Gal d 1) Homeostasis 52 4.00E-06 19/41 (46%) 27/41 (65%) NECLLC    
gi|1683343|gb|AH004615.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3). Homeostasis 50.4 1.00E-04 24/28 (85%) 24/28 (85%) NPGFPPLVAPEPDAL 
gi|693831|gb|AAB32129.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3). Homeostasis 50.4 1.00E-05 24/28 (85%) 24/28 (85%) NPGFPPLVAPEPDAL 
gi|5738962|dbj|BAA83419.1| gi|27807077|ref|NP_777021.1| S100 calcium-binding protein A7 (psoriasin 1) Signal transduction 46.2 2.00E-04 23/81 (28%) 43/81 (53%) FHKYSG 
gi|3822535|gb|AAC69882.1| gi|1352699|sp|P49369| Phospholipase A1 precursor (Allergen Ves v 1) Metabolic 42.7 0.002 21/42 (50%) 28/42 (66%) RNTRLVGQ 
gi|2952306|gb|AAC05499.1| gi|42559584|sp|Q23939| Tropomyosin (Allergen Der f 10) Structural 40.8 0.008 20/28 (71%) 21/28 (74%) ELEEEL
gi|693830|gb|AAB32128.1| gi|13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3). Homeostasis 39.3 0.022 17/17 (100%) 17/17 (100%) EAYKSEIAHRYNDLGEE
gi|693833|gb|AAB32131.1| |13124699|sp|P49822| Serum albumin precursor (Allergen Can f 3). Homeostasis 38.1 0.05 17/17 (100%) 17/17 (100%) VLDEFKPLVDEPQNLVK















Appendix IX. Detail lists of sequence homology matches for cat with query, subject, subject description, functional category, bit 
score, E-value and region of amino acid homology. 
 
Query Hit Hit Description Function Bit-score E-value Identity Positivity 6 amino acid homology
gi|1351908|sp|P49064| gi|1351908|sp|P49064| Serum albumin precursor (Allergen Fel d 2) Homeostasis 1194 0 585/600 (97%) 585/600 (97%) Highly homologous
gi|1363007|pir||S57632 gi|1351908|sp|P49064| Serum albumin precursor (Allergen Fel d 2) Homeostasis 1194 0 585/600 (97%) 585/600 (97%) Highly homologous
gi|886485|emb|CAA59279.1| gi|1351908|sp|P49064| Serum albumin precursor (Allergen Fel d 2) Homeostasis 1194 0 585/600 (97%) 585/600 (97%) Highly homologous
gi|30962111|emb|CAD32275.1| gi|1351908|sp|P49064| Serum albumin precursor (Allergen Fel d 2) Homeostasis 1139 0 555/576 (96%) 557/576 (96%) Highly homologous
gi|6708502|gb|AAD09454.2| gi|42559536|sp|Q9NJA9| Paramyosin (Allergen Ani s 2) Structural 593 e-168 317/828 (38%) 521/828 (62%) RLQAEN 
gi|38492848|pdb|1PUO|B gi|38492847|pdb|1PUO|A[38492847] Chain A, Crystal Structure Of Fel D 1 Unknown 325 2.00E-88 164/164 (100%) 164/164 (100%) Highly homologous
gi|38492847|pdb|1PUO|A gi|38492847|pdb|1PUO|A[38492847] Chain A, Crystal Structure Of Fel D 1 Unknown 325 2.00E-88 164/164 (100%) 164/164 (100%) Highly homologous
gi|25989117|gb|AAK33125.1| gi|4138173|emb|CAA09884.1| allergen [Malassezia sympodialis] Unknown 229 2.00E-59 112/157 (71%) 122/157 (77%) TGEKGFGY , QGGDFT  , NGTGGKSIYG , LSMANAGPNTNGSQFFI , WLDGKHVVFG 
gi|423188|pir||S33876 gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 219 2.00E-56 101/160 (63%) 132/160 (82%) QKVAGTW , AMAASDISLLD , APLRVYV , VLDTDY
gi|462475|sp|P33688| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 219 2.00E-56 101/160 (63%) 132/160 (82%) QKVAGTW , AMAASDISLLD , APLRVYV , VLDTDY
gi|448345|prf||1916447C gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 219 2.00E-56 101/160 (63%) 132/160 (82%) QKVAGTW , AMAASDISLLD , APLRVYV , VLDTDY
gi|462473|sp|P33687| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 218 4.00E-56 98/160 (61%) 133/160 (83%) AMAASDISLLD , APLRVYV , VLDTDY
gi|448343|prf||1916447A gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 218 4.00E-56 98/160 (61%) 133/160 (83%) AMAASDISLLD , APLRVYV , VLDTDY
gi|4322134|gb|AAD15975.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 214 4.00E-55 97/154 (62%) 130/154 (84%) QKVAGTW , AMAASDISLLD , APLRVYV , VLDTDY
gi|2119651|pir||S33875 gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 211 3.00E-54 97/160 (60%) 132/160 (82%) AMAASDISLLD , APLRVYV , VLDTDY
gi|4322130|gb|AAD15971.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 211 4.00E-54 94/152 (61%) 128/152 (84%) AMAASDISLLD , APLRVYV , VLDTDY
gi|4322131|gb|AAD15972.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 207 6.00E-53 93/152 (61%) 127/152 (83%) AMAASDISLLD , APLRVYV , VLDTDY
gi|232086|sp|P30440| gi|232086|sp|P30440| Major allergen I polypeptide chain 2 precursor Unknown 184 5.00E-46 94/109 (86%) 94/109 (86%) Highly homologous
gi|1082946|pir||C56413 gi|232086|sp|P30440| Major allergen I polypeptide chain 2 precursor Unknown 184 5.00E-46 94/109 (86%) 94/109 (86%) Highly homologous
gi|163823|gb|AAC41616.1| gi|232086|sp|P30440| Major allergen I polypeptide chain 2 precursor Unknown 184 5.00E-46 94/109 (86%) 94/109 (86%) Highly homologous
gi|1169666|sp|P30439| gi|1169666|sp|P30439| Major allergen I polypeptide chain 1 minor form precursor Unknown 181 4.00E-45 88/88 (100%) 88/88 (100%) Highly homologous
gi|395407|emb|CAA44345.1| gi|423192|pir||JC1127[423192] major allergen chain 2 precursor, short form Unknown 181 3.00E-45 92/107 (85%) 92/107 (85%) Highly homologous
gi|423192|pir||JC1127 gi|423192|pir||JC1127[423192] major allergen chain 2 precursor, short form Unknown 181 3.00E-45  92/107 (85%) 92/107 (85%) Highly homologous
gi|423191|pir||JC1126 gi|423191|pir||JC1126[423191] major allergen chain 1 precursor B Unknown 181 3.00E-45 88/88 (100%) 88/88 (100%) Highly homologous
gi|108170|pir||S14719 gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 181 7.00E-45 88/158 (55%) 120/158 (75%) AMAASDISLLD , APLRVYV , VLDTDY  
gi|125905|sp|P21664| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 181 7.00E-45 88/158 (55%) 120/158 (75%) AMAASDISLLD , APLRVYV , VLDTDY  
gi|163827|gb|AAC41617.1| gi|163827|gb|AAC41617.1|[163827] major allergen I Unknown 181 4.00E-45 88/88 (100%) 88/88 (100%) Highly homologous
gi|4322133|gb|AAD15974.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 177 6.00E-44 86/154 (55%) 118/154 (76%) AMAASDISLLD ,   APLRVYV , VLDTDY  
gi|448344|prf||1916447B gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 177 7.00E-44 87/158 (55%) 119/158 (75%) AMAASDISLLD , APLRVYV , VLDTDY  
gi|4322132|gb|AAD15973.1| gi|125910|sp|P02754| Beta-lactoglobulin precursor (Beta-LG) Homeostasis 175 2.00E-43 85/154 (55%) 117/154 (75%) AMAASDISLLD , APLRVYV , VLDTDY  
gi|1082944|pir||A56413 gi|1082944|pir||A56413[1082944] major allergen Fel dI chain 1 long form precursor Unknown 165 3.00E-40 81/92 (88%) 81/92 (88%) Highly homologous
gi|163825|gb|AAC37318.1| gi|1082944|pir||A56413[1082944] major allergen Fel dI chain 1 long form precursor Unknown 165 3.00E-40 81/92 (88%) 81/92 (88%) Highly homologous
gi|1169665|sp|P30438| gi|1169665|sp|P30438| Major allergen I polypeptide chain 1 major form precursor Unknown 164 6.00E-40 81/92 (88%) 81/92 (88%) Highly homologous
gi|423190|pir||JC1136 gi|423190|pir||JC1136[423190] major allergen chain 1 precursor A Unknown 164 4.00E-40 81/92 (88%) 81/92 (88%) Highly homologous
gi|1364212|emb|CAA44343.1| gi|423191|pir||JC1126[423191] major allergen chain 1 precursor B Unknown 150 8.00E-36 75/85 (88%) 77/85 (90%) Highly homologous
gi|1364213|emb|CAA44344.1| gi|423190|pir||JC1136[423190] major allergen chain 1 precursor A Unknown 149 1.00E-35 75/90 (83%) 77/90 (85%) Highly homologous
gi|1708844|sp|P55031| gi|548449|sp|Q06478| Phospholipase A1 1 precursor (Allergen Dol m 1.01) Metabolic 111 3.00E-23 77/276 (27%) 126/276 (45%) GLDPAGP , 
gi|1150861|gb|AAB03848.1| gi|548449|sp|Q06478| Phospholipase A1 1 precursor (Allergen Dol m 1.01) Metabolic 111 3.00E-23 77/276 (27%) 126/276 (45%) GLDPAGP
gi|3914455|sp|Q28412| gi|1314736|gb|AAA99805.1|[1314736] Der f 3 mite allergen Metabolic 94 1.00E-18 55/156 (35%) 80/156 (51%) GDSGGP
gi|1304038|dbj|BAA07807.1| gi|1314736|gb|AAA99805.1|[1314736] Der f 3 mite allergen Metabolic 94 1.00E-18 55/156 (35%) 80/156 (51%) GDSGGP
gi|124848|sp|P08480| gi|124757|sp|P01005|I Ovomucoid precursor (Allergen Gal d 1) Homeostasis 93.2 1.00E-18 46/119 (38%) 64/119 (53%) PLCGSD 
gi|89087|pir||A29654 gi|124757|sp|P01005| Ovomucoid precursor (Allergen Gal d 1) Homeostasis 93.2 1.00E-18 46/119 (38%) 64/119 (53%) PLCGSD 
gi|131098|sp|P80079| gi|18281421|sp|Q91483| Parvalbumin beta 2 (Major allergen Sal s 1) Signal-transduction 92 2.00E-18 47/101 (46%) 62/101 (61%) DKSGFIEEDEL  
gi|7441490|pir||S27209 gi|18281421|sp|Q91483| Parvalbumin beta 2 (Major allergen Sal s 1) Signal-transduction 92 2.00E-18 47/101 (46%) 62/101 (61%) DKSGFIEEDEL  







Appendix X. List of putative allergens predicted in pork using wavelet transform.  
  
Subject (hits) Subject Description Motif no. E-values
P29700 Alpha-2-HS-glycoprotein precursor (Fetuin-A). 4 0.015
P18137 Alpha-lactalbumin precursor (Lactose synthase B protein). 17 9.00E-23
Q28944 Cathepsin L precursor. 6 0.03
P79401 Cytochrome P450 3A29 (CYPIIIA29). 13 0.00087
Q8WNV7 Dehydrogenase/reductase SDR family member 4 24 0.04
O02772 Fatty acid-binding protein, heart (H-FABP) (Heart-type fatty acid-binding protein). 8 0.0024
P10173 Fumarate hydratase, mitochondrial (Fumarase). 52 0.00053
P34930 HEAT SHOCK 70 KD PROTEIN 1 (HSP70.1). 15 6.70E-06
P34934 HEAT SHOCK 70 KD PROTEIN. 13 0.00031
Q04967 HEAT SHOCK 70 KDA PROTEIN 6 (HEAT SHOCK 70 KDA PROTEIN B'). 15 0.00014
O02705 Heat shock protein HSP 90-alpha (HSP 86). 14 0.00049
Q29545 Inhibitor of carbonic anhydrase precursor. 27 0.0044
P14632 Lactotransferrin precursor (Lactoferrin). 28 0.0025
P00346 Malate dehydrogenase, mitochondrial precursor. 45 0.00016
Q95250 Membrane associated progesterone receptor component 1. 13 0.043
P79293 Myosin heavy chain, cardiac muscle beta isoform (MyHC-beta). 13 2.40E-05
Q29558 NADP-dependent malic enzyme (NADP-ME) (Malic enzyme 1). 34 0.00088
P00791 Pepsin A precursor. 25 0.0003
P09571 Serotransferrin (Transferrin) (Siderophilin) (Beta-1-metal binding globulin). 28 0.016
P08835 Serum albumin precursor. 34 1.80E-10
P42639 Tropomyosin 1 alpha chain (Alpha-tropomyosin). 26 1.50E-07








Appendix XI. List of putative allergens predicted in chicken using wavelet transform. 
 
Subject (hits) Subject Description Motif no. E-values
P01005 Ovomucoid precursor (Allergen Gal d 1) (Gal d I). 55 5.50E-10
P79781 40S ribosomal protein S27a. 5 0.049
P27463 Aldehyde dehydrogenase 1A1 (Aldehyde dehydrogenase, cytosolic) 28 2.80E-05
O93344 Aldehyde dehydrogenase 1A2 (Retinaldehyde-specific dehydrogenase type 2) (RALDH(II)) (RALDH-2). 28 3.90E-05
P51913 Alpha enolase (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase). 42 4.20E-08
P07322 Beta enolase (2-phospho-D-glycerate hydro-lyase) (Phosphopyruvate hydratase). 42 4.20E-08
Q9DE13 Bromodomain adjacent to zinc finger domain 2B (Extracellular matrix protein F22). 33 0.0034
P07090 Calretinin (CR). 24 0.34
Q90640 Chromosome-associated kinesin KIF4A (Chromokinesin). 31 0.059
O42130 DNA topoisomerase II, alpha isozyme. 61 0.037
Q05423 Fatty acid-binding protein, retina (R-FABP). 8 1.30E-05
O57391 Gamma enolase (2-phospho-D-glycerate hydro-lyase) (Neural enolase) (NSE). 42 1.00E-08
P01013 GENE X PROTEIN (OVALBUMIN-RELATED). 34 1.30E-10
P01014 Gene Y protein (Ovalbumin-related). 34 3.30E-15
P08106 HEAT SHOCK 70 KD PROTEIN (HSP70). 15 4.20E-06
Q04619 Heat shock cognate protein HSP 90-beta. 14 0.022
P11501 Heat shock protein HSP 90-alpha. 14 0.00047
O93532 Keratin, type II cytoskeletal cochleal (Cytokeratin otokeratin). 55 5.00E-11
P29616 Myosin heavy chain, cardiac muscle isoform. 13 0.012
P02565 Myosin heavy chain, fast skeletal muscle, embryonic. 13 3.90E-07
P13538 Myosin heavy chain, skeletal muscle, adult. 13 0.005
P01012 Ovalbumin (Plakalbumin) (Allergen Gal d 2) (Gal d II). 48 5.50E-10
P02789 Ovotransferrin precursor (Conalbumin) (Allergen Gal d 3) (Gal d III) (Serum transferrin). 27 1.90E-12
P80026 Parvalbumin, muscle. 45 0.016
P19753 Parvalbumin, thymic (Avian thymic hormone) (ATH) (Thymus-specific antigen T1). 45 7.60E-06
P43305 Parvalbumin, thymic CPV3 (Parvalbumin 3). 45 0.00021
P00793 Pepsin A precursor. 25 0.00043
P24367 Peptidyl-prolyl cis-trans isomerase B precursor (PPIase) (Rotamase) (Cyclophilin B) (S-cyclophilin) (SCYLP). 60 0.00028
O42184 Restin (Cytoplasmic linker protein-170) (CLIP-170). 13 0.057
P19121 Serum albumin precursor (Alpha-livetin) (Allergen Gal d 5). 9 3.80E-21
P00940 Triosephosphate isomerase (TIM) (Triose-phosphate isomerase). 7 0.0019
P04268 Tropomyosin 1 alpha chain (Alpha-tropomyosin). 26 1.10E-06
P19352 Tropomyosin beta chain (Tropomyosin 2) (Beta-tropomyosin). 26 4.10E-07
P02845 Vitellogenin II precursor (Major vitellogenin) [Contains: Lipovitellin I (LVI); Phosvitin (PV); Lipovitellin II (LVII);YG 57 5.30E-12  
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Appendix XII. List of putative allergens predicted in sheep using wavelet transform. 
 
Subject (hits) Subject Description Motif no. E-values
P51977 Aldehyde dehydrogenase 1A1 (Aldehyde dehydrogenase, cytosolic) (ALDH class 1) (ALHDII) (ALDH-E1). 28 0.0031
P09462 Alpha-lactalbumin precursor (Lactose synthase B protein). 17 4.20E-36
P04653 Alpha-S1 casein precursor. 2 0.005
P04654 Alpha-S2 casein precursor. 16 0.0011
P11839 Beta casein precursor. 12 0.013
P02757 Beta-lactoglobulin 1/B, 2/A, and 3/C precursor. 14 6.30E-06
Q06435 Interleukin-3 precursor (IL-3) (Multipotential colony-stimulating factor) (Hematopoietic growth factor) (P-cell stimu 29 0.041
P02539 Keratin, type II microfibrillar (Low-sulfur keratin). 55 4.30E-05
P25691 Keratin, type II microfibrillar, component 5. 55 6.50E-06
P15241 Keratin, type II microfibrillar, component 7C. 55 6.20E-06
P14639 Serum albumin precursor. 34 1.20E-09
P22793 Trichohyalin. 13 0.00089
 
Appendix XIII.  List of putative allergens predicted in dog using wavelet transform. 
 
Subject (hits) Subject Description Motif no. E-values
Q9N2G9 Alpha-lactalbumin precursor (Lactose synthase B protein) 17 3.00E-25
P24643 Calnexin precursor (pp90) 41 0.026
O18873 Major allergen Can f 1 precursor (Allergen Dog 1) 46 8.30E-15
Q28269 Occludin 36 0.013
P49822 Serum albumin precursor (Allergen Can f 3) 34 1.20E-09
Q9XT60 Sex-determining region Y protein (Testis-determining factor) 36 0.079  
 
Appendix XIV. List of putative allergens predicted in cat using wavelet transform. 
 
Subject (hits) Subject Description Motif no. E-values
P30439 Major allergen I polypeptide chain 1 minor form precursor (Allergen Fel d 1-A) 44 1.40E-09
P30438 Major allergen I polypeptide chain 1 precursor (Allergen Fel d 1-A) 44 1.40E-09
P30440 Major allergen I polypeptide chain 2 precursor (Allergen Fel d 1-B) 10 2.00E-06
P49064 Serum albumin precursor (Allergen Fel d 2) 34 3.80E-13  
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Molecular cloning of Tropo 3. (A) PCR amplification of target tropomyosin gene 
with gene specific primers using Expand long-template Taq DNA polymerase. 
Amplicons in Lane 1 and 2 corresponds to correct expected size of ~800 bp. PCR 
amplicons from both lanes were extracted and purified using QIA quick Gel extraction 
Kit (Qiagen) and ligated to pGEMT-Easy vector followed by transformation into XL-1 
blue non-expression host. (B) Colony screening of PCR inserts in pGEMT vector 
using SP6 and T7 primers: A total of 10 colonies were screened for insert. Only five 
lanes were showed here (Lane: 1 to 5). Only 4 out of 10 clones showed the presence of 
insert with expected size of ~800 bp. (C): Colony screening of pET32a ligated insert in 
transformed XL 1-blue non-expression host strain using LIC primers. Lane 1 to 5 
corresponds to 5 clones chosen with the correct size of insert. (D): Sub cloning of 
ligated Pet Vector plasmid into BL-21 (DE3) (Novagen, USA) expression host. 
Again, colony screening was performed (lane 1 to 5). The clones with the correct size 
insert were subsequently sequenced from both ends to check for correct reading frame. 
Clone 1 and 2 were selected for protein expression. Glycerol stocks were made from 















Molecular cloning of TRNT. (A) PCR amplification of target troponin gene with 
gene specific primers using Expand long-template Taq DNA polymerase. Amplicons in 
Lane 1 and 2 corresponds to correct expected size of ~800 bp. PCR amplicons from both 
lanes were extracted and purified using QIA quick Gel extraction Kit (Qiagen) and 
ligated to pGEMT-Easy vector followed by transformation into XL-1 blue non-
expression host. (B) Colony screening of PCR inserts in pGEMT vector using SP6 
and T7 primers: All five colonies showed the presence of insert with expected size of 
~800 bp. (C): PCR amplification of target gene from pGEM-T plasmids with correct 
insert using designed LIC primer adaptors. Purified pGEM-T plasmid from clone 1 
(Lane 1 of Fig B) was used. The PCR amplified band was gel extracted, and purified. The 
final digested DNA fragment was ligated into pET-32a (+) expression vector (Novagen, 
USA) using T4 DNA ligase (Invitrogen, USA) and transformed into XL1-Blue non-
expression host cell. (D): Colony screening of pET32a ligated insert in transformed XL 
1-blue non-expression host strain using LIC primers. Lane 1 to 5 corresponds to 5 clones 
chosen with the correct size of insert. (E): Sub cloning of ligated Pet Vector plasmid 
into BL-21 (DE3) (Novagen, USA) expression host. Again, colony screening was 
performed (lane 1 to 5). The clones with the correct size insert were subsequently 
sequenced from both ends to check for correct reading frame. Clone 1 and 2 were 
selected for protein expression. Glycerol stocks were made from those clones that were 













Molecular cloning of Myo_L. (A) PCR amplification of target myosin light chain 
gene with gene specific primers using Expand long-template Taq DNA polymerase. 
Amplicons in Lane 1 and 2 corresponds to correct expected size of ~500 bp. PCR 
amplicons from both lanes were extracted and purified using QIA quick Gel extraction 
Kit (Qiagen) and ligated to pGEMT-Easy vector followed by transformation into XL-1 
blue non-expression host. (B) Colony screening of PCR inserts in pGEMT vector 
using SP6 and T7 primers: All five colonies showed the presence of insert with 
expected size of ~500 bp. (C): PCR amplification of target gene from pGEM-T 
plasmids with correct insert using designed LIC primer adaptors. Purified pGEM-T 
plasmid from clone 1 (Lane 1 of Fig B) was used. The PCR amplified band was gel 
extracted, and purified. The final digested DNA fragment was ligated into pET-32a (+) 
expression vector (Novagen, USA) using T4 DNA ligase (Invitrogen, USA) and 
transformed into XL1-Blue non-expression host cell. (D): Colony screening of pET32a 
ligated insert in transformed XL 1-blue non-expression host strain using LIC primers. 
Four of the five clones chosen have the correct size insert. (E): Sub cloning of ligated 
Pet Vector plasmid into BL-21 (DE3) (Novagen, USA) expression host. Again, colony 
screening was performed (lane 1 to 5). The clones with the correct size insert were 
subsequently sequenced from both ends to check for correct reading frame. Clone 1 and 2 
were selected for protein expression. Glycerol stocks were made from those clones that 









Molecular cloning of ADH. (A)  Colony screening of PCR inserts in pGEMT vector 
using SP6 and T7 primers: Three out of five clones showed the presence of insert with 
expected size of ~1500 bp. (B): PCR amplification of target gene from pGEM-T 
plasmids with correct insert using designed LIC primer adaptors. Purified pGEM-T 
plasmid from clone 1 (Lane 1 of Fig A) was used. The PCR amplified band was gel 
extracted, and purified. The final digested DNA fragment was ligated into pET-32a (+) 
expression vector (Novagen, USA) using T4 DNA ligase (Invitrogen, USA) and 
transformed into XL1-Blue non-expression host cell. (C): Colony screening of pET32a 
ligated insert in transformed XL 1-blue non-expression host strain using LIC primers. 
Lane 1 to 5 corresponds to 5 clones chosen with the correct size of insert. (D): Sub 
cloning of ligated Pet Vector plasmid into BL-21 (DE3) (Novagen, USA) expression 
host. Again, colony screening was performed (lane 1 to 5). The clones with the correct 
size insert were subsequently sequenced from both ends to check for correct reading 
frame. Clone 1 and 2 were selected for protein expression. Glycerol stocks were made 














                              
 
 
Appendix XIX.  
Molecular cloning of ENO 1. (A) PCR amplification of target enolase 1 gene with 
gene specific primers using Expand long-template Taq DNA polymerase. Amplicons in 
Lane 1 and 2 corresponds to correct expected size of ~1300 bp. PCR amplicons from 
both lanes were extracted and purified using QIA quick Gel extraction Kit (Qiagen) and 
ligated to pGEMT-Easy vector followed by transformation into XL-1 blue non-
expression host. (B) Colony screening of PCR inserts in pGEMT vector using SP6 
and T7 primers: Four out of five clones showed the presence of insert with expected 
size of ~900 bp. (C): PCR amplification of target gene from pGEM-T plasmids with 
correct insert using designed LIC primer adaptors. Purified pGEM-T plasmid from 
clone 1 (Lane 2 of Fig B) was used. The PCR amplified band was gel extracted, and 
purified. The final digested DNA fragment was ligated into pET-32a (+) expression 
vector (Novagen, USA) using T4 DNA ligase (Invitrogen, USA) and transformed into 
XL1-Blue non-expression host cell. (D): Colony screening of pET32a ligated insert in 
transformed XL 1-blue non-expression host strain using LIC primers. Three of the five 
clones chosen have the correct size insert. (E): Sub cloning of ligated Pet Vector 
plasmid into BL-21 (DE3) (Novagen, USA) expression host. Again, colony screening 
was performed (lane 1 to 5). The clones with the correct size insert were subsequently 
sequenced from both ends to check for correct reading frame. Clone 1 and 3 were 
selected for protein expression. Glycerol stocks were made from those clones that were 











Molecular cloning of pHSP70. (A) PCR amplification of target heat shock protein 70 
gene with gene specific primers using Expand long-template Taq DNA polymerase. 
Amplicons in Lane 1 and 2 corresponds to correct expected size of ~2000 bp. PCR 
amplicons from both lanes were extracted and purified using QIA quick Gel extraction 
Kit (Qiagen) and ligated to pGEMT-Easy vector followed by transformation into XL-1 
blue non-expression host. (B) Colony screening of PCR inserts in pGEMT vector 
using SP6 and T7 primers: All five colonies showed the presence of insert with 
expected size of ~2000 bp. (C) PCR amplification of target gene from pGEM-T 
plasmids with correct insert using designed LIC primer adaptors. Purified pGEM-T 
plasmid from clone 1 (Lane 1 of Fig B) was used. The PCR amplified band was gel 
extracted, and purified. The final digested DNA fragment was ligated into pET-32a (+) 
expression vector (Novagen, USA) using T4 DNA ligase (Invitrogen, USA) and 
transformed into XL1-Blue non-expression host cell. (D): Colony screening of pET32a 
ligated insert in transformed XL 1-blue non-expression host strain using LIC primers. 
Three of the four clones chosen have the correct size insert. (D): Sub cloning of ligated 
Pet Vector plasmid into BL-21 (DE3) (Novagen, USA) expression host. Again, colony 
screening was performed (lane 1 to 5). The clones with the correct size insert were 
subsequently sequenced from both ends to check for correct reading frame. Clone 3 and 4 
were selected for protein expression. Glycerol stocks were made from those clones that 






                            




Molecular cloning of bHSP70. (A) PCR amplification of target heat shock protein 70 
gene with gene specific primers using Expand long-template Taq DNA polymerase. 
Amplicons in Lane 1 and 2 corresponds to correct expected size of ~2000 bp. PCR 
amplicons from both lanes were extracted and purified using QIA quick Gel extraction 
Kit (Qiagen) and ligated to pGEMT-Easy vector followed by transformation into XL-1 
blue non-expression host. (B) Colony screening of PCR inserts in pGEMT vector 
using SP6 and T7 primers: All five colonies showed the presence of insert with 
expected size of ~2000 bp. (C) PCR amplification of target gene from pGEM-T 
plasmids with correct insert using designed LIC primer adaptors. Purified pGEM-T 
plasmid from clone 1 (Lane 2 of Fig B) was used. The PCR amplified band was gel 
extracted, and purified. The final digested DNA fragment was ligated into pET-32a (+) 
expression vector (Novagen, USA) using T4 DNA ligase (Invitrogen, USA) and 
transformed into XL1-Blue non-expression host cell. (D): Colony screening of pET32a 
ligated insert in transformed XL 1-blue non-expression host strain using LIC primers. 
Seven of the nine clones chosen have the correct size insert. (D): Sub cloning of ligated 
Pet Vector plasmid into BL-21 (DE3) (Novagen, USA) expression host. Again, colony 
screening was performed (lane 1 to 5). The clones with the correct size insert were 
subsequently sequenced from both ends to check for correct reading frame. Clone 5 and 6 
were selected for protein expression. Glycerol stocks were made from those clones that 









Molecular cloning of bHSP90. (A) PCR amplification of target heat shock protein 90 
gene with gene specific primers using Expand long-template Taq DNA polymerase. 
Amplicons in Lane 1 and 2 corresponds to correct expected size of ~2200 bp. PCR 
amplicons from both lanes were extracted and purified using QIA quick Gel extraction 
Kit (Qiagen) and ligated to pGEMT-Easy vector followed by transformation into XL-1 
blue non-expression host. (B) Colony screening of PCR inserts in pGEMT vector 
using SP6 and T7 primers: All five colonies showed the presence of insert with 
expected size of ~2000 bp. (C) PCR amplification of target gene from pGEM-T 
plasmids with correct insert using designed LIC primer adaptors. Purified pGEM-T 
plasmid from clone 1 (Lane 4 of Fig B) was used. The PCR amplified band was gel 
extracted, and purified. The final digested DNA fragment was ligated into pET-32a (+) 
expression vector (Novagen, USA) using T4 DNA ligase (Invitrogen, USA) and 
transformed into XL1-Blue non-expression host cell. (D): Colony screening of pET32a 
ligated insert in transformed XL 1-blue non-expression host strain using LIC primers. 
Four of the five clones chosen have the correct size insert. (D): Sub cloning of ligated 
Pet Vector plasmid into BL-21 (DE3) (Novagen, USA) expression host. Again, colony 
screening was performed (lane 1 to 5). The clones with the correct size insert were 
subsequently sequenced from both ends to check for correct reading frame. Clone 2 and 3 
were selected for protein expression. Glycerol stocks were made from those clones that 
were used for expression. 
 
 
 
